Qin ID,Effect     ,Reported     ,Exon     ,DNA change (cDNA)     ,RNA change     ,Protein     ,P-domain     ,Classification method     ,Clinical classification     ,DNA change (genomic) (hg19)     ,DNA change (hg38)     ,Published as     ,ISCN     ,DB-ID     ,Variant remarks     ,Reference     ,ClinVar ID     ,dbSNP ID     ,Origin     ,Segregation     ,Frequency     ,Re-site     ,VIP     ,Methylation     ,Owner     
1,"+/+, +/., +?/+, +?/., -/-, ?/.",1054,13,c.2299del,"r.(2299del), r.(?), r.2299delU","p.(Glu767Glyfs*21), p.(Glu767Serfs*21), p.(Glu767SerfsTer21), p.Glu767Serfs*21",Laminin EGF-like 5 (747-794),ACMG,"benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216420437del,g.216247095del,"1214delA (N405fs), 1:216420436TC>T ENST00000307340.3:c.2299delG (Glu767SerfsTer21), 2299delG, 85 more items",-,USH2A_000001,"ACMG GN005 criteria: PVS1_VS PS4_P PP1_S, ACMG PM2, PVS1, PP5, PS4, compound heterozygous, Homozygous, 25 more items","Liquori et al., accepted, Tranebjaerg 2011, PubMed: Dad 2016, Journal: Reurink 2021, PubMed: Abdi 2016, 117 more items","560516, SCV000065508, ClinVar-1058404, ClinVar-1945653, ClinVar-2351, ClinVar-560516",rs80338903,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes","0/160 controls, 0/190 controls, 0/192 controls, 0/256 controls, 1/143 cases, 1/258, 2/844 controls, 2 more items",none,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, Feng Wang, David Baux, Peter Krawitz, María González-del Pozo, Marta de Castro-Miró, Mieke Wesdorp, VKGL-NL_Leiden, VKGL-NL_Rotterdam, VKGL-NL_Groningen, VKGL-NL_Nijmegen, VKGL-NL_AMC, Barbara Vona, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Eva Lenassi, Shzeena Dad, Crystel Bonnet, Vladimir Strelnikov, Nereida Bravo Gil, Anna Tracewska, Janine Reurink, Rocio Villafuerte-de la Cruz"
2,"+/+, +/., +?/+, +?/., -/-, -?/., ?/+, ?/.",610,13,c.2276G>T,"r.(2276g>u), r.(?), r.2276g>u, r.2276U>T","p.(Cys759Phe), p.(Cys759Phe)$, p.Cys759Phe",Laminin EGF-like 5 (747-794),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item",g.216420460C>A,g.216247118C>A,"1:216420460C>A ENST00000307340.3:c.2276G>T (Cys759Phe), c.2276G/T (p.Cys759Phe) (homozygous), 92 more items",NM_206933.4:c.2276G>T,USH2A_000016,"ACMG GN005 criteria: PS4_S PP1_S PP3_P BS1_P, ACMG PP3, PM2, PM1_SUPPORTING, PP5_STRONG, PS4_MODERATE, 27 more items","0, Liquori et al., accepted, USMA missense analysis, missense variant in MSV3d, Journal: Reurink 2021, 94 more items","2356, ClinVar-1069487, ClinVar-128241, ClinVar-2356, ClinVar-5732, ClinVar-955307",rs80338902,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown, 1 more item","?, no, yes","0/200 controls, 1/143 cases, 1/380 controls, 1/899 cases, 2/200 controls, 7/899 cases",+MboII;-HpyCH4V,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, Feng Wang, David Baux, Marcel Nelen, María González-del Pozo, Marta de Castro-Miró, Sandro Banfi, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_VUmc, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, Nereida Bravo Gil, MobiDetails, Janine Reurink, Rocio Villafuerte-de la Cruz"
3,-/-,352,63,c.12612A>G,r.(?),p.(=),Fibronectin type-III 27 (4154-4258),-,benign,g.215848641T>C,-,-,-,USH2A_000028,7 more items,"PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 6 more items",-,rs2797235,Germline,-,-,-,-,-,"Anne-Françoise Roux, Jose Maria Millan"
4,"-/-, -/.",324,2,c.373G>A,r.(?),p.(Ala125Thr),-,-,benign,g.216595306C>T,g.216421964C>T,USH2A(NM_206933.4):c.373G>A (p.A125T),-,USH2A_000044,"Heterozygous, Heterozygous; Neutral, Heterozygous; non causative, Homozygous, Homozygous; Neutral, 2 more items","PubMed: Adato 2000, USMA missense analysis, missense variant in MSV3d, 11 more items",-,rs10779261,"CLASSIFICATION record, Germline",-,"312/1204 cases with retinitis pigmentosa, 850/1204 cases with retinitis pigmentosa",-HpyCH4V,-,-,"VKGL-NL_Groningen, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
5,"-/-, -/.",316,3,c.504A>G,r.(?),"p.(=), p.(Thr168=)",-,-,benign,g.216592003T>C,g.216418661T>C,USH2A(NM_206933.4):c.504A>G (p.T168=),-,USH2A_000043,"Heterozygous, Heterozygous; Neutral, Homozygous, Homozygous; Neutral, Homozygous; non causative, 1 more item","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 5 more items",-,rs4253963,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Groningen, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
6,"+/+, -/-",312,15i,c.3157+35G>A,"r.(=), r.(?)","p.(=), p.(?)",-,-,"benign, pathogenic",g.216390694C>T,g.216217352C>T,-,-,USH2A_000041,"Heterozygous, Homozygous","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jaijo 2010, 6 more items",-,rs1324330,Germline,-,-,-ApeKI;-BbvI;-Fnu4HI;-TseI;,-,-,"Anne-Françoise Roux, Jose Maria Millan"
7,-/-,298,18i,c.4082-66A>C,r.(=),p.(=),-,-,benign,g.216370130T>G,g.216196788T>G,-,-,USH2A_000040,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs386851,Germline,-,-,+EcoRI;-MseI;,-,-,"Anne-Françoise Roux, Jose Maria Millan"
8,"-/-, -/.",263,21,c.4457G>A,r.(?),p.(Arg1486Lys),-,-,benign,g.216348764C>T,-,-,-,USH2A_000039,7 more items,"PubMed: Adato 2000, USMA missense analysis, missense variant in MSV3d, 11 more items",-,rs1805049,Germline,-,"358/1204 cases with retinitis pigmentosa, 787/1204 cases with retinitis pigmentosa",-,-,-,"Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
9,"+/+, +/., +?/., -/-",256,61,c.11864G>A,"r.(11864g>a), r.(?)","p.(Trp3955*), p.(Trp3955Ter)",Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215901574C>T,g.215728232C>T,"1:215901574C>T ENST00000307340.3:c.11864G>A (Trp3955Ter), c.11864G>A, c.11864G>A,p.W3955X, 33 more items",-,USH2A_000159,"ACMG GN005 criteria: PVS1_VS PS4_S PP1_S, ACMG PM2, PVS1, PP5, BS2_SUPPORTING, PS4_MODERATE, 17 more items","Journal: Reurink 2021, PubMed: Baux 2014, PubMed: Baux, Vaché 2017, PubMed: Birtel 2018, 49 more items",2357,rs111033364,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes","0/188 controls, 1/2420 IRD families, 1/899 cases, 2/864 controls",+SfcI,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, Vladimir Strelnikov, Janine Reurink"
10,"-/-, -/.",243,52,c.10232A>C,r.(?),p.(Glu3411Ala),Fibronectin type-III 19 (3404-3494),-,benign,g.215960167T>G,g.215786825T>G,USH2A(NM_206933.4):c.10232A>C (p.E3411A),-,USH2A_000031,"Heterozygous, Heterozygous; Neutral, Heterozygous; non causative, Heterozygous; polymorphism, 4 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 11 more items",-,rs10864198,"CLASSIFICATION record, Germline",-,"464/1204 cases with retinitis pigmentosa, 544/1204 cases with retinitis pigmentosa",+DraIII,-,-,"VKGL-NL_Groningen, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
11,-/-,242,27i,c.5573-34del,r.(=),p.(=),-,-,benign,g.216246678del,g.216073336del,"5573-34delC, 5573-36delC",-,USH2A_000035,"Hemizygous, Heterozygous, Heterozygous; Neutral, Heterozygous; Presumed non-pathogenic, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 4 more items",-,rs71556647,Germline,-,7/130 controls,-MwoI,-,-,"Anne-Françoise Roux, Jose Maria Millan"
12,"+/+, +/., +/?, +?/.",239,13,c.2802T>G,r.(?),p.(Cys934Trp),Laminin EGF-like 8 (900-950),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.216246592A>C, g.216419934A>C","g.216246592A>C, g.72264997del","1:216419934A>C ENST00000307340.3:c.2802T>G (Cys934Trp), c.2802A>C, p.( Cys934Trp), 29 more items",-,USH2A_000742,"ACMG GN005 criteria: PS4_S PP1_S PP3_P, ACMG PM3_VS, PP3, BS1_P, alleles in cis or trans; heterozygous, 15 more items","0, PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 45 more items",-,rs201527662,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/2420 IRD families, 1/86 cases, 2/200 controls, 204, 23/1204 cases with retinitis pigmentosa, 3 more items",-HincII;-Hpy166II;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet, Yoshito Koyanagi, Jinu Han"
13,"+/+, -/-, -/.",232,34,c.6506T>C,r.(?),p.(Ile2169Thr),Fibronectin type-III 8 (2142-2236),-,benign,g.216172380A>G,g.215999038A>G,"USH2A(NM_206933.2):c.6506T>C (p.I2169T), USH2A(NM_206933.4):c.6506T>C (p.I2169T)",-,USH2A_000033,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, Homozygous; Neutral, 3 more items","PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, 13 more items",-,rs10864219,"CLASSIFICATION record, Germline",-,"241/1204 cases with retinitis pigmentosa, 942/1204 cases with retinitis pigmentosa",none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Groningen, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
14,"+/+, +/., +/?, +?/.",231,"41i, 42i, 55",c.8559-2A>G,"r.(8559_8681del), r.(?), r.8559_8681del, r.spl, r.spl?","p.(?), p.(Tyr2854_Arg2894del), p.?, p.Tyr2854_Arg2894del",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.215877882T>C, g.216051224T>C",g.215877882T>C,"c.8559-2A>G, c.8559-2T>C, p.?, M3: USH2A IVS42-2A>G, R2853G, USH2A c.8559-2A>G, -, 9 more items",-,USH2A_000003,"ACMG GN005 criteria: PVS1_VS PS4_S PM2_P PM3_VS PP1_S PP4_P, ACMG PM2, PVS1_STRONG, PP5_STRONG, 12 more items","0, PubMed: Chen 2014, PubMed: Chen 2020, PubMed: Chen 2020, PubMed: Dai 2008, PubMed: Dan 2020, 28 more items",48604,rs397518039,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/200 controls, 0/270 controls, 0/300 controls, 0/400 controls, 2/1204 cases with retinitis pigmentosa",-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Yoshito Koyanagi, Jinu Han, Janine Reurink"
15,"+/+, -/-",231,52i,c.10388-27T>C,"r.(=), r.(?)","p.(=), p.(?)",-,-,benign,g.215956304A>G,g.215782962A>G,-,-,USH2A_000030,"Heterozygous, Heterozygous; Neutral, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 4 more items",-,rs7518466,Germline,-,-,+MnlI,-,-,"Anne-Françoise Roux, Jose Maria Millan"
16,"-/-, ?/?",228,32,c.6317C>T,r.(?),p.(Thr2106Ile),Fibronectin type-III 7 (2052-2138),-,benign,g.216219781G>A,-,-,-,USH2A_000034,7 more items,"PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, 12 more items",-,rs6657250,Germline,-,-,-HpyCH4III,-,-,"Anne-Françoise Roux, Jose Maria Millan"
17,"-/-, -/.",196,63,c.12666A>G,r.(?),"p.(=), p.(Thr4222=)",Fibronectin type-III 27 (4154-4258),-,benign,g.215848587T>C,g.215675245T>C,-,-,USH2A_000047,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, Homozygous; Neutral, 3 more items","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jaijo 2010, 7 more items",-,rs2797234,"CLASSIFICATION record, Germline",-,-,+HpyCH4IV,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
18,"+/., +?/., -/-, -/., -?/., ?/.",171,22,c.4714C>T,r.(?),"-, p.(Leu1572Phe)",Laminin G-like 1 (1517-1709),ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216270469G>A,g.216097127G>A,"1:216270469G>A ENST00000307340.3:c.4714C>T (Leu1572Phe), c.4714C>T, c.4714C>T,p.L1572F, 20 more items",-,USH2A_000038,"ACMG GN005 criteria:, ACMG PP3, PM2, BP6_STRONG, Hemizygous, Heterozygous, Heterozygous; Neutral, 6 more items","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, PubMed: Birtel 2018, 27 more items",-,rs111033333,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-AcuI,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Groningen, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
19,"-/-, -/.",109,8,c.1419C>T,r.(?),"p.(=), p.(Thr473=)",Laminin N-terminal (271-517),-,benign,g.216496947G>A,g.216323605G>A,-,-,USH2A_000065,"Hemizygous, Heterozygous, Heterozygous; Neutral, Homozygous, Homozygous; Neutral, 1 more item","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jaijo 2010, 6 more items",-,rs1805050,"CLASSIFICATION record, Germline",-,240/864,none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
20,"+/+, +/., +?/., -/-, ?/.",107,"39i, 40i",c.7595-2144A>G,"r.(=), r.(?), r.7594_7595ins7595-2296_7595-2143, r.spl, r.spl?","p.(=), p.(?), p.(Lys2532Thrfs*56), p.(Lys2532ThrfsTer56), p.?, p.Lys2532Thrfs*56, p.Lys2532ThrfsTer56",Fibronectin type-III 12 (2533-2619),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216064540T>C,g.215891198T>C,"1:216064540T>C ENST00000307340.3:c.7595-2144A>G, c.7595-2144A>G, IVS40-2144A>G, 14 more items",-,"USH2A_000654, USH2A_001209","ACMG GN005 criteria: PS3_P PS4_S PM2_P PM3_VS PP1_M PP3_P, ACMG PM2, PP5_STRONG, BP7, PS4_MODERATE, 12 more items","Sharon, submitted, PubMed: Aparisi 2014, PubMed: Bahena 2021, PubMed: Baux 2007, PubMed: Baux 2014, 28 more items",-,rs786200928,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/180 controls, 0/190 controls, 1/2420 IRD families, 1/899 cases",+BsaJI;+StyI;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, Dror Sharon, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Barbara Vona, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Janine Reurink"
21,"-/-, -/.",106,25,c.4994T>C,r.(?),p.(Ile1665Thr),Laminin G-like 1 (1517-1709),-,benign,g.216258213A>G,g.216084871A>G,-,-,USH2A_000036,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Heterozygous; potential, Homozygous, 3 more items","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, 13 more items",-,rs56222536,"CLASSIFICATION record, Germline",-,"11.1% (150 controls), 2/1204 cases with retinitis pigmentosa, 48/1204 cases with retinitis pigmentosa",none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi"
22,"-/-, -/.",102,61,c.11946G>A,r.(?),"p.(=), p.(Leu3982=)",Fibronectin type-III 25 (3961-4062),-,benign,g.215901492C>T,g.215728150C>T,USH2A(NM_206933.2):c.11946G>A (p.L3982=),-,USH2A_000058,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, Homozygous; Neutral, 2 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 4 more items",-,rs2820718,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
23,"+/+, +/., +?/+, +?/., -/-, ?/.",101,6,c.920_923dup,"r.(920_923dup), r.(?)","p.(His308Glnfs*16), p.(His308GlnfsTer16), p.(His308Serfs*16)",Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.216498867_216498870dup, g.216498869_216498872dup, g.216498872_216498873insGCTG","g.216325525_216325528dup, g.216325527_216325530dup","917_918insCAGC, 920_923dupGCCA, c.917_918insCAGC, c.920-923dupGCCA, p.H308Qfs*16, c.920_923dupGCCA, 20 more items",-,USH2A_000019,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, compound heterozygous, heterozygous, Heterozygous; mutation, 9 more items","Journal: Reurink 2021, PubMed: Aller 2004, PubMed: Baux 2014, PubMed: Bonnet 2011, PubMed: Bonnet 2016, 40 more items",-,rs397518043,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes","0/256 controls, 1/899 cases","+CviKI_1;+Cac8I, ;none",-,-,"Global Variome, with Curator vacancy, David Baux, Peter Krawitz, Mieke Wesdorp, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Nereida Bravo Gil, Janine Reurink"
24,"-/-, -/.",96,60,c.11602A>G,r.(?),p.(Met3868Val),Fibronectin type-III 24 (3863-3960),-,benign,g.215914826T>C,g.215741484T>C,-,-,USH2A_000029,"Heterozygous, Heterozygous; Neutral, Heterozygous; non causative, Heterozygous; polymorphism, 4 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 10 more items",-,rs35309576,"CLASSIFICATION record, Germline",-,"315/1204 cases with retinitis pigmentosa, 34/1204 cases with retinitis pigmentosa",+BsrI;+BmrI;+TspRI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
25,-/-,93,17i,c.3812-8T>G,r.(=),p.(=),-,-,benign,g.216371934A>C,g.216198592A>C,chr1:g.216371934A>C-c.1258-8A>C in ENST00000307340,-,USH2A_000064,"Heterozygous, Heterozygous; Neutral, Heterozygous; non causative, Homozygous, Homozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Eudy 1998, 6 more items",-,rs646094,Germline,-,0/192 controls,+BsmAI;-Tsp509I;,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
26,"+/+, +/., +/?, +?/., ?/.",88,7,c.1256G>T,"r.(1256g>u), r.(?)",p.(Cys419Phe),Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216497582C>A,g.216324240C>A,"1:216497582C>A ENST00000307340.3:c.1256G>T (Cys419Phe), 2029C>T (Cys419Phe), c.1256G>T, 6 more items",-,USH2A_000154,"ACMG GN005 criteria: PS4_S PP1_P, Heterozygous, Heterozygous; causative, Heterozygous; Pathogenic, 5 more items","Journal: Reurink 2021, PubMed: Austin-Tse 2018, PubMed: Booij-2011, PubMed: Carss 2017, 27 more items",SCV000065420,rs121912600,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/190 controls, 0/380 controls, 0/878 controls",+ApoI,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, Janine Reurink"
27,"-/-, -/.",88,63,c.13191G>A,r.(?),"p.(=), p.(Glu4397=)",Fibronectin type-III 29 (4356-4439),-,benign,g.215848062C>T,g.215674720C>T,-,-,USH2A_000027,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, Homozygous; Neutral, 2 more items","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jaijo 2010, 6 more items",-,rs2009923,"CLASSIFICATION record, Germline",-,-,+TfiI;-BsmFI;-MlyI;-PleI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
28,"-/-, -/.",82,59,c.11504C>T,r.(?),p.(Thr3835Ile),Fibronectin type-III 23 (3768-3862),-,benign,g.215916563G>A,g.215743221G>A,-,-,USH2A_000094,"Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; non causative, Homozygous, 3 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 9 more items",-,rs11120616,"CLASSIFICATION record, Germline",-,"311/1204 cases with retinitis pigmentosa, 34/1204 cases with retinitis pigmentosa",+TfiI;-PleI;-MlyI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
29,-/-,77,42i,c.8559-65T>C,r.(=),p.(=),-,-,benign,g.216051287A>G,g.215877945A>G,-,-,USH2A_000073,"Heterozygous, Heterozygous; Neutral, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010, PubMed: Le Quesne Stabej 2012, 1 more item",-,rs7518358,Germline,-,-,+AvaI;+BsoBI;+BslI;-BspCNI;-DdeI;,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
30,"-/-, -/.",72,36i,c.6957+19A>G,r.(=),p.(=),-,-,benign,g.216143948T>C,g.215970606T>C,-,-,USH2A_000048,"Heterozygous, Heterozygous; Neutral, Homozygous, Homozygous; Neutral, 1 more item","PubMed: Aller 2004, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, 4 more items",-,rs6689120,"CLASSIFICATION record, Germline",-,82/872 controls,+HpyCH4IV,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
31,"+/., +?/., +?/?, ?/.",71,57,c.11156G>A,"r.(?), r.11156U>A","p.(Arg3719His), p.(Pro5107Ser), p.Arg3719His",Fibronectin type-III 22 (3677-3767),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.215759735C>T, g.215802356G>A, g.215933077C>T","g.215629014G>A, g.215759735C>T","1:215933077C>T ENST00000307340.3:c.11156G>A (Arg3719His), c.11156C>T, p.(Arg3719His), 14 more items",-,USH2A_000433,"ACMG GN005 criteria: PM2_P PM3_VS PP1_S, ACMG PM2_P, PM3_S, PP4, heterozygous, Heterozygous; mutation, 8 more items","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Bravo-Gil 2017, 32 more items",-,rs527236139,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/300 controls, 1/1204 cases with retinitis pigmentosa, 1/143 cases, 175, 1 more item",-,-,-,"Johan den Dunnen, David Baux, María González-del Pozo, VKGL-NL_Nijmegen, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet, Nereida Bravo Gil, Yoshito Koyanagi, So Young Kim"
32,"+/., +?/., -/., -?/., -?/?, ?/.",71,63,c.12575G>A,"r.(12575g>a), r.(?)",p.(Arg4192His),Fibronectin type-III 27 (4154-4258),ACMG,"benign, likely benign, likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215848678C>T,g.215675336C>T,"1:215848678C>T ENST00000307340.3:c.12575G>A (Arg4192His), c.12575, C.12575G>A, c.G12575A, 12 more items",-,"USH2A_000438, USH2A_001126","ACMG GN005 criteria: BS2_S BP4_P, ACMG PM2, PP5_STRONG, PS4_MODERATE, compound heterozygous, 12 more items","Sharon, submitted, Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Avila Fernandez 2010, 34 more items","166434, ClinVar-1028115, ClinVar-281325",rs199605265,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/100 controls, 0/878 controls, 1/143 cases, 20/2420 IRD families",-BcgI,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Dror Sharon, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Nereida Bravo Gil, Janine Reurink, Rocio Villafuerte-de la Cruz"
33,"+/+, -/-",70,18i,c.4082-44G>A,"r.(=), r.(?)","p.(=), p.(?)",-,-,benign,g.216370108C>T,g.216196766C>T,-,-,USH2A_000063,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs447102,Germline,-,-,none,-,-,"Anne-Françoise Roux, Jose Maria Millan"
34,-/-,70,21i,c.4628-63C>T,r.(=),p.(=),-,-,benign,g.216270618G>A,g.216097276G>A,-,-,USH2A_000037,"Heterozygous, Heterozygous; Neutral, Homozygous, Homozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010, PubMed: Le Quesne Stabej 2012, 1 more item",-,rs7540411,Germline,-,-,-CviQI;-BsrGI;-RsaI;,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
35,"+/., +?/+?, +?/., +?/?",70,54,c.10712C>T,"r.(10712c>u), r.(?)",p.(Thr3571Met),"Fibronectin type-III 20 (3499-3585), Fibronectin type-III 20 (3501 - 3589)",ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215955412G>A,g.215782070G>A,"c.10712C>T, p.T3571M, USH2A c.10712C>T, p.Thr3571Met, USH2A c.10712C>T, p.(Thr3571Met), 7 more items",-,USH2A_000115,"1 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PM2_P PM3_VS, heterozygous, 7 more items","Journal: Reurink 2021, PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, 31 more items",ClinVar-48355,rs202175091,"Germline, SUMMARY record, Unknown","?, yes","0/270 controls, 0/306 controls, 1/2795 individuals",+FatI;+NlaIII;+CviAI;-HpyCH4III;,-,-,"Global Variome, with Curator vacancy, David Baux, Sandro Banfi, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet, Nereida Bravo Gil, Mohammed Faruq, Janine Reurink"
36,"-/-, -/.",66,11,c.1931A>T,r.(?),p.(Asp644Val),Laminin EGF-like 3 (641-693),-,benign,g.216462662T>A,g.216289320T>A,-,-,USH2A_000042,"Heterozygous, Heterozygous; Neutral, Homozygous, VKGL data sharing initiative Nederland","PubMed: Adato 2000, USMA missense analysis, missense variant in MSV3d, 9 more items",-,rs1805048,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
37,"+/+, +/., +/?, +?/., +?/?, ?/.",66,51,c.10073G>A,r.(?),p.(Cys3358Tyr),Cystein rich (3192-3358),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215963510C>T,g.215790168C>T,"1:215963510C>T ENST00000307340.3:c.10073G>A (Cys3358Tyr), c.10073G>A, USH2A c.10073G>A, 13 more items",-,USH2A_000131,"ACMG GN005 criteria: PS4_S PP1_M, compound heterozygous, Heterozygous, Heterozygous; Pathogenic, 9 more items","PubMed: Avila Fernandez 2010, PubMed: Carss 2017, PubMed: Charng 2020, PubMed: Colombo-2020, 22 more items",-,rs148660051,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/878 controls, 1/2420 IRD families",+HpyCH4III,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Eva Lenassi"
38,-/-,66,59i,c.11548+98G>A,r.(=),p.(=),-,-,benign,g.215916421C>T,g.215743079C>T,-,-,USH2A_000059,"Hemizygous, Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs2797223,Germline,-,-,none,-,-,"Anne-Françoise Roux, Jose Maria Millan"
39,"-/-, -/.",65,25,c.5013C>A,r.(?),"p.(=), p.(Gly1671=)",Laminin G-like 1 (1517-1709),-,benign,g.216258194G>T,g.216084852G>T,-,-,USH2A_000082,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, Homozygous; polymorphism, 1 more item","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jaijo 2010, 5 more items",-,rs56110889,"CLASSIFICATION record, Germline",-,-,+BtsCI;+FokI;+CviKI_1;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
40,"+/., +/?, +?/.",60,50,c.9799T>C,"r.(?), r.9799T>C","p.(Cys3267Arg), p.Cys3267Arg",Cystein rich (3192-3358),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215972408A>G,g.215799066A>G,"c.9799T>C, c.9799T>C:p.C3267R, c.T9799C, M14: c.9799T > C; p.Cys3267Arg, p.C3267R, 6 more items",-,USH2A_000176,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, compound heterozygous, Heterozygous, Heterozygous; mutation, 4 more items","Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Avila Fernandez 2010, PubMed: Numa-2020, 25 more items",ClinVar-48634,rs111033263,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/96 controls, 1/1204 cases with retinitis pigmentosa",+FauI;+MspA1I;+AciI;,-,-,"Global Variome, with Curator vacancy, David Baux, María González-del Pozo, Marta de Castro-Miró, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Yoshito Koyanagi, Rocio Villafuerte-de la Cruz"
41,"+/+, +/., +?/.",58,11,c.1876C>T,r.(?),"p.(Arg626*), p.(Arg626Ter)",Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216462717G>A,g.216289375G>A,"c.1876C>T, c.1876C>T p.(Arg626*), c.2299delG p.(Glu767Serfs*21), c.1876C>T, p.Arg626Ter, 6 more items",-,USH2A_000010,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, Heterozygous, Heterozygous; Disease causing, Homozygous, 7 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Dreyer 2000, 26 more items",-,rs534534437,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/190 controls, 0/256 controls, 0/878 controls",-MmeI,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet"
42,-/-,56,51i,c.10182+27C>T,r.(=),p.(=),-,-,benign,g.215963374G>A,g.215790032G>A,-,-,USH2A_000060,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 1 more item",-,rs11120629,Germline,-,-,-HinP1I;-HaeII;-HhaI;,-,-,"Anne-Françoise Roux, Jose Maria Millan"
43,"+/., +?/., +?/?",54,4,c.653T>A,"r.(653u>a), r.(?), r.653u>a","p.(Val218Glu), p.Val218Glu",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216538426A>T,g.216365084A>T,"1:216538426A>T ENST00000307340.3:c.653T>A (Val218Glu), USH2A c.653T>A, p.(Val218Glu), 9 more items",-,USH2A_000067,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, ACMG PM2, PP5_STRONG, Heterozygous, Heterozygous; mutation, 5 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 17 more items",48564,rs397518026,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/100 controls, 0/200 controls, 0/306 controls",-HpyCH4V,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, MobiDetails, Janine Reurink"
44,-/-,53,03i,c.652-80T>C,r.(=),p.(=),-,-,benign,g.216538507A>G,g.216365165A>G,-,-,USH2A_000121,"Heterozygous, Heterozygous; Neutral, Homozygous, Homozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010, PubMed: Le Quesne Stabej 2012, 2 more items",-,rs45594833,Germline,-,-,+MseI,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
45,"+/+, +/., +/?, +?/.",49,6,c.949C>A,"r.(949c>a,951_1143del), r.(=), r.(?), r.spl, r.spl?, r.[(949c>a, 951_1143del)], 2 more items","p.(=), p.(=,Tyr318Cysfs*17), p.(=,Tyr318CysfsTer17), p.(Arg317=), p.([(=,Tyr318CysfsTer17)]), p.?, 3 more items",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216498841G>T,g.216325499G>T,"c.949C>A, USH2A c.949C>A, p.(Arg317=), USH2A c.949C>A, p.[=,Tyr318Cysfs*17], 5 more items",-,USH2A_000155,"ACMG GN005 criteria: PS4_P PM2_P PM3_VS PP3_P PP1_P, compound heterozygous, heterozygous, 5 more items","Tranebjaerg 2011, PubMed: Dad 2016, Journal: Reurink 2021, PubMed: Austin-Tse 2018, PubMed: Baux 2014, 22 more items",SCV000065652,rs111033272,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes","0/114 controls, 0/306 controls, 0/368 controls, 1/899 cases",+MnlI;-AciI;-MspA1I;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Sandro Banfi, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
46,"-/-, -/.",49,47,c.9343A>G,r.(?),p.(Thr3115Ala),Fibronectin type-III 18 (3110-3200),-,benign,g.216011361T>C,g.215838019T>C,-,-,USH2A_000068,"Hemizygous, Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; non causative, 3 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 8 more items",-,rs56032526,"CLASSIFICATION record, Germline",-,"21/1204 cases with retinitis pigmentosa, 277/1204 cases with retinitis pigmentosa",none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi"
47,"+/+, +/., +?/., ?/.",49,"61i, 62",c.12067-2A>G,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215853720T>C,g.215680378T>C,"c.12067-2A>G, M22: c.12067-2A > G; r.spl, USH2A c.12067-2A>G, USH2A c.12067-2A>G, p.(?), 1 more item",-,"USH2A_000134, USH2A_001332","ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_P, heterozygous, Heterozygous; mutation, Homozygous, 5 more items","Sharon, submitted, Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Aparisi 2014, 20 more items","ClinVar-2355, ClinVar-29874, ClinVar-48390","rs121912599, rs397517978","CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/54 controls, 1/2420 IRD families, 16/2420 IRD families, 7/2420 IRD families",none,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, María González-del Pozo, Dror Sharon, VKGL-NL_Nijmegen, Barbara Vona, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet, Janine Reurink, Rocio Villafuerte-de la Cruz"
48,"+/., +?/., +?/?, ?/.",49,70,c.15178T>C,r.(?),p.(Ser5060Pro),Transmembrane (5043-5063),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215807920A>G,g.215634578A>G,"c.15178A>G, p.(Ser5060Pro), c.15178T>C, T15178C, USH2A c.15178T>C, p.Ser5060pro, 6 more items",-,USH2A_000890,"ACMG GN005 criteria: PM2_P PM3_S PP1_P, alleles in trans; heterozygous, compound heterozygous, 6 more items","PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Jauregui 2020, PubMed: Katagiri 2014, 11 more items",-,rs752377040,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","2/1204 cases with retinitis pigmentosa, 1 more item",-,-,-,"David Baux, VKGL-NL_Nijmegen, Eva Lenassi, Yoshito Koyanagi"
49,"+/+, +/., +?/., -?/., ?/.",48,6,c.1000C>T,"r.(1000c>t), r.(?), r.1000c>t","p.(Arg334Trp), p.Arg334Trp",Laminin N-terminal (271-517),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item",g.216498790G>A,g.216325448G>A,"c.1000C>T, c.1000C>T (R334W), USH2A c.1000C>T, p.Arg334Trp, USH2A c.1000C>T, 3 more items",-,"USH2A_000025, USH2A_001447","ACMG GN005 criteria: PM2_P PM3_S PP1_S, compound heterozygous, Heterozygous, Heterozygous; mutation, 5 more items","Sharon, submitted, Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Bravo-Gil 2016, 24 more items",ClinVar-228411,rs397517963,"Germline, SUMMARY record, Unknown","?, yes","0/1176 controls, 0/256 controls, 1/2420 IRD families, 2/456 controls, 3/2420 IRD families",-,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, Dror Sharon, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet, Rocio Villafuerte-de la Cruz"
50,"+/+, +/., +?/., +?/?",47,6,c.1036A>C,r.(?),p.(Asn346His),Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216498754T>G,g.216325412T>G,"c.1036A>C, p.Asn346His:c.1036A/C, p.Ser1369Leu:c.4106C/T(alleles in trans), p.N346H, 2 more items",-,USH2A_000022,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, ACMG PP3, PM2, PP5_STRONG, Heterozygous, 7 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Booij-2011, 22 more items",48347,rs369522997,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/150 controls, 0/256 controls, 0/878 controls, 5/899 cases",+FatI;+MslI;+CviAII;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet"
51,"+/+, +/., +?/., +?/?, ?/.",47,"63, 68",c.13010C>T,"r.(13010c>u), r.(?)",p.(Thr4337Met),Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215848243G>A,g.215674901G>A,"c.13010C>T, c.13010C>T, p.Thr4337Met, c.13010C>T:p.T4337M, USH2A c.13010C>T, p.Thr4337Met, 7 more items",-,USH2A_000194,"ACMG GN005 criteria: PM2_P PM3_VS PP1_P, ACMG PM2, PP5_STRONG, compound heterozygous, heterozygous, 6 more items","Journal: Reurink 2021, PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, 27 more items",143172,rs527236137,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no, yes","0/130 controls, 4/1204 cases with retinitis pigmentosa",-,-,-,"Johan den Dunnen, David Baux, Marta de Castro-Miró, VKGL-NL_Rotterdam, Anne-Françoise Roux, Jose Maria Millan, Eva Lenassi, Crystel Bonnet, Yoshito Koyanagi, Janine Reurink"
52,"+/+, +/., +?/.",45,2,c.99_100insT,r.(?),"p.(Arg34Serfs), p.(Arg34Serfs*41), p.(Arg34SerfsTer41)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)","g.216422237_216422238insA, g.216595579_216595580insA",g.216422237_216422238insA,"c.99_100insT, c.99_100insT, p.(R34Sfs41), c.99_100insT, p.Ser33Serfs42, 11 more items",-,USH2A_000889,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_S, compound heterozygous, heterozygous, homozygous, 4 more items","PubMed: Chen 2020, PubMed: Fu 2020, PubMed: Fu-2013, PubMed: Gao 2019, PubMed: Gao 2021, 11 more items",-,rs141672841,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",129,-,-,-,"David Baux, Eva Lenassi"
53,"+/+, +/., +?/+, +?/.",44,9,c.1606T>C,r.(?),p.(Cys536Arg),Laminin EGF-like 1 (518-574),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216495263A>G,g.216321921A>G,"c.1606T>C, c.1606T>C, p.Cys536Arg, USH2A c.1606T>C, p.(Cys536Arg), c.9056-2A>G, p.(?), 1 more item",-,USH2A_000020,"ACMG GN005 criteria: PM2_P PM3_VS PP1_P PP3_P, Heterozygous, Heterozygous; Mutation, 4 more items","Tranebjaerg 2011, PubMed: Dad 2016, Villafuerte-de la Cruz RA, et al., 2023. Submitted, 22 more items",ClinVar-48471,rs111033273,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/306 controls, 0/878 controls",+HgaI;+BsaHI;-SfaNI;-MslI;,-,-,"David Baux, Mieke Wesdorp, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Rocio Villafuerte-de la Cruz"
54,"-/-, -/.",44,43,c.8656C>T,r.(?),p.(Leu2886Phe),Fibronectin type-III 15 (2821-2920),-,benign,g.216051125G>A,g.215877783G>A,-,-,USH2A_000070,"Heterozygous, Heterozygous; benign, Heterozygous; likely polymorphism, Heterozygous; Neutral, 4 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 9 more items",-,rs41277200,"CLASSIFICATION record, Germline",-,"15/1204 cases with retinitis pigmentosa, 260/1204 cases with retinitis pigmentosa, 53/840 controls",-CviKI_1,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi"
55,"+/+, +/., +?/.",43,10i,c.1841-2A>G,"r.(1841_1971del), r.(?), r.1841_1971del, r.spl, r.spl?","p.(?), p.(Gly614Aspfs*6), p.(Gly614AspfsTer6), p.?, p.Gly614Aspfs*6",Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216462754T>C,g.216289412T>C,"c.1841-2A>G, IVS10-2A>G, USH2A c.1841-2A>G, USH2A c.1841-2A>G, p.(?), 2 more items",-,USH2A_000183,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_P, heterozygous, Heterozygous; damaging, Homozygous, 8 more items","PubMed: Baux 2014, PubMed: Bernal 2003, PubMed: Bonnet 2016, PubMed: Bravo-Gil 2017, PubMed: Sodi 2014, 17 more items",-,rs397518003,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/100 controls, 0/878 controls, 1/143 cases",+FauI;+AciI;-EcoNI;-HpyCH4V;,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Nereida Bravo Gil, Janine Reurink"
56,"+/., +?/., +?/?",42,5,c.802G>A,"r.(802g>a), r.(?), r.802g>a","p.(Gly268Arg), p.Gly268Arg",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.216500979C>T, g.64472506C>T","g.216327637C>T, g.63762613C>T","c.802G>A, c.802G>A, p.Gly268Arg, p.G268R, USH2A c.802G>A, p.Gly268Arg, USH2A p.(Gly268Arg), 7 more items",-,"USH2A_000267, USH2A_001448","3 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PM2_P PM3_VS PP1_S PP3_P, 7 more items","0, Sharon, submitted, PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 22 more items",-,rs111033280,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/200 controls, 0/96 controls, 1/1204 cases with retinitis pigmentosa, 3/2420 IRD families, 1 more item",-MmeI,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet, Yoshito Koyanagi, Mohammed Faruq, MobiDetails"
57,"+/., +?/., -?/., ?/.",41,"2, 21i_49i, 22i_32i, 27i_30i, 30i_35i",c.?,"r.(?), r.0?, r.?","p.(?), p.(C3425Ffs*4), p.(Phe12Serfs*9), p.0?, p.?, p?",-,ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item","g.215836170_215851932del, g.215958623_215961591del, g.216009683_216011948del, g.216240159_222780953del, 2 more items",g.?,"(Lys1501Arg), 10272_10273dupA, c.11381+1delG, c.1340A>, ;chr1:g.215836170_215851932del, del ex10-11, 28 more items",-,"NPHS2_000000, USH2A_000000","heterozygous, no protein annotation written; heterozygous, unknown variant 2nd chromosome, 2 more items","PubMed: Bhatia 2019, PubMed: Bravo-Gil 2016, PubMed: Carrigan 2016, PubMed: Charng 2020, 11 more items",-,-,"Germline, Germline/De novo (untested)","?, no, yes",-,-,-,-,"Global Variome, with Curator vacancy"
58,"+/., +?/., -/-, -/., ?/.",40,8,c.1434G>C,r.(?),p.(Glu478Asp),Laminin N-terminal (271-517),ACMG,"benign, likely pathogenic, pathogenic (recessive), VUS",g.216496932C>G,g.216323590C>G,"c.1434G>C, USH2A(NM_206933.2):c.1434G>C (p.E478D)",-,USH2A_000222,"ACMG GN005 criteria: BA1 BS2_S BP4_P, Heterozygous, Heterozygous; mutation, Heterozygous; Neutral, 7 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Booij-2011, 15 more items",-,rs35730265,"CLASSIFICATION record, Germline, SUMMARY record",yes,"0.5% (150 controls), 1/1204 cases with retinitis pigmentosa, 14/854 controls, 9/899 cases",none,-,-,"Global Variome, with Curator vacancy, David Baux, Marta de Castro-Miró, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi"
59,"+/., +?/., +?/?, ?/.",40,50,c.9958G>T,"r.(?), r.[9958g>u,9898_9958del,9740_9958del]","p.(Gly3320Cys), p.[Gly3320Cys,Ser3301Cysfs*9,Glu3248_Gly3320del]",Cystein rich (3192-3358),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215972249C>A,g.215798907C>A,"1:215972249C>A ENST00000307340.3:c.9958G>T (Gly3320Cys), c.9958G>T, 6 more items",-,USH2A_000877,"ACMG GN005 criteria: PM2_P PM3_P PP1_M PP3_P, heterozygous, Heterozygous; mutation, 3 more items","PubMed: Carss 2017, PubMed: Chen 2014, USMA missense analysis, missense variant in MSV3d, 13 more items",-,rs1285853856,"Germline, Germline/De novo (untested), In vitro (cloned), SUMMARY record, Unknown","?, yes","0/300 controls, 129",-,-,-,"David Baux, Anne-Françoise Roux, Janine Reurink"
60,"+/., +?/., +?/?",40,53,c.10561T>C,"r.(10561u>c), r.(?)",p.(Trp3521Arg),Fibronectin type-III 20 (3499-3585),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215956104A>G,g.215782762A>G,"1:215956104A>G ENST00000307340.3:c.10561T>C (Trp3521Arg), c.10561T>C, USH2A c.10561T>C, 7 more items",-,USH2A_000429,"ACMG GN005 criteria: PS4_S PM2_P PM3_VS, ACMG PM2, PP5_STRONG, PS4_MODERATE, heterozygous, 10 more items","Journal: Reurink 2021, PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 22 more items",48352,rs111033264,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes",0/878 controls,+BsaWI;+HpaII;-BsrI;-BpmI;,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet, Janine Reurink"
61,-/-,39,07i,c.1328+37_1328+40del,r.(=),p.(=),-,-,benign,g.216497472_216497475del,g.216324130_216324133del,"1328+35delTGAT, 1328+36_1328+39delGATT",-,USH2A_000141,"Heterozygous, Heterozygous; Neutral, Heterozygous; potential, Homozygous; Neutral","PubMed: Adato 2000, PubMed: Bernal 2003, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 4 more items",-,-,Germline,-,1.6% (150 controls),+BsrI,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
62,"-/-, -/.",39,58i,c.11389+9A>T,r.(=),p.(=),-,-,benign,g.215931928T>A,g.215758586T>A,-,-,USH2A_000084,"Heterozygous, Homozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 1 more item",-,rs12095085,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
63,"+/+, +/., +?/.",38,20,c.4338_4339del,r.(?),"p.(Cys1447Glnfs*29), p.(Cys1447GlnfsTer29)",Fibronectin type-III 4 (1367-1462),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.216363622_216363623del, g.216363626_216363627del",g.216190284_216190285del,"4338delCT, 4338_4339delCT, p.C759F:c.2276G/T, c.4338_4339het_delCT(alleles in trans)",-,USH2A_000007,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Homozygous","PubMed: Ebermann 2009, PubMed: Ebermann 2010, PubMed: Eudy 1998, PubMed: Hariri 2018, 7 more items",-,rs111033367,"Germline, SUMMARY record",?,"0/190 controls, 0/192 controls, 0/207 controls",none,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
64,"-/-, -/.",38,36,c.6875G>A,r.(?),p.(Arg2292His),Fibronectin type-III 9 (2241-2325),-,benign,g.216144049C>T,g.215970707C>T,-,-,USH2A_000054,"69 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; benign, Homozygous, 2 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 8 more items",-,rs41277210,"CLASSIFICATION record, Germline",-,"21/872 controls, 69/2779 individuals",+CviAII;+NlaIII;+FatI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
65,"-/-, -/.",38,47,c.9296A>G,r.(?),p.(Asn3099Ser),Fibronectin type-III 17 (3020-3105),-,benign,g.216011408T>C,g.215838066T>C,USH2A(NM_206933.2):c.9296A>G (p.N3099S),-,USH2A_000087,"13 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, Homozygous, 3 more items","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, 10 more items",-,rs41277194,"CLASSIFICATION record, Germline",-,"13/2795 individuals, 4.5% (150 controls)",+TspRI;+BtsI;-BsrDI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
66,"-/-, -/.",38,49,c.9595A>G,r.(?),p.(Asn3199Asp),Cystein rich (3192-3358),-,benign,g.215987222T>C,g.215813880T>C,-,-,USH2A_000072,"Hemizygous, Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; non causative, 3 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 8 more items",-,rs4129843,"CLASSIFICATION record, Germline",-,"21/1204 cases with retinitis pigmentosa, 277/1204 cases with retinitis pigmentosa",none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi"
67,"+/., +?/., +?/?, ?/.",37,42,c.8284C>G,r.(?),p.(Pro2762Ala),Fibronectin type-III 14 (2724-2812),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216052380G>C,g.215879038G>C,"1:216052380G>C ENST00000307340.3:c.8284C>G (Pro2762Ala), c.8284C>G, 5 more items",-,USH2A_000876,"ACMG GN005 criteria: PM2_P PM3_M PP1_M, heterozygous, Homozygous; mutation","PubMed: Carss 2017, PubMed: Chen 2014, USMA missense analysis, missense variant in MSV3d, 9 more items",-,rs1188281491,"Germline, SUMMARY record, Unknown","?, yes","0/300 controls, 1/314 case chromosomes",-,-,-,"David Baux, Anne-Françoise Roux"
68,-/-,36,41i,c.8224-109T>C,r.(=),p.(=),-,-,benign,g.216052549A>G,g.215879207A>G,-,-,USH2A_000562,"Heterozygous; Not Assessed, Homozygous; Not Assessed",PubMed: Le Quesne Stabej 2012,-,-,Germline,-,-,+DdeI,-,-,Maria Bitner-Glindzicz
69,"+/+, +/., +?/., +?/?, ?/.",36,42,c.8232G>C,r.(?),p.(Trp2744Cys),Fibronectin type-III 14 (2724-2812),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.215879090C>G, g.216052432C>G",g.215879090C>G,"c.8232G>C, USH2A c.8232G>C, p.Trp2744Cys, USH2A c.8232G > C, p.Trp2744Cys, heterozygous, 3 more items",-,USH2A_000743,"ACMG GN005 criteria: PM2_P PM3_VS, ACMG PM2_P, PM3, heterozygous, Heterozygous; Disease causing, 3 more items","PubMed: Gao 2021, PubMed: Huang 2018, PubMed: Kim 2022, Journal: Kim 2022, PubMed: Liu-2020, 8 more items",-,rs1424639717,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",0/200 controls,+HpyCH4V,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
70,"+/., +?/., +?/?, -/-, ?/.",36,63,c.13274C>T,"r.(13274c>u), r.(?)",p.(Thr4425Met),Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215847979G>A,g.215674637G>A,"1:215847979G>A ENST00000307340.3:c.13274C>T (Thr4425Met), c.13274C>T, USH2A c.13274C>T, 6 more items",-,"USH2A_000049, USH2A_001147","1 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PM2_P PM3_M S, heterozygous, 7 more items","Sharon, submitted, Journal: Reurink 2021, PubMed: Booij-2011, PubMed: Carss 2017, PubMed: Gao 2021, 14 more items",-,rs201238640,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no","0/188 controls, 1/2795 individuals",+FatI;+NlaIII;+CviAII;-BsgI;,-,-,"David Baux, Dror Sharon, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, Mohammed Faruq, MobiDetails, Janine Reurink"
71,"+/+, +/., +?/., ?/.",35,13,c.2209C>T,r.(?),"p.(Arg737*), p.(Arg737Ter)",Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, pathogenic, VUS",g.216420527G>A,g.216247185G>A,"c.2209C>T, USH2A c.2209C>T, p.R737*, USH2A:NM_206933 c.C2209T, p.R737X, 1 more item",-,USH2A_000136,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, Heterozygous, Heterozygous; Mutation, 2 more items","Sharon, submitted, PubMed: Auslender 2008, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Huang 2015, 13 more items",-,rs111033334,"Germline, SUMMARY record, Unknown","?, yes","0/230 controls, 1/2420 IRD families, 4/2420 IRD families",+AcuI,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, Marta de Castro-Miró, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet"
72,"+/+, +/., +?/+, +?/.",34,28i,c.5776+1G>A,"r.(?), r.spl, r.spl?","p.(?), p.(Gly1858_Thr1925del), p.?",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216246438C>T,g.216073096C>T,"c.5776+1G>A, USH2A c.5776+1G>A, USH2A c.5776+1G>A, p.(?), 5 more items",-,"USH2A_000175, USH2A_001442","ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_M, compound heterozygous, Hemizygous, Heterozygous, 7 more items","Sharon, submitted, PubMed: Baux 2014, PubMed: Bonnet 2011, PubMed: Bonnet 2016, PubMed: Colombo-2020, 19 more items",-,rs876657731,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","3/2420 IRD families, 5/2420 IRD families",-EcoNI;-BslI;,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Eva Lenassi, Crystel Bonnet, Omamah Jiman"
73,"+/., +?/., +?/?",34,42,c.8254G>A,r.(?),p.(Gly2752Arg),Fibronectin type-III 14 (2724-2812),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS","g.215879068C>T, g.216052410C>T, g.64436439C>G","g.215879068C>T, g.63726546C>G","c.8254G>A, c.8254G>A:p.G2752R, c.G8254A, USH2A c.8254G > A, p.Gly2752Arg, heterozygous, 7 more items",-,USH2A_000150,"ACMG GN005 criteria: PM2_P PM3_VS, compound heterozygous, Heterozygous, homozygous, 6 more items","PubMed: Bonnet 2011, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 17 more items",-,rs201863550,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/270 controls, 0/306 controls, 12/1204 cases with retinitis pigmentosa, 1 more item",none,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Eva Lenassi, Yoshito Koyanagi, Jinu Han"
74,"+/., +?/., +?/?",34,63,c.12574C>T,"r.(12574c>u), r.(?), r.1257C>T","p.(Arg4192Cys), p.Arg4192Cys",Fibronectin type-III 27 (4154-4258),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215848679G>A,g.215675337G>A,"12574G>A, 1:215848679G>A ENST00000307340.3:c.12574C>T (Arg4192Cys), c.12574C.T, c.12574C>T, 6 more items",-,USH2A_000715,"ACMG GN005 criteria: PS4_S PM2_P PM3_S PP1_P, ACMG PS1, PM2, PM5, PS4_MODERATE, Heterozygous, 7 more items","PubMed: Bernardis 2016, PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Colombo-2020, 20 more items",281818,rs750396156,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/200 controls, 0/92 controls",+HpyCH4V;-HinfI;-TfiI;-XmnI;,-,-,"Johan den Dunnen, David Baux, María González-del Pozo, Marta de Castro-Miró, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
75,"+/+, +/., +?/., +?/?, -/-, ?/.",34,63,c.13316C>T,r.(?),p.(Thr4439Ile),Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215847937G>A,g.215674595G>A,"1:215847937G>A ENST00000307340.3:c.13316C>T (Thr4439Ile), p.T4439I, USH2A c.13316C>T, 3 more items",-,USH2A_000385,"ACMG GN005 criteria: PM2_P PM3_VS, Heterozygous, Heterozygous; mutation, Heterozygous; Pathogenic, 6 more items","Tranebjaerg 2011, PubMed: Dad 2016, PubMed: Carss 2017, PubMed: Charng 2020, PubMed: Haer-Wigman 2017, 16 more items",-,rs753330544,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/463 controls, 0/878 controls",none,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet"
76,"+/., +/?, +?/., ?/.",34,63,c.13335_13347delinsCTTG,r.(?),p.(Glu4445_Ser4449delinsAspLeu),Fibronectin type-III 30 (4444-4528),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215847906_215847918delinsCAAG,g.215674564_215674576delinsCAAG,"13335_13347del13ins4, 13335_13347delGAACATGGACTCTinsCTTG, c.13335_13347delinsCTTG, 15 more items",-,USH2A_000410,"ACMG GN005 criteria: PM2_P PM3_VS PM4_M PP3_P PP1_M, ACMG PM2, PM1_SUPPORTING, PP5_STRONG, 7 more items","PubMed: Carss 2017, PubMed: Colombo-2020, PubMed: Falsini 2021, PubMed: Glöckle 2014, 11 more items",-,"rs111033408, rs1553252388","Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
77,"+?/., -?/., -?/?, ?/.",33,10,c.1663C>G,r.(?),p.(Leu555Val),Laminin EGF-like 1 (518-574),ACMG,"likely benign, likely pathogenic, VUS",g.216465694G>C,g.216292352G>C,"c.1663C>G, c.1663C>G, p.Leu555Val, unknown variant 2n chromosome, 1 more item",-,USH2A_000182,"ACMG GN005 criteria: PP1_P BS1_P BS2_S, Heterozygous, Heterozygous; Neutral, Homozygous, 5 more items","PubMed: Avela 2018, PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 12 more items",-,rs35818432,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"0/200 controls, 0/878 controls, 1/2420 IRD families, 2/2791 individuals",-MnlI,-,-,"Gerard C.P. Schaafsma, Global Variome, with Curator vacancy, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
78,"+/., +?/., +?/?, -/-, ?/.",33,50,c.9815C>T,"r.(9815c>u), r.(?)",p.(Pro3272Leu),Cystein rich (3192-3358),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215972392G>A,g.215799050G>A,"c.9815C>T, p.P3272L, USH2A c.9815C>T, p.(Pro3272Leu), USH2A c.9815C>T, p.P3272L, 2 more items",-,USH2A_000163,"ACMG GN005 criteria: PS4_S PM2_P PM3_VS, Heterozygous, Heterozygous; mutation, homozygous, 2 more items","Journal: Reurink 2021, PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 20 more items",-,rs764182950,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes",-,-,-,-,"David Baux, Mieke Wesdorp, Sandro Banfi, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, MobiDetails, Janine Reurink"
79,"+/+, -/-",33,57i,c.11231+45C>T,"r.(=), r.(?)","p.(=), p.(?)",-,-,"benign, pathogenic",g.215932957G>A,g.215759615G>A,-,-,USH2A_000098,"Heterozygous, Heterozygous; Neutral, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs17025373,Germline,-,-,-CviQI;-BsrGI;-RsaI;,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
80,"+/+, +/., +?/.",32,13,c.2610C>A,"r.(2610c>a), r.(?)","p.(Cys870*), p.(Cys870Ter)",Laminin EGF-like 7 (847-899),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216420126G>T,g.216246784G>T,"c.2610C>A, USH2A c.2610C>A, 2 more items",-,USH2A_000594,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, Heterozygous, Heterozygous; mutation, Homozygous; mutation, 5 more items","Tracewska 2021, MolVis in press, PubMed: Baux, Vaché 2017, PubMed: Bonnet 2016, PubMed: Colombo-2020, 11 more items",-,rs767078782,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0 (in-house database, ~5000 samples)",-HpyCH4V,-,-,"David Baux, Peter Krawitz, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet, Janine Reurink"
81,"-/-, -/.",32,48,c.9430G>A,r.(?),p.(Asp3144Asn),Fibronectin type-III 18 (3110-3200),-,benign,g.215990479C>T,g.215817137C>T,-,-,USH2A_000086,"13 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, Homozygous, 1 more item","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, 9 more items",-,rs11120645,Germline,-,13/2795 individuals,-Sau3AI;-DpnII;-BfuCI;-DpnI;,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
82,"+/+, +/., +?/.",30,48,c.9424G>T,r.(?),"p.(Gly3142*), p.(Gly3142Ter)",Fibronectin type-III 18 (3110-3200),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215990485C>A,g.215817143C>A,"c.9424G>T, USH2A c.9424G>T, USH2A c.9424G>T, p.Gly3142Ter, 4 more items",-,USH2A_000057,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, ACMG PM2, PVS1, PP5, Heterozygous, Heterozygous; mutation, 6 more items","Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Baux 2007, PubMed: Baux 2014, 18 more items","48626, ClinVar-48626",rs397518048,"Germline, SUMMARY record, Unknown","?, yes",1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet, Rocio Villafuerte-de la Cruz"
83,"+/., +?/., -?/?, ?/.",30,63,c.13339A>G,r.(?),p.(Met4447Val),Fibronectin type-III 30 (4444-4528),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item",g.215847914T>C,g.215674572T>C,"c.13339A>G, c.13339A>G, p.Met4447Val, USH2A c.13339A>G, p.Met4447Val, 7 more items",-,"USH2A_000441, USH2A_001433","ACMG GN005 criteria: PM2_P PM3_M, alleles in cis or trans; heterozygous, compound heterozygous, 5 more items","Sharon, submitted, PubMed: Chen 2020, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Chen-2013, 13 more items",-,rs139474806,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 1/2420 IRD families, 2/314 case chromosomes, 1 more item",-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, VKGL-NL_Rotterdam, Anne-Françoise Roux, Yoshito Koyanagi"
84,"+/+, +/., +?/.",30,68,c.14803C>T,"r.(14803c>u), r.(?)","p.(Arg4935*), p.(Arg4935Ter)",Fibronectin type-III 35 (4928-5014),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.215814065G>A,g.215640723G>A,"USH2A c.14803C>T, p.Arg4935Ter, 2 more items",-,USH2A_000011,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, compound heterozygous, Heterozygous, Heterozygous; mutation, 3 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Bonnet 2016, 12 more items",-,rs146733615,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
85,"-/-, -/.",29,40,c.7506G>A,r.(?),"p.(=), p.(Pro2502=)",Fibronectin type-III 11 (2435-2528),-,benign,g.216073505C>T,g.215900163C>T,-,-,USH2A_000069,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, 1 more item","PubMed: Aller 2004, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, 4 more items",-,rs12404427,"CLASSIFICATION record, Germline",-,76/866 controls,-RsaI;-HpyCH4III;-Hpy166II;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
86,"+/+, +/., +?/.",28,2,c.187C>T,r.(?),"p.(Arg63*), p.(Arg63Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216595492G>A,g.216422150G>A,"c.187C>T, c.187C>T p.(Arg63*), c.4645C>T p.(Arg1549*), USH2A c.187C>T, p.(Arg63*), 1 more item",-,USH2A_000017,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, PP1_M, Heterozygous, Heterozygous; Mutation, 4 more items","PubMed: Bernal 2003, PubMed: Colombo-2020, PubMed: Dreyer 2000, PubMed: Hagag 2020, PubMed: Ng 2019, 11 more items",-,rs781223647,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,+AcuI,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz"
87,-/-,28,09i,c.1644+34A>C,r.(=),p.(=),-,-,benign,g.216495191T>G,g.216321849T>G,-,-,USH2A_000363,"Heterozygous, Homozygous","PubMed: Aller 2004, PubMed: Aller 2006, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs7515253,Germline,-,0/200 controls,none,-,-,"Anne-Françoise Roux, Jose Maria Millan"
88,"+/., +?/., ?/.",28,55,c.10859T>C,r.(?),p.(Ile3620Thr),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215953265A>G,g.215779923A>G,"c.10859T>C, c.10859T>C:p.I3620T, T10859C, USH2A c.10859T>C, p. Ile3620Thr, 10 more items",-,USH2A_001488,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, alleles in cis or trans; heterozygous, heterozygous, 2 more items","PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Inaba 2020, PubMed: Katagiri 2014, 10 more items",-,rs779716464,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","4/1204 cases with retinitis pigmentosa, 1 more item",-,-,-,"Johan den Dunnen, David Baux, Yoshito Koyanagi"
89,"+/+, +/., +?/.",27,22,c.4645C>T,"r.(4645c>u), r.(?)","p.(Arg1549*), p.(Arg1549Ter)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic",g.216270538G>A,g.216097196G>A,"c.187C>T p.(Arg63*), c.4645C>T p.(Arg1549*), USH2A c.4645C>T, p.(Arg1549), 3 more items",-,USH2A_000103,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, heterozygous, Heterozygous; mutation, Homozygous, 2 more items","Journal: Reurink 2021, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Baux, Vaché 2017, 18 more items",-,rs199679165,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes",-,-BstBI;-TaqI;,-,-,"David Baux, James Hejtmancik, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Nereida Bravo Gil, Janine Reurink"
90,"-/-, -/.",27,43,c.8624G>A,r.(?),p.(Arg2875Gln),Fibronectin type-III 15 (2821-2920),-,benign,g.216051157C>T,g.215877815C>T,-,-,USH2A_000088,"Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; potential, 1 more item","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 7 more items",-,rs12118814,"CLASSIFICATION record, Germline",-,"2/92 controls, 5.7% (150 controls)",+TspRI,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
91,"+/+, +/., +?/.",27,48,c.9469C>T,r.(?),"p.(Gln3157*), p.(Gln3157Ter)",Fibronectin type-III 18 (3110-3200),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.215817098G>A, g.215990440G>A",g.215817098G>A,"c.9469C>T,p.Q3157X, USH2A c.9469C>T, p. Gln3157*, USH2A c.9469C>, p.Gln3157*, 4 more items",-,USH2A_000537,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P, heterozygous, Heterozygous; mutation, 1 more item","PubMed: Gao 2021, PubMed: Huang 2013, PubMed: Huang 2015, PubMed: Huang 2018, PubMed: Jiang 2015, 7 more items",-,rs772100045,"Germline, SUMMARY record, Unknown","?, yes",0/130 controls,+MseI,-,-,"David Baux, Anne-Françoise Roux"
92,"+/., +?/., +?/?, ?/.",26,6,c.908G>A,r.(?),p.(Arg303His),Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216498882C>T,g.216325540C>T,"c.908G>A, R303H, USH2A c.908G>A, p.(Arg303His), 2 more items",-,USH2A_000231,"ACMG GN005 criteria: PM2_P PM3_VS, Heterozygous, Heterozygous; UV1, Heterozygous; UV3, 2 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bravo-Gil 2017, 11 more items",-,rs371777049,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","0/306 controls, 0/878 controls",+BsrDI;+BstXI;-BceAI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet, Nereida Bravo Gil"
93,"+/., +?/., +?/?, ?/.",26,37,c.7068T>G,r.(?),p.(Asn2356Lys),Fibronectin type-III 10 (2328-2432),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS","g.216138711A>C, g.463028T>G",g.215965369A>C,"c.7068T>G, c.7068T>G, p.N2356K, USH2A c.7068T>G, p.Asn2356Lys, USH2A c.7068T>G, p.N2356K, 3 more items",-,USH2A_000779,"ACMG GN005 criteria: PP1_P PM3_P BS1_P, compound heterozygous, heterozygous, homozygous, 2 more items","PubMed: Chen-2013, PubMed: Gao 2021, PubMed: Glockle 2013, PubMed: Huang 2015, PubMed: Inaba 2020, 9 more items",-,rs200038092,"Germline, SUMMARY record, Unknown","?, yes",1/314 case chromosomes,+BsmFI;+Bsu36I;,-,-,"David Baux, Muhammad Ajmal, Anne-Françoise Roux"
94,"+/., +?/., +?/?, -/., -?/., ?/.",25,"22, 22i",c.4758+3A>G,"r.(?), r.4758_4759ins[4758+1_4758+107], r.spl.?, r.spl?","p.(=), p.(?), p.(Gln1586_Gly1587ins5*), p.?",-,ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, VUS, 1 more item","g.216270422T>C, g.331317A>G",g.216097080T>C,"c.4758+3A>G, c.4758+3T>C, p.?, M6: USH2A IVS22+3A>G, Splicing, USH2A c.4758+3A>G, -, 3 more items",-,USH2A_000906,"ACMG GN005 criteria: BS1_P BS2_S, classification based on frequency in 305 unrelated individuals, 6 more items","PubMed: Aparisi 2014, PubMed: Chen 2020, PubMed: Fadaie 2021, PubMed: Gao 2021, PubMed: Le 2019, 8 more items",-,rs117798425,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 37/1204 cases with retinitis pigmentosa, frequency 0.015",-,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Yoshito Koyanagi, Jinu Han, Anna Tracewska, Zeinab Fadaie"
95,"+/+, +/., +?/.",24,"1, 2",c.100C>T,r.(?),"p.(Arg34*), p.(Arg34Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216595579G>A,g.216422237G>A,"1:216595579G>A ENST00000307340.3:c.100C>T (Arg34Ter), USH2A c.100C>T, USH2A c.C100T, p.R34*, 4 more items",-,USH2A_000165,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, ACMG PM2, PVS1, PP5, PS4, Heterozygous, 3 more items","PubMed: Baux 2014, PubMed: Bernal 2005, PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Dreyer 2000, 14 more items",-,rs772808534,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/878 controls, 1/899 cases",+FatI;+BspHI;+NlaIII;+CviAII;-BssSI;-Tsp45I;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Peter Krawitz, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet"
96,"+/+, +/., +?/., +?/?",24,21,c.4474G>T,r.(?),"p.(Glu1492*), p.(Glu1492Ter), p.Glu1492*",-,ACMG,"likely pathogenic, pathogenic",g.216348747C>A,g.216175405C>A,"c.4474G>T p.(Glu1492*), c.5614delGins12 p.(Ala1872Leufs), USH2A c.4474G>T, 1 more item",-,USH2A_000200,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S PP1_P, Heterozygous, Heterozygous; mutation, 3 more items","PubMed: Aparisi 2014, PubMed: Baux 2014, PubMed: Bernal 2005, PubMed: Bonnet 2016, PubMed: Hagag 2020, 8 more items",-,rs869312179,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-AcuI;-MboII;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Crystel Bonnet"
97,"+/., +?/., +?/?, ?/.",24,52,c.10342G>A,r.(?),p.(Glu3448Lys),Fibronectin type-III 19 (3404-3494),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215960057C>T,g.215786715C>T,"1:215960057C>T ENST00000307340.3:c.10342G>A (Glu3448Lys), c.10342G>A, 5 more items",-,USH2A_000426,"ACMG GN005 criteria: PM2_P PM3_M, ACMG PM2, PP5_STRONG, compound heterozygous, heterozygous, 5 more items","PubMed: Carss 2017, PubMed: Comander 2017, PubMed: Consugar 2015, PubMed: Gao 2021, PubMed: Ge 2015, 14 more items",209203,rs368049814,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",1/899 cases,-,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
98,"+/., +/?, +?/.",23,6,c.1055C>T,r.(?),p.(Thr352Ile),Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216498735G>A,g.216325393G>A,"1:216498735G>A ENST00000307340.3:c.1055C>T (Thr352Ile), c.1055C>T, 3 more items",-,USH2A_000046,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P PP1_P, compound heterozygous, heterozygous, 2 more items","PubMed: Austin-Tse 2018, PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 13 more items",SCV000709742,rs780308389,"Germline, Germline/De novo (untested), SUMMARY record","?, yes",0/306 controls,-CviQI;-RsaI;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
99,"+/., +?/., -?/?, ?/.",23,43i,c.8682-9A>G,"r.(=), r.(?), r.spl, r.spl?","p.(=), p.(?), p.?",-,ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item",g.216040521T>C,g.215867179T>C,"c.8682-9A>G, IVS43-9A>G, USH2A c.8682-9A>G, USH2A c.8682-9A>G, p.(?), 3 more items",-,USH2A_000514,"1 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PM2_P PM3_VS PP3_P, heterozygous, 9 more items","PubMed: Colombo-2020, PubMed: Glöckle 2014, PubMed: Ivanova 2018, PubMed: Jauregui 2020, 8 more items",197510,rs372347027,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",1/2790 individuals,none,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Vladimir Strelnikov, Mohammed Faruq"
100,"-/-, -/., -?/.",23,60,c.11677C>A,r.(?),p.(Pro3893Thr),Fibronectin type-III 24 (3863-3960),-,"benign, likely benign",g.215914751G>T,g.215741409G>T,USH2A(NM_206933.4):c.11677C>A (p.P3893T),-,USH2A_000052,"56 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, 3 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 6 more items",-,rs41303285,"CLASSIFICATION record, Germline",-,56/2792 individuals,-,-,-,"VKGL-NL_Groningen, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Mohammed Faruq"
101,"+/+, +/., ?/.",22,2,c.236_239dup,r.(?),"p.(Gln81Tyrfs*28), p.(Gln81TyrfsTer28), p.(Thr80Serfs*29)",-,ACMG,"pathogenic, pathogenic (recessive), VUS",g.216595440_216595443dup,g.216422098_216422101dup,"236_239dupGTAC, 239–242insGTAC (Thr80fs), c.236_239dup",-,USH2A_000135,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_S, Heterozygous, Homozygous","Sharon, submitted, PubMed: Aller 2006, PubMed: Auslender 2008, PubMed: Bahena 2021, 6 more items",-,rs1553258097,"Germline, SUMMARY record, Unknown",yes,"17/2420 IRD families, 2/2420 IRD families, 5/582 controls",-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, Zippi Brownstein, Barbara Vona, Anne-Françoise Roux, Jose Maria Millan"
102,"+/., +?/., -/-, -/., -?/?, ?/.",22,12,c.2137G>C,r.(?),p.(Gly713Arg),Laminin EGF-like 4 (694-746),ACMG,"benign, likely benign, likely pathogenic, pathogenic (recessive), VUS",g.216424275C>G,g.216250933C>G,"p.2137G>C, USH2A/c.2173G>C(p.Gly713Arg);",-,USH2A_000021,"ACMG GN005 criteria: PP3_P BA1 BS2_S, Heterozygous, Homozygous; Mutation, possible duplicate, 2 more items","PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, PubMed: Aller, E. et al., 2006, 14 more items",-,rs696723,"CLASSIFICATION record, Germline, SUMMARY record",yes,"2/200 controls, 5/899 cases",+MslI;+AleI;-HaeIII;,-,-,"Gerard C.P. Schaafsma, Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
103,"+?/., -/-, -?/.",22,13,c.2256T>C,r.(?),"p.(=), p.(His752=)",Laminin EGF-like 5 (747-794),-,"benign, likely benign, likely pathogenic",g.216420480A>G,g.216247138A>G,"USH2A(NM_206933.2):c.2256T>C (p.H752=), USH2A(NM_206933.4):c.2256T>C (p.H752=)",-,USH2A_000055,"Heterozygous, Heterozygous; Neutral, Homozygous, VKGL data sharing initiative Nederland","PubMed: Aller 2004, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Ellingford 2016, PubMed: Jaijo 2010, 3 more items",-,rs111033281,"CLASSIFICATION record, Germline",-,-,+BceAI;-CviAII;-NcoI;-FatI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan"
104,"+/+, +/., +?/.",22,24,c.4957C>T,r.(?),"p.(Arg1653*), p.(Arg1653Ter)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216260091G>A,g.216086749G>A,"c.4957C>T, NM_206933.2:c.4957C>T, NP_996816.2:p.(Arg1653Ter), NC_000001.10:g.216260091G>A, 5 more items",-,USH2A_000288,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, Heterozygous; mutation, Heterozygous; Pathogenic, 4 more items","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Huang 2017, PubMed: Ivanova 2018, 9 more items",-,rs754768875,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,-BstUI;-FauI;-AciI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet, Vladimir Strelnikov, Jinu Han"
105,"+?/., -/-, -/., ?/.",22,35,c.6713A>C,r.(?),p.(Glu2238Ala),-,ACMG,"benign, likely pathogenic, likely pathogenic (recessive), VUS",g.216166454T>G,g.215993112T>G,"c.6713A>C, USH2A c.6713A>C, p.E2238A, USH2A(NM_206933.2):c.6713A>C (p.E2238A), 1 more item",-,USH2A_000062,"94 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: BA1 BS2_S, Heterozygous, 5 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Bryant 2018, 11 more items",-,rs41277212,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"4/89 controls, 94/2795 individuals",+HgaI;+AciI;-MnlI;,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
106,"+?/., -/., -?/?, ?/.",22,71,c.15427C>T,r.(?),p.(Arg5143Cys),Cytoplasmic (5064-5202),ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.215802248G>A,g.215628906G>A,"c.15427C>T, M7: USH2A c.15427C>T, R5143C, USH2A c.15427C>T, p.Arg5143Cys, 4 more items",-,USH2A_000786,"ACMG GN005 criteria: BS1_P BS2_S BP4_P, classification based on frequency in 305 unrelated individuals, 5 more items","0, PubMed: Chen 2020, PubMed: Chen-2013, PubMed: Gao 2021, PubMed: Le 2019, PubMed: Liu-2020, 8 more items",-,rs145771342,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","2/314 case chromosomes, 6/1204 cases with retinitis pigmentosa, frequency 0.019",-,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Yoshito Koyanagi"
107,"+/., +?/., +?/?",21,3,c.538T>C,r.(?),p.(Ser180Pro),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216591969A>G,g.216418627A>G,"c.538T>C, NM_206933.2:c.538T>C, NP_996816.2:p.(Ser180Pro), NC_000001.10:g.216591969A>G, 7 more items",-,USH2A_000143,"ACMG GN005 criteria: PM2_P PM3_VS PP1_P PP3_P, alleles in cis or trans; heterozygous, heterozygous, 3 more items","PubMed: Chen 2020, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Dan 2020, PubMed: Gao 2021, 8 more items",-,rs1171672823,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/270 controls, Taiwan Biobank: 0.000330; GnomAD_exome_East: 0.000109; GnomAD_All: 0.00000797",-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
108,"+/+, +/.",21,7,c.1227G>A,"r.(1227g>a), r.(?)","p.(Trp409*), p.(Trp409Ter)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216497611C>T,g.216324269C>T,"USH2A c.1227G>A, p.(Trp409*), 1 more item",-,USH2A_000156,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, PP1_P, heterozygous, Homozygous, 1 more item","Journal: Reurink 2021, PubMed: Neveling 2012, PubMed: Pennings 2004(2), PubMed: Pennings 2004, 3 more items",-,rs397517979,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no",-,none,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Janine Reurink"
109,"+/., +/?, +?/., +?/?",21,40i,c.7595-3C>G,"r.(7594_7595ins7995-2_7595-1), r.(?), r.7594_7595ins7995-2_7595-1, r.spl, r.spl?","p.(?), p.(Pro2533Asnfs*5), p.(Pro2533AsnfsTer5), p.?, p.Pro2533Asnfs*5",Fibronectin type-III 12 (2533-2619),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216062399G>C,g.215889057G>C,"1:216062399G>C ENST00000307340.3:c.7595-3C>G, USH2A c.7595-3C>G, USH2A c.7595-3C>G,, 2 more items",-,USH2A_000101,"ACMG GN005 criteria: PM2_P PM3_VS, Heterozygous, Heterozygous; ins last 2 nt IVS 40, 4 more items","Journal: Reurink 2021, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Carss 2017, 11 more items",-,rs201657446,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no, yes","0/100 controls, 0/200 controls, 0/878 controls",-AlwNI,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, Janine Reurink"
110,"+/+, +/., +?/.",21,48i,c.9570+1G>A,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215990338C>T,g.215816996C>T,"c.9570+1C>T, p.?, USH2A c.4576G>A(;)9570+1G>A, V1: c.9570+1G>A,, USH2A c.9570+1G>A, 5 more items",-,USH2A_000788,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P, alleles in cis or trans; heterozygous, heterozygous, 4 more items","PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Huang 2013, PubMed: Ng 2019, 8 more items",-,rs760225886,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/400 controls, 1/1204 cases with retinitis pigmentosa, 1 more item",-,-,-,"David Baux, VKGL-NL_AMC, Anne-Françoise Roux, Yoshito Koyanagi"
111,-/-,21,50i,c.9958+69C>T,r.(=),p.(=),-,-,benign,g.215972180G>A,g.215798838G>A,-,-,USH2A_000085,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 1 more item",-,rs12132110,Germline,-,-,+DdeI;-BfaI;,-,-,"Anne-Françoise Roux, Jose Maria Millan"
112,"+/., +?/., -/-, -/?, -?/., -?/?, ?/.",21,63,c.12343C>T,"r.(12343c>u), r.(?)",p.(Arg4115Cys),Fibronectin type-III 26 (4066-4150),ACMG,"likely benign, likely pathogenic, pathogenic, VUS",g.215848910G>A,g.215675568G>A,"USH2A c.12343C>T, p.R4115C, 2 more items",-,USH2A_000050,"ACMG GN005 criteria: BP2_P, compound heterozygous, Heterozygous, Heterozygous; unknown, 4 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet 2016, 10 more items",-,rs111033275,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,0/188 controls,+Tsp509I;-TfiI;-HinfI;,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet, Janine Reurink"
113,"-/-, -?/., -?/?",21,70,c.15091C>T,r.(?),p.(Arg5031Trp),-,-,"benign, likely benign",g.215808007G>A,g.215634665G>A,-,-,USH2A_000294,"41 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; benign, Homozygous; UV1, 4 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 6 more items",-,rs56038610,"CLASSIFICATION record, Germline",-,41/2795 individuals,-AciI;-BstUI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
114,"+/+, +/., +?/+, +?/., ?/.",20,12i,c.2167+5G>A,"r.(1972_2167del,2138_2167del), r.(?), r.(spl?), r.([1972_2167del, 2138_2167del]), r.spl, r.spl?, 2 more items","p.(?), p.(Ile658GlyfsTer33,Gln714_Gly723del), p.([(Ile658GlyfsTer33,Gln714_Gly723del)]), p.?, 3 more items",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216424240C>T,g.216250898C>T,"c.2167+5G>A, IVS12+5G>A, M11: c.2167 + 5G > A; r.(spl?), USH2A c.2167+5G>A, -, 1 more item",-,USH2A_000195,"ACMG GN005 criteria: PS3_P PP3_P, Donor site lost, heterozygous, homozygous, Homozygous; Pathogenic, 2 more items","Sharon, submitted, PubMed: Avila Fernandez 2010, PubMed: Avila-Fernandez 2010, PubMed: Baux 2014, 13 more items",-,rs771583281,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/200 controls, 1/1204 cases with retinitis pigmentosa, 1/2420 IRD families",+NspI;+FatI;+NlaIII;+PciI;-HpyCH4IV;-BsaAI;,-,-,"Global Variome, with Curator vacancy, David Baux, María González-del Pozo, Dror Sharon, Marta de Castro-Miró, Anne-Françoise Roux, Jose Maria Millan, Yoshito Koyanagi"
115,"+/., +?/., -/?, -?/., ?/.",20,30,c.5858C>G,"r.(5858c>g), r.(?)",p.(Ala1953Gly),-,ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216243634G>C,g.216070292G>C,"1:216243634G>C ENST00000307340.3:c.5858C>G (Ala1953Gly), c.5858C>G, c.5858C>G (A1953G), 3 more items",-,USH2A_000342,"ACMG GN005 criteria: BS1_P BS2_S BP4_P, compound heterozygous, heterozygous, Heterozygous; benign, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 13 more items",-,rs41302239,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 1/874 controls, 1/899 cases",+Hpy166II;+Sau96I;+AvaII;-AluI;-CviKI_1;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Yoshito Koyanagi, Janine Reurink"
116,-/-,20,38i,c.7300+43C>T,r.(=),p.(=),-,-,benign,g.216107915G>A,g.215934573G>A,-,-,USH2A_000251,"Heterozygous, Heterozygous; Neutral","PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, PubMed: Le Guédard-Méreuze 2010, 1 more item",-,rs41277206,Germline,-,-,none,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
117,-/-,20,40i,c.7594+22C>T,r.(=),p.(=),-,-,benign,g.216073395G>A,g.215900053G>A,-,-,USH2A_000074,"Heterozygous, Heterozygous; Neutral","PubMed: Aller 2004, PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, 3 more items",-,rs12401812,Germline,-,-,none,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
118,"+/+, +/., +?/.",20,47i,c.9371+1G>C,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216011332C>G,g.215837990C>G,"IVS47+1G>C, USH2A c.9371+1G>C, p.(?), USH2A c.9371+1G>C, p.?, 1 more item",-,USH2A_000592,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, heterozygous, Heterozygous; mutation, 1 more item","Journal: Reurink 2021, PubMed: Bonnet 2016, PubMed: Jiman 2020, PubMed: Le Quesne Stabej 2012, 9 more items",-,rs41308425,"Germline, SUMMARY record, Unknown","?, no",1/866 controls,+AluI;+CviKI_1;-CviQI;-RsaI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, Janine Reurink"
119,"+/+, +/., +?/.",20,57,c.11105G>A,"r.(11105g>a), r.(?)","p.(Trp3702*), p.(Trp3702Ter)",Fibronectin type-III 22 (3677-3767),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215933128C>T,g.215759786C>T,"USH2A c.11105G>A, p.Trp3702Ter, 6 more items",-,USH2A_000772,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_P, ACMG PM2, PVS1, PP5, heterozygous, solved, homozygous, 4 more items","PubMed: Bonnet 2016, PubMed: Ge 2015, PubMed: Glöckle 2014, PubMed: Krawitz 2014, 5 more items",374674,rs1057519193,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, Peter Krawitz, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
120,"-/-, -/., -?/.",20,63,c.13297G>T,r.(?),p.(Val4433Leu),Fibronectin type-III 29 (4356-4439),-,"benign, likely benign",g.215847956C>A,g.215674614C>A,-,-,USH2A_000130,"11 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; benign, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bryant 2018, 4 more items",-,rs111033381,"CLASSIFICATION record, Germline",-,"11/2794 individuals, 24/872 controls",none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Mohammed Faruq"
121,"+?/., -/-, -/., -/?, -?/., ?/.",19,4,c.688G>A,r.(?),p.(Val230Met),-,ACMG,"benign, likely benign, likely pathogenic, VUS",g.216538391C>T,g.216365049C>T,USH2A(NM_206933.2):c.688G>A (p.V230M),-,USH2A_000014,"111 heterozygous; Clinindb (India), 4 homozygous; Clinindb (India), Heterozygous, Homozygous, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Eandi 2017, 11 more items",-,rs45500891,"CLASSIFICATION record, Germline",yes,"0/100 controls, 11/1204 cases with retinitis pigmentosa, 111/2795 individuals, 2/96 controls, 3 more items",+FatI;+NlaIII;+CviAII;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Yoshito Koyanagi, Mohammed Faruq"
122,"+/., +?/., +?/?, ?/.",19,27,c.5329C>T,r.(?),p.(Arg1777Trp),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216251674G>A,g.216078332G>A,"c.5329C>T, NM_206933.2:c.5329C>T, NP_996816.2:p.(Arg1777Trp), NC_000001.10:g.216251674G>A, 6 more items",-,USH2A_000297,"ACMG GN005 criteria: PM2_P PM3_S, alleles in cis or trans; heterozygous, Heterozygous, 4 more items","Liquori et al., accepted, USMA missense analysis, missense variant in MSV3d, PubMed: Chen 2021, 13 more items",-,rs770329105,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/270 controls, 0/878 controls, Taiwan Biobank: 0.00033; GnomAD_exome_East: 0; GnomAD_All: 0.00000399",-MspI;-HpaII;-BsaWI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet, MobiDetails"
123,"+/., +?/., +?/?",19,28,c.5581G>A,r.(?),p.(Gly1861Ser),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216246634C>T,g.216073292C>T,"c.5581C>T , p.(Gly1861Ser), M8: USH2A c.5581G>A, G1861S, USH2A c.5581G>A, p.G1861S, 3 more items",-,USH2A_000785,"ACMG GN005 criteria: PM2_P PM3_S PP1_P PP3_P, alleles in cis or trans; heterozygous, heterozygous, 2 more items","PubMed: Chen 2020, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Huang 2015, 8 more items",-,rs375668376,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",Taiwan Biobank: 0; GnomAD_exome_East: 0.000164; GnomAD_All: 0.0000119,-,-,-,"David Baux, Anne-Françoise Roux"
124,"+/+, +/., +?/., -/-",19,29,c.5836C>T,r.(?),"p.(Arg1946*), p.(Arg1946Ter)",Fibronectin type-III 5 (1871-1949),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216246252G>A,g.216072910G>A,"c.7843delC; p.Arg1946Ter:c.5836C/T(alleles in trans), USH2A c.5836C>T, USH2A c.5836C>T, p.R1946*, 4 more items",-,USH2A_000341,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, alleles in cis or trans; heterozygous, Heterozygous, 3 more items","PubMed: Baux 2014, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Hariri 2018, 9 more items",-,rs751130485,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/143 cases, 1/314 case chromosomes, 1 more item",-TaqI;-MlyI;-PleI;-HinfI;,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Vladimir Strelnikov"
125,"+/., +?/., -/., -/?, -?/., -?/?, ?/.",19,32,c.6240G>T,"r.(6240g>u), r.(?)",p.(Lys2080Asn),Fibronectin type-III 7 (2052-2138),ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic (recessive), VUS",g.216219858C>A,g.216046516C>A,"1:216219858C>A ENST00000307340.3:c.6240G>T (Lys2080Asn), c.6240G>T, 1 more item",-,USH2A_000122,"Heterozygous, Heterozygous; benign, Heterozygous; Predicted benign, no variant 2nd chromome, 1 more item","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Booij-2011, 9 more items",-,rs114402911,"CLASSIFICATION record, Germline",yes,"1/899 cases, 7/899 cases",+HpyCH4V,-,-,"Global Variome, with Curator vacancy, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Janine Reurink"
126,"+/., +?/., -/-, -/., -/?, -?/., ?/.",18,13,c.2522C>A,"r.(2522c>a), r.(?)",p.(Ser841Tyr),Laminin EGF-like 6 (795-846),ACMG,"benign, likely benign, likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216420214G>T,g.216246872G>T,"1:216420214G>T ENST00000307340.3:c.2522C>A (Ser841Tyr), USH2A c.2522C>A, p.Ser841Tyr, 2 more items",-,USH2A_000184,"ACMG PM2, Heterozygous, Heterozygous; UV1, Heterozygous; UV2, no variant 2nd chromome, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 11 more items",-,rs111033282,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,"0/96 controls, 10/899 cases",none,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Janine Reurink"
127,"+/+, +/., +?/.",18,62,c.12234_12235del,"r.(12234_12235del), r.(?)","p.(Asn4079Trpfs*19), p.(Asn4079TrpfsTer19)",Fibronectin type-III 26 (4066-4150),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215853553_215853554del,g.215680211_215680212del,"12231_12232delAG, 12234_12235delGA, USH2A c.12234_12235del, 4 more items",-,USH2A_000066,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, ACMG PM2, PVS1, PP5, heterozygous, Heterozygous; mutation, 4 more items","Journal: Reurink 2021, PubMed: Baux 2007, PubMed: Bonnet 2016, PubMed: Charng 2020, PubMed: Stone 2017, 7 more items",96665,rs398124618,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
128,"+/+, +/., +?/.",18,63,c.13374del,r.(?),"p.(Glu4458Aspfs*3), p.(Glu4458AspfsTer3)",Fibronectin type-III 30 (4444-4528),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.215847879del, g.215847880del",g.215674538del,"13374delA, 1:215847878AT>A ENST00000307340.3:c.13374delA (Glu4458AspfsTer3), c.13374del, 4 more items",-,USH2A_000056,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS PP1_P, Heterozygous, Heterozygous; mutation, 3 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Colombo-2020, 7 more items",-,rs727503715,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,+BfuCI;+DpnII;+DpnI;+MboI;-TfiI;-HinfI;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet, Vladimir Strelnikov"
129,"+/+, +/., +?/., ?/.",17,16,c.3187_3188del,"r.(3187_3188del), r.(?)","p.(Gln1063Serfs*15), p.(Gln1063SerfsTer15)",Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic, VUS","g.216380743_216380744del, g.216380744_216380745del",g.216207402_216207403del,"3187_3188delCA, c.3187_3188delCA, p.Q1063Sfs*15, USH2A c.3187_3188del, p.(Gln1063Serfs*15), 3 more items",-,USH2A_000216,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic, 1 more item","Journal: Reurink 2021, PubMed: Austin-Tse 2018, PubMed: Carrigan 2016, PubMed: Ellingford 2016, 10 more items",SCV000709745,rs886039450,"Germline, SUMMARY record, Unknown","?, no, yes",0/878 controls,none,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
130,-/-,17,21,c.4456A>G,r.(?),p.(Arg1486Gly),-,-,benign,g.216348765T>C,g.216175423T>C,-,-,USH2A_000362,"Heterozygous, Homozygous","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, 3 more items",-,-,Germline,-,-,-,-,-,Jose Maria Millan
131,"+/., +?/+?, +?/., +?/?, ?/.",17,22,c.4732C>T,"r.(4732c>u), r.(?)",p.(Arg1578Cys),Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216270451G>A,g.216097109G>A,"c.4732C>T, NM_206933.2:c.4732C>T, NP_996816.2:p.(Arg1578Cys), NC_000001.10:g.216270451G>A, 1 more item",-,USH2A_000528,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous, Heterozygous; UV4, no variant 2nd chromome, 2 more items","PubMed: Bahena 2021, PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 11 more items",-,rs201529124,"CLASSIFICATION record, Germline, SUMMARY record","?, yes","0/878 controls, 0/90 controls",+BtsCI;+FokI;-AatII;-BsaHI;-BsmFI;-ZraI;,-,-,"Johan den Dunnen, David Baux, Sandro Banfi, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Barbara Vona, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
132,"+/., +?/., ?/.",17,28,c.5608C>T,r.(?),"p.(Arg1807Trp), p.(Arg1870Trp)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216246607G>A,g.216073265G>A,"c.5608C>T, NM_206933.2:c.5608C>T, NP_996816.2:p.(Arg1870Trp), NC_000001.10:g.216246607G>A, 6 more items",-,USH2A_001524,"ACMG GN005 criteria:, heterozygous, solved, homozygous, with two variants in EYS gene, 2 more items","PubMed: Hosono 2018, PubMed: Inaba 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 8 more items",-,rs144768593,"Germline, SUMMARY record, Unknown","?, no, yes","10/1204 cases with retinitis pigmentosa, 2/314 case chromosomes",-,-,-,"David Baux, Yoshito Koyanagi, Kaoruko Torii"
133,"+/+, +/., +?/.",17,55,c.10759C>T,r.(?),"p.(Gln3587*), p.(Gln3587Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215953365G>A,g.215780023G>A,"USH2A c.10759C>T, p.Q3587X, 1 more item",-,USH2A_000128,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1, PP5, compound heterozygous, Heterozygous, 4 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Garcia-Garcia 2011, 9 more items",48357,rs111033418,"Germline, SUMMARY record, Unknown","?, yes",-,+DdeI;+Bsu36I;-BsaJI;-StyI;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet"
134,"+/+, +/., +/?, +?/., ?/.",17,64,c.14131C>T,r.(?),"p.(Gln4711*), p.(Gln4711Ter)",Fibronectin type-III 32 (4633-4730),ACMG,"likely pathogenic, pathogenic, VUS",g.215844316G>A,g.215670974G>A,"USH2A(NM_206933.2):c.14131C>T (p.Q4711*), USH2A(NM_206933.4):c.14131C>T (p.Q4711*)",-,USH2A_000400,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation, Homozygous; mutation, 1 more item","PubMed: Bonnet 2016, PubMed: Krawitz 2014, PubMed: Mansard et al, 2021, PubMed: Neuhaus 2017, 4 more items",-,rs747063294,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet"
135,"+/., +?/., +?/?, ?/.",17,66,c.14426C>T,r.(?),p.(Thr4809Ile),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.215822026G>A,g.215648684G>A,"1:215822026G>A ENST00000307340.3:c.14426C>T (Thr4809Ile), USH2A c.14426C>T, p.Thr4809Ile, 3 more items",-,USH2A_000012,"ACMG GN005 criteria: PM2_P PM3_M PP1_P, Heterozygous, Heterozygous; mutation, Heterozygous; Pathogenic, 2 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 11 more items",-,rs770553471,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,"0/306 controls, 0/878 controls",+SfaNI;-BspMI;-BsgI;-BfuAI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Crystel Bonnet, MobiDetails"
136,"+/., +?/., -/., -/?, -?/., ?/.",17,71,c.15433G>A,"r.(15433g>a), r.(?)",p.(Val5145Ile),Cytoplasmic (5064-5202),ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic (recessive), VUS",g.215802242C>T,g.215628900C>T,"1:215802242C>T ENST00000307340.3:c.15433G>A (Val5145Ile), USH2A c.15433G>A, p.Val5145Ile, 2 more items",-,USH2A_000253,"ACMG PM2, Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; probably benign, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 9 more items",-,rs111033269,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,"1/899 cases, 4/844 controls",+SfaNI;-HgaI;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
137,"+/+, +/., +?/.",16,2,c.100_101insT,r.(?),"p.(Arg34Leufs*41), p.(Arg34LeufsTer41)",-,ACMG,"likely pathogenic, pathogenic",g.216595578_216595579insA,g.216422236_216422237insA,"USH2A c.100_101insT, p.Arg34Leufs*41, USH2A c.100_101insT, p.Arg34Leufs*41, 3 more items",-,USH2A_000957,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, alleles in trans; heterozygous, heterozygous, 2 more items","0, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Jiang 2015, PubMed: Meng 2020, 2 more items",-,-,"Germline, SUMMARY record, Unknown","?, yes",Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,"David Baux, Anne-Françoise Roux"
138,"+/+, +/., +?/.",16,7,c.1214del,r.(?),"p.(Asn405Ilefs*3), p.(Asn405IlefsTer3)",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic","g.216497624del, g.216497627del",g.216324285del,"1214delA, 2299delG (Glu767fs), c.1214delA,p.N405IfsX3, 2 more items",-,USH2A_000199,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, Heterozygous, Homozygous; Pathogenic, 1 more item","PubMed: Aparisi 2014, PubMed: Bernal 2005, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 8 more items",-,rs750228923,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,none,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
139,"+/+, +/., +?/.",16,12i,c.2168-1G>C,"r.(2168_2174del), r.(?), r.2168_2174del, r.spl","p.(?), p.(Leu724Valfs*31), p.(Leu724ValfsTer31), p.?, p.Leu724Valfs*31",Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216420569C>G,g.216247227C>G,"c.2168-1G>C, c.2168-1G>C, p.(?), IVS12-1G>C, USH2A c.2168-1G>C, -, 4 more items",-,USH2A_000091,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, Heterozygous, 3 more items","PubMed: Baux 2007, PubMed: Eandi 2017, PubMed: Gao 2021, PubMed: Li 2019, PubMed: Mansard et al, 2021, 9 more items",-,rs748961218,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
140,"+/., +?/., +?/?, ?/.",16,13,c.2296T>C,r.(?),p.(Cys766Arg),Laminin EGF-like 5 (747-794),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216420440A>G,g.216247098A>G,"c.2296T>C, USH2A, variant 1: c.2296T>C/p.C766R, variant 2: c.11864G>A/p.W3955*, 1 more item",-,USH2A_000129,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, Heterozygous, Heterozygous; likely pathogenic, 3 more items","PubMed: Aparisi 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bernardis 2016, 9 more items",-,rs368687374,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Sandro Banfi, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet"
141,"+/., +?/., ?/.",16,"19, Ex19",c.4106C>T,r.(?),p.(Ser1369Leu),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216370040G>A,g.216196698G>A,"c.4106C>T, p.Asn346His:c.1036A/C, p.Ser1369Leu:c.4106C/T(alleles in trans), 3 more items",-,USH2A_001109,"ACMG GN005 criteria:, compound heterozygous, heterozygous","PubMed: Booij-2011, PubMed: Colombo-2020, PubMed: Comander 2017, PubMed: Dad 2016, PubMed: Hariri 2018, 7 more items",-,rs201709513,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",1/899 cases,-,-,-,"Global Variome, with Curator vacancy, Feng Wang, David Baux"
142,"+/., +?/., +?/?, ?/.",16,21,c.4576G>A,r.(?),p.(Gly1526Arg),Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic, VUS",g.216348645C>T,g.216175303C>T,"USH2A c.3635C>T(;)4576G>A, V1: c.4576G>A, (p.Gly1526Arg), USH2A c.4576G>A, p.G1526R, 6 more items",-,USH2A_000953,"ACMG GN005 criteria: PM2_P PM3_M, alleles in cis or trans; heterozygous, heterozygous, 1 more item","0, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Gao 2021, PubMed: Huang 2015, PubMed: Zhu 2021, 2 more items",-,rs769198746,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",Taiwan Biobank: 0; GnomAD_exome_East: 0.000219; GnomAD_All: 0.0000199,-,-,-,"David Baux, Anne-Françoise Roux"
143,"+/., +/?, +?/.",16,33i,c.6485+5G>A,"r.6326_6485del, r.spl, r.spl?","p.(?), p.(Asp2109Glyfs*7), p.?, p.Asp2109Glyfs*7",Fibronectin type-III 7 (2052-2138),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216173740C>T,g.216000398C>T,"c.6485+5G>A, USH2A c.6485+5G>A, -, USH2A c.6485+5G>A, -, 1 more item",-,USH2A_000146,"ACMG GN005 criteria: PM2_P PM3_S PP1_P PP3_P, heterozygous, with two variants in MYO7A gene, 1 more item","PubMed: Fu 2018, PubMed: Gao 2021, PubMed: Huang 2018, PubMed: Liu-2020, PubMed: Meng 2020, 3 more items",-,rs1668240410,"Germline, SUMMARY record, Unknown","?, yes",0/270 controls,-,-,-,"David Baux, Anne-Françoise Roux"
144,-/-,16,38i,c.7300+29A>G,r.(=),p.(=),-,-,benign,g.216107929T>C,g.215934587T>C,-,-,USH2A_000053,"Heterozygous, Heterozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 1 more item",-,rs41277208,Germline,-,-,+BfaI;-Tsp509I;,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
145,-/-,16,52,c.10233A>C,r.(?),p.(Glu3411Asp),Fibronectin type-III 19 (3404-3494),-,benign,g.215960166T>G,g.215786824T>G,-,-,USH2A_000369,"Heterozygous, Homozygous","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, 3 more items",-,-,Germline,-,-,+DraIII,-,-,Jose Maria Millan
146,"+/+, +/., +?/.",16,61,c.11875_11876del,r.(?),"p.(Gln3959Asnfs*53), p.(Gln3959AsnfsTer53)",Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.215901562_215901563del, g.215901565_215901566del",g.215728223_215728224del,"11872_11873delAC, 11875_11876delCA, c.11875_11876del, p.Gln3959AsnfsTer53, USH2A c.11875_11876del, 4 more items",-,USH2A_000276,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation, 3 more items","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Ellingford 2016, PubMed: Toms 2020, 5 more items",-,rs779791079,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,0/878 controls,none,-,-,"David Baux, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet"
147,-/-,16,61i,c.12067-31del,r.(=),p.(=),-,-,benign,g.215853760del,g.215680418del,12067-31delA,-,USH2A_000325,"Heterozygous, Homozygous","PubMed: Baux 2014, PubMed: Vaché 2012",-,rs11307320,Germline,-,-,none,-,-,Anne-Françoise Roux
148,"+?/., -?/?, ?/.",16,65,c.14219C>A,r.(?),p.(Ala4740Asp),Fibronectin type-III 33 (4732-4825),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.215824058G>T,g.215650716G>T,"c.14219C>A, c.14219C>A, p.Ala4740Asp, USH2A c.14219C>A, p.Ala4740Asp, 4 more items",-,USH2A_000767,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous, Heterozygous; likely pathogenic, homozygous, 3 more items","PubMed: Birtel 2018, PubMed: Colombo-2020, PubMed: Jespersgaar 2019, PubMed: Stone 2017, 6 more items",-,rs539192853,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-BanII;-Bsp1286I;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Eva Lenassi"
149,"+/+, +/., +?/., ?/.",15,10,c.1679del,"r.(1679del), r.(?)","p.(Pro560Leufs*31), p.(Pro560LeufsTer31)",Laminin EGF-like 1 (518-574),ACMG,"likely pathogenic, pathogenic, VUS","g.216465678del, g.216465679del",g.216292337del,"1678delC, 1679delC, c.1679delC, c.1679delC,p.P560LfsX31, USH2A c.1679del",-,USH2A_000206,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; Pathogenic, 2 more items","PubMed: Charng 2020, PubMed: Le Quesne Stabej 2012, PubMed: Lenassi 2015, PubMed: Schwartz 2005, 7 more items",-,rs773539640,"Germline, SUMMARY record, Unknown","?, yes",0/878 controls,+AluI;+HindIII;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Eva Lenassi, Janine Reurink"
150,"+/., +/?, +?/., ?/.",15,10,c.1724G>A,r.(?),p.(Cys575Tyr),Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, pathogenic, VUS",g.216465633C>T,g.216292291C>T,"c.1724G>A, p.Cys575Tyr, p.C575Y, USH2A c.1724G>A, p.C575Y, USH2A c.1724G>A, p.Cys575Tyr",-,USH2A_000344,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, compound heterozygous, heterozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: de Castro-Miró 2016, 8 more items",-,rs483353054,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",0/306 controls,none,-,-,"David Baux, Marta de Castro-Miró, Anne-Françoise Roux, Jinu Han"
151,"+/+, +/., +?/.",15,41,c.8167C>T,"r.(8167c>t), r.(8167c>u), r.(?), r.8167c>t","p.(Arg2723*), p.(Arg2723Ter), p.Arg2723*",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216061824G>A,g.215888482G>A,"c.8167C>T, NM_206933.2:c.8167C>T, NP_996816.2:p.(Arg2723Ter), NC_000001.10:g.216061824G>A, 1 more item",-,USH2A_000181,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, Homozygous, no variant 2nd chromome","PubMed: Jaijo 2010, PubMed: Lee 2020, PubMed: Liu-2020, PubMed: Mansard et al, 2021, PubMed: Wang 2018, 5 more items",-,rs200712760,"Germline, SUMMARY record","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan, Janine Reurink"
152,"+/+, +/., +?/.",15,44,c.8740C>T,"r.(8740c>u), r.(?)","p.(Arg2914*), p.(Arg2914Ter)",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216040454G>A,g.215867112G>A,"USH2A c.8740C>T, p.(Arg2914*), 1 more item",-,USH2A_000275,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, Heterozygous, Heterozygous; mutation, 1 more item","Journal: Reurink 2021, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Ellingford 2016, 7 more items",228417,rs766590491,"Germline, SUMMARY record, Unknown","?, no",-,+DdeI;+BspCNI;+AluI;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
153,"+/., +?/., ?/.",15,47,c.9259G>A,r.(?),p.(Val3087Ile),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216011445C>T,g.215838103C>T,"c.9259G>A, USH2A c.9259G>A, p.Val3087Ile, USH2A c.9259G>A, p.V3087I, 2 more items",-,USH2A_001193,"ACMG GN005 criteria: PM2_P PM3_M BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Chen-2013, PubMed: Gao 2021, PubMed: Guo 2021, Journal: Guo 2021, PubMed: Huang 2015, 6 more items",-,rs200382994,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 1/314 case chromosomes",-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, Yoshito Koyanagi"
154,"+?/., +?/?, ?/.",15,54,c.10636G>A,r.(?),p.(Gly3546Arg),Fibronectin type-III 20 (3499-3585),ACMG,"likely pathogenic, VUS",g.215955488C>T,g.215782146C>T,c.10636G>A,-,USH2A_000290,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic, Heterozygous; UV3, 3 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: de Castro-Miró 2014, 7 more items",-,rs1553261372,"Germline, SUMMARY record, Unknown",yes,0/200 controls,+Hpy188I,-,-,"David Baux, Marta de Castro-Miró, Anne-Françoise Roux, Jose Maria Millan, MobiDetails"
155,"+/., +?/., ?/.",15,63,c.13465G>A,r.(?),p.(Gly4489Ser),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS","g.215674446C>T, g.215847788C>T",g.215674446C>T,"c.13465G>A, c.13465G>A, p.Gly4489Ser, M9: USH2A c.13465G>A, G4489S, USH2A c.G13465A, p.G4489S, 6 more items",-,USH2A_001143,"ACMG GN005 criteria: PM2_P PM3_S, heterozygous, homozygous, VKGL data sharing initiative Nederland","PubMed: Chen 2020, PubMed: Gao 2019, PubMed: Gao 2021, PubMed: Huang 2018, PubMed: Liu-2020, 6 more items",-,rs1293619630,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",128,-,-,-,"David Baux, VKGL-NL_AMC"
156,"+/+, +/., +?/.",15,63,c.13576C>T,r.(?),"p.(Arg4526*), p.(Arg4526Ter)",Fibronectin type-III 30 (4444-4528),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215847677G>A,g.215674335G>A,"1:215847677G>A ENST00000307340.3:c.13576C>T (Arg4526Ter), USH2A c.13576C>T, p.(Arg4526*), 3 more items",-,USH2A_000532,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous, homozygous, Homozygous; Probable pathogenic, 2 more items","PubMed: Bravo-Gil 2017, PubMed: Carss 2017, PubMed: Hagag 2020, PubMed: Inaba 2020, PubMed: Turro 2020, 4 more items",-,rs1003869920,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",0/64 controls,-DpnI;-Sau3AI;-MboI;-BfuCI;-DpnII;-TaqI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Nereida Bravo Gil"
157,"-/., -/?, -?/., -?/?, ?/.",15,64,c.14074G>A,r.(?),"(p.Gly4692Arg), -, p.(Gly4692Arg)",Fibronectin type-III 32 (4633-4730),ACMG,"benign, likely benign, VUS",g.215844373C>T,g.215671031C>T,"1407G>A (Gly4692Arg), USH2A c.14074G>A, p.(Gly4692Arg), [12394del;14074G>A], 1 more item",-,USH2A_000164,"ACMG GN005 criteria: BS1_S BS2_S, heterozygous, Heterozygous; mutation, Heterozygous; UV1, 2 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Eandi 2017, 9 more items",-,rs45549044,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,none,-,-,"Johan den Dunnen, David Baux, Peter Krawitz, VKGL-NL_Leiden, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
158,"+?/., -/-, -/., -?/., ?/.",15,72,c.15562A>G,r.(?),p.(Ser5188Gly),Cytoplasmic (5064-5202),ACMG,"benign, likely benign, likely pathogenic, VUS",g.215799170T>C,g.215625828T>C,"USH2A c.15562A>G, p.S5188G, USH2A c.15562A>G, p.Ser5188Gly, 1 more item",-,USH2A_000281,"ACMG GN005 criteria: BA1 BS2_S BP4_P, heterozygous, Heterozygous; benign, Heterozygous; Neutral, 2 more items","0, PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Gao 2021, 6 more items",-,rs58257972,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes","13/1204 cases with retinitis pigmentosa, 16/860 controls, 185/1204 cases with retinitis pigmentosa",-AluI,-,-,"David Baux, VKGL-NL_Leiden, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Yoshito Koyanagi"
159,"+/., +/?, +?/., ?/.",14,"02i, 2i",c.486-14G>A,"r.(485_486ins486-12_486-1), r.(=), r.485_486ins486-12_486-1, r.spl, r.spl?","p.(=), p.?, p.[(Met162Ile,Met162_Cys163insCysPheLeuArg)], p.[Met162Ile,Met162_Cys163insCysPheLeuArg]",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216592035C>T,g.216418693C>T,-,-,USH2A_000313,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous, Heterozygous; ins last 12 nt IVS2, 3 more items","Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Baux 2014, PubMed: Dad 2016, 6 more items",ClinVar-372543,rs374536346,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record",yes,"0/100 controls, 0/200 controls",+BsrI;-MspI;-HpaII;-BsaWI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jinu Han, Rocio Villafuerte-de la Cruz"
160,"+/+, +/., +?/., +?/?",14,32i,c.6325+1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216219772C>T,g.216046430C>T,"c.6325+1G>A, USH2A c.6325+1G>A, -, USH2A c.6325+1G>A, USH2A c.6325+1G>A, -",-,USH2A_000383,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S PP1_S, heterozygous, homozygous","PubMed: Gao 2019, PubMed: Gao 2021, PubMed: Liu 2010, PubMed: Meng 2020, PubMed: Sun 2018, 2 more items",-,rs1293202153,"Germline, SUMMARY record, Unknown",?,0/100 controls,-,-,-,"David Baux, Anne-Françoise Roux"
161,"+/., +?/., ?/.",14,35,c.6670G>T,"r.(6670g>u), r.(?)",p.(Gly2224Cys),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216166497C>A,g.215993155C>A,"1:216166497C>A ENST00000307340.3:c.6670G>T (Gly2224Cys), USH2A c.6670G>T, p.Gly2224Cys, 4 more items",-,USH2A_001624,"ACMG GN005 criteria:, ACMG PM2, PP5, compound heterozygous, solved, compound heterozygous, 2 more items","PubMed: Carss 2017, PubMed: Consugar 2015, PubMed: Jiman 2020, PubMed: Khan 2017, PubMed: Stone 2017, 6 more items",-,rs149553844,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Janine Reurink"
162,"+/+, +/., +?/+, +?/.",14,69,c.14977_14978del,r.(?),"p.(Phe4993Profs * 7), p.(Phe4993Profs*7), p.(Phe4993ProfsTer7)",Fibronectin type-III 35 (4928-5014),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)","g.215812571_215812572del, g.215812574_215812575del",g.215639232_215639233del,"14977_14978delTT, 14977_14987del (Phe4993Profs*7), c.14977_14978del",-,USH2A_000272,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; mutation, Homozygous; mutation","PubMed: Karali 2019, Journal: Karali 2019, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Eandi 2017, 4 more items",-,rs747160949,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Sandro Banfi, Anne-Françoise Roux, Crystel Bonnet"
163,"-/-, -/.",13,20,c.4371G>A,"r.(=), r.(?)",p.(=),Fibronectin type-III 4 (1367-1462),-,benign,g.216363590C>T,g.216190248C>T,-,-,USH2A_000075,"25 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Le Guédard-Méreuze 2010, 2 more items",-,rs56013136,Germline,-,25/2795 individuals,+AcuI,-,-,"Anne-Françoise Roux, Jose Maria Millan, Mohammed Faruq"
164,"+/., +?/., ?/.",13,23,c.4821G>C,r.(?),p.(Trp1607Cys),-,ACMG,"likely pathogenic, pathogenic, VUS",g.216262419C>G,g.216089077C>G,"USH2A c.4821G>C, p.Trp1607Cys, USH2A c.4821G>C, p.Trp1607Cys, USH2A c.4821G>C, p.W1607C",-,USH2A_002573,"ACMG GN005 criteria: PM2_P PM3_S PP1_S PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
165,"+?/., -/., -?/., -?/?, ?/.",13,30,c.5975A>G,r.(?),p.(Tyr1992Cys),Fibronectin type-III 6 (1954-2051),ACMG,"benign, likely benign, likely pathogenic, VUS",g.216243517T>C,g.216070175T>C,"c.5975A>G, USH2A c.2522C>A, p.(Ser841Tyr), c.5975A>G, p.(Tyr1992Cys), 1 more item",-,USH2A_000415,"ACMG GN005 criteria: BS1_S BS2_S, Heterozygous; likely polymorphism, Heterozygous; mutation, 4 more items","PubMed: Booij-2011, PubMed: Ellingford 2016, PubMed: Garcia-Garcia, G. et al., 2011, 7 more items",-,rs41303287,"CLASSIFICATION record, Germline, SUMMARY record",?,"1/96 controls, 4/899 cases",none,-,-,"Global Variome, with Curator vacancy, David Baux, Peter Krawitz, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
166,"+/+, +/., +?/.",13,36,c.6862G>T,r.(?),"p.(Glu2288*), p.(Glu2288Ter)",Fibronectin type-III 9 (2241-2325),ACMG,"likely pathogenic, pathogenic",g.216144062C>A,g.215970720C>A,"c.2299delG p.(Glu767Serfs*21), c.6862G>T p.(Glu2288*), c.6862G>T, p.Glu2288Ter, 3 more items",-,USH2A_000234,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, compound heterozygous, heterozygous, Heterozygous; mutation, 2 more items","PubMed: Bonnet 2016, PubMed: Hagag 2020, PubMed: Jiman 2020, PubMed: Le Quesne Stabej 2012, 5 more items",-,rs398124619,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",0/878 controls,-Hpy188I;-DdeI;-BspCNI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet"
167,"+?/., ?/.",13,37,c.6998T>C,r.(?),p.(Val2333Ala),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216138781A>G,g.215965439A>G,"USH2A c.6998T>C, p.V2333A, USH2A c.6998T>C, p.Val2333Ala, 1 more item",-,USH2A_001212,"ACMG GN005 criteria:, heterozygous, VKGL data sharing initiative Nederland, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Sun, T. et al., 2018, PubMed: Huang 2018, 3 more items",-,rs144817385,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,3/314 case chromosomes,-,-,-,"David Baux, VKGL-NL_Leiden, VKGL-NL_Rotterdam"
168,"+/+, +/., +?/.",13,44,c.8834G>A,r.(?),"p.(Trp2945*), p.(Trp2945Ter)",Fibronectin type-III 16 (2925-3015),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216040360C>T,g.215867018C>T,"c.2299delG p.(Glu767Serfs*21), c.8834G>A p.(Trp2945*), c.8834G>A, c.8834G>A, p.Trp2945Ter, 3 more items",-,USH2A_000584,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous, Heterozygous; likely pathogenic, 4 more items","PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Glöckle 2014, PubMed: Hagag 2020, 5 more items",-,rs760302201,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",0/878 controls,none,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet"
169,"+/+, +/., +?/.",13,45,c.8981G>A,"r.(8981g>a), r.(?)","p.(Trp2994*), p.(Trp2994Ter)",Fibronectin type-III 16 (2925-3015),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216019240C>T,g.215845898C>T,"1:216019240C>T ENST00000307340.3:c.8981G>A (Trp2994Ter), c.8981G>A, p.Trp2994Ter, 3 more items",-,USH2A_000232,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, 1 more item","Journal: Reurink 2021, PubMed: Carss 2017, PubMed: Ellingford 2016, PubMed: Hagag 2020, 6 more items",-,rs397518041,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, Anne-Françoise Roux, Janine Reurink"
170,"+/., +?/., ?/., ?/?",13,48,c.9433C>T,"r.(9433c>u), r.(?)",p.(Leu3145Phe),Fibronectin type-III 18 (3113 - 3209),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.215990476G>A,g.215817134G>A,"USH2A c.9433C>T, p.(Leu3145Phe), USH2A(NM_206933.4):c.9433C>T (p.L3145F), 1 more item",-,USH2A_001187,"ACMG GN005 criteria: PM2_P PM3_M PP1_M, heterozygous, PM2_P, PM3_S following ClinGen GN005, 2 more items","Journal: Reurink 2021, PubMed: Ge 2015, PubMed: Perez-Carro 2016, PubMed: Reurink 2021, 4 more items",-,rs267598373,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no, yes",-,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Janine Reurink"
171,"+/., +?/., ?/.",13,64,c.14017T>C,r.(?),p.(Tyr4673His),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.215844430A>G,g.215671088A>G,"c.14017T>C, M2: USH2A c.14017T>C, Y4673H, USH2A c.14017T>C, p.Tyr4673His, 3 more items",-,USH2A_001460,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, marked as causative, heterozygous, 1 more item","PubMed: Chen 2020, PubMed: Gao 2021, PubMed: Huang 2016, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 5 more items",-,rs1040917329,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",4/1204 cases with retinitis pigmentosa,-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Yoshito Koyanagi"
172,"+/., +?/., +?/?, ?/.",13,65,c.14243C>T,r.(?),p.(Ser4748Phe),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic, VUS",g.215824034G>A,g.215650692G>A,"c.14243C>T:p.S4748F, USH2A c.14243C>T, p.(Ser4748Phe), USH2A p.(Ser4748Phe)",-,USH2A_000865,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, Heterozygous; possible pathogenic, homozygous, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 4 more items",-,rs527236126,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,"0/400 controls, 6/1204 cases with retinitis pigmentosa",-,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi, Jinu Han"
173,"+/+, +/., +?/.",12,12,c.2023C>T,r.(?),"p.(Gln675*), p.(Gln675Ter)",Laminin EGF-like 3 (641-693),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216424389G>A,g.216251047G>A,"2023C>T;2797C>T, c.2023C>T p.(Gln675*), c.2299delG p.(Glu767Serfs*21), USH2A c.2023C>T, 1 more item",-,USH2A_000024,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic, possible duplicate, 2 more items","PubMed: Dreyer 2000, PubMed: Dreyer 2000, PubMed: Dreyer 2008, Tranebjaerg 2011, PubMed: Dad 2016, 7 more items",-,rs868562952,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,0/878 controls,+Tsp509I;-TspRI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz"
174,"+/., +?/., +?/?",12,25,c.5012G>A,r.(?),p.(Gly1671Asp),Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216258195C>T,g.216084853C>T,"1:216258195C>T ENST00000307340.3:c.5012G>A (Gly1671Asp), c.[12448A>G;5012G>A], 1 more item",-,"USH2A_000616, USH2A_001444","heterozygous, Heterozygous; Neutral, homozygous","Sharon, submitted, PubMed: Carss 2017, PubMed: Ge 2015, PubMed: Midgley 2024, PubMed: Sharon 2019, 2 more items",-,rs727505116,"Germline, Germline/De novo (untested)",?,1/2420 IRD families,+Hpy166II;+HpyCH4III;-CviKI_1;,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, Dror Sharon, Maria Bitner-Glindzicz"
175,"+/., +?/., -?/., ?/.",12,34,c.6628C>G,r.(?),p.(Pro2210Ala),-,ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216172258G>C,g.215998916G>C,"USH2A c.6628C>G, p.P2210A, 1 more item",-,USH2A_001221,"ACMG GN005 criteria:, heterozygous, VKGL data sharing initiative Nederland","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Qu 2020, PubMed: Sun 2018, PubMed: Xu 2014, 2 more items",-,rs192115090,"CLASSIFICATION record, Germline, SUMMARY record",yes,"24/1204 cases with retinitis pigmentosa, 5/314 case chromosomes",-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Yoshito Koyanagi"
176,"-/-, -/?",12,38i,c.7301-65C>T,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,"benign, likely benign",g.216074312G>A,g.215900970G>A,-,-,USH2A_000338,"Heterozygous, Heterozygous; UV1","PubMed: Aller 2004, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 2 more items",-,rs41277204,Germline,-,-,-TaqI,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
177,"+?/., -/?, -?/., -?/?",12,41,c.7685T>C,r.(?),p.(Val2562Ala),Fibronectin type-III 12 (2533-2619),ACMG,"likely benign, likely pathogenic",g.216062306A>G,g.215888964A>G,"c.4222C>T p.(Gln1408*), c.13576C>T p.(Arg4526*), c.7685T>C p.(Val2562Ala), 1 more item",-,USH2A_000266,"Heterozygous, Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Eisenberger 2018, 5 more items",-,rs56385601,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,0.6% (150 controls),+CviKI_1,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
178,"+/+, +/., +?/.",12,46i,c.9258+1G>A,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216017635C>T,g.215844293C>T,"c.9258+1G/A, c.2276G/T (p.Cys759Phe), USH2A c.9258+1G>A, p.(?), 4 more items",-,USH2A_001071,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous, Heterozygous; mutation, 2 more items","Journal: Reurink 2021, PubMed: Bonnet 2016, PubMed: Hariri 2018, PubMed: Mansard et al, 2021, 4 more items",-,rs748810737,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no, yes",-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
179,"-/-, -/., -?/.",12,62,c.12093C>T,r.(?),"p.(=), p.(Tyr4031=)",Fibronectin type-III 25 (3961-4062),-,"benign, likely benign",g.215853692G>A,g.215680350G>A,"USH2A(NM_206933.2):c.12093C>T (p.Y4031=), USH2A(NM_206933.4):c.12093C>T (p.Y4031=)",-,USH2A_000109,"Heterozygous, Heterozygous; polymorphism, Homozygous, Homozygous; polymorphism, 1 more item","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010, PubMed: McGee 2010",-,rs55921307,"CLASSIFICATION record, Germline",-,-,+MslI;+BstXI;-CviQI;-RsaI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
180,"+/+, +/., +?/.",12,64,c.13822C>T,r.(?),"p.(Arg4608*), p.(Arg4608Ter)",Fibronectin type-III 31 (4529-4627),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215844625G>A,g.215671283G>A,"USH2A c.C13822T, p.R4608*, 1 more item",-,USH2A_000132,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, Heterozygous, Heterozygous; mutation, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bravo-Gil 2017, PubMed: Fuster-Garcia 2018, 5 more items",-,rs367674026,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Anne-Françoise Roux, Crystel Bonnet, Nereida Bravo Gil"
181,"+/+, +/., +?/.",12,70,c.15089C>A,"r.(15089c>a), r.(?)","p.(Ser5030*), p.(Ser5030Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215808009G>T,g.215634667G>T,"c.15089C>A,p.S5030X, M18: c.15089C > A; p.Ser5030*",-,USH2A_000045,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation, 1 more item","PubMed: Baux 2007, PubMed: Bonnet 2011, PubMed: Bonnet 2016, PubMed: Gonzalez del Pozo 2018, 4 more items",-,rs758660532,"Germline, SUMMARY record",yes,-,-AlwI;-Sau3AI;-MboI;-BstUI;-DpnI;-BfuCI;,-,-,"David Baux, María González-del Pozo, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
182,"+/., +?/., -/., ?/.",11,3,c.490G>T,r.(?),p.(Val164Phe),-,ACMG,"benign, likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216592017C>A,g.216418675C>A,"c.490G>T, c.490G>T:p.V164F, USH2A c.490G>T, p.(Val164Phe), USH2A p.(Val164Phe)",-,USH2A_001553,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020; PubMed: Inaba, A. et al., 2020, PubMed: Maeda 2018, 5 more items",-,rs527236123,"Germline, SUMMARY record, Unknown",?,2/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
183,"+/., +?/., +?/?",11,6,c.907C>A,"r.(907c>a), r.(?), r.907C>A","p.(Arg303Ser), p.Arg303Ser",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic, VUS",g.216498883G>T,g.216325541G>T,M20: c.907C > A; p.Arg303Ser,-,USH2A_000189,"ACMG GN005 criteria: PM2_P PM3_M PP1_S, Heterozygous","PubMed: Aller 2004, USMA missense analysis, missense variant in MSV3d, PubMed: Gonzalez del Pozo 2018, 4 more items",-,rs748465849,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","0/100 controls, 0/116 controls, 1/143 cases",+HpyCH4V;-BceAI;,-,-,"Johan den Dunnen, David Baux, María González-del Pozo, Anne-Françoise Roux, Jose Maria Millan"
184,"+/+, +/., +?/.",11,19,c.4222C>T,r.(?),"p.(Gln1408*), p.(Gln1408Ter)",Fibronectin type-III 4 (1367-1462),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216369924G>A,g.216196582G>A,"1:216369924G>A ENST00000307340.3:c.4222C>T (Gln1408Ter), USH2A c.4222C>T, p.(Gln1408), 4 more items",-,USH2A_000217,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; mutation, homozygous, 1 more item","PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Ellingford 2016, PubMed: Hagag 2020, 5 more items",-,rs746551311,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet"
185,"+/+, +/., +?/.",11,21,c.4510dup,"r.(4510dup), r.(?)","p.(Arg1504Lysfs*26), p.(Arg1504LysfsTer26)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216348713dup,g.216175371dup,"4510dupA, USH2A c.4510dup, USH2A c.4510dup, p.(Arg1504Lysfs*26), USH2A c.4510dup, p.Arg1504LysfsTer26, 1 more item",-,"USH2A_000218, USH2A_000587","ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; Pathogenic, 3 more items","Journal: Reurink 2021, PubMed: de Bruijn 2023, PubMed: Le Quesne Stabej 2012, PubMed: Reurink 2021, 5 more items",-,rs727503731,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, no",-,none,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
186,-/-,11,39i,c.7451+39T>C,r.(=),p.(=),-,-,benign,g.216074058A>G,g.215900716A>G,-,-,USH2A_000032,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010, 1 more item",-,-,Germline,-,-,-,-,-,"Anne-Françoise Roux, Jose Maria Millan"
187,"+/+, +/., +?/.",11,42,c.8522G>A,r.(?),"p.(Trp2841*), p.(Trp2841Ter)",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216052142C>T,g.215878800C>T,"c.8522G>A, USH2A, variant 1: c.11864G>A/p.W3955*, variant 2: c.8522G>A/p.W2841*, 3 more items",-,USH2A_001018,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, ACMG PM2, PVS1, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2016, PubMed: Foote-2019, PubMed: Neuhaus 2017, PubMed: Stone 2017, PubMed: Tiwari 2016, 3 more items",-,rs1064797134,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, Crystel Bonnet"
188,"-/-, -/., -?/., -?/?, ?/.",11,47,c.9262G>A,r.(?),p.(Glu3088Lys),Fibronectin type-III 17 (3020-3105),ACMG,"benign, likely benign, VUS",g.216011442C>T,g.215838100C>T,"USH2A(NM_206933.2):c.9262G>A (p.E3088K), USH2A(NM_206933.4):c.9262G>A (p.E3088K)",-,USH2A_000123,"13 heterozygous, no homozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, 2 more items","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2014, 4 more items",-,rs56056328,"CLASSIFICATION record, Germline",-,"13/2795 individuals, 4/844 controls",+MseI,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Mohammed Faruq"
189,"+/., +?/.",11,49,c.9676C>T,r.(?),"p.(Arg3226*), p.(Arg3226Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215987141G>A,g.215813799G>A,"c.9676C>T, C9676T, USH2A c.9676C>T, p.Arg3226*, USH2A c.9676C>T, p.Arg3226*, 2 more items",-,USH2A_001600,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_M, compound heterozygous, heterozygous, 1 more item","PubMed: Colombo-2020, PubMed: Gao 2021, PubMed: Jauregui 2020, PubMed: Katagiri 2014, PubMed: Zhu 2021, 3 more items",-,rs760858249,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
190,"+?/., -/., -/?, -?/., ?/.",11,50,c.9915G>C,r.(?),p.(Glu3305Asp),Cystein rich (3192-3358),ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.215972292C>G,g.215798950C>G,"c.9915G>C, USH2A c.9915G>C, p.E3305D, USH2A c.9915G>C, p.Glu3305Asp, 1 more item",-,USH2A_000780,"ACMG GN005 criteria: BS2_S BP4_P, heterozygous, Heterozygous; polymorphism, 2 more items","PubMed: Chen-2013, PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Xu 2014, 3 more items",-,rs145278250,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"2/314 case chromosomes, 21/1204 cases with retinitis pigmentosa",+HpyCH4III,-,-,"David Baux, VKGL-NL_Rotterdam, Anne-Françoise Roux, Yoshito Koyanagi"
191,"+/+, +/., +?/.",11,53,c.10450C>T,r.(?),"p.(Arg3484*), p.(Arg3484Ter)",Fibronectin type-III 19 (3404-3494),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.215956215G>A,g.215782873G>A,"c.10450C>T, USH2A c.10450C>T, p.Arg3484Ter",-,USH2A_000475,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S PP1_P, Heterozygous, Heterozygous; Mutation","PubMed: Colombo-2020, PubMed: Eandi 2017, PubMed: Holtan 2020, PubMed: Huang 2013, PubMed: Sodi 2014, 3 more items",-,rs111033379,"Germline, SUMMARY record, Unknown","?, yes",1/899 cases,-,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux"
192,"+/., +?/., ?/.",11,58i,c.11389+3A>T,"r.(11347_11389del), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.215931934T>A,g.215758592T>A,"c.1810_1817delGTTTGTGA; c.11389+3A/T(alleles in trans), USH2A c.11389+3A>T(;)13339A>G; p.?, 2 more items",-,USH2A_001482,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, alleles in cis or trans; heterozygous, heterozygous, 2 more items","PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022, PubMed: Chen 2021, PubMed: Chen 2021, 5 more items",SCV000579424.1,rs753886165,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 1 more item",-,-,-,"Johan den Dunnen, David Baux, Barbara Vona, Yoshito Koyanagi, Jinu Han"
193,"+/., +?/?",11,65,c.14287G>C,r.(?),p.(Gly4763Arg),Fibronectin type-III 33 (4732-4825),ACMG,"pathogenic, VUS",g.215823990C>G,g.215650648C>G,"USH2A c.14287C>G, p.G4763R, USH2A c.14287G>C, p.G4763R, USH2A c.14287G>C, p.Gly4763Arg",-,USH2A_000874,"ACMG GN005 criteria: PM2_P PM3_S PP1_S, heterozygous, Homozygous; mutation, 1 more item","PubMed: Chen 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Gao 2021, 2 more items",-,rs397517990,"Germline, SUMMARY record, Unknown",?,0/300 controls,-,-,-,"David Baux, Anne-Françoise Roux"
194,"+/., +?/., ?/.",11,66,c.14384T>G,"r.(14384u>g), r.(?)",p.(Leu4795Arg),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215822068A>C,g.215648726A>C,"USH2A c.14384T>G, p.(Leu4795Arg)",-,USH2A_000502,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous, possible duplicate, 1 more item","Journal: Reurink 2021, PubMed: Dad 2016, PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, 3 more items",-,rs199851839,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Janine Reurink"
195,"-/-, -/., -/?",11,66,c.14543G>A,r.(?),p.(Arg4848Gln),Fibronectin type-III 34 (4826-4927),-,benign,g.215821909C>T,g.215648567C>T,-,-,USH2A_000279,"Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Heterozygous; Predicted benign, 2 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 4 more items",-,rs77211159,"CLASSIFICATION record, Germline",-,"13/1204 cases with retinitis pigmentosa, 15/874 controls, 189/1204 cases with retinitis pigmentosa",+BsrI;+TspRI;-MspI;-HpaII;-BsaWI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Yoshito Koyanagi"
196,"+/., +?/., +?/?, ?/.",11,69,c.15017C>T,r.(?),p.(Thr5006Met),Fibronectin type-III 35 (4928-5014),ACMG,"likely pathogenic, pathogenic, VUS","g.215812532G>A, g.215812532G>C","g.215639190G>A, g.215639190G>C","c.15017C>T,p.T5006M, USH2A c.15017C>T, p.Thr5006Met",-,USH2A_001053,"ACMG GN005 criteria: PM2_P PM3_S, Conflicting in silico model predictions, heterozygous, heterozygous, 2 more items","{PMID27460420:Bonnet et al., 2016}, USMA missense analysis, missense variant in MSV3d, 7 more items",-,rs757676723,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Crystel Bonnet"
197,"+?/., +?/?",10,11,c.1859G>T,r.(?),p.(Cys620Phe),Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, VUS",g.216462734C>A,g.216289392C>A,"c.1859G>T p.(Cys620Phe), c.4821G>A p.(Trp1607*), c.1859G>T,p.C620F, USH2A c.1859G>T, 2 more items",-,USH2A_000572,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, compound heterozygous, heterozygous, Heterozygous; Pathogenic, 1 more item","PubMed: Ellingford 2016, PubMed: Hagag 2020, PubMed: Jiman 2020, PubMed: Molina-Ramirez 2020, 4 more items",-,rs758571672,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,0/878 controls,-HpyCH4V,-,-,"David Baux, Maria Bitner-Glindzicz"
198,"+/+, +/., +?/.",10,13,c.2431_2432del,r.(?),"p.(Lys811Aspfs*11), p.(Lys811AspfsTer11)",Laminin EGF-like 6 (795-846),ACMG,"likely pathogenic, pathogenic",g.216420304_216420305del,g.216246962_216246963del,"2431_2432delAA, USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.13 c.2431_2432del p.(Lys811fs*11)",-,USH2A_000196,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, Heterozygous, 1 more item","PubMed: Bernal 2005, PubMed: Jaijo 2010, PubMed: Martin Merida 2019, PubMed: Najera 2002, 2 more items",-,rs2102545818,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
199,"+/., +?/., +?/?",10,17,c.3407G>A,r.(?),p.(Ser1136Asn),Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216373373C>T,g.216200031C>T,"USH2A c.14911C>T, p.(Arg4971*), c.3407G>A, p.(Ser1136Asn), USH2A c.3407G>A, p.(Ser1136Asn), 1 more item",-,USH2A_000644,"ACMG GN005 criteria: PM2_P PM3_M, compound heterozygous, heterozygous, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Dad 2016, 7 more items",-,rs483353055,"Germline, SUMMARY record, Unknown",?,0/878 controls,none,-,-,"David Baux, Maria Bitner-Glindzicz, Crystel Bonnet"
200,"+/+, +/., +?/.",10,17,c.3788G>A,r.(?),"p.(Trp1263*), p.(Trp1263Ter)",Fibronectin type-III 3 (1242-1357),ACMG,"likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216372992C>T,g.216199650C>T,"c.3788G>A, NM_206933.2:c.3788G>A, NP_996816.2:p.(Trp1263Ter), NC_000001.10:g.216372992C>T, 2 more items",-,USH2A_000745,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P, heterozygous, Heterozygous; Disease causing","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Sun, T. et al., 2018, PubMed: Liu-2020, 4 more items",-,rs1572042090,"Germline, SUMMARY record, Unknown",?,0/200 controls,-BsaI,-,-,"David Baux, Anne-Françoise Roux"
201,"+?/., +?/?, ?/.",10,20,c.4325T>C,"r.(=), r.(?), r.4325T>C","p.(Phe1442Ser), p.Phe1442Ser",Fibronectin type-III 4 (1367-1462),ACMG,"likely pathogenic, VUS",g.216363636A>G,g.216190294A>G,"c.4325T>C, M19: c.4325T >C; p.Phe1442Ser",-,USH2A_000856,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; pathogenic","PubMed: de Castro-Miró 2014, PubMed: de Castro-Miró-2014, PubMed: Gonzalez del Pozo 2018, 2 more items",-,rs766108245,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, María González-del Pozo, Marta de Castro-Miró, Anne-Françoise Roux"
202,"+/+, +/., +?/.",10,"21i_24i, 22-24, 22_24",c.4627+25435_4987+660del,"r.(4627_4987del), r.(4628_4987del), r.(?)","p.(?), p.(Gly1543_Pro1662del), p.?",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic",g.216259402_216323160del,g.216086060_216149818del,"del22-23, hg19:chr1:g.216259403_216323159del, USH2A c.4627+25435_4987+660del, p.(Gly1543_Pro1662del)",-,USH2A_000095,"Heterozygous, Heterozygous; mutation, Heterozygous; nomenclature modified 12/2012, 1 more item","Journal: Reurink 2021, PubMed: Baux 2007, PubMed: Bonnet 2016, PubMed: Dad 2015, PubMed: Dad 2016, 2 more items",-,-,Germline,yes,-,-,-,-,"Anne-Françoise Roux, Shzeena Dad, Crystel Bonnet, Janine Reurink"
203,"+/+, +/., +?/., +?/?",10,26,c.5200G>C,r.(?),p.(Gly1734Arg),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216256896C>G,g.216083554C>G,"c.5200G>C, USH2A c.5200G>C, p.G1734R, USH2A c.5200G>C, p.Gly1734Arg",-,USH2A_000382,"ACMG GN005 criteria: PM2_P PM3_S PP1_M, heterozygous, Heterozygous; mutation, Homozygous","PubMed: Gao 2021, PubMed: Jiang 2015, USMA missense analysis, missense variant in MSV3d, 4 more items",-,-,"Germline, SUMMARY record, Unknown","?, yes",0/100 controls,-NlaIII,-,-,"David Baux, Anne-Françoise Roux"
204,"+/., +?/., ?/.",10,27,c.5516T>A,"r.(5516u>a), r.(?)",p.(Val1839Glu),-,ACMG,"likely pathogenic, pathogenic, VUS",g.216251487A>T,g.216078145A>T,"USH2A c.5516T>A, p.(Val1839Glu), 1 more item",-,USH2A_001240,"ACMG GN005 criteria: PM2_P, ACMG PM2, heterozygous, no variant 2nd chromome, 1 more item","Journal: Reurink 2021, PubMed: Haer-Wigman 2017, PubMed: Neuhaus 2017, PubMed: Reurink 2021, 3 more items",-,rs886039867,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Janine Reurink"
205,-/-,10,30i,c.6049+76A>T,"r.(=), r.(?)","p.(=), p.(?)",-,-,benign,g.216243367T>A,g.216070025T>A,-,-,USH2A_000113,"Heterozygous, Heterozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012, PubMed: Vaché 2012",-,rs55865063,Germline,-,-,+NdeI,-,-,"Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
206,"+/., +?/., ?/.",10,36,c.6937G>T,r.(?),p.(Gly2313Cys),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216143987C>A,g.215970645C>A,"USH2A c.6937G>T, p.G2313C, USH2A c.6937G>T, p.G231C, 1 more item",-,USH2A_001439,"ACMG GN005 criteria:, compound heterozygous, VKGL data sharing initiative Nederland, 1 more item","PubMed: Bravo-Gil 2016, PubMed: Comander 2017, PubMed: Jauregui 2020, PubMed: Sharon 2019, 3 more items",-,rs199840367,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"1/1204 cases with retinitis pigmentosa, 1/2420 IRD families",-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon, VKGL-NL_Leiden, VKGL-NL_Rotterdam, Yoshito Koyanagi"
207,"-/-, -/?",10,36i,c.6958-132G>A,r.(=),p.(=),-,ACMG,"benign, likely benign",g.216138953C>T,g.215965611C>T,-,-,USH2A_000379,"Heterozygous, Heterozygous; Not Assessed","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs12069955,Germline,-,-,-MnlI,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
208,+/.,10,37i_56i,c.7121-8313_11048-962delins12,"r.(7121_11048del), r.(?)",p.(Val2374_Gly3683del),-,ACMG,pathogenic,"g.215934147_216116450delins12, g.215934147_216116450delinsN[12]",g.215760805_215943108delins12,"USH2A c.7121-8313_11048-962delins12, p.(Val2374_Gly3683del)",-,USH2A_002109,"error in annotation,this change has 12 unknown inserted nucleotides; heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021",-,-,"Germline, Unknown","?, no, yes",-,-,-,-,Janine Reurink
209,"+?/+?, +?/., ?/., ?/?",10,41,c.7915T>C,r.(?),p.(Ser2639Pro),Fibronectin type-III 13 (2621-2718),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216062076A>G,g.215888734A>G,"c.7915T>C, USH2A(NM_206933.2):c.7915T>C (p.S2639P)",-,USH2A_000422,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; benign, Heterozygous; UV2, PM2_Sup, PM3_St, PP1_M, PP3, 2 more items","PubMed: Bahena 2021, PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 4 more items",ClinVar-96667,rs398124620,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,none,-,-,"David Baux, VKGL-NL_Rotterdam, Barbara Vona, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet"
210,"+/., +?/.",10,43,c.8638_8641dup,r.(?),"p.(Ser2881Leufs*9), p.(Ser2881LeufsTer9)",-,ACMG,"likely pathogenic, pathogenic",g.216051144_216051147dup,g.215877802_215877805dup,"USH2A (NM_206933.2):c.13465G>A(p.G4489S)/c.8641_8642insTATT(p.S2881Lfs*9), 4 more items",-,USH2A_002150,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_M, heterozygous, solved, compound heterozygous, 1 more item","PubMed: Gao 2021, PubMed: Sun 2018, PubMed: Weisschuh 2020, PubMed: Zhu 2021, 1 more item",-,-,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",128,-,-,-,David Baux
211,"+/+, +/., +?/.",10,45i,c.9056-2A>G,"r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216017840T>C,g.215844498T>C,"USH2A c.1606T>C, p.(Cys536Arg), c.9056-2A>G, p.(?), USH2A c.9056-2A>G, 4 more items",-,USH2A_000882,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, Heterozygous, 3 more items","PubMed: Jespersgaar 2019, PubMed: Lenassi 2015, PubMed: Weisschuh 2020, PubMed: Weisschuh 2024, 2 more items",-,rs754970095,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Eva Lenassi"
212,"+/+, +/., +?/.",10,47,c.9270C>A,r.(?),"p.(Cys3090*), p.(Cys3090Ter)",Fibronectin type-III 17 (3020-3105),ACMG,"likely pathogenic, pathogenic",g.216011434G>T,g.215838092G>T,"c.9270C>A, USH2A, variant 1: c.2276G>T/p.C759F, variant 2: c.9270C>A/p.C3090*, 3 more items",-,USH2A_000404,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_VS, Heterozygous, Heterozygous; likely pathogenic, 3 more items","PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Glöckle 2014, PubMed: McGee 2010, 3 more items",-,rs779572631,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
213,"+/+, +/., +?/.",10,"52, 58",c.11235C>G,r.(?),"p.(Tyr3745*), p.(Tyr3745Ter)",Fibronectin type-III 22 (3677-3767),ACMG,"likely pathogenic, pathogenic",g.215932091G>C,g.215758749G>C,"USH2A c.11235C>G, Tyr3745*, USH2A c.11235C>G, p.Tyr3745*, USH2A c.11235C>G, p.Y3745*",-,USH2A_000873,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Homozygous; mutation","PubMed: Chen 2014, PubMed: Gao 2021, PubMed: Meng 2020, PubMed: Zhu 2021, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",0/300 controls,-,-,-,"David Baux, Anne-Françoise Roux"
214,"+/., +?/.",10,58i,c.11389+1G>C,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215931936C>G,g.215758594C>G,"USH2A c.11389+1G>C, USH2A c.11389+1G>C, -",-,USH2A_002082,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, 1 more item","0, PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Huang, X. F. et al., 2015, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
215,-/-,10,58i,c.11389+15G>A,r.(=),p.(=),-,-,benign,g.215931922C>T,g.215758580C>T,-,-,USH2A_000089,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
216,"+?/., -/., ?/.",10,-,c.11549-5del,"r.(=), r.(?), r.spl?","p.(=), p.(?), p.?",-,ACMG,"benign, likely pathogenic, VUS",g.215914895del,g.215741553del,"11549-5delT, c.11549-5delT, c.115495delT, USH2A c.11549-5delT, -",-,USH2A_001340,"ACMG GN005 criteria: BA1 BS2_S BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Xu 2014",-,rs34565443,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,7/314 case chromosomes,-,-,-,"David Baux, VKGL-NL_Nijmegen"
217,"+/+, +/., +?/., ?/.",10,59i,c.11549-1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215914880C>T,g.215741538C>T,"USH2A c.11549-1G>A, USH2A, variant 1: c.11549-1G>A/p.?, variant 2: c.14761G>T/p.E4921*",-,USH2A_000899,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation, 2 more items","PubMed: Bonnet 2016, PubMed: de Bruijn 2023, PubMed: Reurink 2023, Journal: Reurink 2023, 6 more items",-,rs878853407,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Eva Lenassi, Crystel Bonnet, Janine Reurink"
218,"+?/., -?/?, ?/.",10,61,c.11927C>T,"r.(11927c>u), r.(?)",p.(Thr3976Met),Fibronectin type-III 25 (3961-4062),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.215901511G>A,g.215728169G>A,"c.11927C>T, 1 more item",-,USH2A_000076,"ACMG GN005 criteria:, Heterozygous, no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo, L. et al., 2021, 4 more items",-,rs142381713,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Groningen, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Janine Reurink"
219,"+/., +?/., +?/?, -?/?",10,62i,c.12295-3T>A,"r.12295_13811del, r.spl, r.spl?","p.(?), p.(Thr4099ValfsTer2), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215848961A>T,g.215675619A>T,"IVS62-3T>A, USH2A c.12295-3T>A, 1 more item",-,USH2A_000625,"ACMG GN005 criteria: PM2_P PM3_S PP1_P PP3_P, Heterozygous, Heterozygous; UV2, no variant 2nd chromome, 1 more item","PubMed: Le Quesne Stabej 2012, PubMed: Lenassi 2015, PubMed: Reurink 2023, Journal: Reurink 2023, 4 more items",-,rs111033518,"Germline, SUMMARY record, Unknown",?,0/96 controls,+BbsI;+Hpy188I;+AcuI;-Hpy166II;-AccI;-SfcI;,-,-,"David Baux, Maria Bitner-Glindzicz, Eva Lenassi, Janine Reurink"
220,"+?/+?, +?/., +?/?, ?/.",10,63,c.12845T>C,r.(?),p.(Leu4282Pro),"Fibronectin type-III 28 (4262 - 4357), Fibronectin type-III 28 (4265-4351)",ACMG,"likely pathogenic, VUS",g.215848408A>G,g.215675066A>G,-,-,USH2A_000315,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous, Heterozygous; mutation, Homozygous; mutation, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 3 more items",-,rs1657968255,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
221,"+/., +?/.",10,63,c.13112_13115del,r.(?),"p.(Gln4371Argfs*19), p.(Gln4371ArgfsTer19)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215848138_215848141del,g.215674796_215674799del,"13112_13115delAAAT, USH2A c.13112_13115del, p.G4371fs*19, USH2A c.13112_13115del, p.Q4371Rfs, 4 more items",-,USH2A_001469,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PVS1, PM2_P, PM3_P, heterozygous, 4 more items","PubMed: Gao 2021, PubMed: Jauregui 2020, PubMed: Kim 2022, Journal: Kim 2022, PubMed: Koyanagi 2020, 4 more items",-,rs768161313,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",1/1204 cases with retinitis pigmentosa,-,-,-,"Johan den Dunnen, David Baux, Yoshito Koyanagi"
222,"+/., +?/., +?/?, ?/.",10,65,c.14285A>G,r.(?),p.(Asn4762Ser),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS","g.215650650T>C, g.215823992T>C",g.215650650T>C,"USH2A c.14285A>G,, USH2A c.14285A > G, p.Asn4762Ser, homozygous, USH2A c.14285A>G, 1 more item",-,USH2A_000580,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; UV3, VKGL data sharing initiative Nederland, 2 more items","PubMed: Huang 2018, PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 6 more items",-,rs1254637647,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",0/878 controls,+BseYI;+MspA1I;+AciI;+FauI;,-,-,"David Baux, VKGL-NL_Nijmegen, Maria Bitner-Glindzicz"
223,"-/-, -/.",10,66,c.14481C>T,r.(?),"p.(=), p.(Ala4827=)",Fibronectin type-III 34 (4826-4927),-,benign,g.215821971G>A,g.215648629G>A,-,-,USH2A_000277,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous; Neutral, 1 more item","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012, PubMed: McGee 2010",-,rs41304083,"CLASSIFICATION record, Germline",-,16/876 controls,none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz"
224,"-/-, -/.",10,66,c.14513G>A,r.(?),p.(Gly4838Glu),Fibronectin type-III 34 (4826-4927),-,benign,g.215821939C>T,g.215648597C>T,-,-,USH2A_000448,"Heterozygous; benign, Heterozygous; Neutral, Homozygous; Neutral, 1 more item","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 2 more items",-,rs41315587,"CLASSIFICATION record, Germline",-,"13/1204 cases with retinitis pigmentosa, 16/876 controls, 189/1204 cases with retinitis pigmentosa",+BsmBI;+BsmAI;+TaqI;-BsmFI;-BslI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Yoshito Koyanagi"
225,"-/-, -/.",10,70,c.15076A>G,r.(?),p.(Lys5026Glu),-,-,benign,g.215808022T>C,g.215634680T>C,USH2A(NM_206933.2):c.15076A>G (p.K5026E),-,USH2A_000280,"Heterozygous, Heterozygous; benign, Heterozygous; Neutral, Homozygous; Neutral, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 3 more items",-,rs41308435,"CLASSIFICATION record, Germline",-,"13/1204 cases with retinitis pigmentosa, 16/876 controls, 185/1204 cases with retinitis pigmentosa",none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Yoshito Koyanagi"
226,"+/., +?/., -?/., ?/.",10,-,c.15233C>G,r.(?),p.(Pro5078Arg),-,ACMG,"likely benign, likely pathogenic, pathogenic, VUS",g.215807865G>C,g.215634523G>C,"USH2A c.15233C>G, p.(Pro5078Arg), USH2A c.C15233G, p.P5078R, USH2A p.(Pro5078Arg)",-,USH2A_001455,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, heterozygous, marked as causative, heterozygous, 2 more items","PubMed: Inaba 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Koyanagi 2020, 3 more items",-,rs527236122,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,13/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi, Jinu Han"
227,"+?/., -/., -/?, ?/.",10,71,c.15377T>C,"r.(15377u>c), r.(?)",p.(Ile5126Thr),Cytoplasmic (5064-5202),ACMG,"benign, likely benign, likely pathogenic, VUS",g.215802298A>G,g.215628956A>G,"c.15377T>C, USH2A c.15377T>C, I5126T",-,USH2A_000235,"Heterozygous, Heterozygous; benign, Heterozygous; UV1, no variant 2nd chromome, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Booij-2011, 6 more items",-,rs111033266,"CLASSIFICATION record, Germline, Unknown",?,0/150 controls,-BtsCI;-FokI;-SfaNI;-Hpy188III;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
228,"+/+, +/., +?/.",9,"4i_10i, 5-1",c.785-6636_1840+208del,"r.(785_1840del), r.(?), r.?","p.(?), p.(Leu263_Gly614del), p.?","Laminin N-terminal (271-517), Laminin EGF-like 1 (518-574), Laminin EGF-like 2 (575-640), 1 more item",ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216465309_216507632del,g.216291967_216334290del,"USH2A allele 1: Exon 5-10 deletion, g.216465309_216507632del, allele 2: none",-,USH2A_000739,"Heterozygous, Heterozygous; mutation, Homozygous; mutation, 1 more item","PubMed: Austin-Tse 2018, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: De Bruijn 2023, 2 more items",SCV000205103,-,Germline,yes,-,-,-,-,"Anne-Françoise Roux, Crystel Bonnet, Janine Reurink, Suzanne de Bruijn"
229,"+/+, +/., +?/.",9,5,c.820C>T,r.(?),"p.(Arg274*), p.(Arg274Ter)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216500961G>A,g.216327619G>A,"USH2A c.[820C>T];[15178T>C], V1: c.820C>T, (p.Arg274Ter), 1 more item",-,USH2A_000289,"4 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, 3 more items","PubMed: Baux 2014, PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Garcia-Garcia 2011, 3 more items",-,rs397518036,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes","4/2795 individuals, Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0.00000797",-BcgI;-TaqI;,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan, Jinu Han, Mohammed Faruq"
230,"+/., +?/., +?/?, ?/.",9,8,c.1531G>A,r.(?),"p.(Glu511Lys ), p.(Glu511Lys)",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216496835C>T,g.216323493C>T,"c.1531G>A, USH2A(NM_206933.4):c.1531G>A (p.E511K), 1 more item",-,USH2A_000529,"ACMG GN005 criteria: PM2_P PM3_M PP1_P, Heterozygous, solved, compound heterozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 4 more items",-,rs767209934,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,0/184 controls,none,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, VKGL-NL_VUmc, Anne-Françoise Roux, Crystel Bonnet"
231,"+/+, +?/?, ?/.",9,8,c.1550G>C,r.(?),p.(Arg517Thr),Laminin N-terminal (271-517),ACMG,VUS,g.216496816C>G,g.216323474C>G,"1550G>C/1550G>C, c.1550G>C, p.Arg517Thr, USH2A c.1550G>C, p.Arg517Thr",-,USH2A_000224,"heterozygous, homozygous","PubMed: Schwartz 2005, PubMed: Seyedahmadi 2004, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
232,"+/+, +/., +?/., +?/?",9,12,c.2071T>C,r.(?),p.(Cys691Arg),Laminin EGF-like 3 (641-693),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216424341A>G,g.216250999A>G,c.2071T>C,-,USH2A_000938,"ACMG GN005 criteria: PM2_P PM3_VS PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 2 more items",-,rs770293341,"Germline, SUMMARY record",-,0/200 controls,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
233,"+/?, +?/., +?/?, ?/.",9,17,c.3368A>G,r.(?),p.(Tyr1123Cys),Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic, VUS",g.216373412T>C,g.216200070T>C,"c.3368A>G, USH2A c.3368A>G, p.Y1123C",-,USH2A_000285,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous, Heterozygous, Heterozygous; Mutation, 2 more items","PubMed: Behar 2014, Journal: Behar 2014, PubMed: Colombo-2020, PubMed: Jauregui 2020, 4 more items",-,rs775177930,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,none,-,-,"David Baux, Zippi Brownstein, VKGL-NL_Nijmegen, Anne-Françoise Roux"
234,"-/-, -/., -?/.",9,18,c.3945T>C,"r.(=), r.(?)","p.(=), p.(Asn1315=)",Fibronectin type-III 3 (1242-1357),-,"benign, likely benign",g.216371793A>G,g.216198451A>G,USH2A(NM_206933.2):c.3945T>C (p.N1315=),-,USH2A_000633,"90 heterozygous, no homozygous; Clinindb (India), Heterozygous; Neutral, Heterozygous; UV2, 2 more items","PubMed: Baux 2014, PubMed: Jaijo 2010, PubMed: Le Quesne Stabej 2012, PubMed: Saihan 2011, 1 more item",-,rs41303257,"CLASSIFICATION record, Germline",-,"10/844 controls, 10/858 controls, 90/2795 individuals",-NsiI;-HpyCH4V;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz, Mohammed Faruq"
235,"+?/., -?/?, ?/.",9,36,c.6902T>C,r.(?),p.(Leu2301Ser),Fibronectin type-III 9 (2241-2325),ACMG,"likely benign, likely pathogenic, VUS",g.216144022A>G,g.215970680A>G,"c.6902T>C , p.Leu2301Ser, USH2A, variant 1: c.6084T>A/p.Y2028*, variant 2: c.6902T>C/p.L2301S, 3 more items",-,USH2A_000766,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous, Heterozygous; likely pathogenic, 2 more items","PubMed: Birtel 2018, PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, 4 more items",-,rs759494205,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
236,"+/+, +?/., +?/?",9,43,c.8681G>A,"r.8550_8681del, r.spl?","p.(Arg2894Lys), p.Tyr2854_Arg2894del",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, VUS",g.216051100C>T,g.215877758C>T,-,-,USH2A_000872,"Homozygous; last nucleotide of exon 43; mutation, 1 more item","PubMed: Reddy 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, In vitro (cloned)",-,-,-,-,-,"Rima Slim, Janine Reurink"
237,-/-,9,43i,c.8681+120G>A,r.(=),p.(=),-,-,benign,g.216050980C>T,g.215877638C>T,-,-,USH2A_000127,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011",-,rs56301415,Germline,-,-,-NspI;-AflIII;-FatI;-PciI;,-,-,"Anne-Françoise Roux, Jose Maria Millan"
238,"+?/., -/., -?/., ?/.",9,47,c.9340C>T,r.(?),p.(Pro3114Ser),-,ACMG,"benign, likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.216011364G>A,g.215838022G>A,"c.9340C>T, USH2A c.9340C>T, p.Pro3114Ser, USH2A c.9340C>T, p.Pro3114Ser, 1 more item",-,USH2A_001497,"ACMG GN005 criteria: BS1_P BS2_S BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020, 3 more items",-,rs201071654,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"3/314 case chromosomes, 46/1204 cases with retinitis pigmentosa",-,-,-,"David Baux, VKGL-NL_Rotterdam, Yoshito Koyanagi"
239,"+/+, +/., +?/., +?/?, ?/.",9,61,c.11713C>T,r.(?),p.(Arg3905Cys),Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.215901725G>A,g.215728383G>A,"c.11713C>T, USH2A, variant 1: c.11713C>T/p.R3905C, variant 2: c.11864G>A/p.W3955*",-,USH2A_000270,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous, Heterozygous; mutation, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 6 more items",-,rs368675850,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Peter Krawitz, Sandro Banfi, Anne-Françoise Roux"
240,"+/+, +/., +?/.",9,62,c.12093del,r.(?),"p.(Tyr4031*), p.(Tyr4031Ter)",Fibronectin type-III 25 (3961-4062),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215853692del,g.215680350del,"12093delC, c.12093delC, NM_206933, c.12093del, p.Tyr4031Ter, 2 more items",-,USH2A_000664,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, Heterozygous; mutation, 1 more item","PubMed: Aparisi 2014, PubMed: Bonnet 2016, PubMed: Ezquerra-Inchausti 2018, PubMed: Fuster-Garcia 2018, 3 more items",-,rs1658186071,"Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,+BslI;+SfcI;-CviQI;-RsaI;,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet"
241,"+/+, +/., +?/.",9,63,c.13130C>A,r.(?),"p.(Ser4377*), p.(Ser4377Ter)",Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, pathogenic",g.215848123G>T,g.215674781G>T,"USH2A allele 1: Exon 21-33 deletion, g.216172825_216356708del, allele 2: p.Ser4377X, 3 more items",-,USH2A_000627,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous, Heterozygous; Pathogenic, 2 more items","PubMed: Austin-Tse 2018, PubMed: Falsini 2021, PubMed: Le Quesne Stabej 2012, PubMed: Sodi 2014, 3 more items",SCV000065431,rs111033385,"Germline, SUMMARY record, Unknown","?, yes",0/878 controls,-Tsp45I;-HphI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
242,"+/+, +/., +?/.",9,65,c.14225_14232dup,r.(?),"p.(Val4745Argfs*4), p.(Val4745ArgfsTer4)",Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic",g.215824045_215824052dup,g.215650703_215650710dup,"USH2A, variant 1: c.14225_14232dup/p.V4745Rfs*4, variant 2: c.14225_14232dup/ p.V4745Rfs*4, 2 more items",-,USH2A_000713,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous; mutation, Homozygous, solved, homozygous, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Mansard et al, 2021, PubMed: Weisschuh 2020, 1 more item",-,rs1657036615,"Germline, SUMMARY record, Unknown","?, yes",-,+BccI,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
243,"+/., +?/., +?/?",9,65,c.14287G>A,r.(?),p.(Gly4763Arg),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic, VUS",g.215823990C>T,g.215650648C>T,"USH2A c.13045_13046insG(;)14287G>A, V2: c.14287G>A, (p.Gly4763Arg), 1 more item",-,USH2A_000444,"ACMG GN005 criteria: PS1_S PM2_P PM3_S, alleles in cis or trans; heterozygous, heterozygous, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Chen 2021, 4 more items",-,rs397517990,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: N.A.; GnomAD_All: N.A.,-,-,-,"David Baux, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet, Jinu Han"
244,"+/., +?/., +?/?, ?/.",9,66,c.14453C>T,r.(?),p.(Pro4818Leu),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, pathogenic, VUS","g.215821999G>A, g.88519100A>G","g.215648657G>A, g.88125323A>G","c.1112T>C; p.Val371Ala, USH2A c.14453C>T, p.P4818L",-,USH2A_000171,"ACMG GN005 criteria:, compound heterozygous, Heterozygous, Heterozygous; possibly deleterious, 1 more item","PubMed: Holtan 2020, PubMed: Jaijo 2010, USMA missense analysis, missense variant in MSV3d, 6 more items",-,rs143344549,"Germline, SUMMARY record, Unknown",?,1/899 cases,-,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux, Jose Maria Millan"
245,-/-,8,_1,c.-2202C>T,r.(=),p.(=),-,-,benign,g.216598553G>A,g.216425211G>A,-,-,USH2A_000806,Homozygous,PubMed: Baux 2014,-,rs4323773,Germline,-,-,-,-,-,Anne-Françoise Roux
246,-/-,8,_1,c.-1707A>G,r.(=),p.(=),-,-,benign,g.216598058T>C,g.216424716T>C,-,-,USH2A_000807,Homozygous,PubMed: Baux 2014,-,rs11117574,Germline,-,-,-,-,-,Anne-Françoise Roux
247,-/-,8,_1,c.-1689C>A,r.(=),p.(=),-,-,benign,g.216598040G>T,g.216424698G>T,-,-,USH2A_000808,Homozygous,PubMed: Baux 2014,-,rs10863240,Germline,-,-,-,-,-,Anne-Françoise Roux
248,-/-,8,_1,c.-1408T>C,r.(=),p.(=),-,-,benign,g.216597759A>G,g.216424417A>G,-,-,USH2A_000809,Homozygous,PubMed: Baux 2014,-,rs11117573,Germline,-,-,-,-,-,Anne-Françoise Roux
249,"+/+, +/.",8,6,c.852_853del,r.(?),"p.(Glu284Aspfs*38), p.(Glu284AspfsTer38)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216498942_216498943del,g.216325600_216325601del,852_853delGA,-,USH2A_000210,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; mutation, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Le Quesne Stabej 2012, PubMed: Seyedahmadi 2004, 1 more item",-,rs1188025733,"Germline, SUMMARY record",-,-,+XcmI,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Crystel Bonnet"
250,"+/+, +/., +?/., ?/.",8,6,c.956G>A,r.(?),p.(Cys319Tyr),Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic, VUS",g.216498834C>T,g.216325492C>T,"c.956G>A,p.C319Y",-,USH2A_000207,"ACMG GN005 criteria: PM2_P, Homozygous","Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Sloan-Heggen, C. M. et al., 2016, 2 more items","ClinVar-2355, ClinVar-39614",rs121912599,"Germline, SUMMARY record",yes,0/190 controls,-,-,-,"David Baux, Anne-Françoise Roux, Rocio Villafuerte-de la Cruz"
251,"+?/., +?/?, ?/., ?/?",8,"08, 8",c.1547G>T,r.(?),p.(Gly516Val),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216496819C>A,g.216323477C>A,c.1547G>T,-,USH2A_000223,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous, Heterozygous; mutation, Homozygous; Mutation, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 3 more items",-,rs1415484067,"Germline, SUMMARY record",-,-,+MslI;-BslI;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
252,"+/., +?/.",8,-,c.(2809+1_2810-1)_(2993+1_2994-1)del,"r.(?), r.spl",p.(?),-,-,"likely pathogenic, pathogenic",g.?,g.?,"USH2A c.(2809+1_2810-1)_(2993+1_2994-1)del, p.(?), 1 more item",-,NPHS2_000000,"heterozygous, solved, homozygous","PubMed: Falsini 2021, PubMed: Weisschuh 2020",-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
253,"+/+, +/.",8,13,c.2797C>T,r.(?),"-, p.(Gln933*)",Laminin EGF-like 8 (900-950),ACMG,"pathogenic, pathogenic (recessive)",g.216419939G>A,g.216246597G>A,"2023C>T;2797C>T, USH2A c.2797C>T, p.Q933*",-,USH2A_000015,"Heterozygous, Heterozygous; mutation, possible duplicate","PubMed: Dreyer 2000, PubMed: Dreyer 2000, PubMed: Dreyer 2008, Tranebjaerg 2011, PubMed: Dad 2016, 3 more items",-,-,Germline,yes,-,-,-,-,"Peter Krawitz, Anne-Françoise Roux"
254,"+/., +?/., -/., -?/?, ?/.",8,18,c.3902G>T,r.(?),p.(Gly1301Val),Fibronectin type-III 3 (1242-1357),ACMG,"benign, likely benign, likely pathogenic, pathogenic (recessive), VUS",g.216371836C>A,"g.215629014G>A, g.216198494C>A","1:216371836C>A ENST00000307340.3:c.3902G>T (Gly1301Val), 1 more item",-,USH2A_000543,"1 homozygous; Clinindb (India), 30 heterozygous; Clinindb (India), ACMG GN005 criteria:, Heterozygous, 2 more items","PubMed: Bonnet 2011, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 5 more items",-,rs111033524,"Germline, SUMMARY record, Unknown","?, yes","0/484 controls, 1/2795 individuals, 30/2795 individuals",none,-,-,"David Baux, Anne-Françoise Roux, Eva Lenassi, Mohammed Faruq"
255,"+/+, +/.",8,20,c.4384del,r.(?),"p.(Thr1462Leufs*2), p.(Thr1462LeufsTer2)",Fibronectin type-III 4 (1367-1462),ACMG,pathogenic,g.216363579del,g.216190237del,"4382delA, 4384delA, USH2A c.4384del(;)5329C>T, V1: c.4384delA, (p.Thr1462LeufsTer2), 1 more item",-,"USH2A_000790, USH2A_000951","ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, alleles in cis or trans; heterozygous, Homozygous; Mutation","PubMed: Chen 2021, PubMed: Huang 2013, PubMed: Shu 2015, PubMed: Zhu 2021, 1 more item",-,rs2034687946,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
256,"+/., +?/., ?/.",8,21,c.4616C>T,r.(?),p.(Thr1539Ile),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216348605G>A,g.216175263G>A,"c.4616C>T, C4616T, USH2A c.4616C>T, p.(Thr1539Ile), USH2A c.4616C>T, p.Thr1539Ile, 1 more item",-,USH2A_001531,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, homozygous","PubMed: Chen-2013, PubMed: Dan 2020, PubMed: Gao 2021, PubMed: Katagiri 2014, PubMed: Sun 2018, 3 more items",-,rs758095361,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",5/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
257,+?/.,8,-,c.(4627+1_4628-1)_(4987+1_4988-1)del,"r.(?), r.spl",p.(?),-,ACMG,likely pathogenic,g.?,g.?,"USH2A c.12161G>T, p.(Ser4054Ile) c.(4627+1_4628-1) _(4987+1_4988-1)del, 6 more items",-,NPHS2_000000,"solved, compound heterozygous","PubMed: Jespersgaar 2019, PubMed: Weisschuh 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
258,"+/., +?/., ?/.",8,25,c.5018T>C,r.(?),p.(Leu1673Pro),-,ACMG,"likely pathogenic, pathogenic, VUS",g.216258189A>G,g.216084847A>G,"p.L1673P, USH2A(NM_206933.2):c.5018T>C (p.L1673P), USH2A(NM_206933.4):c.5018T>C (p.L1673P)",-,USH2A_001113,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, VKGL data sharing initiative Nederland","PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021, PubMed: Zazo Seco 2017, Journal: Zazo Seco 2017",-,rs1162305984,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, Mieke Wesdorp, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
259,"+?/., +?/?, ?/.",8,25,c.5153A>C,"r.(=), r.(?)",p.(Gln1718Pro),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, VUS",g.216258054T>G,g.216084712T>G,"c.5153A>C, USH2A c.5153A>C, p.(Gln1718Pro)",-,USH2A_000845,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, heterozygous, Heterozygous; mutation, Heterozygous; UV3","PubMed: Colombo-2020, PubMed: Falsini 2021, 3 more items",-,rs2102561067,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Peter Krawitz, Anne-Françoise Roux"
260,"+/., +?/.",8,"27i, 28",c.5572+1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216251430C>T,g.216078088C>T,"c.5572+1G>A, USH2A c.5572+1G>A, -, USH2A c.5572+1G>A, USH2A c.5572+1G>A, -",-,USH2A_002065,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_P, heterozygous","PubMed: Gao 2019, PubMed: Meng 2020, PubMed: Qu 2020, PubMed: Xu 2014, PubMed: Zampaglione 2020, 2 more items",-,rs775293551,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
261,"+/., +?/., ?/.",8,30,c.5953G>A,r.(?),p.(Glu1985Lys),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216243539C>T,g.216070197C>T,"c.5953G>A, p.Glu1985Lys, USH2A c.5953G>A, p.E1985K, USH2A p.(Glu1985Lys)",-,USH2A_001521,"ACMG GN005 criteria: PM2_P, heterozygous, 1 more item","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Koyanagi 2020, PubMed: Sun 2018, 5 more items",-,rs150143291,"Germline, SUMMARY record, Unknown","?, yes","1/1204 cases with retinitis pigmentosa, 1/314 case chromosomes",-,-,-,"David Baux, Yoshito Koyanagi"
262,"+/., +?/., ?/.",8,33,c.6446C>A,r.(?),p.(Pro2149Gln),-,ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216173784G>T,g.216000442G>T,"1:216173784G>T ENST00000307340.3:c.6446C>A (Pro2149Gln), USH2A c.6446C>A, p.(Pro2149Gln), 2 more items",-,USH2A_001821,"ACMG GN005 criteria: PM2_P PM3_M, compound heterozygous, heterozygous","PubMed: Carss 2017, PubMed: Ellingford 2016, PubMed: Ellingsford 2018, PubMed: Ellingford 2016, 4 more items",-,rs869312182,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,David Baux
263,"+/., +?/., +?/?, ?/.",8,36,c.6926G>T,r.(?),p.(Cys2309Phe),Fibronectin type-III 9 (2241-2325),ACMG,"likely pathogenic, pathogenic, VUS",g.216143998C>A,g.215970656C>A,"USH2A, variant 1: c.2299del/p.E767Sfs*21, variant 2: c.6926G>T/p.C2309F",-,USH2A_000769,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, Heterozygous; likely pathogenic, solved, compound heterozygous, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Haer-Wigman 2017, 4 more items",-,rs748983904,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,+BsmI;-Cac8I;-CviAII;-FatI;-HpyCH4V;-NlaIII;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet"
264,"+/+, +/., +?/.",8,40,c.7524del,r.(?),"p.(Arg2509Glyfs*19), p.(Arg2509GlyfsTer19)",Fibronectin type-III 11 (2435-2528),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.216073487del, g.216073489del",g.215900147del,"7522delT, 7524delT, USH2A c.7524del, p.R2509GfsX19",-,USH2A_000547,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2011, PubMed: Bonnet 2016, PubMed: Dad 2016, PubMed: Jauregui 2020, 2 more items",-,rs751176116,"Germline, SUMMARY record, Unknown",?,-,none,-,-,"David Baux, Peter Krawitz, IMGAG, Anne-Françoise Roux, Crystel Bonnet"
265,"+/+, +/., +?/.",8,41,c.7950dup,r.(?),"p.(Asn2651Glnfs*10), p.(Asn2651GlnfsTer10)",Fibronectin type-III 13 (2621-2718),ACMG,"likely pathogenic, pathogenic",g.216062044dup,g.215888702dup,"7950dupC, USH2A, variant 1: c.7950dup/p.N2651Qfs*10, variant 2: c.11864G>A/p.W3955*, 3 more items",-,USH2A_001014,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous; mutation, solved, compound heterozygous, 1 more item","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Weisschuh, N. et al., 2020, 2 more items",-,rs886041502,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_Leiden, VKGL-NL_AMC, Crystel Bonnet"
266,"+/., +?/., -/?, ?/.",8,42,c.8431C>A,r.(?),p.(Pro2811Thr),Fibronectin type-III 14 (2724-2812),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), 1 more item",g.216052233G>T,g.215878891G>T,"1:216052233G>T ENST00000307340.3:c.8431C>A (Pro2811Thr), USH2A c.8431C>A, p.(P2811T), 1 more item",-,USH2A_000358,"3 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria:, Heterozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 5 more items",-,rs111033529,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",yes,3/2794 individuals,-,-,-,"David Baux, VKGL-NL_Rotterdam, Anne-Françoise Roux, Mohammed Faruq"
267,"+?/., +?/?, ?/.",8,"3i, 44",c.8693A>C,r.(?),p.(Tyr2898Ser),Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, VUS",g.216040501T>G,g.215867159T>G,"c.8693A>C, USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.44 c.8693A>C p.(Tyr2898Ser)",-,USH2A_000859,"ACMG GN005 criteria: PM2_P PP3_P, compound heterozygous, Heterozygous; mutation","PubMed: de Castro-Miró 2014, PubMed: de Castro-Miró-2014, PubMed: Del Pozo-Valero, M. et al., 2022, 3 more items",-,rs1553270997,"Germline, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, Marta de Castro-Miró, Anne-Françoise Roux"
268,"+/+, +/.",8,49,c.9723C>A,r.(?),"p.(Tyr3241*), p.(Tyr3241Ter)",Cystein rich (3192-3358),ACMG,pathogenic,g.215987094G>T,g.215813752G>T,"USH2A c.9723C>A, p.Y3241*, USH2A c.C9723A, p.Y3241*",-,USH2A_000954,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Homozygous; mutation, 1 more item","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,rs6660707,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
269,"+/., +?/., +?/?, ?/.",8,51,c.10182G>A,"r.(=), r.(?), r.9959_10182del","p.(=), p.(?), p.(Lys3394=), p.Met3321Asnfs*22",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215963401C>T,g.215790059C>T,"c.10182G>A, USH2A, variant 1: c.10182G>A/p.?, variant 2: c.10182G>A/p.?",-,USH2A_000762,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Homozygous; likely pathogenic, possibly solved, homozygous, 1 more item","PubMed: Colombo-2020, PubMed: Glöckle 2014, PubMed: Reurink 2022, Journal: Reurink 2022, 2 more items",-,rs751903445,"Germline, In vitro (cloned), SUMMARY record, Unknown",?,-,-HpyAV,-,-,"David Baux, Anne-Françoise Roux, Janine Reurink"
270,"+/., +?/., ?/.",8,52,c.10331G>A,r.(?),p.(Cys3444Tyr),-,ACMG,"likely pathogenic, pathogenic, VUS",g.215960068C>T,g.215786726C>T,"USH2A c.10331G>A, p.C3444Y, USH2A c.10331G>A, p.Cys3444Tyr",-,USH2A_001953,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Huang 2018, PubMed: Zhu 2021",-,rs1167540054,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
271,"+/+, +/., ?/.",8,54,c.10612C>T,r.(?),"p.(Arg3538*), p.(Arg3538Ter)",Fibronectin type-III 20 (3499-3585),ACMG,"pathogenic, VUS",g.215955512G>A,g.215782170G>A,"c.10612C>T, p.Arg3538Ter, USH2A c.C10612T, p.R3538*, 1 more item",-,USH2A_000902,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Ellingford 2016, PubMed: Jiang 2015, PubMed: Lenassi 2015, 4 more items",-,rs878853413,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux, Eva Lenassi, Crystel Bonnet"
272,"+/+, +/., +?/.",8,61,c.11754G>A,r.(?),"p.(Trp3918*), p.(Trp3918Ter)",Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, pathogenic",g.215901684C>T,g.215728342C>T,"NM_206933, c.11754G>A, p.Trp3918Ter, USH2A c.11754G>A, p.W3918*, USH2A c.G11754A, p.W3918X, 1 more item",-,USH2A_000466,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: Ezquerra-Inchausti 2018, PubMed: Wang 2018, PubMed: Zhu 2020, 2 more items",-,rs1358947010,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
273,"+/., +?/., +?/?, ?/.",8,61,c.11806A>C,r.(?),p.(Thr3936Pro),Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.215901632T>G,g.215728290T>G,"c.118036A>C, c.11806A>C, USH2A c.11806A>C, p.Thr3936Pro, USH2A c.11806A>C, p.Thr3936Pro, 1 more item",-,USH2A_000002,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous, homozygous","PubMed: Dai 2008, USMA missense analysis, missense variant in MSV3d, PubMed: Gao 2021, 5 more items",-,rs2102713705,"Germline, SUMMARY record, Unknown",?,0/200 controls,-,-,-,"David Baux, Anne-Françoise Roux"
274,"-/-, -/.",8,61,c.11907A>T,r.(?),"p.(=), p.(Pro3969=)",Fibronectin type-III 25 (3961-4062),-,benign,g.215901531T>A,g.215728189T>A,-,-,USH2A_000366,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, 1 more item","PubMed: Aller 2006, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: McGee 2010",-,rs61635304,"CLASSIFICATION record, Germline",-,-,-AluI;-CviKI_1;-BstXI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
275,"+?/., +?/?, ?/.",8,63,c.12505A>C,r.(?),p.(Thr4169Pro),Fibronectin type-III 27 (4154-4258),ACMG,"likely pathogenic, VUS",g.215848748T>G,g.215675406T>G,-,-,USH2A_000727,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 1 more item",-,rs113107803,"Germline, SUMMARY record",-,-,+BmrI;+BsmFI;-CspCI;,-,-,"David Baux, Anne-Françoise Roux"
276,"+/+, +/., +?/.",8,63i,c.13811+2T>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215847440A>C,g.215674098A>C,-,-,USH2A_000751,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation","PubMed: Aparisi 2014, PubMed: Besnard, Garcia-Garcia 2014, PubMed: Bonnet 2016, 3 more items",-,rs766515318,"Germline, SUMMARY record",yes,-,+MnlI,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
277,"+/., +?/., +?/?, ?/.",8,64,c.13847G>T,r.(?),p.(Gly4616Val),Fibronectin type-III 31 (4529-4627),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215844600C>A,g.215671258C>A,"c.13847G>T:p.G4616V, USH2A c.13847G>T, p.(Gly4616Val)",-,USH2A_000541,"ACMG GN005 criteria: PM2_P, heterozygous, Heterozygous; Presumed non-pathogenic, homozygous, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 3 more items",-,rs527236124,"Germline, SUMMARY record, Unknown","?, yes",4/1204 cases with retinitis pigmentosa,-BtsCI;-FokI;-BsaBI;,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi"
278,"-?/?, ?/.",8,66,c.14519T>C,r.(?),p.(Leu4840Pro),Fibronectin type-III 34 (4826-4927),ACMG,"likely benign, VUS",g.215821933A>G,g.215648591A>G,"USH2A(NM_206933.2):c.14519T>C (p.L4840P), USH2A(NM_206933.4):c.14519T>C (p.L4840P)",-,USH2A_000248,"ACMG GN005 criteria:, Heterozygous, Heterozygous; unknown, Homozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 2 more items",-,rs143275144,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet"
279,"+/+, +/., +?/.",8,68,c.14911C>T,r.(?),"p.(Arg4971*), p.(Arg4971Ter)",Fibronectin type-III 35 (4928-5014),ACMG,"likely pathogenic, pathogenic",g.215813957G>A,g.215640615G>A,"c.2299delG p.(Glu767Serfs*21), c.14911C>T p.(Arg4971*), USH2A c.14911C>T, 3 more items",-,USH2A_000552,"ACMG GN005 criteria: PVS1_VS PM2_P PM3, Heterozygous; mutation, Heterozygous; Pathogenic, 2 more items","PubMed: Hagag 2020, PubMed: Jespersgaar 2019, PubMed: Jiang 2015, PubMed: Le Quesne Stabej 2012, 4 more items",-,rs397517994,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,+Tsp45I;+HphI;-Hpy99I;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
280,-/-,8,72,c.*1109C>T,r.(=),p.(=),3'UTR,-,benign,g.215798014G>A,g.215624672G>A,-,-,USH2A_000816,Homozygous,PubMed: Baux 2014,-,rs2797255,Germline,-,-,-,-,-,Anne-Françoise Roux
281,-/-,8,72,c.*2773A>C,r.(=),p.(=),3'UTR,-,benign,g.215796350T>G,g.215623008T>G,-,-,USH2A_000586,"Heterozygous; Not Assessed, Homozygous, Homozygous; Not Assessed","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs6667509,Germline,-,-,+BbsI;-Tsp509I;-EcoRI;-ApoI;,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
282,-/-,8,72_,c.*3333C>T,r.(=),p.(=),3'UTR,-,benign,g.215795790G>A,g.215622448G>A,-,-,USH2A_000817,Homozygous,PubMed: Baux 2014,-,rs2677118,Germline,-,-,-,-,-,Anne-Françoise Roux
283,"+/., +?/., +?/?, ?/.",7,2,c.206G>T,r.(?),p.(Ser69Ile),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216595473C>A,g.216422131C>A,"USH2A c.206G>T, p.S69I, USH2A(NM_206933.2):c.206G>T (p.(Ser69Ile))",-,USH2A_000972,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation, VKGL data sharing initiative Nederland","PubMed: Jiang 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Sun 2018, 3 more items",-,rs377254440,"CLASSIFICATION record, Germline, SUMMARY record",yes,1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, VKGL-NL_Leiden, Anne-Françoise Roux, Yoshito Koyanagi"
284,"+?/., +?/?, ?/.",7,8,c.1390C>T,r.(?),p.(Arg464Cys),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216496976G>A,g.216323634G>A,"c.1390C>T, p.Arg464Cys, USH2A, variant 1: c.1390C>T/p.R464C, variant 2: c.8782G>T/p.G2928*, 1 more item",-,USH2A_000221,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, heterozygous, individual solved, variant causal, 1 more item","PubMed: Rodriguez-Munoz 2020, PubMed: Stone 2017, PubMed: Weisschuh 2020, PubMed: Zampaglione 2020, 2 more items",-,rs1423536179,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
285,"+/., +?/., ?/.",7,8,c.1397G>T,r.(?),p.(Gly466Val),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive), VUS",g.216496969C>A,g.216323627C>A,"c.1397G>T, NM_206933.2:c.1397G>T, NP_996816.2:p.(Gly466Val), NC_000001.10:g.216496969C>A, 2 more items",-,USH2A_002069,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, homozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020, PubMed: Liu-2020, PubMed: Wang 2018, PubMed: Xu 2014, 1 more item",-,rs1553250627,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
286,"+/+, +/., +?/.",7,"10-11, 9i_11i",c.1644+10004_1972-12164del,"r.(1644_1972del), r.(?), r.?","p.(?), p.(Cys549_Gln657del), p.?",Laminin EGF-like 1 (518-574);Laminin EGF-like 2 (575-640);Laminin EGF-like 3 (641-693),ACMG,"likely pathogenic (recessive), pathogenic",g.216436604_216485221del,g.216263262_216311879del,"USH2A allele 1: Exon 10-11 deletion, g.216436604_ 216485221 del, allele 2: p.Gly602GlufsX34, 1 more item",-,USH2A_000463,"ACMG PM2, PVS1, breakpoints identical to ClinVar variant, Heterozygous","Journal: Reurink 2021, PubMed: Austin-Tse 2018, PubMed: Baux 2014, PubMed: Reurink 2021, 1 more item",SCV000709744,-,"Germline, Unknown","?, no, yes",-,-,-,-,"Johan den Dunnen, Anne-Françoise Roux, Janine Reurink"
287,"+?/., +?/?",7,10,c.1751G>T,r.(?),p.(Cys584Phe),Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216465606C>A,g.216292264C>A,c.1751G>T,-,USH2A_000858,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, Heterozygous; mutation","PubMed: Colombo, L. et al., 2022; PubMed: Mansard, L. et al., 2021; PubMed: Colombo, L. et al., 2021, 5 more items",-,rs2037016118,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Marta de Castro-Miró, Anne-Françoise Roux"
288,"+?/., -?/?, ?/.",7,12,c.2052A>G,"r.(?), r.spl","p.(=), p.(Gln684=), p.?",Laminin EGF-like 3 (641-693),ACMG,"likely benign, likely pathogenic, VUS",g.216424360T>C,g.216251018T>C,"USH2A(NM_206933.2):c.2052A>G (p.Q684=), USH2A(NM_206933.4):c.2052A>G (p.Q684=)",-,USH2A_000205,"Heterozygous, Heterozygous; Neutral, VKGL data sharing initiative Nederland","PubMed: Holtan 2020, PubMed: Le Quesne Stabej 2012, PubMed: Sodi 2014, PubMed: Weston 2000",-,rs111033248,"CLASSIFICATION record, Germline",-,"0/190 controls, 1/899 cases, 3/876 controls",+SfcI,-,-,"Global Variome, with Curator vacancy, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz"
289,"+/?, +?/., ?/.",7,12,c.2149T>G,r.(?),p.(Cys717Gly),Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, VUS",g.216424263A>C,g.216250921A>C,-,-,USH2A_000347,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 2 more items",-,rs1304016981,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
290,"+?/., -/-, -/., -?/., ?/.",7,13,c.2546G>A,r.(?),p.(Cys849Tyr),Laminin EGF-like 7 (847-899),ACMG,"benign, likely benign, likely pathogenic, VUS",g.216420190C>T,g.216246848C>T,"p.C849Y, USH2A(NM_206933.2):c.2546G>A (p.C849Y), USH2A(NM_206933.4):c.2546G>A (p.C849Y), 1 more item",-,USH2A_000306,"ACMG GN005 criteria: PP3_P BS1_S BS2_S, solved, compound heterozygous, 2 more items","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Wafa-2021, 3 more items",-,rs111033481,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
291,"+/., +?/., ?/.",7,-,c.2653C>T,r.(?),p.(His885Tyr),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216420083G>A,g.216246741G>A,"USH2A c.2653C>T, p.(His885Tyr), USH2A c.2653C>T, p.His885Tyr",-,USH2A_001537,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, heterozygous, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Inaba, A. et al., 2020, PubMed: Inaba 2020, 2 more items",-,rs746071929,"Germline, SUMMARY record, Unknown","?, yes",1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
292,"+/., +?/., +?/?, ?/.",7,13,c.2776C>T,r.(?),"p.(Arg926Cys), p.R926C",Laminin EGF-like 8 (900-950),ACMG,"likely pathogenic, likely pathogenic (dominant), pathogenic, VUS","g.216419960G>A, g.62381092dup","g.216246618G>A, g.62613620dup","PRPF31 c.357_358delAA (p.K120Efs*4), USH2A c.2776C>T (p.R926C), USH2A c.C2776T, p.R926C",-,USH2A_000863,"ACMG GN005 criteria: PM2_P, heterozygous, Heterozygous; very likely pathogenic, 1 more item","PubMed: Holtan 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Ma 2021, PubMed: Xiao 2017, 2 more items",-,rs749621457,"Germline, SUMMARY record, Unknown","?, no","0/400 controls, 1/899 cases, 3/1204 cases with retinitis pigmentosa",-,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux, Yoshito Koyanagi"
293,"+/., +?/., ?/.",7,13,c.2792G>A,r.(?),p.(Cys931Tyr),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS","g.216144001G>T, g.216419944C>T","g.215970659G>T, g.216246602C>T","c.2792C>T, p.(Cys931Tyr), M1: USH2A c.2792G>A, C931Y, USH2A c.2792G>A, p.C931Y, 1 more item",-,"USH2A_001657, USH2A_002063","error in annotation: c.2792C>T instead of G>A , compound heterozygous, heterozygous, 2 more items","PubMed: Chen 2020, PubMed: Wang 2019, PubMed: Xu 2014, PubMed: Zhu 2021",-,rs145383772,"CLASSIFICATION record, Germline, Unknown",?,1/314 case chromosomes,-,-,-,VKGL-NL_AMC
294,"-/?, -?/., ?/.",7,15,c.3123C>A,r.(?),p.(His1041Gln),Laminin EGF-like 10 (1002-1052),ACMG,"likely benign, VUS",g.216390763G>T,g.216217421G>T,"c.3123C>A, USH2A(NM_206933.2):c.3123C>A (p.H1041Q), USH2A(NM_206933.4):c.3123C>A (p.H1041Q)",-,USH2A_000929,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Bujakowska 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Simpson-2011, 1 more item",-,rs149304901,"CLASSIFICATION record, Germline",-,0.30% in 360 controls,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
295,"+/+, +/., +?/.",7,16,c.3309C>A,"r.(3309c>a), r.(?)","p.(Tyr1103*), p.(Tyr1103Ter)",Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic",g.216380622G>T,g.216207280G>T,"USH2A allele 1: Exon 10 deletion, g.216462804_ 216472385del, allele 2: p.Tyrll03X, 1 more item",-,USH2A_000908,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, Heterozygous; mutation, no variant 2nd chromome","PubMed: Austin-Tse 2018, PubMed: Bonnet 2016, PubMed: Dad 2015, PubMed: Dad 2016, PubMed: Zhao 2015, 3 more items",SCV000065521,rs397518011,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Shzeena Dad, Crystel Bonnet, Janine Reurink"
296,"-/., -?/.",7,-,c.3364T>G,r.(?),p.(Ser1122Ala),-,ACMG,"benign, likely benign",g.216373416A>C,g.216200074A>C,"USH2A c.T3364G, p.S1122A",-,USH2A_001536,"23 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: BS1_S BS2_S, 2 more items","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021, 1 more item",-,rs148135241,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"2/1204 cases with retinitis pigmentosa, 23/2793 individuals, 60/1204 cases with retinitis pigmentosa",-,-,-,"David Baux, VKGL-NL_Nijmegen, Yoshito Koyanagi, Mohammed Faruq"
297,"+/., +?/., +?/?, ?/., ?/?",7,20,c.4378G>A,r.(?),p.(Gly1460Arg),Fibronectin type-III 4 (1367-1462),ACMG,"likely pathogenic, pathogenic, VUS",g.216363583C>T,g.216190241C>T,"c.4378G>A, USH2A c.4378G>A, p.G1460R, USH2A(NM_206933.4):c.4378G>A (p.G1460R)",-,USH2A_000891,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Wang-2014, 2 more items",-,rs139311927,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"Feng Wang, David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Eva Lenassi"
298,-/-,7,21i,c.4627+2446T>C,r.(=),p.(=),-,-,benign,g.216346148A>G,g.216172806A>G,-,-,USH2A_000813,"Heterozygous, Homozygous",PubMed: Baux 2014,-,rs452747,Germline,-,-,-,-,-,Anne-Françoise Roux
299,"+/+, +/., +?/., ?/.",7,25,c.5167G>C,"r.(?), r.[4988_5298del,4988_5167del]","p.(Gly1723Arg), p.[Glu1663Aspfs*31,Glu1663_Ala1722del]",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic, VUS",g.216258040C>G,g.216084698C>G,-,-,USH2A_000287,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous, Heterozygous; UV3, 1 more item","PubMed: Aparisi 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Ge 2015, 3 more items",-,rs1342455785,"Germline, In vitro (cloned), SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Janine Reurink"
300,"+/+, +/., +?/.",7,26,c.5278del,r.(?),"p.(Asp1760Metfs*10), p.(Asp1760MetfsTer10)",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic",g.216256818del,g.216083476del,"5278delG, c.5278del, p.Asp1760MetfsTer10, NM_206933, c.5278del, p.Asp1760MetfsTer10",-,USH2A_000672,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; Pathogenic, Homozygous","Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Aparisi 2014, PubMed: Jaijo 2010, 3 more items",ClinVar-555362,rs754374132,"Germline, SUMMARY record, Unknown","?, yes",-,-BccI,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan, Rocio Villafuerte-de la Cruz"
301,"+/+, +/.",7,27,c.5418_5424del,r.(?),"p.(Lys1807Alafs*8), p.(Lys1807AlafsTer8)",Laminin G-like 2 (1714-1891),ACMG,"pathogenic, pathogenic (recessive)","g.216251579_216251585del, g.216251581_216251587del",g.216078239_216078245del,"5419_5422delAAAAAGG, c.5418_5424del",-,USH2A_000933,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Homozygous; UV3","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs756486771,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
302,"+/+, +/., ?/.",7,27,c.5519G>T,r.(?),p.(Gly1840Val),Laminin G-like 2 (1714-1891),ACMG,"pathogenic, VUS",g.216251484C>A,g.216078142C>A,c.5519G>T,-,"USH2A_000133, USH2A_001443",Heterozygous,"Sharon, submitted, PubMed: Auslender 2008, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, Unknown",-,"0/230 controls, 2/2420 IRD families",-,-,-,"Global Variome, with Curator vacancy, Dror Sharon, Anne-Françoise Roux"
303,"+?/+?, +?/?, ?/.",7,27,c.5528C>T,r.(?),p.(Pro1843Leu),"Laminin G-like 2 (1714 - 1891), Laminin G-like 2 (1714-1891)",ACMG,"likely pathogenic, VUS",g.216251475G>A,g.216078133G>A,-,-,USH2A_000717,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, Heterozygous, Heterozygous; Mutation, 2 more items","PubMed: Besnard, Garcia-Garcia 2014, USMA missense analysis, missense variant in MSV3d, 3 more items",-,rs200209833,"CLASSIFICATION record, Germline, SUMMARY record",-,-,+SfcI;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet"
304,"+/., +?/., +?/?, ?/.",7,28,c.5603T>G,r.(?),p.(Phe1868Cys),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic (recessive), VUS",g.216246612A>C,g.216073270A>C,"1:216246612A>C ENST00000307340.3:c.5603T>G (Phe1868Cys), USH2A c.5603T>G, 1 more item",-,USH2A_000650,"ACMG GN005 criteria: PM2_P PM3_M PP1_P, compound heterozygous, Heterozygous; UV2, 1 more item","PubMed: Carss 2017, PubMed: Eandi 2017, PubMed: Jauregui 2020, PubMed: Toms 2020, 2 more items",-,rs1553298240,"Germline, SUMMARY record, Unknown",?,0/96 controls,+Hpy166II;+CviQI;+BsrGI;+RsaI;-Tsp509I;-ApoI;,-,-,"David Baux, Maria Bitner-Glindzicz"
305,"+/., +?/.",7,-,c.5777-1G>A,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.216246312C>T,g.216072970C>T,"USH2A c.5777-1G>A, p.?",-,USH2A_002222,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_S, exon skipping and the in-frame deletion of 81 bp","PubMed: Pater 2019, PubMed: Pater, J. A. et al., 2019",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
306,"+?/., ?/.",7,34,c.6590C>T,"r.(6590c>u), r.(?)",p.(Thr2197Ile),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216172296G>A,g.215998954G>A,"1:216172296G>A ENST00000307340.3:c.6590C>T (Thr2197Ile), m10: c.6590 C > T; p.Thr2197Ile, 1 more item",-,USH2A_001224,"ACMG GN005 criteria:, VKGL data sharing initiative Nederland","PubMed: Carss 2017, PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,rs140487302,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, María González-del Pozo, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
307,"+/., +?/., ?/.",7,35,c.6722C>T,"r.(6722c>u), r.(?)",p.(Pro2241Leu),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216166445G>A,g.215993103G>A,"USH2A c.6722C>T, p.(Pro2241Leu)",-,USH2A_001375,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, VKGL data sharing initiative Nederland","Journal: Reurink 2021, PubMed: Haer-Wigman 2017, PubMed: Reurink 2021, PubMed: Van Huet 2015, 1 more item",-,rs1057518826,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Janine Reurink"
308,"+?/., -/?, ?/.",7,35,c.6730G>A,r.(?),p.(Val2244Met),Fibronectin type-III 9 (2241-2325),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.216166437C>T,g.215993095C>T,"1:216166437C>T ENST00000307340.3:c.6730G>A (Val2244Met), USH2A c.6730G>A, 1 more item",-,USH2A_000249,"ACMG GN005 criteria:, Heterozygous, protein variant annotation not written; heterozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 3 more items",-,rs550772689,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet"
309,"+/., +?/.",7,37,c.6967C>T,"r.(6967c>u), r.(?)","p.(Arg2323*), p.(Arg2323Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216138812G>A,g.215965470G>A,"USH2A c.6967C>T, USH2A c.6967C>T, p.(Arg2323*)",-,USH2A_001766,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, VKGL data sharing initiative Nederland, 1 more item","Journal: Reurink 2021, PubMed: Fuster-Garcia 2018, PubMed: Reurink 2021, PubMed: Sun 2018, 2 more items",-,rs1485173724,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, Janine Reurink"
310,"+/., +?/.",7,-,c.7018_7019del,r.(?),"p.(Gln2340Glyfs*16), p.(Gln2340GlyfsTer16)",-,ACMG,"likely pathogenic, pathogenic",g.216138763_216138764del,g.215965421_215965422del,"7018_7019delCA, USH2A c.7018_7019delCA, p.Gln2340GlyfsX16",-,USH2A_002556,"ACMG GN005 criteria: PVS1_VS PM2_P PP1_S, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
311,"-/-, -/., -/?, -?/., ?/.",7,38,c.7130A>G,r.(?),p.(Asn2377Ser),Fibronectin type-III 10 (2328-2432),ACMG,"benign, likely benign, VUS",g.216108128T>C,g.215934786T>C,"USH2A(NM_206933.2):c.7130A>G (p.N2377S), USH2A(NM_206933.4):c.7130A>G (p.N2377S)",-,USH2A_000626,"4 heterozygous, no homozygous; Clinindb (India), Heterozygous; Neutral, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2014, 2 more items",-,rs111033394,"CLASSIFICATION record, Germline",-,"4/2792 individuals, 7/864 controls",+AluI;+CviKI_1;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz, Mohammed Faruq"
312,"+/., +?/.",7,41,c.8079G>A,"r.(8079g>a), r.(?)","p.(Trp2693*), p.(Trp2693Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216061912C>T,g.215888570C>T,"USH2A c.8079G>A, USH2A c.8079G>A, p.(Trp2693*), 1 more item",-,USH2A_001361,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, VKGL data sharing initiative Nederland, 1 more item","Journal: Reurink 2021, PubMed: Khan 2017, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021, 1 more item",-,rs1553273330,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Janine Reurink"
313,"+/+, +/.",7,"41, 45",c.8906C>G,r.(?),"p.(Ser2969*), p.(Ser2969Ter)",Fibronectin type-III 16 (2925-3015),ACMG,"pathogenic, pathogenic (recessive)",g.216019315G>C,g.215845973G>C,"c.8906C>G, USH2A(NM_206933.4):c.8906C>G (p.S2969*)",-,USH2A_000911,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Homozygous, Homozygous; mutation, 1 more item","PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Sodi 2014, 1 more item",-,-,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,-,-,-,"David Baux, VKGL-NL_AMC, Anne-Françoise Roux, Crystel Bonnet"
314,"+/., +?/., ?/.",7,46,c.9258G>T,"r.(?), r.[9106_9258del,9143_9258del]","p.(Gln3086His), p.[Arg3037_Val3087del,Val3049Ter]",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216017636C>A,g.215844294C>A,"USH2A(NM_206933.2):c.9258G>T (p.Q3086H), USH2A(NM_206933.4):c.9258G>T (p.Q3086H), 1 more item",-,USH2A_001195,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, no variant 2nd chromome, solved, compound heterozygous, 1 more item","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Weisschuh 2020, 1 more item",-,rs1380261595,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Janine Reurink"
315,"+/., +?/.",7,-,c.9571-2A>G,"r.spl, r.spl?","p.(?), p.?",-,-,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215987248T>C,g.215813906T>C,"1:215987248T>C ENST00000307340.3:c.9571-2A>G, IVS48-2A>G, USH2A c.9571-2A>G, 1 more item",-,USH2A_001814,heterozygous,"PubMed: Carss 2017, PubMed: Comander 2017, PubMed: Stone 2017, PubMed: Turro 2020, 1 more item",-,-,"Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
316,"+/+, +/.",7,50,c.9811del,r.(?),"p.(Met3271Cysfs*30, p.(Met3271Cysfs*30), p.(Met3271CysfsTer30)",Cystein rich (3192-3358),ACMG,pathogenic,"g.215972396del, g.215972397del",g.215799055del,"9811delA, c.9811del",-,USH2A_000914,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; mutation, Heterozygous; UV3","PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Lenarduzzi 2015, PubMed: Sodi 2014, 1 more item",-,rs767328784,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
317,-/-,7,51i,c.10182+55C>T,r.(=),p.(=),-,-,benign,g.215963346G>A,g.215790004G>A,-,-,USH2A_000110,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
318,"+/+, +/.",7,54,c.10684G>T,r.(?),"p.(Glu3562*), p.(Glu3562Ter)",Fibronectin type-III 20 (3499-3585),ACMG,"pathogenic, pathogenic (recessive)",g.215955440C>A,g.215782098C>A,-,-,USH2A_000476,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; Pathogenic, possible duplicate","PubMed: Baux 2014, PubMed: Bonnet 2011, PubMed: Dad 2015, PubMed: Dad 2016, PubMed: Malm 2010, 3 more items",-,rs749702843,"Germline, SUMMARY record",-,-,-Hpy188III,-,-,"David Baux, Anne-Françoise Roux, Shzeena Dad"
319,"+/., +?/.",7,54,c.10699del,r.(?),"p.(Leu3567*), p.(Leu3567Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215955425del,g.215782083del,"10699delC, c.10699del, c.10699del, p.Leu3567Ter, USH2A c.10699del, p.(Leu3567*), 1 more item",-,USH2A_002279,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous, homozygous","PubMed: Colombo-2020, PubMed: Falsini 2021, PubMed: Zampaglione 2020, 1 more item",-,rs1661659605,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
320,"+?/., +?/?, ?/.",7,55,c.10817T>C,"r.(10817u>c), r.(?)",p.(Leu3606Pro),Fibronectin type-III 21 (3590-3676),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215953307A>G,g.215779965A>G,"c.10817T>C, USH2A c.10817T>C, p.(Leu3606Pro)",-,USH2A_000430,"ACMG GN005 criteria: PM2_P PM3_S, heterozygous, Heterozygous; possibly deleterious","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 4 more items",-,rs1402464909,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
321,"+/., +?/.",7,"56, 56i",c.11048-2A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215933187T>C,g.215759845T>C,"USH2A c.11048-2A>G, p.(?), USH2A, variant 1: c.11048-2A>G/p.?, variant 2: c.8682-9A>G/p.?",-,USH2A_001083,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, compound heterozygous, heterozygous, 1 more item","Journal: Reurink 2021, PubMed: Ivanova 2018, PubMed: Jauregui 2020, PubMed: Neuhaus 2017, 3 more items",-,rs200871041,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Vladimir Strelnikov, Janine Reurink"
322,"+/+, +/., +?/.",7,51,c.11065C>T,r.(?),"p.(Arg3689*), p.(Arg3689Ter)",Fibronectin type-III 22 (3677-3767),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215933168G>A,g.215759826G>A,"c.76457661del p.(Met2549Alafs*3), c.11065C>T p.(Arg3689*), USH2A c.11065C>T",-,USH2A_000598,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1, PP5, Heterozygous, Heterozygous; Pathogenic, 1 more item","PubMed: Aparisi 2014, PubMed: Hagag 2020, PubMed: Le Quesne Stabej 2012, PubMed: Neuhaus 2017, 3 more items",620107,rs41314534,"Germline, Germline/De novo (untested), SUMMARY record, Unknown","?, yes",-,-MnlI;-TaqI;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
323,-/-,7,58i,c.11389+8A>T,r.(=),p.(=),-,-,benign,g.215931929T>A,g.215758587T>A,-,-,USH2A_000368,Heterozygous,"PubMed: Aller 2006, PubMed: Jaijo 2010, PubMed: Najera 2002",-,-,Germline,-,-,-,-,-,Jose Maria Millan
324,"-/-, -/.",7,61,c.11736G>A,r.(?),"p.(=), p.(Glu3912=)",Fibronectin type-III 24 (3863-3960),-,benign,g.215901702C>T,g.215728360C>T,-,-,USH2A_000365,"Heterozygous, Heterozygous; Neutral, Heterozygous; polymorphism, Homozygous, 1 more item","PubMed: Aller 2006, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: McGee 2010",-,rs56053654,"CLASSIFICATION record, Germline",-,-,+TfiI;-PleI;-MlyI;-BseRI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
325,"+?/., +?/?",7,62,c.12268C>A,r.(?),p.(Pro4090Thr),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215853517G>T,g.215680175G>T,"USH2A c.12268C>A, p.Pro4090Thr, 2 more items",-,USH2A_000768,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, ACMG PP3, PM2, PP5_STRONG, Heterozygous; likely pathogenic, 2 more items","PubMed: Dockery 2017, PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, 4 more items",550401,rs780893919,"Germline, SUMMARY record, Unknown","?, yes",1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Johan den Dunnen, David Baux, Anne-Françoise Roux"
326,"+/+, +/.",7,63,c.12868C>T,r.(?),"p.(Gln4290*), p.(Gln4290Ter)",Fibronectin type-III 28 (4265-4351),ACMG,"pathogenic, pathogenic (recessive)",g.215848385G>A,g.215675043G>A,-,-,USH2A_000317,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous","PubMed: Baux 2014, PubMed: Mansard et al, 2021, PubMed: Sun 2018, 1 more item",-,rs397517983,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
327,"+/+, +/., +?/.",7,63,c.13257_13263del,r.(?),"p.(Phe4419Leufs*2), p.(Phe4419LeufsTer2)",Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, pathogenic","g.215847990_215847996del, g.215847993_215847999del",g.215674651_215674657del,"c.13257_13263del, USH2A c.13257_13263del, p.(Phe4419Leufs1*), 1 more item",-,USH2A_000759,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P, Heterozygous; causative, solved, compound heterozygous, 2 more items","PubMed: Eisenberger 2013, PubMed: Eisenberger-2013, PubMed: Falsini 2021, PubMed: Glöckle 2014, 2 more items",-,rs1057517533,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
328,"-/-, -/., -/?, -?/.",7,63,c.13440G>A,r.(?),"p.(=), p.(Arg4480=)",Fibronectin type-III 30 (4444-4528),ACMG,"benign, likely benign",g.215847813C>T,g.215674471C>T,USH2A(NM_206933.2):c.13440G>A (p.R4480=),-,USH2A_000381,"Heterozygous, Heterozygous; polymorphism, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: Lenassi 2015, PubMed: McGee 2010",-,rs111033378,"CLASSIFICATION record, Germline",-,-,+HpyAV;-MnlI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Eva Lenassi"
329,"+/+, +/., +?/.",7,63,c.13621C>T,r.(?),"p.(Gln4541*), p.(Gln4541Ter)",Fibronectin type-III 31 (4529-4627),ACMG,"likely pathogenic, pathogenic",g.215847632G>A,g.215674290G>A,-,-,USH2A_000560,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Pathogenic","PubMed: Ellingford 2016, PubMed: Huang 2017, PubMed: Le Quesne Stabej 2012, PubMed: Stone 2017, 1 more item",-,rs765476745,"Germline, SUMMARY record",-,0/878 controls,-HpyCH4V;-Cac8I;,-,-,"David Baux, Maria Bitner-Glindzicz"
330,"-?/., -?/?, ?/.",7,63,c.13709G>A,r.(?),p.(Arg4570His),Fibronectin type-III 31 (4529-4627),ACMG,"likely benign, VUS",g.215847544C>T,g.215674202C>T,"USH2A(NM_206933.2):c.13709G>A (p.R4570H), USH2A(NM_206933.4):c.13709G>A (p.R4570H)",-,USH2A_000442,"Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: Bryant 2018, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,rs730254,"CLASSIFICATION record, Germline",-,1/1204 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Yoshito Koyanagi"
331,-/-,7,70i,c.15297+57T>C,r.(=),p.(=),-,-,benign,g.215807744A>G,g.215634402A>G,-,-,USH2A_000102,"Heterozygous, Heterozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010, PubMed: Le Quesne Stabej 2012, 1 more item",-,rs79341918,Germline,-,-,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
332,-/-,7,70i,c.15298-24T>C,r.(=),p.(=),-,-,benign,g.215802401A>G,g.215629059A>G,-,-,USH2A_000283,"Heterozygous, Heterozygous; Neutral, Homozygous; Neutral","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs73087440,Germline,-,14/854 controls,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
333,"+?/., +?/?, ?/.",6,2,c.176G>A,r.(?),p.(Gly59Glu),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216595503C>T,g.216422161C>T,"USH2A, variant 1: c.12574C>T/p.R4192C, variant 2: c.176G>A/p.G59E, 1 more item",-,USH2A_000770,"ACMG GN005 criteria: PM2_P PM3_M PP3_P PP1_P, ACMG PM2, PP5_STRONG, Heterozygous; likely pathogenic, 2 more items","PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 2 more items",-,rs1378799607,"Germline, SUMMARY record, Unknown",?,-,-HinfI;-MlyI;-PleI;-XcmI;,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
334,+/+,6,2,c.237_238insCGTA,r.(?),p.(Thr80Argfs*29),-,-,pathogenic,g.216595441_216595442insTACG,g.216422099_216422100insTACG,-,-,USH2A_000139,Homozygous,"PubMed: Adato 2000, PubMed: Leroy 2001",-,-,Germline,-,0/120 controls,-,-,-,Anne-Françoise Roux
335,"+/., +?/., ?/.",6,4,c.754G>T,r.(?),p.(Gly252Cys),-,ACMG,"likely pathogenic, pathogenic, VUS",g.216538325C>A,g.216364983C>A,"USH2A Ex.4 c.754G>T p.(Gly252Cys), Ex.13 c.2276G>T p.(Cys759Phe)",-,USH2A_001449,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous","Sharon, submitted, PubMed: Bravo-Gil 2016, PubMed: Martin Merida 2019, PubMed: Perez-Carro 2018, 2 more items",-,rs777682016,"Germline, SUMMARY record",yes,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon"
336,"+/., +?/., -?/?, ?/.",6,5,c.842C>A,r.(?),p.(Thr281Lys),Laminin N-terminal (271-517),ACMG,"likely benign, likely pathogenic, pathogenic, VUS",g.216500939G>T,g.216327597G>T,USH2A(NM_206933.4):c.842C>A (p.T281K),-,USH2A_000642,"ACMG GN005 criteria: PM2_P PM3_P, Homozygous; UV2, VKGL data sharing initiative Nederland","PubMed: Ge 2015, PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs2037760415,"CLASSIFICATION record, Germline, SUMMARY record",-,0/93 controls,+MseI,-,-,"David Baux, VKGL-NL_AMC, Maria Bitner-Glindzicz"
337,"+/., +?/., +?/?, ?/.",6,6,c.926C>T,r.(?),p.(Pro309Leu),Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216498864G>A,g.216325522G>A,"1:216498864G>A ENST00000307340.3:c.926C>T (Pro309Leu), USH2A c.926C>T, 2 more items",-,USH2A_000985,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 4 more items",-,rs1359713084,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Crystel Bonnet"
338,"+/., +?/., +?/?, ?/.",6,6,c.1001G>A,r.(?),p.(Arg334Gln),Laminin N-terminal (271-517),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216498789C>T,g.216325447C>T,-,-,USH2A_000099,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Sharon 2019, 2 more items",-,rs758303489,"CLASSIFICATION record, Germline, SUMMARY record",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
339,"+/., +?/., ?/.",6,12,c.2081G>A,r.(?),p.(Cys694Tyr),-,-,"likely pathogenic, pathogenic (recessive), VUS",g.216424331C>T,g.216250989C>T,"1:216424331C>T ENST00000307340.3:c.2081G>A (Cys694Tyr), USH2A c.2081G>A, 3 more items",-,USH2A_001266,"compound heterozygous, heterozygous, protein variant annotation not written; heterozygous, 1 more item","PubMed: Carss 2017, PubMed: Martin Merida 2019, PubMed: Toms 2020, PubMed: Turro 2020",-,-,"CLASSIFICATION record, Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
340,"-/-, -/., -?/.",6,12,c.2109T>C,"r.(=), r.(?)","p.(=), p.(Asp703=)",Laminin EGF-like 4 (694-746),-,"benign, likely benign",g.216424303A>G,g.216250961A>G,USH2A(NM_206933.2):c.2109T>C (p.D703=),-,USH2A_000118,"52 heterozygous; Clinindb (India), Heterozygous, Heterozygous; Neutral, 1 more item","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, 1 more item",-,rs45555435,"CLASSIFICATION record, Germline",-,52/2794 individuals,+Hpy166II;+BtsCI;+BccI;+FokI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Mohammed Faruq"
341,"+/+, +/., +?/., ?/.",6,12,c.2135del,r.(?),"p.(Ser712*), p.(Ser712Ter)",Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216424277del,g.216250935del,"2135delC, c.2135delC",-,USH2A_000197,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Bernal 2005, PubMed: Fuster-Garcia 2018, PubMed: Perez-Carro 2018, 1 more item",ClinVar-000803390,rs1238314101,"Germline, SUMMARY record","?, yes",-,-,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux, Bailey Glen"
342,"+/., +?/., +?/?, ?/.",6,13,c.2332G>T,r.(?),p.(Asp778Tyr),Laminin EGF-like 5 (747-794),ACMG,"likely pathogenic, pathogenic, VUS",g.216420404C>A,g.216247062C>A,-,-,USH2A_000179,"ACMG GN005 criteria:, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, PubMed: Zenteno 2020, 2 more items",-,rs142898216,"CLASSIFICATION record, Germline, SUMMARY record",-,1/143 cases,-,-,-,"Johan den Dunnen, David Baux, VKGL-NL_Nijmegen, Jose Maria Millan, Eva Lenassi"
343,"+?/., -/., -/?, -?/., ?/.",6,13,c.2633G>A,r.(?),p.(Arg878His),Laminin EGF-like 7 (847-899),ACMG,"benign, likely benign, likely pathogenic, VUS",g.216420103C>T,g.216246761C>T,"USH2A c.2633G>A, p.Arg878His, USH2A(NM_206933.4):c.2633G>A (p.R878H)",-,USH2A_001078,"ACMG GN005 criteria: BS1_P BS2_S, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Riera 2017, 3 more items",-,rs200124505,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,-,-,-,"David Baux, VKGL-NL_AMC, Eva Lenassi"
344,"+/+, +/., +?/.",6,13i,c.2809+1G>A,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216419926C>T,g.216246584C>T,"USH2A Ex.13 c.2276G>T p.(Cys759Phe), IVS13 c.2809+1G>A p.(?), USH2A(NM_206933.4):c.2809+1G>A",-,USH2A_000361,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, Homozygous, 1 more item","PubMed: Baux 2014, PubMed: Mansard et al, 2021, PubMed: Martin Merida 2019, 1 more item",-,rs759433119,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, VKGL-NL_AMC, Anne-Françoise Roux"
345,"+/., +?/., +?/?, ?/.",6,14,c.2914T>G,r.(?),p.(Cys972Gly),Laminin EGF-like 9 (951-1001),ACMG,"likely pathogenic, pathogenic, VUS",g.216405374A>C,g.216232032A>C,"USH2A c.2914T>G, p. Cys972Gly, USH2A c.2914T>G, p.Cys972Gly, USH2A c.T2914G, p.C972G",-,USH2A_000965,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous, Heterozygous; mutation","PubMed: Gao 2021, PubMed: Huang 2018, PubMed: Meng 2020, PubMed: Zhu 2021, 2 more items",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
346,"+/., +?/., ?/.",6,15,c.3045C>G,r.(?),p.(His1015Gln),-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216390841G>C,g.216217499G>C,"USH2A Ex.15 c.3045C>G p.(His1015Gln), Ex.28 c.5612G>A p.(Gly1871Asp), 1 more item",-,USH2A_001654,"ACMG GN005 criteria:, compound heterozygous, Parents unavailable for testing., 1 more item","PubMed: Bahena 2021, PubMed: Haer-Wigman 2017, PubMed: Karali 2019, Journal: Karali 2019, 2 more items",-,rs541918040,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,-,-,-,"David Baux, Sandro Banfi, VKGL-NL_Rotterdam, Barbara Vona"
347,"+/+, +/., +?/.",6,16i,c.3317-2A>G,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216373465T>C,g.216200123T>C,"USH2A, variant 1: c.3317-2A>G/p.?, variant 2: c.10721G>T/p.G3475V",-,USH2A_000125,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_S, Heterozygous, Heterozygous; likely pathogenic, 2 more items","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Glöckle 2014, 2 more items",-,rs2034951427,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
348,"+/., +?/., +?/?, ?/.",6,17,c.3395G>A,r.(?),p.(Gly1132Asp),Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216373385C>T,g.216200043C>T,"1:216373385C>T ENST00000307340.3:c.3395G>A (Gly1132Asp), 1 more item",-,USH2A_000550,"ACMG GN005 criteria: BS1_P, Heterozygous; Mutation, VKGL data sharing initiative Nederland","PubMed: Carss 2017, PubMed: Sloan-Heggen, C. M. et al., 2016, PubMed: Wang 2014, 1 more item",-,rs34596189,"CLASSIFICATION record, Germline, SUMMARY record",-,-,+TfiI;+HinfI;,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux"
349,"+/., +?/., +?/?, ?/.",6,17,c.3596_3598del,r.(?),p.(Glu1199del),Fibronectin type-III 1 (1058-1143),ACMG,"likely pathogenic, pathogenic, VUS",g.216373183_216373185del,g.216199841_216199843del,"3595_3597delGAA, p.E1119del, 3596_3598delAAG, USH2A c.3595_3597delGAA, p.(Glu1199del), 1 more item",-,USH2A_000861,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, Heterozygous; very likely pathogenic","PubMed: Inaba 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Zhao 2014, 1 more item",-,rs1294733964,"De novo, Germline, SUMMARY record, Unknown",?,"0/400 controls, 5/1204 cases with retinitis pigmentosa",-,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi"
350,"+/., +?/., +?/?, ?/.",6,17,c.3713C>G,r.(?),p.(Thr1238Arg),Fibronectin type-III 2 (1145-1238),ACMG,"likely pathogenic, pathogenic, VUS",g.216373067G>C,g.216199725G>C,"c.3713C>G, USH2A c.3713C>G, p.T1238R, 1 more item",-,USH2A_000524,"ACMG GN005 criteria: PM2_P PM3_M, compound heterozygous, Heterozygous; Pathogenic","PubMed: Avila Fernandez 2010, PubMed: Jauregui 2020, PubMed: Martin Merida 2019, 3 more items",-,rs768461447,"Germline, SUMMARY record, Unknown","?, yes",0/100 controls,+Bsp1286I;+BanII;,-,-,"David Baux, Anne-Françoise Roux"
351,"+/+, +/.",6,18,c.3883C>T,r.(?),"p.(Arg1295*), p.(Arg1295Ter)",Fibronectin type-III 3 (1242-1357),ACMG,pathogenic,g.216371855G>A,g.216198513G>A,"USH2A c.3883C>T, p.Arg1295*",-,USH2A_000166,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Dreyer 2000, PubMed: Gao 2021, PubMed: Jaijo 2010, PubMed: Weston 2000, 1 more item",-,rs764797292,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
352,"+/+, +/., +?/.",6,18,c.3920C>G,r.(?),"p.(Ser1307*), p.(Ser1307Ter)",Fibronectin type-III 3 (1242-1357),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216371818G>C,g.216198476G>C,"USH2A Ex.13 c.2299del p.(Glu767Serfs*21), Ex.18 c.3920C>G (p.Ser1307*)",-,USH2A_000464,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1, PP5, compound heterozygous, Heterozygous, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2011, PubMed: Colombo, L. et al., 2022, PubMed: Martin Merida 2019, 1 more item",-,rs756623509,"Germline, Germline/De novo (untested), SUMMARY record",?,-,none,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
353,+/.,6,-,c.(4627+1_4628-1)_(4758+1_4759-1)del,r.(?),"p.(?), p.(Ile1544ValfsTer9)",-,ACMG,pathogenic,"g.(216084878_216086718)_(216097214_216175251)del, g.(216089140_216097082)_(216097214_216175251)del",-,-,-,USH2A_002299,-,"PubMed: Mansard et al, 2021",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
354,"+/+, +/.",6,26,c.5189_5199del,r.(?),"p.(Tyr1730Trpfs*6), p.(Tyr1730TrpfsTer6)",Laminin G-like 2 (1714-1891),ACMG,pathogenic,"g.216256897_216256907del, g.216256900_216256910del",g.216083558_216083568del,c.5189_5199del,-,USH2A_000351,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; Pathogenic, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2011, PubMed: Colombo, L. et al., 2022, PubMed: Colombo-2020, 1 more item",-,-,"Germline, SUMMARY record",yes,-,+NcoI;+BsaJI;+BtgI;+StyI;,-,-,"David Baux, Anne-Françoise Roux"
355,"+/+, +/.",6,28,c.5735_5736del,r.(?),"p.(Lys1912Argfs*24), p.(Lys1912ArgfsTer24)",Fibronectin type-III 5 (1871-1949),ACMG,"pathogenic, pathogenic (recessive)",g.216246481_216246482del,g.216073139_216073140del,"5735_5736del - p.1912_1912del, 5735_5736delAA, c.5735_5736delAA, 1 more item",-,USH2A_000956,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Jiang, L. et al., 2015, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
356,"+/+, +/., +?/.",6,31,c.6084T>A,"r.(=), r.(?)","p.(Tyr2028*), p.(Tyr2028Ter)",Fibronectin type-III 6 (1954-2051),ACMG,"likely pathogenic, pathogenic",g.216221955A>T,g.216048613A>T,"USH2A, variant 1: c.6084T>A/p.Y2028*, variant 2: c.11864G>A/p.W3955*, 1 more item",-,USH2A_000838,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P, Heterozygous; mutation, solved, compound heterozygous","PubMed: Krawitz 2014, PubMed: Neuhaus 2017, PubMed: Weisschuh 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Peter Krawitz"
357,"-/-, -/., -?/., ?/.",6,32,c.6257C>A,r.(?),p.(Thr2086Asn),Fibronectin type-III 7 (2052-2138),ACMG,"benign, likely benign, VUS",g.216219841G>T,g.216046499G>T,"USH2A(NM_206933.2):c.6257C>A (p.T2086N), USH2A(NM_206933.4):c.6257C>A (p.T2086N)",-,USH2A_000493,"ACMG PM2, Heterozygous; Neutral, Heterozygous; Predicted non pathogenic, 1 more item","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs149202379,"CLASSIFICATION record, Germline",-,5/844 controls,-BspCNI;-DdeI;,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz"
358,"+/., +?/., +?/?, ?/.",6,33,c.6383G>A,r.(?),p.(Cys2128Tyr),Fibronectin type-III 7 (2052-2138),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.216173847C>T,g.216000505C>T,"c.6383G>A, NM_206933.2:c.6383G>A, NP_996816.2:p.(Cys2128Tyr), NC_000001.10:g.216173847C>T, 1 more item",-,USH2A_000417,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; likely deleterious, solved, compound heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Liu-2020, 4 more items",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
359,"+?/., -/-, -/.",6,34,c.6587G>C,r.(?),p.(Ser2196Thr),Fibronectin type-III 8 (2142-2236),-,"benign, likely pathogenic",g.216172299C>G,g.215998957C>G,c.6587G>C,-,USH2A_000170,"Heterozygous, Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: Booij-2011, PubMed: Holtan 2020, 2 more items",-,rs79444516,"CLASSIFICATION record, Germline",-,1/899 cases,-,-,-,"Global Variome, with Curator vacancy, VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan"
360,"+?/., -?/., ?/.",6,-,c.6683T>A,r.(?),p.(Val2228Glu),-,ACMG,"likely benign, likely pathogenic, VUS",g.216166484A>T,g.215993142A>T,"USH2A c.T6683A, p.V2228E, USH2A(NM_206933.2):c.6683T>A (p.V2228E)",-,USH2A_001220,"ACMG GN005 criteria:, marked as causative, heterozygous, VKGL data sharing initiative Nederland, 1 more item","PubMed: Huang 2017, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Ma 2021, 1 more item",-,rs117461552,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,25/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, VKGL-NL_Rotterdam, Yoshito Koyanagi"
361,+/.,6,-,c.6741del,r.(?),"p.(Ala2249Profs*30), p.(Ala2249ProfsTer30)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216166430del,g.215993088del,"6741delC, c.6741delC, USH2A c.6741delC, p.Ala2249ProfsTer30",-,USH2A_001860,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, heterozygous","PubMed: Gao 2021, PubMed: Sun 2018, 1 more item",-,rs1335175914,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
362,"+?/., ?/.",6,36,c.6929C>T,r.(?),p.(Thr2310Met),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216143995G>A,g.215970653G>A,"c.6929C>T, USH2A c.6929C>T, p.T2310M, USH2A c.6929C>T, p.Thr2310Met, 1 more item",-,USH2A_001787,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, VKGL data sharing initiative Nederland","PubMed: Colombo-2020, PubMed: Gao 2021, PubMed: Zhu 2021, 1 more item",-,rs151057466,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC"
363,"+/., +?/., -/?, ?/.",6,40,c.7525C>T,r.(?),p.(Arg2509Trp),Fibronectin type-III 11 (2435-2528),ACMG,"likely benign, likely pathogenic, pathogenic, VUS",g.216073486G>A,g.215900144G>A,"USH2A c.7525C>T, p.Arg2509Trp",-,USH2A_000699,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bravo-Gil 2017, 3 more items",-,rs1394948601,"Germline, SUMMARY record, Unknown",?,1/1204 cases with retinitis pigmentosa,none,-,-,"David Baux, Anne-Françoise Roux, Nereida Bravo Gil, Yoshito Koyanagi"
364,"-/-, -/.",6,40i,c.7595-2389C>T,r.(=),p.(=),-,-,benign,g.216064785G>A,g.215891443G>A,-,-,USH2A_000818,"Heterozygous, Homozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,rs72742769,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
365,"+/., +?/.",6,41,c.7698T>A,r.(?),"p.(Tyr2566*), p.(Tyr2566Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216062293A>T,g.215888951A>T,"USH2A c.7698T>A, p.Tyr2566*, USH2A c.7698T>A, p.Tyr2566*, USH2A c.7698T>A, p.Y2566*, 1 more item",-,USH2A_002549,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Meng 2020, PubMed: Qu 2020, PubMed: Zhu 2021, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
366,"-/-, -/.",6,43i,c.8681+18A>G,r.(=),p.(=),-,-,benign,g.216051082T>C,g.215877740T>C,-,-,USH2A_000350,"Heterozygous, Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012, PubMed: Najera 2002",-,rs41277198,"CLASSIFICATION record, Germline",-,4/92 controls,+HpyCH4III,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Jose Maria Millan, Maria Bitner-Glindzicz"
367,"+/+, +?/.",6,47,c.9345_9346del,r.(?),"p.(Pro3116Hisfs*13), p.(Pro3116HisfsTer13)",Fibronectin type-III 18 (3110-3200),ACMG,"likely pathogenic, pathogenic",g.216011360_216011361del,g.215838018_215838019del,9345_9346delAC,-,USH2A_000815,"ACMG GN005 criteria: PVS1, Heterozygous; mutation, Homozygous, Homozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, 1 more item",-,rs536593247,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
368,"+/., +?/., +?/?, ?/.",6,53,c.10421A>G,"r.(=), r.(?)",p.(Tyr3474Cys),Fibronectin type-III 19 (3404-3494),ACMG,"likely pathogenic, pathogenic, VUS",g.215956244T>C,g.215782902T>C,"c.10421A>G, USH2A, variant 1: c.12234_12235del/p.N4079Wfs*19, variant 2: c.10421A>G/p.Y3474C, 1 more item",-,USH2A_000854,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; causative, solved, compound heterozygous, 1 more item","PubMed: Eisenberger 2013, USMA missense analysis, missense variant in MSV3d, PubMed: Eisenberger-2013, 2 more items",-,rs749121941,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
369,+/.,6,53,c.10576C>T,r.(?),"p.(Gln3526*), p.(Gln3526Ter)",-,ACMG,pathogenic,g.215956089G>A,g.215782747G>A,"USH2A c.10576C>T, p.Gla3526Ter, USH2A c.10576C>T, p.Gln3526*, USH2A c.10576C>T, p.Q3526*",-,USH2A_001346,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, VKGL data sharing initiative Nederland, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Mansard, L. et al., 2021, PubMed: Zhu 2021, 1 more item",-,rs773875669,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux"
370,+/+,6,57,c.11095G>T,r.(?),p.(Glu3699*),Fibronectin type-III 22 (3677-3767),-,pathogenic,g.215933138C>A,g.215759796C>A,-,-,USH2A_000300,"Heterozygous, Homozygous",PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
371,"+/+, +/., +?/., ?/.",6,58,c.11328T>G,r.(?),"p.(Tyr3776*), p.(Tyr3776Ter)",Fibronectin type-III 23 (3768-3862),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.215931998A>C,g.215758656A>C,"USH2A c.11328T>G, p.(Tyr3776*), USH2A c.T11328G, p.Y3776X",-,USH2A_000534,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PVS1, PM2, heterozygous, 2 more items","PubMed: Inaba 2020, PubMed: Kim 2022, Journal: Kim 2022, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 3 more items",-,rs749726310,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,"0/64 controls, 3/1204 cases with retinitis pigmentosa",+BfaI;+CviKI_1;,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi, So Young Kim"
372,-/-,6,58i,c.11390-53C>T,r.(=),p.(=),-,-,benign,g.215916730G>A,g.215743388G>A,-,-,USH2A_000258,"Heterozygous, Homozygous",PubMed: Baux 2014,-,rs6540907,Germline,-,-,-,-,-,Anne-Françoise Roux
373,"+/+, +/., +?/.",6,59i,c.11548+2T>G,"r.(?), r.spl","p.(?), p.?, Splicing defect",-,ACMG,"likely pathogenic, pathogenic",g.215916517A>C,g.215743175A>C,-,-,USH2A_000683,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S PP1_P, Heterozygous; mutation, Heterozygous; Pathogenic","PubMed: Bonnet 2016, PubMed: Garcia-Garcia 2011, PubMed: Mansard et al, 2021, PubMed: Perez-Carro 2018, 1 more item",-,rs1371160062,"Germline, SUMMARY record",yes,-,-HphI,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan, Crystel Bonnet"
374,"+/., +?/., +?/?, -?/?, ?/.",6,61,c.11831C>A,"r.(=), r.(?)",p.(Ala3944Asp),Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, pathogenic, VUS",g.215901607G>T,g.215728265G>T,-,-,USH2A_000842,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 4 more items",-,rs1431048303,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Anne-Françoise Roux, Crystel Bonnet"
375,+/+,6,61,c.11907del,r.(?),p.(Ala3970Leufs*14),Fibronectin type-III 25 (3961-4062),-,pathogenic,g.215901531del,g.215728189del,11907delA,-,USH2A_000868,Homozygous; mutation,PubMed: Reddy 2014,-,-,Germline,-,-,-,-,-,Rima Slim
376,"+/., +?/., -?/?, ?/.",6,62,c.12145G>A,r.(?),p.(Ala4049Thr),Fibronectin type-III 25 (3961-4062),ACMG,"likely benign, likely pathogenic, pathogenic (recessive), VUS",g.215853640C>T,g.215680298C>T,"1:215853640C>T ENST00000307340.3:c.12145G>A (Ala4049Thr), USH2A c.12145G>A, p.Ala4049Thr, 1 more item",-,USH2A_000304,"Heterozygous, there is 1 homozygote in gnomAD, heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Carss 2017, 2 more items",-,-,"CLASSIFICATION record, Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
377,"+/., +?/., -?/., -?/?, ?/.",6,63,c.12505A>G,r.(?),p.(Thr4169Ala),Fibronectin type-III 27 (4154-4258),ACMG,"likely benign, likely pathogenic, pathogenic (recessive), VUS",g.215848748T>C,g.215675406T>C,"1:215848748T>C ENST00000307340.3:c.12505A>G (Thr4169Ala), USH2A c.12505A>G, p.Thr4169Ala, 1 more item",-,USH2A_000604,"Heterozygous; UV1, homozygous, VKGL data sharing initiative Nederland","PubMed: Carss 2017, PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs113107803,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,0/878 controls,+EciI;+AciI;-Hpy166II;-CspCI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Maria Bitner-Glindzicz"
378,"+/., +?/., ?/.",6,63,c.12560G>A,r.(?),p.(Arg4187His),-,ACMG,"likely pathogenic (recessive), pathogenic, VUS",g.215848693C>T,g.215675351C>T,"c.12560G>A, NM_206933.2:c.12560G>A, NP_996816.2:p.(Arg4187His), NC_000001.10:g.215848693C>T, 2 more items",-,USH2A_002046,"ACMG GN005 criteria: PM2_P PM3_P BP4_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Gonzalez-del Pozo 2020, PubMed: Liu-2020, 2 more items",-,rs147304271,"Germline, SUMMARY record, Unknown","?, yes",1/314 case chromosomes,-,-,-,David Baux
379,"+?/., -?/., ?/.",6,-,c.12790G>A,r.(?),p.(Glu4264Lys),-,ACMG,"likely benign, likely pathogenic (recessive), VUS",g.215848463C>T,g.215675121C>T,"USH2A c.12790G>A, p.Glu4264Lys, USH2A(NM_206933.2):c.12790G>A (p.E4264K)",-,USH2A_002045,"ACMG GN005 criteria: BS2_S BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Xu 2014",-,rs200792578,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,1/314 case chromosomes,-,-,-,"David Baux, VKGL-NL_Rotterdam"
380,"-/?, -?/., ?/.",6,63,c.12823T>A,r.(?),p.(Ser4275Thr),Fibronectin type-III 28 (4265-4351),ACMG,"likely benign, VUS",g.215848430A>T,g.215675088A>T,USH2A(NM_206933.2):c.12823T>A (p.S4275T),-,USH2A_000578,"ACMG PM2, Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Costa 2017, PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs138607917,"CLASSIFICATION record, Germline",-,1/876 controls,none,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Maria Bitner-Glindzicz"
381,"+/+, +/., +?/.",6,63,c.13207_13208del,r.(?),"p.(Gly4403Profs*15), p.(Gly4403ProfsTer15)",Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic","g.215848045_215848046del, g.215848046_215848047del",g.215674704_215674705del,"13207_13208delGG, c.13207_13208delGG, p.G4403Pfs*15",-,"USH2A_000126, USH2A_002267","ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic","PubMed: Baux 2007, PubMed: Bryant 2018, PubMed: Le Quesne Stabej 2012, PubMed: Wafa-2021, 1 more item",-,rs746447649,"Germline, SUMMARY record",-,0/878 controls,-BstNI;-Sau96I;-StyD4I;-BssKI;-PspGI;-AlwNI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
382,"+/., +?/.",6,-,c.13331C>T,r.(?),p.(Pro4444Leu),-,ACMG,"likely pathogenic, pathogenic (recessive)",g.215847922G>A,g.215674580G>A,"1:215847922G>A ENST00000307340.3:c.13331C>T (Pro4444Leu), USH2A c.13331C>T, 2 more items",-,USH2A_001801,"heterozygous, protein variant annotation not written; heterozygous","PubMed: Carss 2017, PubMed: Jespersgaar 2019, PubMed: Toms 2020, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
383,"+/+, +/?",6,64,c.14031dup,r.(?),p.(Ala4678Serfs*5),Fibronectin type-III 32 (4633-4730),-,pathogenic,g.215844416dup,g.215671074dup,14031dupA,-,USH2A_000867,Homozygous; mutation,PubMed: Reddy 2014,-,-,Germline,-,-,-,-,-,Rima Slim
384,"+?/., +?/?",6,64,c.14020A>G,"r.(14020a>g), r.(?)",p.(Arg4674Gly),Fibronectin type-III 32 (4633-4730),ACMG,"likely pathogenic, VUS",g.215844427T>C,g.215671085T>C,-,-,"USH2A_000137, USH2A_001432","Heterozygous, no variant 2nd chromome","Sharon, submitted, PubMed: Kaiserman 2007, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs80338904,Germline,-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Dror Sharon, Anne-Françoise Roux, Janine Reurink"
385,"+?/., +?/?, ?/.",6,65,c.14204C>G,r.(?),"p.(Pro4735Arg ), p.(Pro4735Arg)",Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215824073G>C,g.215650731G>C,c.14204C>G,-,USH2A_001049,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 2 more items",-,rs1333608275,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
386,"+?/., ?/.",6,66,c.14350G>A,r.(?),p.(Glu4784Lys),-,ACMG,"likely pathogenic, VUS",g.215822102C>T,g.215648760C>T,"USH2A c.14350G>A, p.Glu4784Lys, USH2A c.14350G>A, p.E4784K",-,USH2A_001754,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Sharon 2019, PubMed: Zhu 2021",-,rs746837034,"Germline, SUMMARY record, Unknown","?, yes",1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux"
387,"+/+, +/., +?/., ?/.",6,66,c.14424C>A,r.(?),"p.(Cys4808*), p.(Cys4808Ter)",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215822028G>T,g.215648686G>T,c.14424C>A,-,"USH2A_000870, USH2A_001430","ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_M, Heterozygous; mutation","Sharon, submitted, PubMed: Khalaileh, A. et al., 2018, PubMed: Khalaileh-2018, PubMed: Reddy 2014, 2 more items",-,rs1553250184,"Germline, SUMMARY record, Unknown",-,3/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Rima Slim, Dror Sharon"
388,"+/., +?/., ?/.",6,66,c.14570G>T,r.(?),p.(Gly4857Val),-,ACMG,"likely pathogenic, pathogenic, VUS",g.215821882C>A,g.215648540C>A,"USH2A c.14570G>T, p.G4857V, USH2A c.14570G>T, p.Gly4857Val",-,USH2A_001457,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
389,"-/., -/?, -?/., ?/.",6,67,c.14642G>C,r.(?),p.(Ser4881Thr),Fibronectin type-III 34 (4826-4927),ACMG,"benign, likely benign, VUS",g.215821013C>G,g.215647671C>G,"USH2A c.14642G>C, p.Ser4881Thr, USH2A(NM_206933.2):c.14642G>C (p.S4881T)",-,USH2A_000542,"ACMG GN005 criteria: BS2_S BP4_P, heterozygous, Heterozygous; Presumed non-pathogenic, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,rs200949691,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,"1/1204 cases with retinitis pigmentosa, 3/270 controls, 44/1204 cases with retinitis pigmentosa",-BseYI;-CviKI_1;,-,-,"David Baux, VKGL-NL_Rotterdam, Anne-Françoise Roux, Yoshito Koyanagi"
390,"-?/., -?/?, ?/.",6,67,c.14753C>T,"r.(14753c>u), r.(?)",p.(Thr4918Met),Fibronectin type-III 34 (4826-4927),ACMG,"likely benign, VUS",g.215820902G>A,g.215647560G>A,USH2A(NM_206933.2):c.14753C>T (p.T4918M),-,USH2A_000450,"Heterozygous; unknown, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2014, 2 more items",-,rs56136489,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux, Janine Reurink"
391,"+?/., +?/?, ?/.",6,71,c.15496A>G,r.(?),p.(Ile5166Val),Cytoplasmic (5064-5202),ACMG,"likely pathogenic, VUS",g.215802179T>C,g.215628837T>C,"USH2A(NM_206933.2):c.15496A>G (p.I5166V), 1 more item",-,USH2A_001054,"ACMG GN005 criteria: PP1_P BP4_P, Heterozygous; mutation, possibly solved, compound heterozygous, 1 more item","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 1 more item",-,rs111033419,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, Crystel Bonnet"
392,"+?/., +?/?, ?/.",5,2,c.232T>G,r.(?),p.(Phe78Val),-,ACMG,"likely pathogenic, VUS",g.216595447A>C,g.216422105A>C,c.232T>G,-,USH2A_000979,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo-2020, 1 more item",-,rs775094277,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
393,+/+,5,2,c.239_240insGATC,r.(?),p.(Gln81Ilefs*28),-,-,pathogenic,g.216595440_216595441insATCG,g.216422098_216422099insATCG,-,-,USH2A_000138,Heterozygous,PubMed: Kaiserman 2007,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
394,"+?/., -/., -?/., ?/.",5,-,c.478G>A,r.(?),p.(Gly160Ser),-,ACMG,"benign, likely benign, likely pathogenic, VUS",g.216595201C>T,g.216421859C>T,"USH2A c.478G>A, p.G160S, 1 more item",-,USH2A_001288,"ACMG GN005 criteria: BS1_P, homozygous, VKGL data sharing initiative Nederland","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs111033479,"CLASSIFICATION record, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
395,"+/., +?/.",5,-,c.486-1G>C,r.spl,"p.(?), p.?",-,-,"likely pathogenic, pathogenic",g.216592022C>G,g.216418680C>G,USH2A c.486-1G>C,-,USH2A_002037,"heterozygous, homozygous","PubMed: Méjécase 2020, PubMed: Neuhaus 2017, PubMed: Zampaglione 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
396,"+/+, +/.",5,4,c.775_776del,r.(?),"p.(Ser259Phefs*63), p.(Ser259PhefsTer63)",-,ACMG,pathogenic,g.216538305_216538306del,g.216364963_216364964del,775_776delAG,-,USH2A_000209,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Neuhaus 2017, PubMed: Seyedahmadi 2004, 1 more item",-,rs2038566220,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
397,"+?/., -/.",5,-,c.848+5G>C,"r.(?), r.spl?","p.(=), p.?",-,ACMG,"benign, likely pathogenic (recessive)",g.216500928C>G,g.216327586C>G,-,-,USH2A_001425,"ACMG GN005 criteria: BA1 BS2_S BP4_P, VKGL data sharing initiative Nederland","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs74329863,"CLASSIFICATION record, Germline, SUMMARY record",-,59/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, VKGL-NL_Nijmegen, Yoshito Koyanagi"
398,"+/., -?/?, ?/.",5,6,c.1048G>A,r.(?),p.(Val350Ile),Laminin N-terminal (271-517),ACMG,"likely benign, pathogenic, VUS",g.216498742C>T,g.216325400C>T,"USH2A c.1048G>A, p.V350I",-,USH2A_000970,"ACMG GN005 criteria: PM2_P BP4_P, Heterozygous; mutation","PubMed: Jiang 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Jiang, L. et al., 2015, 2 more items",-,rs148848581,"Germline, SUMMARY record, Unknown",?,2/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi"
399,"+?/., ?/.",5,-,c.1391G>A,r.(?),p.(Arg464His),-,ACMG,"likely pathogenic, VUS",g.216496975C>T,g.216323633C>T,"USH2A c.1391G>A, USH2A c.1391G>A, p.(Arg464His), c.13576C>T, p.(Arg4526*), $",-,USH2A_001548,"ACMG GN005 criteria: PM2_P PM3_M PP1_P, no protein annotation written; heterozygous","PubMed: Bravo-Gil 2017, PubMed: Bravo-Gil, N. et al., 2017, PubMed: Charng 2020, 2 more items",-,rs771000800,"Germline, SUMMARY record","?, yes",4/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Nereida Bravo Gil, Yoshito Koyanagi"
400,?/.,5,8,c.1439T>C,"r.(1439u>c), r.(?)",p.(Val480Ala),-,ACMG,VUS,g.216496927A>G,g.216323585A>G,"USH2A(NM_206933.2):c.1439T>C (p.V480A), USH2A(NM_206933.4):c.1439T>C (p.V480A)",-,USH2A_001275,"no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Janine Reurink"
401,"+?/?, ?/.",5,9,c.1558T>C,"r.(=), r.(?)",p.(Cys520Arg),Laminin EGF-like 1 (518-574),ACMG,VUS,g.216495311A>G,g.216321969A>G,-,-,USH2A_000832,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation, Homozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
402,"-/-, -/., -?/.",5,10,c.1731C>T,r.(?),"p.(=), p.(Cys577=)",Laminin EGF-like 2 (575-640),-,"benign, likely benign",g.216465626G>A,g.216292284G>A,USH2A(NM_206933.4):c.1731C>T (p.C577=),-,USH2A_000568,"Heterozygous; UV1, Homozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, PubMed: Maranha 2015, Journal: Maranhao 2015",-,rs41313732,"CLASSIFICATION record, Germline",-,"2/844 controls, 2/846 controls",-HpyCH4V,-,-,"VKGL-NL_AMC, Maria Bitner-Glindzicz"
403,"+/., ?/.",5,13,c.2414G>C,r.(?),p.(Gly805Ala),-,ACMG,"pathogenic, VUS",g.216420322C>G,g.216246980C>G,"G2414C, USH2A c.G2414C, p.G805A",-,USH2A_001539,"ACMG GN005 criteria: PM2_P, marked as causative, heterozygous, 1 more item","PubMed: Katagiri 2014, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Ma 2021, 1 more item",-,rs587783023,"Germline, SUMMARY record, Unknown",?,8/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
404,"+/., +?/.",5,13,c.2710_2720dup,r.(?),"p.(Leu908Profs*63), p.(Leu908ProfsTer63)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216420016_216420026dup,g.216246674_216246684dup,"c.2710_2720dup, c.2710_2720dup, p.Leu908ProfsTer63",-,USH2A_002335,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, heterozygous","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 2 more items",-,rs755218835,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux"
405,+/+,5,14,c.2810-?_2993+?del,r.(?),p.(Gly937Aspfs*13),Laminin EGF-like 8 (900-950),-,pathogenic,g.216405295_216405478del,-,E14del,-,USH2A_000760,2 more items,"PubMed: Aparisi 2014, PubMed: Glöckle 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
406,+/+,5,14,c.2898del,r.(?),p.(Thr967Leufs*44),Laminin EGF-like 9 (951-1001),-,pathogenic,g.216405390del,g.216232048del,2898delG,-,USH2A_000188,"Heterozygous, Homozygous","PubMed: Jaijo 2010, PubMed: Seyedahmadi 2004, PubMed: Weston 2000",-,-,Germline,-,0/190 controls,-,-,-,"Anne-Françoise Roux, Jose Maria Millan"
407,-/?,5,14,c.2844C>G,r.(?),p.(Cys948Trp),Laminin EGF-like 8 (900-950),ACMG,likely benign,g.216405444G>C,g.216232102G>C,-,-,USH2A_000378,"Heterozygous, Heterozygous; UV1","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,0/878 controls,+PflMI;+BslI;+CviKI_1;-MwoI;,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
408,"+/+, +/., +?/.",5,15,c.3034G>T,r.(?),"p.(Glu1012*), p.(Glu1012Ter)",Laminin EGF-like 10 (1002-1052),ACMG,"likely pathogenic (recessive), pathogenic",g.216390852C>A,g.216217510C>A,"c.3034G>T, USH2A c.3034G>T, p.E1012*",-,USH2A_000976,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Liu-2020, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
409,"+/., +?/?, ?/.",5,16,c.3176C>T,r.(?),p.(Pro1059Leu),Fibronectin type-III 1 (1058-1143),ACMG,"pathogenic, VUS",g.216380755G>A,g.216207413G>A,-,-,"USH2A_000229, USH2A_001446","Heterozygous, VKGL data sharing initiative Nederland","PubMed: Licastro 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Sharon 2019, 1 more item",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Dror Sharon, VKGL-NL_Nijmegen, Anne-Françoise Roux"
410,"+/+, +/., +?/.",5,17,c.3684T>A,r.(?),"p.(Cys1228 *), p.(Cys1228*), p.(Cys1228Ter)",Fibronectin type-III 2 (1145-1238),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216373096A>T,g.216199754A>T,"c.3684T>A, USH2A c.3684T>A, p.Cys1228X",-,USH2A_000995,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, compound heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Colombo-2020, PubMed: Jauregui 2020, 2 more items",-,rs2102466516,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Sandro Banfi, Crystel Bonnet"
411,"+/+, +/.",5,17,c.3737dup,r.(?),"p.(Ser1247Lysfs*4), p.(Ser1247LysfsTer4)",Fibronectin type-III 3 (1242-1357),ACMG,pathogenic,g.216373043dup,g.216199701dup,3737dupT,-,USH2A_000694,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation, Homozygous, 1 more item","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs2034937352,"CLASSIFICATION record, Germline, SUMMARY record",-,-,+PshAI;+AflII;+SmlI;-PflFI;-DdeI;-Tth111I;,-,-,"David Baux, VKGL-NL_Nijmegen, Anne-Françoise Roux, Crystel Bonnet"
412,"+/+, +/.",5,18,c.3890_3891del,r.(?),"p.(Phe1297Serfs*17), p.(Phe1297SerfsTer17)",Fibronectin type-III 3 (1242-1357),ACMG,"pathogenic, pathogenic (recessive)","g.216371847_216371848del, g.216371850_216371851del",g.216198508_216198509del,"3890_3891delTT, c.3890_3891del",-,USH2A_000997,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Colombo-2020, 1 more item",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Crystel Bonnet"
413,+/.,5,-,c.4029T>G,r.(?),p.(Asn1343Lys),-,-,pathogenic,g.216371709A>C,g.216198367A>C,"USH2A c.4029T > G, p.Asn1343Lys",-,USH2A_002679,heterozygous,PubMed: Ahmed 2021,-,-,Germline,yes,-,-,-,-,LOVD
414,"+?/?, ?/.",5,19,c.4133T>C,"r.(4133u>c), r.(?)",p.(Leu1378Pro),Fibronectin type-III 4 (1367-1462),ACMG,VUS,g.216370013A>G,g.216196671A>G,-,-,USH2A_000637,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous, Heterozygous; UV4","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Comander 2017, 3 more items",-,rs2034852728,"Germline, SUMMARY record",-,0/878 controls,none,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz, Janine Reurink"
415,"+/., +?/.",5,19,c.4217C>A,r.(?),"p.(Ser1406*), p.(Ser1406Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216369929G>T,g.216196587G>T,"USH2A c.4217C>A, p.Ser1406*, USH2A c.4217C>A, p.S1406*, USH2A c.4217C>A, p.S1406XS",-,USH2A_001772,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: He, C. et al., 2020; PubMed: Meng, X. et al., 2021, PubMed: Kim 2019, PubMed: Kim 2019, 2 more items",-,rs1308702971,"Germline, SUMMARY record, Unknown","?, yes",1/86 cases,-,-,-,"Global Variome, with Curator vacancy, David Baux"
416,"+/., +?/.",5,20,c.4321G>T,r.(?),"p.(Glu1441*), p.(Glu1441Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216363640C>A,g.216190298C>A,"c.[2299del]+[4321G>T], USH2A c.4321G>T, p.(Glu1441X), 1 more item",-,USH2A_002126,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, heterozygous","PubMed: Ellingford 2016, PubMed: Jiman 2020, PubMed: Molina-Ramirez 2020, PubMed: O'Sullivan-2012, 1 more item",-,rs869312186,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux"
417,"+?/., -/-, -/., -?/.",5,21,c.4560C>T,"r.(=), r.(?)","p.(=), p.(Ile1520=)",Laminin G-like 1 (1517-1709),-,"benign, likely benign, likely pathogenic",g.216348661G>A,g.216175319G>A,"c.4560C>T, USH2A(NM_206933.2):c.4560C>T (p.I1520=), USH2A(NM_206933.4):c.4560C>T (p.I1520=)",-,USH2A_000603,"Heterozygous; Neutral, VKGL data sharing initiative Nederland","PubMed: Booij-2011, PubMed: Le Quesne Stabej 2012",-,-,"CLASSIFICATION record, Germline",-,4/844 controls,+Tsp509I;+EcoRI;+ApoI;-TfiI;-HinfI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Maria Bitner-Glindzicz"
418,"+/+, +/., +?/.",5,24,c.4933G>T,r.(?),"p.(Gly1645*), p.(Gly1645Ter)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic",g.216260115C>A,g.216086773C>A,"USH2A, variant 1: c.4933G>T/p.G1645*, variant 2 :Deletion exon 22-24",-,USH2A_001002,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation, solved, compound heterozygous","PubMed: Bonnet 2016, PubMed: Neuhaus 2017, PubMed: Weisschuh 2020, 1 more item",-,rs2032147505,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Crystel Bonnet"
419,"+?/., -?/?, ?/.",5,25,c.5051C>T,r.(?),p.(Pro1684Leu),Laminin G-like 1 (1517-1709),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), VUS",g.216258156G>A,g.216084814G>A,"c.5051C>T, USH2A c.5051C>T, p.P1684L",-,USH2A_000937,Heterozygous; mutation,"PubMed: Liu-2020, PubMed: Sun 2015, PubMed: Zhu 2021, 1 more item",-,-,"Germline, Unknown",?,"1/596 chromosomes, 1/624 control chromosomes",-,-,-,Anne-Françoise Roux
420,"+?/., ?/.",5,-,c.5400G>T,r.(?),p.(Trp1800Cys),-,ACMG,"likely pathogenic, VUS",g.216251603C>A,g.216078261C>A,-,-,USH2A_002233,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, MobiDetails"
421,"+/+, +/., +?/.",5,27,c.5399G>A,r.(?),"p.(Trp1800*), p.(Trp1800Ter)",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic",g.216251604C>T,g.216078262C>T,"USH2A, variant 1: c.9056-2A>G/p.?, variant 2: c.5399G>A/p.W1800*",-,USH2A_000728,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic, 1 more item","PubMed: Baux 2014, PubMed: Lenarduzzi 2015, PubMed: Mansard et al, 2021, PubMed: Weisschuh 2020, 1 more item",-,rs1553299079,"Germline, SUMMARY record, Unknown",?,-,none,-,-,"David Baux, Anne-Françoise Roux"
422,"+/+, +/., +?/.",5,28,c.5614_5620del,r.(?),"p.(Ala1872Leufs*58), p.(Ala1872LeufsTer58)",Fibronectin type-III 5 (1871-1949),ACMG,"likely pathogenic, pathogenic",g.216246595_216246601del,g.216073253_216073259del,"5614_5620delGCTGTCG, c.5614_5620del, USH2A c.5614_5620del",-,USH2A_000597,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Pathogenic, 1 more item","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012, PubMed: Toms 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-HincII;-Hpy166II;-DraIII;-HpaI;,-,-,"David Baux, Maria Bitner-Glindzicz"
423,"+?/., +?/?, ?/.",5,28,c.5776G>A,"r.(?), r.5573_5776del, r.spl?","p.(Glu1926Lys), p.Gly1858_Thr1925del",Fibronectin type-III 5 (1871-1949),ACMG,"likely pathogenic, VUS",g.216246439C>T,g.216073097C>T,-,-,USH2A_000402,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; likely to alter splicing (last nucleotide of exon 28), 1 more item","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 3 more items",-,rs1404685640,"Germline, In vitro (cloned), SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Eva Lenassi, Janine Reurink"
424,"+/., +?/., ?/.",5,30,c.5976T>G,r.(?),"p.(Tyr1992*), p.(Tyr1992Ter)",-,ACMG,"likely pathogenic (recessive), pathogenic, VUS",g.216243516A>C,g.216070174A>C,"c.5976T>G, USH2A c.5976T>G, p.Tyr1992*, USH2A c.5976T>G, p.Y1993*",-,USH2A_002439,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous, 1 more item","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,rs779826128,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
425,"+/+, +/., +?/.",5,32,c.6249del,r.(?),"p.(Ile2084Leufs*2), p.(Ile2084LeufsTer2)",Fibronectin type-III 7 (2052-2138),ACMG,"likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216219849del,g.216046507del,"6249delT, c.6249delT",-,USH2A_000744,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Disease causing","PubMed: Liu-2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Xu 2011",-,-,"Germline, SUMMARY record",-,0/200 controls,none,-,-,"David Baux, Anne-Françoise Roux"
426,"-/., -/?, -?/.",5,32,c.6270A>G,r.(?),"p.(=), p.(Leu2090=)",Fibronectin type-III 7 (2052-2138),ACMG,"benign, likely benign",g.216219828T>C,g.216046486T>C,"USH2A(NM_206933.2):c.6270A>G (p.L2090=), USH2A(NM_206933.4):c.6270A>G (p.L2090=)",-,USH2A_000454,"Heterozygous; polymorphism, Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, PubMed: McGee 2010",-,rs56245532,"CLASSIFICATION record, Germline",-,-,+CviQI;+BsrGI;+RsaI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz"
427,"+?/., +?/?, ?/.",5,33,c.6383G>T,r.(?),p.(Cys2128Phe),Fibronectin type-III 7 (2052-2138),ACMG,"likely pathogenic, VUS",g.216173847C>A,g.216000505C>A,"c.6383G>T,p.C2128F, p.C2128F, USH2A p.C2128F",-,USH2A_000418,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; likely deleterious, 1 more item","PubMed: Jacobson 2014, PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
428,"+/+, +/.",5,35,c.6752C>A,r.(?),p.(Ser2251*),Fibronectin type-III 9 (2241-2325),ACMG,pathogenic,g.216166415G>T,g.215993073G>T,"USH2A c.6752C>A, p.S2251*",-,USH2A_000963,Heterozygous; mutation,"PubMed: Jiang 2015, PubMed: Zhu 2021",-,-,"Germline, Unknown","?, yes",-,-,-,-,Anne-Françoise Roux
429,"+/., +?/., +?/?, ?/.",5,35,c.6795_6797del,r.(?),"p.(Glu2265_Tyr2266delinsAsp), p.(p.Glu2265_Tyr2266delinsAsp)",Fibronectin type-III 9 (2241-2325),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.216166371_216166373del,g.215993029_215993031del,"6795_6797delATA, USH2A c.6795_6797del",-,USH2A_000483,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; Pathogenic, possible duplicate, 1 more item","PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, PubMed: Ge 2015, PubMed: Toms 2020, 2 more items",-,rs727503723,"Germline, SUMMARY record, Unknown",?,-,+AlwI;+Sau3AI;+MboI;+DpnI;+BfuCI;+DpnII;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
430,"+?/., ?/.",5,37,c.6986C>A,r.(?),p.(Pro2329His),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS","g.216138793G>T, g.462946C>A",g.215965451G>T,"c.6986C>A, c.6986C>A, p.P2329H, USH2A c.6986C>A, p.P2329H, USH2A c.C6986A, p.P2329H",-,USH2A_002241,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, compound heterozygous, marked as causative, heterozygous","PubMed: Liu 2020, PubMed: Liu-2020, PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021, PubMed: Zhu 2021",-,rs554957414,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
431,"+/., ?/.",5,-,c.7334C>T,r.(?),p.(Ser2445Phe),-,-,"pathogenic, pathogenic (recessive), VUS",g.216074214G>A,g.215900872G>A,"1:216074214G>A ENST00000307340.3:c.7334C>T (Ser2445Phe), USH2A c.7334 C > T, p.Ser2445Phe, 1 more item",-,USH2A_001820,"heterozygous, VKGL data sharing initiative Nederland","PubMed: Ahmed 2021, PubMed: Carss 2017",-,-,"CLASSIFICATION record, Germline",yes,-,-,-,-,VKGL-NL_Rotterdam
432,"+/., +?/.",5,"40, 55",c.7569G>A,r.(?),"p.(Trp2523*), p.(Trp2523Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216073442C>T,g.215900100C>T,"c.7569G>A, USH2A c.7569G>A, p.Trp2523*, USH2A c.7569G>A, p.W2523*",-,USH2A_002018,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous, not in 100 controls","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Yang 2015, 1 more item",-,rs2102469493,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
433,"+?/., ?/.",5,41,c.7871C>T,r.(?),p.(Pro2624Leu),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216062120G>A,g.215888778G>A,"USH2A c.7871C>T, p.P2624L",-,USH2A_001114,"ACMG GN005 criteria: PM2_P PM3_M, VKGL data sharing initiative Nederland","PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Zazo Seco 2017, Journal: Zazo Seco 2017, 1 more item",-,rs748455430,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Mieke Wesdorp, VKGL-NL_Nijmegen"
434,"+?/., ?/.",5,-,c.7951A>G,r.(?),p.(Asn2651Asp),-,-,"likely pathogenic, VUS",g.216062040T>C,g.215888698T>C,1 more item,-,USH2A_001207,VKGL data sharing initiative Nederland,"PubMed: Ben Yosef 2023, PubMed: Haer-Wigman 2017",-,-,"CLASSIFICATION record, Germline, Unknown",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Groningen, VKGL-NL_Nijmegen, Tamar Ben-Yosef"
435,"-?/., -?/?, ?/.",5,42,c.8357T>C,r.(?),p.(Phe2786Ser),Fibronectin type-III 14 (2724-2812),ACMG,"likely benign, VUS",g.216052307A>G,g.215878965A>G,"USH2A(NM_206933.2):c.8357T>C (p.F2786S), USH2A(NM_206933.4):c.8357T>C (p.F2786S)",-,USH2A_000423,"15 heterozygous, no homozygous; Clinindb (India), Heterozygous; unclear, 1 more item","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2014, 1 more item",-,rs111033262,"CLASSIFICATION record, Germline",-,15/2794 individuals,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux, Mohammed Faruq"
436,"+/+, +/.",5,42,c.8483del,r.(?),"p.(Ser2828Leufs*2), p.(Ser2828LeufsTer2)",Fibronectin type-III 15 (2821-2920),ACMG,"pathogenic, pathogenic (recessive)",g.216052181del,g.215878839del,"8483delC, c.8483delC",-,USH2A_000005,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_M, Heterozygous","PubMed: Dai 2008, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Dai, H. et al., 2008",-,-,"Germline, SUMMARY record",-,0/200 controls,-,-,-,"David Baux, Anne-Françoise Roux"
437,"-/?, -?/., ?/.",5,43,c.8575C>T,"r.(=), r.(?)",p.(Arg2859Cys),Fibronectin type-III 15 (2821-2920),ACMG,"likely benign, VUS",g.216051206G>A,g.215877864G>A,"USH2A c.8575C>T, p.Arg2859Cys, USH2A(NM_206933.4):c.8575C>T (p.R2859C)",-,USH2A_000755,"ACMG GN005 criteria: BS2_S BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Besnard, Garcia-Garcia 2014, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs138087806,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-BsmAI;-BsmBI;-HpyCH4IV;,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
438,"+/., +?/.",5,43,c.8584C>T,r.(?),"p.(Gln2862*), p.(Gln2862Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216051197G>A,g.215877855G>A,"c.8584C>T,p.Q2862X, USH2A c.8584C>T, p.(Gln2862*), USH2A c.C8584T, p.Q2862*",-,USH2A_002485,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021; PubMed: Falsini, B. et al., 2021, 2 more items",-,rs748863844,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
439,"-/-, -?/?",5,43i,c.8682-77A>C,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,"benign, likely benign",g.216040589T>G,g.215867247T>G,-,-,USH2A_000298,"Heterozygous, Heterozygous; Neutral",PubMed: Le Quesne Stabej 2012,-,rs41277196,Germline,-,-,+Tsp45I;-MboII;,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
440,"+/+, +/.",5,44,c.8723_8724del,r.(?),"p.(Val2908Glyfs*29), p.(Val2908GlyfsTer29)",Fibronectin type-III 15 (2821-2920),ACMG,pathogenic,g.216040473_216040474del,g.215867131_215867132del,"8723_8724delTG, USH2A(NM_206933.4):c.8723_8724delTG (p.V2908Gfs*29)",-,USH2A_000162,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Van Wijk 2004",-,rs2102440742,"CLASSIFICATION record, Germline, SUMMARY record",yes,0/188 controls,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
441,+/.,5,"13, 46",c.9120G>A,r.(?),p.(Trp3040*),-,ACMG,"pathogenic, pathogenic (recessive)",g.216017774C>T,g.215844432C>T,"1920G>A, USH2A c.9120G>A, p.W3040*",-,USH2A_000474,"possible duplicate, possible duplicate; unknown variant 2nd chromosome","PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, PubMed: Zhu 2021",-,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
442,"+/., +?/.",5,46i,c.9258+1G>T,"r.(?), r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216017635C>A,g.215844293C>A,"c.9258+1G>T, USH2A c.9258+1G>T, ., 1 more item",-,USH2A_001498,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, marked as causative, heterozygous","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Liu-2020, PubMed: Ma 2021, 2 more items",-,rs748810737,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
443,"+/., +?/.",5,47,c.9304C>T,r.(?),"p.(Gln3102*), p.(Gln3102Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216011400G>A,g.215838058G>A,"USH2A c.9304C>T, p.(Gln3102*), 1 more item",-,USH2A_002214,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, heterozygous, homozygous","PubMed: Dineiro 2020, PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, 1 more item",-,rs397518046,"Germline, SUMMARY record","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
444,"+/+, +/.",5,48,c.9450G>A,r.(?),"p.(Trp3150*), p.(Trp3150Ter)",Fibronectin type-III 18 (3110-3200),ACMG,"pathogenic, pathogenic (recessive)",g.215990459C>T,g.215817117C>T,-,-,USH2A_000006,"ACMG GN005 criteria: PVS1_VS PM2_P PP1_M, Heterozygous","PubMed: Dai 2008, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Dai, H. et al., 2008",-,-,"Germline, SUMMARY record",-,0/200 controls,-,-,-,"David Baux, Anne-Françoise Roux"
445,"+/+, +/.",5,48,c.9453T>A,r.(?),"p.(Tyr3151*), p.(Tyr3151Ter)",Fibronectin type-III 18 (3110-3200),ACMG,"pathogenic, pathogenic (recessive)",g.215990456A>T,g.215817114A>T,"USH2A c.9453T>A, p.Y3151*",-,USH2A_000975,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation, 1 more item","PubMed: Jiang 2015, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Jiang, L. et al., 2015, 1 more item",-,rs1553265829,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
446,"+/+, +?/.",5,48,c.9459C>A,r.(?),"p.(Cys3153*), p.(Cys3153Ter)",Fibronectin type-III 18 (3110-3200),ACMG,"likely pathogenic, pathogenic",g.215990450G>T,g.215817108G>T,"c.9459C>A p.(Cys3153*), c.1333513347delinsCTTG p.(Glu4445_4449delinsAspLeu), 1 more item",-,USH2A_000613,"ACMG GN005 criteria: PVS1_VS PM2_P, compound heterozygous, Heterozygous; Pathogenic, 1 more item","PubMed: Hagag 2020, PubMed: Jauregui 2020, PubMed: Le Quesne Stabej 2012, PubMed: Stone 2017, 1 more item",-,rs73090721,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,+AluI;+CviKI_1;- HinP1I;-HhaI;,-,-,"David Baux, Maria Bitner-Glindzicz"
447,"+/., +?/., -?/?, ?/.",5,49,c.9611A>G,r.(?),p.(His3204Arg),Cystein rich (3192-3358),ACMG,"likely benign, likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.215987206T>C,g.215813864T>C,"USH2A c.9611A>G, p.H3204R",-,USH2A_000894,"ACMG GN005 criteria: PM2_P BP4_P, Heterozygous","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Lenassi, E. et al., 2015, PubMed: Xu 2014, 2 more items",-,rs745539518,"Germline, SUMMARY record",yes,"1/1204 cases with retinitis pigmentosa, 1/314 case chromosomes",-,-,-,"David Baux, Eva Lenassi, Yoshito Koyanagi"
448,+/.,5,-,c.9740-5486_11389+5456del,r.?,p.(Glu3248_Gly3797del),-,ACMG,pathogenic (recessive),g.215926542_215978014del,g.215753200_215804672del,-,-,USH2A_002890,"ACMG PVS1, PM2, PP1",PubMed: Basharat 2024,-,-,Germline,yes,-,-,-,-,Rabia Basharat
449,"+?/., -/., -?/?",5,50i,c.9959-11T>G,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,"benign, likely benign, likely pathogenic",g.215963635A>C,g.215790293A>C,"USH2A c.9959-11T>G, p.(?), USH2A(NM_206933.4):c.9959-11T>G",-,USH2A_000312,"ACMG GN005 criteria: BA1 BS2_S, Heterozygous, homozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs116150014,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
450,"-/?, -?/.",5,51,c.10062G>C,r.(?),"p.(=), p.(Val3354=)",Cystein rich (3192-3358),ACMG,likely benign,g.215963521C>G,g.215790179C>G,"USH2A(NM_206933.2):c.10062G>C (p.V3354=), USH2A(NM_206933.4):c.10062G>C (p.V3354=)",-,USH2A_000595,"Heterozygous; UV1, Homozygous; UV1, VKGL data sharing initiative Nederland",PubMed: Le Quesne Stabej 2012,-,-,"CLASSIFICATION record, Germline",-,1/872 controls,+Sau96I;+PflFI;+BmrI;+AvaII;+Tth111I;-BanI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Maria Bitner-Glindzicz"
451,"+/+, +/.",5,52,c.10272_10274dup,r.(?),p.(Cys3425Phefs*4),Fibronectin type-III 19 (3404-3494),-,pathogenic,g.215960125_215960127dup,g.215786783_215786785dup,C3425Ffs*4,-,USH2A_000177,Heterozygous,"PubMed: Aller 2006, PubMed: Jaijo 2010, PubMed: Najera 2002, PubMed: Sanchez-Alcudia 2014",-,-,Germline,-,-,-,-,-,Jose Maria Millan
452,"+/., +?/., -?/?, ?/.",5,53,c.10437G>T,r.(?),p.(Trp3479Cys),Fibronectin type-III 19 (3404-3494),ACMG,"likely benign, likely pathogenic (recessive), pathogenic, VUS",g.215956228C>A,g.215782886C>A,"c.10437G>T, USH2A c.10437G>T, p.(Trp3479Cys), USH2A c.10437G>T, p.Trp3479Cys",-,USH2A_000428,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, Heterozygous; unknown","PubMed: Colombo-2020, PubMed: Falsini 2021, PubMed: Zampaglione 2020, 2 more items",-,rs1308924086,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
453,"-/., -/?, -?/.",5,53,c.10552G>A,r.(?),p.(Val3518Ile),Fibronectin type-III 20 (3499-3585),ACMG,"benign, likely benign",g.215956113C>T,g.215782771C>T,"USH2A(NM_206933.2):c.10552G>A (p.V3518I), USH2A(NM_206933.4):c.10552G>A (p.V3518I)",-,USH2A_000303,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2017",-,rs75397806,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
454,"+?/., ?/.",5,54,c.10601A>G,r.(?),p.(Tyr3534Cys),-,ACMG,"likely pathogenic, VUS","g.215782181T>C, g.215955523T>C",g.215782181T>C,"USH2A c.10601A>G, p.Tyr3534Cys, USH2A c.10601A > G, p.Tyr3534Cys, heterozygous, 2 more items",-,USH2A_002245,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021; PubMed: Sun, Y. et al., 2020, PubMed: Sun 2020, 1 more item",-,rs750231701,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
455,-/?,5,55,c.10836C>A,r.(?),p.(=),Fibronectin type-III 21 (3590-3676),ACMG,likely benign,g.215953288G>T,g.215779946G>T,-,-,USH2A_000459,"Heterozygous; polymorphism, Heterozygous; UV1, Homozygous; polymorphism","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012, PubMed: McGee 2010",-,rs61276761,Germline,-,1/830 controls,+Hpy166II;+CviQI;+RsaI;-BsmFI,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
456,"-/., -?/., ?/.",5,-,c.10858A>G,r.(?),p.(Ile3620Val),-,ACMG,"benign, likely benign, VUS",g.215953266T>C,g.215779924T>C,USH2A(NM_206933.2):c.10858A>G (p.I3620V),-,USH2A_001177,"1 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: BS1_P BS2_S, 1 more item","PubMed: Narang 2020, Journal: Narang 2020, PubMed: Sloan-Heggen, C. M. et al., 2016, PubMed: Wang 2014",-,rs145207584,"CLASSIFICATION record, Germline, SUMMARY record",-,1/2795 individuals,-,-,-,"David Baux, VKGL-NL_Rotterdam, Mohammed Faruq"
457,"+?/., ?/.",5,55,c.10859T>G,r.(?),p.(Ile3620Ser),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215953265A>C,g.215779923A>C,"c.10859T>G, USH2A c.10859T>G, p.Ile3620Ser",-,USH2A_002010,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Yang 2015",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
458,"+/., +?/?, ?/.",5,55,c.10939G>A,"r.(?), r.spl?, r.[10741_10939del,10878_10939del]","p.(Gly3647Ser), p.[Val3582Serfs*26,Gln3627Serfs*35]",Fibronectin type-III 21 (3590-3676),ACMG,"pathogenic, VUS",g.215953185C>T,g.215779843C>T,-,-,USH2A_000840,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; last nucleotide of exon 55; mutation, 2 more items","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 3 more items",-,-,"Germline, In vitro (cloned), SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet, Janine Reurink"
459,"+/., +?/., ?/.",5,-,c.10999A>C,r.(?),p.(Thr3667Pro),-,-,"likely pathogenic, likely pathogenic (recessive), pathogenic, VUS",g.215940071T>G,g.215766729T>G,"1:215940071T>G ENST00000307340.3:c.10999A>C (Thr3667Pro), USH2A p.(Thr3667Pro)",-,USH2A_001486,1 more item,"PubMed: Carss 2017, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Koyanagi 2020, 1 more item",-,rs150822759,"Germline, Unknown",?,"1/1204 cases with retinitis pigmentosa, 1/143 cases, 4/1204 cases with retinitis pigmentosa",-,-,-,"Johan den Dunnen, Yoshito Koyanagi"
460,"+/+, +/.",5,56i,c.11047+1G>A,"r.spl, r.spl?",p.?,-,ACMG,pathogenic,g.215940022C>T,g.215766680C>T,c.11047+1G>A,-,USH2A_000582,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic, 1 more item","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012, PubMed: Maranhao 2014",-,rs201730567,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,+MboII;-HpyAV,-,-,"David Baux, VKGL-NL_Nijmegen, Maria Bitner-Glindzicz"
461,"+/., ?/.",5,56i,c.11048-1G>T,r.spl,"p.(?), p.?",-,ACMG,"pathogenic, VUS",g.215933186C>A,g.215759844C>A,"USH2A c.11048-1G>T, -, USH2A c.11048-1G>T",-,USH2A_002534,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
462,"+?/., +?/?, ?/.",5,59,c.11534A>C,r.(?),p.(Gln3845Pro),Fibronectin type-III 23 (3768-3862),ACMG,"likely pathogenic, VUS",g.215916533T>G,g.215743191T>G,-,-,USH2A_000259,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 3 more items",-,rs1553257674,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
463,"-/-, -/., -?/.",5,61,c.11928G>A,r.(?),"p.(=), p.(Thr3976=)",Fibronectin type-III 25 (3961-4062),-,"benign, likely benign",g.215901510C>T,g.215728168C>T,USH2A(NM_206933.2):c.11928G>A (p.T3976=),-,USH2A_000565,"Heterozygous; UV1, VKGL data sharing initiative Nederland",PubMed: Le Quesne Stabej 2012,-,rs55961436,"CLASSIFICATION record, Germline",-,-,-BssSI,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Maria Bitner-Glindzicz"
464,"+/., +?/., +?/?, ?/.",5,62,c.12094G>A,r.(?),p.(Gly4032Arg),Fibronectin type-III 25 (3961-4062),ACMG,"likely pathogenic, pathogenic, VUS",g.215853691C>T,g.215680349C>T,"USH2A c.12094G>A, p.(Gly4032Arg)",-,USH2A_001032,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Ge 2015, 3 more items",-,rs908265742,"Germline, SUMMARY record, Unknown",?,1/258,-,-,-,"David Baux, Crystel Bonnet"
465,"+?/., +?/?, ?/.",5,62,c.12284G>A,"r.(=), r.(?)",p.(Gly4095Asp),Fibronectin type-III 26 (4066-4150),ACMG,"likely pathogenic, VUS",g.215853501C>T,g.215680159C>T,"USH2A c.G12284A, p.G4095D, USH2A, variant 1: c.9921T>G/p.C3307W, variant 2: c.12284G>A/p.G4095D",-,USH2A_000846,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation, solved, compound heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 3 more items",-,rs759898765,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
466,"+?/., -/., -/?",5,63,c.12445T>C,r.(?),p.(Trp4149Arg),Fibronectin type-III 26 (4066-4150),ACMG,"benign, likely benign, likely pathogenic",g.215848808A>G,g.215675466A>G,"USH2A c.12445T>C, W4149R",-,USH2A_000261,"Heterozygous, Heterozygous; unknown, VKGL data sharing initiative Nederland","PubMed: Chebil 2016, PubMed: Neveling 2012, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs115884084,"CLASSIFICATION record, Germline, Unknown",?,-,+AciI;-Hpy166II;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
467,"+?/., ?/.",5,63,c.12448A>G,r.(?),p.(Thr4150Ala),-,ACMG,"likely pathogenic, VUS",g.215848805T>C,g.215675463T>C,"c.[12448A>G;5012G>A], USH2A, variant 1: c.1841-2A>G/p.?, variant 2: c.12448A>G/p.T4150A",-,USH2A_001434,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","Sharon, submitted, PubMed: Sharon 2019, PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1172628170,"Germline, SUMMARY record, Unknown",?,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon"
468,"+/., +?/., ?/.",5,63,c.12580T>C,r.(?),p.(Cys4194Arg),-,ACMG,"likely pathogenic (recessive), pathogenic, VUS",g.215848673A>G,g.215675331A>G,"c.12580T>C, NM_206933.2:c.12580T>C, NP_996816.2:p.(Cys4194Arg), NC_000001.10:g.215848673A>G, 1 more item",-,USH2A_002138,"ACMG GN005 criteria: PM2_P PM3_M BP4_P, heterozygous","PubMed: Lenassi, E. et al., 2015; PubMed: Meng, X. et al., 2021, PubMed: Liu-2020, PubMed: Meng 2020, 1 more item",-,rs769001387,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
469,"+/., +?/., +?/?, ?/?",5,63,c.12874A>G,r.(?),p.(Asn4292Asp),Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic (recessive), VUS",g.215848379T>C,g.215675037T>C,"1:215848379T>C ENST00000307340.3:c.12874A>G (Asn4292Asp), USH2A c.12874A>G, p.Asn4292Asp",-,USH2A_000879,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020, 1 more item",-,rs397517984,"Germline, Germline/De novo (untested)",?,-,-,-,-,"Christopher Watson, Anne-Françoise Roux"
470,"+/+, +/., +?/.",5,63,c.12954C>A,r.(?),p.(Tyr4318*),Fibronectin type-III 28 (4265-4351),-,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215848299G>T,g.215674957G>T,"1:215848299G>T ENST00000307340.3:c.12954C>A (Tyr4318Ter), 2 more items",-,USH2A_000409,"Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Carss 2017, PubMed: Hagag 2020, PubMed: McGee 2010",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,"Anne-Françoise Roux, Crystel Bonnet"
471,"+?/., +?/?, ?/.",5,63,c.13018G>C,r.(?),p.(Gly4340Arg),Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215848235C>G,g.215674893C>G,"USH2A c.13018G>C, p.(Gly4340Arg)",-,USH2A_001039,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous, Heterozygous; mutation, 1 more item","PubMed: Bahena 2021, PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs2102665930,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Barbara Vona, Crystel Bonnet"
472,"+/., +?/.",5,63,c.13040_13062delinsTCAGAAGTCA,r.(?),"p.(Thr4347Ilefs*22), p.(Thr4347IlefsTer22)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215848191_215848213delinsTGACTTCTGA,g.215674849_215674871delinsTGACTTCTGA,"c.13040_13062delinsTCAGAAGTCA,p.T4347IfsX22, USH2A c.13040_13062delinsTCAGAAGTCA, p.T4347Ifs*22, 1 more item",-,USH2A_001841,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Sun, T. et al., 2018, PubMed: Sun 2018, 2 more items",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
473,?/.,5,-,c.13202G>A,r.(?),p.(Gly4401Asp),-,ACMG,VUS,g.215848051C>T,g.215674709C>T,"USH2A c.13202G>A, p.Gly4401Asp",-,USH2A_002512,"ACMG GN005 criteria: PM2_P PM3_P PP1_P BP2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs763576540,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
474,"-/., -?/., ?/.",5,-,c.13478G>A,r.(?),p.(Arg4493His),-,ACMG,"benign, likely benign, VUS",g.215847775C>T,g.215674433C>T,USH2A(NM_206933.2):c.13478G>A (p.R4493H),-,USH2A_001142,"ACMG GN005 criteria: BS2_S BP4_P, VKGL data sharing initiative Nederland","PubMed: Huang, L. et al., 2018, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Xu 2014",-,rs138879998,"CLASSIFICATION record, Germline, SUMMARY record",-,"1/314 case chromosomes, 2/1204 cases with retinitis pigmentosa, 1 more item",-,-,-,"David Baux, VKGL-NL_Rotterdam, Yoshito Koyanagi"
475,?/.,5,63,c.13514A>G,r.(?),p.(Tyr4505Cys),-,ACMG,VUS,g.215847739T>C,g.215674397T>C,"c.13514A>G, p.Tyr4505Cys, USH2A c.13514A>G, p.Tyr4505Cys, USH2A c.13514A>G, p.Y4505C",-,USH2A_001316,"heterozygous, homozygous, VKGL data sharing initiative Nederland","PubMed: Zampaglione 2020, PubMed: Zhu 2021",-,-,"CLASSIFICATION record, Unknown",?,-,-,-,-,VKGL-NL_Nijmegen
476,"+/., +?/., ?/.",5,63,c.13546G>T,r.(?),p.(Gly4516Trp),-,ACMG,"likely pathogenic, pathogenic, VUS",g.215847707C>A,g.215674365C>A,"USH2A c.13546G>T, p.G4516W, USH2A c.13546G>T, p.Gly4516Trp",-,USH2A_001944,"ACMG GN005 criteria: PM2_P PM3_P PP1_P PP3_P, heterozygous","PubMed: Bernardis 2016, PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
477,"+?/., ?/.",5,-,c.13649T>G,r.(?),p.(Val4550Gly),-,ACMG,"likely pathogenic, VUS",g.215847604A>C,g.215674262A>C,"USH2A, variant 1: c.3902G>T/p.G1301V, variant 2: c.13649T>G/p.V4550G",-,USH2A_001895,"ACMG GN005 criteria:, solved, compound heterozygous","PubMed: Stone 2017, PubMed: Wang 2014, PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs553956503,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, MobiDetails"
478,"+/+, +/., +?/.",5,63,c.13745del,r.(?),"p.(Ile4582Lysfs*14), p.(Ile4582LysfsTer14)",Fibronectin type-III 31 (4529-4627),ACMG,"likely pathogenic, pathogenic",g.215847508del,g.215674166del,"13745delT, c.13745del, USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.63 c.13745del p.(Ile4582Lysfs*14)",-,USH2A_000525,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, compound heterozygous, Heterozygous; Pathogenic","PubMed: Avila Fernandez 2010, PubMed: Avila-Fernandez 2010, PubMed: Martin Merida 2019, 2 more items",-,-,"Germline, SUMMARY record",yes,-,none,-,-,"David Baux, Anne-Françoise Roux"
479,"+/+, +/., +?/.",5,64,c.14091del,r.(?),"p.(Phe4697Leufs*2), p.(Phe4697LeufsTer2)",Fibronectin type-III 32 (4633-4730),ACMG,"likely pathogenic, pathogenic",g.215844359del,g.215671017del,"14091delT, NM_206933, c.14091del, p.Phe4697LeufsTer2, 1 more item",-,USH2A_001047,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, compound heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Ezquerra-Inchausti 2018, PubMed: Martin Merida 2019, 2 more items",-,rs2102661189,"Germline, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, Crystel Bonnet"
480,?/.,5,66,c.14404T>C,r.(?),p.(Ser4802Pro),-,ACMG,VUS,g.215822048A>G,g.215648706A>G,"USH2A c.14404T>C, P.Ser4802Pro, USH2A c.14404T>C, p.Ser4802Pro",-,USH2A_002501,"ACMG GN005 criteria: PM2_P PM3_S, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020",-,rs200375504,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
481,"+/., +?/.",5,66,c.14439_14454del,r.(?),"p.(Cys4813*), p.(Cys4813Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215821999_215822014del,g.215648657_215648672del,"USH2A c.14439_14454del, (p.4813_4818del), 1 more item",-,USH2A_001307,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, solved, homozygous, 1 more item","PubMed: Koparir 2015, PubMed: Neuhaus 2017, PubMed: Weisschuh 2020, 1 more item",RCV001090612.2,rs1656942613,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
482,"+/+, +/., +?/., ?/.",5,67i,c.14791+4A>G,"r.14583_14791del, r.spl, r.spl?","p.?, p.Tyr4862Alafs*22",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215820860T>C,g.215647518T>C,-,-,USH2A_001074,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Mansard, L. et al., 2021, 3 more items",-,rs1408904076,"Germline, In vitro (cloned), SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet, Vladimir Strelnikov, Janine Reurink"
483,"+?/., +?/?, ?/.",5,67i,c.14791+5G>T,"r.14583_14791del, r.spl, r.spl?","p.?, p.Tyr4862AlafsTer22",-,ACMG,"likely pathogenic, VUS",g.215820859C>A,g.215647517C>A,-,-,USH2A_000462,"ACMG GN005 criteria: PM2_P PP3_P, Heterozygous","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, 1 more item",-,rs1235430504,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet, Janine Reurink"
484,"+/., +?/+, +?/.",5,67i,c.14792-2A>G,"r.spl, r.spl?",p.?,-,ACMG,"likely pathogenic, pathogenic, VUS",g.215814078T>C,g.215640736T>C,"c.14792-2A>G, c.147922A>G",-,USH2A_002006,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Ge 2015, PubMed: Song-2011, PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs137853923,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",-,-,-,-,-,"David Baux, Jinu Han"
485,"+/+, +/.",5,70,c.15104_15105del,r.(?),p.(Thr5035Argfs*142),-,ACMG,pathogenic,g.215807995_215807996del,g.215634653_215634654del,"USH2A c.15104_15105del, p.(Thr5035Argfs*142)",-,USH2A_000941,Heterozygous; mutation,"PubMed: Qu 2014, PubMed: Zhu 2021",-,-,"Germline, Unknown","?, yes",-,-,-,-,Anne-Françoise Roux
486,"+/., +?/.",5,70,c.15063_15081delinsGC,"r.(15063_15081delinsgc), r.(?)","p.(Thr5022Glnfs*150), p.(Thr5022GlnfsTer150)",-,ACMG,"likely pathogenic, pathogenic",g.215808017_215808035delinsGC,g.215634675_215634693delinsGC,"c.15063-15081delinsGC, c.15063_15081delinsGC, p.T5022Qfs*150, 1 more item",-,USH2A_002365,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, solved, compound heterozygous","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Wafa-2021, PubMed: Weisschuh 2020, 1 more item",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Janine Reurink"
487,+?/?,5,70,c.15188T>G,r.(=),p.(Leu5063Arg),Transmembrane (5043-5063),ACMG,VUS,g.215807910A>C,g.215634568A>C,-,-,USH2A_000857,Heterozygous; pathogenic,"PubMed: Méndez-Vidal 2013, USMA missense analysis, missense variant in MSV3d",-,rs376816523,Germline,-,-,-,-,-,Anne-Françoise Roux
488,-/-,5,72,c.*49A>C,r.(=),p.(=),3'UTR,-,benign,g.215799074T>G,g.215625732T>G,-,-,USH2A_000284,"Heterozygous, Heterozygous; Neutral, Homozygous; Neutral","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs7531580,Germline,-,-,+TspRI,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
489,-/-,5,72,c.*131G>A,r.(=),p.(=),3'UTR,-,benign,g.215798992C>T,g.215625650C>T,-,-,USH2A_000096,"Heterozygous, Heterozygous; Neutral","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,-,Germline,-,-,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
490,"+?/., +?/?, ?/.",4,2,c.130G>A,r.(?),p.(Gly44Arg),-,ACMG,"likely pathogenic, VUS",g.216595549C>T,g.216422207C>T,"c.130G>A; p.(Gly44Arg), USH2A:NM_206933 c.G130A, p.G44R",-,USH2A_000676,"ACMG GN005 criteria: PM2_P PM3_M PP4_P, heterozygous, individual solved, variant causal, 1 more item","PubMed: Garcia-Garcia 2011, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs1381795491,"Germline, SUMMARY record",yes,0/200 controls,none,-,-,"David Baux, Jose Maria Millan"
491,"+/?, +?/., +?/?, ?/.",4,"2, 7",c.269A>G,r.(?),p.(Tyr90Cys),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216595410T>C,g.216422068T>C,-,-,USH2A_000907,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous; mutation, Heterozygous; UV3","PubMed: Aparisi 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Eandi 2017, 2 more items",-,rs755435330,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
492,"+/., +?/.",4,2,c.449T>G,r.(?),"p.(Leu150*), p.(Leu150Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216595230A>C,g.216421888A>C,"USH2A c.449T>G, p.Leu150*, USH2A c.449T>G, p.L150X, USH2A c.T449G, p.L150*",-,USH2A_002600,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Fu 2020, PubMed: Meng 2020, PubMed: Qu 2020, 1 more item",-,rs1553258037,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
493,"+/., +?/., -?/?",4,"12, 3",c.488G>A,r.(?),p.(Cys163Tyr),-,ACMG,"likely benign, likely pathogenic, pathogenic (recessive)",g.216592019C>T,g.216418677C>T,-,-,USH2A_000023,"Heterozygous, possible duplicate","PubMed: Dreyer 2000, PubMed: Dreyer 2008, Tranebjaerg 2011, PubMed: Dad 2016, PubMed: Huang 2018, 1 more item",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
494,"+/., +?/., ?/.",4,3,c.497A>G,r.(?),p.(Glu166Gly),-,ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216592010T>C,g.216418668T>C,1 more item,-,USH2A_001712,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous","PubMed: Karali 2019, Journal: Karali 2019, PubMed: Karali 2019, Journal: Karali 2019, 2 more items",-,rs747778052,"Germline, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, Sandro Banfi"
495,"+/+, +/., +?/.",4,03i,c.651+1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216591855C>T,g.216418513C>T,c.651+1G>A,-,USH2A_000645,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; Pathogenic","PubMed: Gao 2019, PubMed: Le Quesne Stabej 2012, PubMed: Mansard et al, 2021, 1 more item",-,rs1553257761,"Germline, SUMMARY record",?,-,-BspMI;-HphI;-BfuAI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
496,"+/+, +?/.",4,"03i, 3i",c.652-2A>G,"r.spl, r.spl?",p.?,-,-,"likely pathogenic, pathogenic",g.216538429T>C,g.216365087T>C,c.652-2A>G,-,USH2A_000860,Heterozygous; mutation,"PubMed: de Castro-Miro 2014, PubMed: de Castro-Miró-2014",-,-,Germline,-,-,-,-,-,"Marta de Castro-Miró, Anne-Françoise Roux"
497,"+?/., +?/?, ?/.",4,4,c.685G>C,r.(?),p.(Gly229Arg),-,ACMG,"likely pathogenic, VUS",g.216538394C>G,g.216365052C>G,"USH2A c.685G>C, p.(Gly229Arg)",-,USH2A_000862,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous, Heterozygous; very likely pathogenic","PubMed: Inaba 2020, PubMed: Zhao 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs2038568675,"Germline, SUMMARY record, Unknown",?,0/400 controls,-,-,-,"David Baux, Anne-Françoise Roux"
498,"+/+, +/., +?/.",4,4,c.710del,r.(?),"p.(Phe237Serfs*6), p.(Phe237SerfsTer6)",-,ACMG,"likely pathogenic, pathogenic",g.216538371del,g.216365029del,"710delT, c.710delT, p.Phe237Serfs*6, USH2A c.710delT, p.(Phe237Serfs*6)",-,USH2A_000973,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous, Heterozygous; mutation","PubMed: Gao 2019, PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
499,"+/., +?/?, ?/.",4,4,c.769G>A,r.(?),p.(Gly257Arg),-,ACMG,"pathogenic, VUS",g.216538310C>T,g.216364968C>T,"USH2A c.769G>A, p.Gly257Arg",-,USH2A_000636,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, heterozygous, Heterozygous; UV2","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Le Quesne Stabej, P. et al., 2012, 2 more items",-,rs2102708440,"Germline, SUMMARY record, Unknown",?,0/96 controls,none,-,-,"David Baux, Maria Bitner-Glindzicz"
500,"+/+, +/., +?/.",4,"4, 4_4i",c.781_784+1375del,"r.?, r.spl, r.spl?",p.?,-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.216536920_216538298del, g.216536924_216538302del","g.216363578_216364956del, g.216363582_216364960del","781_c784+1375del1379ttaAATG…, USH2A exon 4 deleted c.781_784+1375del, p.?",-,USH2A_000799,Heterozygous; Pathogenic,"PubMed: de Bruijn 2023, PubMed: Le Quesne Stabej 2012, PubMed: Steele-Stallard 2013, 1 more item",-,-,Germline,yes,-,-,-,-,"Johan den Dunnen, Maria Bitner-Glindzicz"
501,"+/., +?/., ?/.",4,-,c.820C>G,r.(?),p.(Arg274Gly),-,ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216500961G>C,g.216327619G>C,"1:216500961G>C ENST00000307340.3:c.820C>G (Arg274Gly), USH2A c.820C>G, 1 more item",-,USH2A_001832,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, protein variant annotation not written; heterozygous","PubMed: Carss 2017, PubMed: Toms 2020, PubMed: Toms, M. et al., 2020, PubMed: Turro 2020",-,rs397518036,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,David Baux
502,"+?/., ?/.",4,6,c.905G>A,r.(?),p.(Cys302Tyr),-,ACMG,"likely pathogenic, VUS",g.216498885C>T,g.216325543C>T,"USH2A c.905G>A , p.C302Y, USH2A c.905G>A, p.Cys302Tyr",-,USH2A_002597,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
503,"+/., +?/.",4,-,c.895del,r.(?),"p.(Gln299Asnfs*37), p.(Gln299AsnfsTer37)",-,ACMG,"likely pathogenic, pathogenic (recessive)","g.216498895del, g.216498897del",g.216325555del,"1:216498894TG>T ENST00000307340.3:c.895delC (Gln299AsnfsTer37), 895delC, USH2A c.895del, 1 more item",-,USH2A_001831,"ACMG GN005 criteria: PVS1_VS PM2_P, compound heterozygous, 1 more item","PubMed: Carss 2017, PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, 2 more items",-,rs1338169194,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
504,"+/., +?/., ?/.",4,6,c.997T>C,r.(?),p.(Ser333Pro),-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic (recessive), VUS",g.216498793A>G,g.216325451A>G,"c.997T>C, USH2A c.997T>C, p.S333P",-,USH2A_002071,"ACMG GN005 criteria: PM2_P, single heterozygous variant in a recessive disesase, no second allele","PubMed: Kuang, L. et al., 2020, PubMed: Liu-2020, PubMed: Xu 2014, PubMed: Zhu 2021",-,rs368986242,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
505,"+/., +?/.",4,-,c.922_923insGCCA,r.(?),p.(His308Argfs*16),-,-,"likely pathogenic (recessive), pathogenic (recessive)",g.216498867_216498868insTGGC,-,1:216498866G>GTGGC ENST00000307340.3:c.920_923dupGCCA (His308GlnfsTer16),-,USH2A_001830,-,PubMed: Carss 2017,-,-,Germline,-,-,-,-,-,LOVD
506,"+/+, +/.",4,"06i, 6i",c.1144-2A>T,r.spl,"p.(?), p.?",-,ACMG,"pathogenic, pathogenic (recessive)",g.216497696T>A,g.216324354T>A,USH2A c.1144-2A>T,-,USH2A_001075,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021, 1 more item",-,"rs2037686445, rs750651679","Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, Crystel Bonnet"
507,"-?/., -?/?",4,7,c.1179A>G,r.(?),"p.(=), p.(Gln393=)",Laminin N-terminal (271-517),ACMG,likely benign,g.216497659T>C,g.216324317T>C,"USH2A(NM_206933.2):c.1179A>G (p.Q393=), USH2A(NM_206933.4):c.1179A>G (p.Q393=)",-,USH2A_000239,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
508,"+?/., ?/.",4,-,c.1190T>A,r.(?),p.(Ile397Lys),-,ACMG,"likely pathogenic (recessive), VUS",g.216497648A>T,g.216324306A>T,-,-,USH2A_001880,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Kim, Y. N. et al., 2021",-,rs2037684112,"Germline, Germline/De novo (untested), SUMMARY record",-,-,-,-,-,"David Baux, Jinu Han"
509,"+?/., ?/.",4,-,c.1448C>T,r.(?),p.(Thr483Met),-,ACMG,"likely pathogenic (recessive), VUS",g.216496918G>A,g.216323576G>A,-,-,USH2A_001719,"7 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PM2_P","PubMed: Narang 2020, Journal: Narang 2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, 1 more item",-,rs201847741,"Germline, SUMMARY record",-,"1/314 case chromosomes, 7/2795 individuals",-,-,-,"David Baux, Mohammed Faruq"
510,+/+,4,14-Sep,c.1551_2993del,r.(?),p.(?),1 more item,-,pathogenic,g.216405297_216495320del,g.216231955_216321978del,-,-,USH2A_000201,Homozygous,PubMed: Bernal 2005,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
511,"+?/., ?/.",4,9,c.1571C>T,r.(?),p.(Ala524Val),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216495298G>A,g.216321956G>A,"USH2A Ex.9 c.1571C>T p.(Ala524Val), Ex.50 c.9804T>A p.(Cys3268*)",-,USH2A_001672,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous, VKGL data sharing initiative Nederland","PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022, PubMed: Martin Merida 2019",-,rs772624410,"CLASSIFICATION record, Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Barbara Vona"
512,"+?/., ?/.",4,9,c.1606T>A,"r.(1606u>a), r.(?)",p.(Cys536Ser),-,ACMG,"likely pathogenic, VUS",g.216495263A>T,g.216321921A>T,"USH2A c.1606T>A, USH2A c.1606T>A, p.(Cys536Ser)",-,USH2A_002116,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, heterozygous, 1 more item","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021, PubMed: Toms 2020",-,rs111033273,"Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, Janine Reurink"
513,"+/., +?/., ?/.",4,9,c.1644+4A>G,"r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216495221T>C,g.216321879T>C,"USH2A c.1644+4A>G, -",-,USH2A_002593,"ACMG GN005 criteria: PM2_P PM3_S PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Qu, L. H. et al., 2020, PubMed: Qu 2020",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
514,"+/., +?/?, ?/.",4,10,c.1729T>C,r.(?),p.(Cys577Arg),Laminin EGF-like 2 (575-640),ACMG,"pathogenic, VUS",g.216465628A>G,g.216292286A>G,-,-,USH2A_000657,"ACMG GN005 criteria: PM2_P PP3_P, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Colombo, L. et al., 2022, 2 more items",-,rs1553327470,"Germline, SUMMARY record",-,"0/170 controls, 1/1204 cases with retinitis pigmentosa",+HincII;+Hpy166II;-HpyCH4V;,-,-,"David Baux, Anne-Françoise Roux, Yoshito Koyanagi"
515,"+?/., +?/?, ?/.",4,10,c.1760_1762del,r.(?),p.(Asn587del),Laminin EGF-like 2 (575-640),ACMG,"likely pathogenic, VUS","g.216465595_216465597del, g.216465598_216465600del",g.216292256_216292258del,"1760_1762delACA, c.1760_1762del, c.1760_1762delACA",-,USH2A_000226,"ACMG GN005 criteria: PM2_P PM4_M, Heterozygous","PubMed: Colombo, L. et al., 2022; PubMed: Wafa, T. T. et al., 2021; PubMed: Colombo, L. et al., 2021, 3 more items",-,rs2037015853,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
516,+?/.,4,10,c.1824dup,r.(?),"p.(Glu609*), p.(Glu609Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive)",g.216465533dup,g.216292191dup,"1824dupT, c.1824dupT",-,USH2A_002455,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Liu-2020, PubMed: Meng, X. et al., 2021",-,rs2037013894,"Germline, SUMMARY record",-,-,-,-,-,David Baux
517,"+?/., ?/.",4,-,c.1966G>A,r.(?),p.(Asp656Asn),-,-,"likely pathogenic, likely pathogenic (recessive), VUS",g.216462627C>T,g.216289285C>T,"1:216462627C>T ENST00000307340.3:c.1966G>A (Asp656Asn), 1 more item",-,USH2A_001667,VKGL data sharing initiative Nederland,"PubMed: Carss 2017, PubMed: Holtan 2020",-,-,"CLASSIFICATION record, Germline",-,1/899 cases,-,-,-,"Global Variome, with Curator vacancy, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
518,"+/+, +/., +?/.",4,12,c.2028C>A,r.(?),p.(Cys676*),Laminin EGF-like 3 (641-693),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216424384G>T,g.216251042G>T,"c.2028C>A, p.Cys676Ter, USH2A c.2028C>A, p.(Cys676*)",-,USH2A_000334,"heterozygous, single heterozygous variant (recessive)","Tranebjaerg 2011, PubMed: Dad 2016, PubMed: Baux 2014, PubMed: Jespersgaar 2019, 1 more item",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
519,+/.,4,13,c.2187C>A,r.(?),"p.(Cys729*), p.(Cys729Ter)",-,ACMG,pathogenic,g.216420549G>T,g.216247207G>T,"USH2A c.2187C>A, p.C729*, USH2A c.[2187C>A];[14583-40_14583-10del]; p.(Cys729Ter), 1 more item",-,USH2A_002473,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, alleles in trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021, PubMed: Kuang, L. et al., 2020, PubMed: Zhu 2021",-,rs757154662,"Germline, SUMMARY record, Unknown","?, yes",Taiwan Biobank: 0.000659; GnomAD_exome_East: 0.000273; GnomAD_All: 0.0000201,-,-,-,David Baux
520,-?/?,4,13,c.2703G>C,r.(?),p.(Glu901Asp),Laminin EGF-like 8 (900-950),ACMG,likely benign,g.216420033C>G,g.216246691C>G,-,-,USH2A_000241,Homozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
521,"+/+, +/.",4,13,c.2755C>T,r.(?),"p.(Gln919*), p.(Gln919Ter)",Laminin EGF-like 8 (900-950),ACMG,pathogenic,g.216419981G>A,g.216246639G>A,-,-,USH2A_000314,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
522,"+?/., ?/.",4,17,c.3544T>C,r.(?),p.(Tyr1182His),-,ACMG,"likely pathogenic, VUS",g.216373236A>G,g.216199894A>G,"USH2A c.3544T>C, p.Tyr1182His, USH2A c.3544T>C, p.Tyr1182His, USH2A c.3544T>C, p.Y1182H",-,USH2A_002580,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020, 1 more item",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
523,"+/+, +/., +?/.",4,17,c.3518C>A,r.(?),"p.(Ser1173*), p.(Ser1173Ter)",Fibronectin type-III 2 (1145-1238),ACMG,"likely pathogenic, pathogenic",g.216373262G>T,g.216199920G>T,"c.920_923dupGCCA p.(His308Glnfs*16), c.3518C>A p.(Ser1173*), USH2A c.3518C>A",-,USH2A_000564,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Pathogenic, 1 more item","PubMed: Hagag 2020, PubMed: Le Quesne Stabej 2012, PubMed: Toms 2020, 1 more item",-,-,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,0/878 controls,none,-,-,"David Baux, Maria Bitner-Glindzicz"
524,"+?/., -?/.",4,-,c.3532C>G,r.(?),p.(Pro1178Ala),-,-,"likely benign, likely pathogenic",g.216373248G>C,g.216199906G>C,"USH2A(NM_206933.2):c.3532C>G (p.P1178A), USH2A(NM_206933.4):c.3532C>G (p.P1178A), 1 more item",-,USH2A_001403,VKGL data sharing initiative Nederland,PubMed: Hariri 2018,-,-,"CLASSIFICATION record, Germline",?,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
525,"-/-, -/.",4,17i,c.3812-8T>C,r.(=),p.(=),-,-,benign,g.216371934A>G,g.216198592A>G,-,-,USH2A_000291,"Heterozygous, Homozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
526,"+?/., -?/?, ?/.",4,18,c.3840G>C,r.(?),p.(Met1280Ile),Fibronectin type-III 3 (1242-1357),ACMG,"likely benign, likely pathogenic, VUS",g.216371898C>G,g.216198556C>G,USH2A c.3840G>C,-,USH2A_000630,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; UV4, 1 more item","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Toms 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,+Hpy188I;-FatI;-NlaIII;-CviAII;,-,-,"David Baux, Maria Bitner-Glindzicz"
527,+/.,4,18,c.3932C>A,r.(?),"p.(Ser1311*), p.(Ser1311Ter)",Fibronectin type-III 3 (1242-1357),ACMG,"pathogenic, pathogenic (recessive)",g.216371806G>T,g.216198464G>T,c.3932C>A,-,USH2A_000470,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Colombo, L. et al., 2022; PubMed: Mansard, L. et al., 2021; PubMed: Colombo, L. et al., 2021, 3 more items",-,rs79279902,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Vladimir Strelnikov"
528,"+/., +?/., ?/.",4,-,c.4251+1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216369894C>T,g.216196552C>T,"USH2A c.4251+1G>A, -, USH2A c.4251+1G>A, p.(?)",-,USH2A_001978,"ACMG GN005 criteria: PVS1_VS PM2_P, compound heterozygous, heterozygous","PubMed: Ellingford 2016, PubMed: Gao 2021, PubMed: Jauregui 2020, 1 more item",-,rs878853405,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
529,"+/+, +/.",4,20,c.4354dup,r.(?),"p.(Cys1452Leufs*25), p.(Cys1452LeufsTer25)",Fibronectin type-III 4 (1367-1462),ACMG,pathogenic,g.216363608dup,g.216190266dup,4354dupT,-,USH2A_000569,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic, Homozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Maria Bitner-Glindzicz"
530,"+/+, +/.",4,21,c.4405C>T,r.(?),"p.(Gln1469*), p.(Gln1469Ter)",-,ACMG,pathogenic,g.216348816G>A,g.216175474G>A,-,-,USH2A_000157,"1 heterozygous, no homozygous; Clinindb (India), ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Narang 2020, Journal: Narang 2020, PubMed: Pennings 2004(2), PubMed: Pennings 2004, 1 more item",-,rs797045113,"Germline, SUMMARY record",-,1/2795 individuals,-,-,-,"David Baux, Anne-Françoise Roux, Mohammed Faruq"
531,+/.,4,21,c.4517_4518del,r.(?),"p.(Glu1506Valfs*23), p.(Glu1506ValfsTer23)",-,ACMG,pathogenic,g.216348708_216348709del,g.216175366_216175367del,"4517_4518delAG, USH2A c.4517_4518delCT, USH2A c.4517_4518delCT, p.Arg1505Serfs*7",-,USH2A_002575,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, 2 more items","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,rs866243264,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
532,"+?/., -?/., -?/?",4,21,c.4544C>T,r.(?),p.(Thr1515Met),-,ACMG,"likely benign, likely pathogenic",g.216348677G>A,g.216175335G>A,USH2A(NM_206933.4):c.4544C>T (p.T1515M),-,"USH2A_000140, USH2A_001445","Heterozygous, VKGL data sharing initiative Nederland","Sharon, submitted, PubMed: Adato 2000, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"CLASSIFICATION record, Germline",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Dror Sharon, VKGL-NL_AMC, Anne-Françoise Roux"
533,"-/., ?/.",4,-,c.4586A>T,r.(?),p.(Lys1529Ile),-,ACMG,"benign, VUS",g.216348635T>A,g.216175293T>A,"USH2A(NM_206933.2):c.4586A>T (p.K1529I), USH2A(NM_206933.4):c.4586A>T (p.K1529I)",-,USH2A_001637,"ACMG GN005 criteria: BS1_S BS2_S, VKGL data sharing initiative Nederland","PubMed: Sloan-Heggen, C. M. et al., 2016, PubMed: Wang 2014",-,rs41303255,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC"
534,"+?/., ?/.",4,-,c.4646G>C,r.(?),p.(Arg1549Pro),-,ACMG,"likely pathogenic, VUS",g.216270537C>G,g.216097195C>G,-,-,USH2A_001792,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs190170807,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, MobiDetails"
535,"+/., +?/.",4,22,c.4685C>A,r.(?),"p.(Ser1562*), p.(Ser1562Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.216270498G>T,g.216097156G>T,"c.4685C>A, NM_206933.2:c.4685C>A, NP_996816.2:p.(Ser1562Ter), NC_000001.10:g.216270498G>T, 1 more item",-,USH2A_002145,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Wang 2018",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
536,"+/+, +/., +?/.",4,22i,c.4758+1G>A,"r.spl, r.spl?",p.?,-,ACMG,"likely pathogenic, pathogenic",g.216270424C>T,g.216097082C>T,c.4758+1G>A,-,USH2A_000401,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: McGee 2010, PubMed: Wafa-2021",-,rs751414710,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
537,"+/+, +?/.",4,23,c.4821G>A,r.(?),"p.(Trp1607*), p.(Trp1607Ter)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic",g.216262419C>T,g.216089077C>T,"c.1859G>T p.(Cys620Phe), c.4821G>A p.(Trp1607*), USH2A c.4821G>A",-,USH2A_000573,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; Pathogenic, 1 more item","PubMed: Hagag 2020, PubMed: Le Quesne Stabej 2012, PubMed: Toms 2020, 1 more item",-,rs745350407,"Germline, Germline/De novo (untested), SUMMARY record, Unknown",?,1/864 controls,none,-,-,"David Baux, Maria Bitner-Glindzicz"
538,"+?/., ?/.",4,23i,c.4885+375A>G,"r.(?), r.4885_4886ins4885+241_4885+370, r.spl, r.spl?","p.(?), p.?, p.Gly1628_Ser1629insTer51",-,ACMG,"likely pathogenic, VUS",g.216261980T>C,g.216088638T>C,-,-,USH2A_002318,"ACMG GN005 criteria: PS3_P PM2_P PM3_M PP3_P, ACMG PM2, BP7","PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Weisschuh 2024, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux, Janine Reurink"
539,"+/., ?/.",4,"26i, 5i",c.5168-2_5168-1ins17,"r.spl, r.spl?",p.(?),-,ACMG,"pathogenic, VUS",g.?,g.?,"USH2A c.5168-2_5168-1ins17, -, USH2A c.5168-2_5168-1ins17",-,NPHS2_000000,"error in annotation, 17 inserted nucleotides not written; heterozygous, 1 more item","PubMed: Meng 2020, PubMed: Zhu 2021",-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
540,"+/., +?/., -/?, ?/.",4,26,c.5266G>A,r.(?),p.(Val1756Ile),Laminin G-like 2 (1714-1891),ACMG,"likely benign, likely pathogenic, pathogenic, VUS",g.216256830C>T,g.216083488C>T,"USH2A c.5266G>A, p.V1756I",-,USH2A_000826,"ACMG GN005 criteria:, heterozygous, 1 more item","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Qu 2020, 2 more items",-,rs143208990,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
541,"+/., +?/., ?/.",4,-,c.5375G>A,r.(?),p.(Gly1792Glu),-,-,"likely pathogenic (recessive), pathogenic (recessive), VUS",g.216251628C>T,g.216078286C>T,-,-,USH2A_002026,-,"PubMed: Sun 2015, PubMed: Xu 2014",-,rs527598451,Germline,-,"1/314 case chromosomes, 2/596 chromosomes, 2/624 control chromosomes",-,-,-,LOVD
542,"-/?, -?/.",4,27,c.5409C>G,r.(?),"p.(=), p.(Val1803=)",Laminin G-like 2 (1714-1891),ACMG,likely benign,g.216251594G>C,g.216078252G>C,USH2A(NM_206933.2):c.5409C>G (p.V1803=),-,USH2A_000455,"Heterozygous; polymorphism, VKGL data sharing initiative Nederland",PubMed: McGee 2010,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux"
543,"+/., +?/., ?/.",4,27,c.5485C>T,r.(?),"p.(Cys1829Ter), p.(Gln1829*)",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216251518G>A,g.216078176G>A,"USH2A c.5485C>T, p.Gln1829*, USH2A c.5485C>T, p.Cys1829*, USH2A c.5485C>T, p.Q1829*",-,USH2A_002565,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020, 1 more item",-,rs2102554289,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
544,"+/+, +/?",4,27i,c.5573-2A>G,r.spl,p.?,-,-,pathogenic,g.216246644T>C,g.216073302T>C,-,-,USH2A_000695,"Heterozygous, Homozygous",PubMed: Baux 2014,-,-,Germline,-,-,+BseYI;-BfaI;,-,-,Anne-Françoise Roux
545,"+?/., +?/?, ?/.",4,28,c.5588T>C,r.(?),p.(Met1863Thr),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, VUS",g.216246627A>G,g.216073285A>G,"USH2A, variant 1: c.5588T>C/p.M1863T, variant 2 : c.11864G>A/p.W3955*",-,USH2A_000763,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; likely pathogenic, solved, compound heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 2 more items",-,rs1012665311,"Germline, SUMMARY record, Unknown",?,-,-CviAII;-FatI;-NlaIII;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
546,?/.,4,-,c.5624A>G,r.(?),p.(Asn1875Ser),-,-,VUS,g.216246591T>C,g.216073249T>C,USH2A(NM_206933.2):c.5624A>G (p.N1875S),-,USH2A_001390,VKGL data sharing initiative Nederland,PubMed: Wang 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
547,"+?/?, ?/.",4,28,c.5698T>G,r.(?),p.(Cys1900Gly),Fibronectin type-III 5 (1871-1949),ACMG,VUS,g.216246517A>C,g.216073175A>C,-,-,USH2A_001007,"ACMG GN005 criteria:, Homozygous; mutation, VKGL data sharing initiative Nederland","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs201026468,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Crystel Bonnet"
548,+/.,4,-,c.5728C>T,r.(?),p.(Gln1910Ter),-,ACMG,pathogenic,g.216246487G>A,g.216073145G>A,USH2A(NM_206933.4):c.5728C>T (p.Q1910*),-,USH2A_001388,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, VKGL data sharing initiative Nederland","PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs2031617950,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
549,"+/., +?/., ?/.",4,28,c.5775A>T,"r.(=), r.(?), r.5573_5776del","p.(=), p.(Thr1925=), p.Gly1858_Thr1925del",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216246440T>A,g.216073098T>A,c.5775A>T,-,USH2A_001956,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Bernardis 2016, PubMed: Colombo, L. et al., 2021; PubMed: Jauregui, R. et al., 2020, 2 more items",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Janine Reurink"
550,"+/+, +/., +?/.",4,29i,c.5858-1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216243635C>T,g.216070293C>T,"c.5858-1C>T, p.?, USH2A c.5858-1G>A, Splicesite",-,USH2A_000897,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, 1 more item","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015, PubMed: Ng 2019, PubMed: Wang 2019",-,rs397518023,"Germline, SUMMARY record","?, yes",-,-,-,-,"David Baux, Eva Lenassi"
551,"+/+, +/., +?/.",4,30,c.5933_5940del,r.(?),"p.(Pro1978Glnfs*5), p.(Pro1978GlnfsTer5)",Fibronectin type-III 6 (1954-2051),ACMG,"likely pathogenic (recessive), pathogenic, pathogenic (recessive)","g.216243552_216243559del, g.216243553_216243560del",g.216070211_216070218del,c.5933_5940del,-,USH2A_000388,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Colombo-2020, PubMed: Eandi 2017, PubMed: Sandberg 2008, 1 more item",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
552,"+?/., -/., ?/.",4,30,c.6001C>T,"r.(6001c>u), r.(?)",p.(Arg2001Cys),-,ACMG,"benign, likely pathogenic (recessive), VUS",g.216243491G>A,g.216070149G>A,USH2A(NM_206933.4):c.6001C>T (p.R2001C),-,USH2A_001629,"no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Xu 2014",-,rs141539554,"CLASSIFICATION record, Germline",-,2/314 case chromosomes,-,-,-,"VKGL-NL_AMC, Janine Reurink"
553,"-/., -?/., -?/?, ?/.",4,31,c.6077A>G,r.(?),p.(Lys2026Arg),Fibronectin type-III 6 (1954-2051),ACMG,"benign, likely benign, VUS",g.216221962T>C,g.216048620T>C,"USH2A(NM_206933.2):c.6077A>G (p.K2026R), USH2A(NM_206933.4):c.6077A>G (p.K2026R)",-,USH2A_000505,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Wang 2014",-,rs115039883,"CLASSIFICATION record, Germline",-,-,+AcuI;+Hpy188I;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
554,"+?/., ?/.",4,31,c.6083A>G,r.(?),p.(Tyr2028Cys),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216221956T>C,g.216048614T>C,"c.6083A>G, NM_206933.2:c.6083A>G, NP_996816.2:p.(Tyr2028Cys), NC_000001.10:g.216221956T>C",-,USH2A_001863,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Liu-2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Wang 2018",-,rs756571385,"Germline, SUMMARY record",?,-,-,-,-,David Baux
555,"+/+, +/.",4,32,c.6317_6318del,r.(?),"p.(Ile2106Serfs*51), p.(Thr2106Serfs*51), p.(Thr2106SerfsTer51)",Fibronectin type-III 7 (2052-2138),ACMG,"pathogenic, pathogenic (recessive)",g.216219781_216219782del,g.216046439_216046440del,6317_6318delCA,-,"USH2A_001081, USH2A_002306",Homozygous,"PubMed: Baux, Vaché 2017, PubMed: Colombo-2020, PubMed: Mansard et al, 2021",-,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
556,"+/+, +/., ?/.",4,32,c.6289_6302del,r.(?),"p.(Ile2097*), p.(Ile2097Ter)",Fibronectin type-III 7 (2052-2138),-,"pathogenic, pathogenic (recessive), VUS",g.216219797_216219810del,g.216046455_216046468del,"6289_6302delATCTATTCAGGC, 6289_6302delATCTATTCAGGCAG, 1 more item",-,USH2A_000403,"Heterozygous, heterozygous, ACMG unclassified - no access to supplementary table 2, 1 more item","PubMed: Hull 2020, PubMed: McGee 2010, PubMed: Midgley 2024, PubMed: Pradhan 2009",-,rs111033268,Germline,"?, yes",-,-,-,-,"Johan den Dunnen, Anne-Françoise Roux"
557,"-/., -/?",4,33,c.6369C>T,r.(?),p.(=),Fibronectin type-III 7 (2052-2138),ACMG,"benign, likely benign",g.216173861G>A,g.216000519G>A,-,-,USH2A_000268,"Heterozygous, Heterozygous; polymorphism, VKGL data sharing initiative Nederland","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: McGee 2010",-,rs111033472,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
558,?/.,4,35,c.6661T>C,r.(?),p.(Cys2221Arg),-,ACMG,VUS,g.216166506A>G,g.215993164A>G,"USH2A c.6661T>C, p.Cys2221Arg, USH2A c.6661T>C, p.Cys2221Arg",-,USH2A_002557,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Meng 2020",-,rs1668046327,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
559,"-?/?, ?/.",4,35,c.6728G>T,r.(?),p.(Gly2243Val),Fibronectin type-III 9 (2241-2325),ACMG,"likely benign, VUS",g.216166439C>A,g.215993097C>A,"USH2A c.2276G>T, p.(Cys759Phe), c.6728G>T, p.(Gly2243Val), 1 more item",-,USH2A_000928,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Bujakowska 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Jespersgaar 2019",-,rs201526850,"CLASSIFICATION record, Germline",?,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
560,"+/+, +/.",4,35i,c.6805+2T>C,r.spl,p.?,-,ACMG,pathogenic,g.216166360A>G,g.215993018A>G,-,-,USH2A_000830,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Neuhaus, C. et al., 2017, 2 more items",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
561,"+/+, +?/.",4,36,c.6931del,r.(?),"p.(Ala2311Profs*15), p.(Ala2311ProfsTer15)",Fibronectin type-III 9 (2241-2325),ACMG,"likely pathogenic, pathogenic",g.216143994del,g.215970652del,"6931delG, USH2A c.6931del, p.A231PfsX15",-,USH2A_000092,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, 1 more item","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Jauregui 2020, 1 more item",-,rs1667471296,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
562,"+?/., ?/.",4,37,c.7037A>G,r.(?),p.(His2346Arg),-,ACMG,"likely pathogenic, VUS",g.216138742T>C,g.215965400T>C,"USH2A c.7037A>G, p.H2346R, USH2A c.7037A>G, p.His2346Arg",-,USH2A_002555,"ACMG GN005 criteria: PM2_P PM3_S BP4_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,rs776390437,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
563,"+/+, +?/.",4,38,c.7139_7140del,"r.(=), r.(?)","p.(Leu2380Profs*37), p.(Leu2380ProfsTer37)",Fibronectin type-III 10 (2328-2432),ACMG,"likely pathogenic, pathogenic",g.216108118_216108119del,g.215934776_215934777del,7139_7140delTT,-,USH2A_000841,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Krawitz 2014",-,rs2102499800,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
564,"+/., +?/.",4,38i,c.7300+1G>T,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216107957C>A,g.215934615C>A,"USH2A c.7300+1G>T, USH2A c.7300+1G>T, -",-,USH2A_002552,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
565,"+/+, +?/.",4,38i,c.7301-1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216074248C>T,g.215900906C>T,"USH2A, variant 1: c.6713A>C/p.E2238A, variant 2: c.7301-1G>A/p.?, 1 more item",-,USH2A_000761,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; likely pathogenic, solved, compound heterozygous","PubMed: Glöckle 2014, PubMed: Glockle, N. et al., 2014; PubMed: Weisschuh, N. et al., 2020, 1 more item",-,rs1438496892,"Germline, SUMMARY record, Unknown",?,-,-AluI;-CviKI_1;,-,-,"David Baux, Anne-Françoise Roux"
566,-/-,4,39i,c.7451+123C>A,r.(=),p.(=),-,-,benign,g.216073974G>T,g.215900632G>T,-,-,USH2A_000061,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014",-,rs41277202,Germline,-,-,-,-,-,Anne-Françoise Roux
567,+/.,4,-,c.7501C>T,r.(?),"p.(Gln2501*), p.(Gln2501Ter)",-,ACMG,pathogenic,g.216073510G>A,g.215900168G>A,"USH2A c.7501C>T, p.(Gln2501*)",-,USH2A_001371,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021, PubMed: Haer-Wigman 2017",-,rs1558151555,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
568,"-/-, -/.",4,40i,c.7595-2420C>T,r.(=),p.(=),-,-,benign,g.216064816G>A,g.215891474G>A,-,-,USH2A_000696,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,rs12408624,"CLASSIFICATION record, Germline",-,-,+BspMI;+BfuAI;-PhoI;-HaeIII;-BsrI;-CviKI_1;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
569,"+/+, +/.",4,41,c.7984A>T,r.(?),"p.(Arg2662*), p.(Arg2662Ter)",Fibronectin type-III 13 (2621-2718),ACMG,"pathogenic, pathogenic (recessive)",g.216062007T>A,g.215888665T>A,"USH2A c.7984A>T, p.R2662*",-,USH2A_000978,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Jiang, L. et al., 2015, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
570,"+?/?, -?/., ?/.",4,42,c.8342C>T,r.(?),p.(Thr2781Ile),Fibronectin type-III 14 (2724-2812),ACMG,"likely benign, VUS",g.216052322G>A,g.215878980G>A,USH2A(NM_206933.2):c.8342C>T (p.T2781I),-,USH2A_000792,"ACMG GN005 criteria:, Heterozygous; Mutation, VKGL data sharing initiative Nederland","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Yang, T. et al., 2013, 1 more item",-,rs143240767,"CLASSIFICATION record, Germline, SUMMARY record",-,"0/400 controls, 18/1204 cases with retinitis pigmentosa",-,-,-,"David Baux, VKGL-NL_Rotterdam, Anne-Françoise Roux, Yoshito Koyanagi"
571,"+/+, +/., +?/.",4,43,c.8603del,r.(?),"p.(Asn2868Ilefs*6), p.(Asn2868IlefsTer6)",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, pathogenic",g.216051180del,g.215877838del,"8602delA, 8603delA, USH2A c.8603delA, p.(Asn2868Ilefs*6)",-,USH2A_000787,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Mutation","0, PubMed: Huang 2013, PubMed: Huang, X. F. et al., 2013, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
572,-/-,4,43i,c.8682-53A>G,r.(=),p.(=),-,-,benign,g.216040565T>C,g.215867223T>C,-,-,USH2A_000117,"Heterozygous, Heterozygous; Neutral, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs115882431,Germline,-,-,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
573,"+/., +?/.",4,-,c.(8681+1_8682-1)_(8845+1_8846-1)del,"r.(?), r.spl",p.(?),-,-,"likely pathogenic, pathogenic",g.?,g.?,"del Ex.44, USH2A, variant 1: c.13098dup/p.V4367Rfs*22, variant 2 :Deletion exon 44, 1 more item",-,NPHS2_000000,"solved, compound heterozygous","PubMed: Austin-Tse 2018, PubMed: Perez-Carro 2018, PubMed: Weisschuh 2020",SCV000206020,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
574,"+/+, +/.",4,45,c.8890dup,r.(?),"p.(Trp2964Leufs*89), p.(Trp2964LeufsTer89)",Fibronectin type-III 16 (2925-3015),ACMG,pathogenic,g.216019336dup,g.215845994dup,8890dupT,-,USH2A_000331,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; Neutral, 1 more item","PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Vaché 2012, 1 more item",-,-,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
575,"+/., +?/.",4,45,c.8917_8918del,r.(?),"p.(Leu2973Lysfs*79), p.(Leu2973LysfsTer79)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216019307_216019308del,g.215845965_215845966del,"8917_8918delCT, USH2A c.8917_8918delCT",-,USH2A_002084,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5, no protein annotation written","0, PubMed: Weisschuh 2024, PubMed: Zhu 2021, 1 more item",-,rs1553268582,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"Johan den Dunnen, David Baux"
576,"+?/., ?/.",4,45,c.9002A>G,r.(?),p.(Asn3001Ser),-,ACMG,"likely pathogenic, VUS",g.216019219T>C,g.215845877T>C,"c.9002A>G, USH2A c.9002A>G, p.Asn3001Ser, USH2A c.9002A>G, p.N3001S",-,USH2A_002433,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,rs201564941,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
577,"+/+, +/.",4,45,c.8954del,"r.(8954del), r.(?)","p.(Gly2985Alafs*3), p.(Gly2985AlafsTer3)",Fibronectin type-III 16 (2925-3015),ACMG,pathogenic,g.216019268del,g.215845926del,"8954delG, USH2A c.8954del, p.(Gly2985Alafs*3)",-,USH2A_000660,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; Pathogenic","Journal: Reurink 2021, PubMed: Jaijo 2010, PubMed: Reurink 2021, 1 more item",-,-,"Germline, SUMMARY record",yes,-,+BsrDI;-EaeI;-MscI;-HaeIII;-PhoI;-CviKI_1;,-,-,"David Baux, Jose Maria Millan, Janine Reurink"
578,"-/., -?/?",4,46,c.9213G>A,r.(?),"p.(=), p.(Ser3071=)",Fibronectin type-III 17 (3020-3105),ACMG,"benign, likely benign",g.216017681C>T,g.215844339C>T,-,-,USH2A_000458,"Heterozygous; polymorphism, Homozygous; polymorphism, VKGL data sharing initiative Nederland",PubMed: McGee 2010,-,rs111033397,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
579,"+/., ?/.",4,-,c.9244A>G,r.(?),p.(Ile3082Val),-,ACMG,"pathogenic, pathogenic (recessive), VUS",g.216017650T>C,g.215844308T>C,"USH2A c.9244A>G, p.Ile3082Val",-,USH2A_001499,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,rs527689947,"Germline, SUMMARY record, Unknown",?,1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
580,"+/+, +/., +?/.",4,47,c.9319G>T,r.(?),"p.(Glu3107*), p.(Glu3107Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216011385C>A,g.215838043C>A,"USH2A c.9319G>T, p.Glu3107*, USH2A c.9319G>T, p.E3107*",-,USH2A_000959,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021; PubMed: Jiang, L. et al., 2015, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Anne-Françoise Roux"
581,"+?/?, ?/.",4,47,c.9355C>T,r.(?),p.(Arg3119Cys),Fibronectin type-III 18 (3110-3200),ACMG,VUS,g.216011349G>A,g.215838007G>A,USH2A(NM_206933.2):c.9355C>T (p.R3119C),-,USH2A_001021,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation, VKGL data sharing initiative Nederland","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs576236830,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Crystel Bonnet"
582,+?/.,4,47i_48i,c.(9371+1_9372-1)_(9570+1_9571-1)del,r.(del),"p.(Ser3125Phefs*26), p.?",-,-,likely pathogenic,g.(215987247_215990338)_(215990538_216011332)del,-,-,-,USH2A_001119,-,"PubMed: Neveling 2013, PubMed: Zazo Seco 2017, Journal: Zazo Seco 2017",-,-,"Germline, Unknown",?,-,-,-,-,"Marcel Nelen, Mieke Wesdorp"
583,"+/., +?/.",4,-,c.9740-1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215972468C>T,g.215799126C>T,"USH2A c.9740-1G>A, .",-,USH2A_001730,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P, ACMG PM2, PVS1_STRONG, PP5_STRONG, 1 more item","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021, PubMed: Weisschuh 2024",-,rs1662239185,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, IMGAG"
584,"+/., +/?, +?/., ?/.",4,50,c.9751T>C,r.(?),p.(Cys3251Arg),Cystein rich (3192-3358),ACMG,"likely pathogenic, pathogenic, VUS",g.215972456A>G,g.215799114A>G,"USH2A c.9751T>C, p.(Cys3251Arg)",-,USH2A_000192,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous, 1 more item","PubMed: Aller, E. et al., 2006; PubMed: Inaba, A. et al., 2020, PubMed: Inaba 2020, PubMed: Oishi 2014, 1 more item",-,rs527236118,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Jose Maria Millan"
585,"+/., +?/., ?/.",4,50,c.9801C>G,r.(?),p.(Cys3267Trp),-,ACMG,"likely pathogenic, pathogenic, VUS",g.215972406G>C,g.215799064G>C,"USH2A c.9801C>G, p.C3267W, USH2A c.9801C>G, p.Cys3267Trp",-,USH2A_002083,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Huang, X. F. et al., 2015, PubMed: Zhu 2021, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
586,"+/., +?/.",4,-,c.9860_9873del,r.(?),p.(His3287Profs*54),-,-,"likely pathogenic, likely pathogenic (recessive), pathogenic (recessive)","g.215972334_215972347del, g.215972335_215972348del",g.215798993_215799006del,"1:215972333GGCCATGGCCATCAT>G ENST00000307340.3:c.9860_9873delATGATGGCCATGGC (His3287ProfsTer54), 2 more items",-,USH2A_001812,"homozygous, protein variant annotation not written; heterozygous","PubMed: Carss 2017, PubMed: Toms 2020, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
587,+/.,4,50,c.9882C>G,r.(?),p.(Cys3294Trp),-,-,"pathogenic, pathogenic (recessive)",g.215972325G>C,g.215798983G>C,"1:215972325G>C ENST00000307340.3:c.9882C>G (Cys3294Trp), c.9882C>G",-,USH2A_001811,-,"PubMed: Biswas 2017, PubMed: Carss 2017, PubMed: Consugar 2015, PubMed: Nishiguchi-2013",-,rs749228276,Germline,yes,-,-,-,-,LOVD
588,"+/., +?/., +?/?, ?/.",4,50,c.9921T>G,r.(?),p.(Cys3307Trp),Cystein rich (3192-3358),ACMG,"likely pathogenic, pathogenic, VUS",g.215972286A>C,g.215798944A>C,"USH2A, variant 1: c.9921T>G/p.C3307W, variant 2: c.12284G>A/p.G4095D",-,USH2A_000544,"ACMG GN005 criteria: PM2_P, Heterozygous; Presumably pathogenic, solved, compound heterozygous","PubMed: Bonnet 2011, USMA missense analysis, missense variant in MSV3d, PubMed: Ge 2015, 2 more items",-,rs1057519382,"Germline, SUMMARY record, Unknown",?,0/482 controls,none,-,-,"David Baux, Anne-Françoise Roux"
589,"+/., +/?",4,50i,c.9959-4159A>G,r.(=),p.(=),-,ACMG,"likely pathogenic, pathogenic",g.215967783T>C,g.215794441T>C,"USH2A(NM_206933.2):c.9959-4159A>G, USH2A(NM_206933.4):c.9959-4159A>G",-,USH2A_000945,"Heterozygous; induces inclusion 155 bp (pseudo-exon) in minigenes; induces PE insertion, 1 more item","Liquori et al., accepted",-,-,"CLASSIFICATION record, Germline",-,1/522 controls,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
590,"+/+, +/., +?/.",4,50i,c.9959-1G>C,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215963625C>G,g.215790283C>G,-,-,USH2A_000915,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous","PubMed: Karali 2019, Journal: Karali 2019, PubMed: Karali, M. et al., 2019, PubMed: Sodi 2014",-,rs970237364,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi, Anne-Françoise Roux"
591,"+?/?, -?/., ?/.",4,52,c.10246T>G,r.(?),p.(Cys3416Gly),Fibronectin type-III 19 (3404-3494),ACMG,"likely benign, VUS",g.215960153A>C,g.215786811A>C,-,-,USH2A_000784,"ACMG GN005 criteria: BS1_S, Heterozygous; Mutation","PubMed: Bryant 2018, PubMed: Huang 2013, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs527236140,"Germline, SUMMARY record",-,-,+HphI;-BfuAI;-BspMI;,-,-,"David Baux, Anne-Françoise Roux"
592,"+/., +?/.",4,52,c.10211del,r.(?),"p.(Pro3404Glnfs*23), p.(Pro3404Glnfs*24), p.(Pro3404GlnfsTer24)",-,ACMG,"likely pathogenic, pathogenic","g.215960188del, g.215960190del",g.215786848del,"10211delC, c.10211delC",-,USH2A_001435,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"Sharon, submitted, PubMed: Khalaileh, A. et al., 2018, PubMed: Khalaileh-2018, PubMed: Sharon 2019",-,rs1571686349,"Germline, SUMMARY record, Unknown",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon"
593,"-/., ?/.",4,-,c.10312G>A,r.(?),p.(Ala3438Thr),-,-,"benign, VUS",g.215960087C>T,g.215786745C>T,-,-,USH2A_001493,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Xu 2014",-,rs146980351,Germline,-,"3/1204 cases with retinitis pigmentosa, 3/314 case chromosomes",-,-,-,Yoshito Koyanagi
594,"+/., +?/.",4,-,c.10388-2A>G,r.spl,"p. (Asp3463Alafs*6), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215956279T>C,g.215782937T>C,"USH2A c.10388-2A>G, p. (Asp3463Alafs*6)",-,USH2A_002210,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_M, 1 more item","PubMed: Pater 2019, PubMed: Pater, J. A. et al., 2019",-,rs1553261479,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
595,"+?/., ?/.",4,53,c.10417G>A,r.(?),"p.(Glu3473Lys), p.(Gly3475Lys)",-,ACMG,"likely pathogenic, VUS",g.215956248C>T,g.215782906C>T,"USH2A c.10417G>A, p.Glu3473Lys, USH2A c.10417G>A, p.E3473K, 1 more item",-,USH2A_002192,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,-,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_AMC"
596,"+/., -/., -/?, ?/.",4,53,c.10510C>G,r.(?),p.(Pro3504Ala),Fibronectin type-III 20 (3499-3585),ACMG,"benign, likely benign, pathogenic (recessive), VUS",g.215956155G>C,g.215782813G>C,"USH2A(NM_206933.2):c.10510C>G (p.P3504A), USH2A(NM_206933.4):c.10510C>G (p.P3504A)",-,USH2A_000635,"Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"CLASSIFICATION record, Germline",-,1/842 controls,+BaeGI;+Bsp1286I;-BsmFI;-MlyI;-PleI;-HinfI;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Maria Bitner-Glindzicz"
597,"+/+, +/.",4,53,c.10525A>T,r.(?),"p.(Lys3509*), p.(Lys3509Ter)",Fibronectin type-III 20 (3499-3585),-,pathogenic,g.215956140T>A,g.215782798T>A,"USH2A(NM_206933.2):c.10525A>T (p.K3509*), USH2A(NM_206933.4):c.10525A>T (p.K3509*)",-,USH2A_000701,"Heterozygous; Pathogenic, VKGL data sharing initiative Nederland",PubMed: Neveling 2012,-,-,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
598,?/.,4,-,c.10564A>G,r.(?),p.(Arg3522Gly),-,ACMG,VUS,g.215956101T>C,g.215782759T>C,"USH2A c.10564A>G , p.Arg3522Gly, USH2A c.10564A>G, p.Arg3522Gly, 1 more item",-,USH2A_002427,"ACMG PM2, heterozygous, VKGL data sharing initiative Nederland","PubMed: Thorsteinsson 2021, PubMed: Weisschuh 2024",-,-,"CLASSIFICATION record, Germline, Unknown",?,-,-,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam"
599,"+?/., +?/?, ?/.",4,53,c.10585G>A,r.(?),p.(Gly3529Ser),Fibronectin type-III 20 (3499-3585),ACMG,"likely pathogenic, VUS",g.215956080C>T,g.215782738C>T,p.G3529S,-,USH2A_000431,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; unknown, Heterozygous; UV3","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Wafa-2021, 2 more items",-,rs111033439,"Germline, SUMMARY record",-,0/96 controls,none,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
600,+?/?,4,54,c.10607T>G,r.(?),p.(Leu3536Arg),Fibronectin type-III 20 (3499-3585),ACMG,VUS,g.215955517A>C,g.215782175A>C,-,-,USH2A_000240,Homozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
601,"+/., +?/.",4,54,c.10695T>A,r.(?),"p.(Tyr3565*), p.(Tyr3565Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215955429A>T,g.215782087A>T,"USH2A c.10695T>A, p.Tyr3565*, USH2A c.10695T>A, p.Y3565X, USH2A c.T10695A, p.Y3565*",-,USH2A_002535,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","PubMed: Fu 2020, PubMed: Meng 2020, PubMed: Qu 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
602,"+?/., +?/?, ?/.",4,54,c.10721G>T,r.(?),p.(Gly3574Val),Fibronectin type-III 20 (3499-3585),ACMG,"likely pathogenic, VUS",g.215955403C>A,g.215782061C>A,"USH2A, variant 1: c.3317-2A>G/p.?, variant 2: c.10721G>T/p.G3475V",-,USH2A_000764,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; likely pathogenic, 1 more item","PubMed: Coppieters 2014, PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs1259758261,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
603,"+?/., +?/?, ?/.",4,54,c.10724G>A,r.(?),p.(Cys3575Tyr),Fibronectin type-III 20 (3499-3585),ACMG,"likely pathogenic (recessive), VUS",g.215955400C>T,g.215782058C>T,-,-,USH2A_000581,"ACMG GN005 criteria: PM2_P, ACMG PM2, PM1_SUPPORTING, PP5_STRONG, Heterozygous, Heterozygous; UV4","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 3 more items",-,rs111033265,"Germline, SUMMARY record",-,0/878 controls,none,-,-,"Johan den Dunnen, David Baux, Maria Bitner-Glindzicz, Eva Lenassi"
604,"+?/., ?/.",4,55,c.10931C>T,"r.(10931c>u), r.(?)",p.(Thr3644Met),-,ACMG,"likely pathogenic (recessive), VUS",g.215953193G>A,g.215779851G>A,"c.10931C>T, C10931T",-,USH2A_001973,-,"PubMed: Katagiri 2014, PubMed: Liu-2020, PubMed: Reurink 2023, Journal: Reurink 2023, 1 more item",-,rs185823130,Germline,-,-,-,-,-,Janine Reurink
605,"-/-, -/?",4,55i,c.10939+44C>T,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,likely benign,g.215953141G>A,g.215779799G>A,-,-,USH2A_000348,"Heterozygous, Heterozygous; UV1","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs56147129,Germline,-,-,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
606,"+/., +?/.",4,56,c.10962C>A,r.(?),"p.(Tyr3654*), p.(Tyr3654Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.215940108G>T,g.215766766G>T,"c.10962C>A, USH2A c.10962C>, p.Tyr3654*",-,USH2A_001845,"ACMG GN005 criteria: PVS1_VS PM2_P, 1 more item","PubMed: Gao 2021, PubMed: Liu-2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs1661141590,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
607,"+/+, +/.",4,56,c.10979del,r.(?),"p.(Ala3660fsVal*14), p.(Ala3660Valfs*14), p.(Ala3660ValfsTer14)",Fibronectin type-III 21 (3590-3676),ACMG,pathogenic,g.215940091del,g.215766749del,10979delC,-,USH2A_000321,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
608,"+/+, +/.",4,58,c.11234dup,r.(?),"p.(Tyr3745*), p.(Tyr3745Ter)",Fibronectin type-III 22 (3677-3767),ACMG,pathogenic,g.215932092dup,g.215758750dup,11234dupA,-,USH2A_000186,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Aller 2006, PubMed: Aller, E. et al., 2006, PubMed: Baux 2014, PubMed: Najera 2002",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
609,?/.,4,-,c.11288A>G,r.(?),p.(Tyr3763Cys),-,ACMG,VUS,g.215932038T>C,g.215758696T>C,"USH2A c.[11288A>G];[?], V1: c.11288A>G, (p.Tyr3763Cys), 1 more item",-,USH2A_002467,"heterozygous; single variant in a recessive gene, no second allele found, 1 more item","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline, Unknown","?, yes",Taiwan Biobank: 0.000989; GnomAD_exome_East: 0.000924; GnomAD_All: 0.0000676,-,-,-,LOVD
610,"+/., +?/.",4,58,c.11328T>A,"r.(11328u>a), r.(?)","p.(Tyr3776*), p.(Tyr3776Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215931998A>T,g.215758656A>T,"USH2A c.11328T>A, p.(Tyr3776*), 1 more item",-,USH2A_002108,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","Journal: Reurink 2021, PubMed: Hariri 2018, PubMed: Reurink 2021, 1 more item",-,rs749726310,"Germline, SUMMARY record","?, yes",-,-,-,-,"David Baux, Janine Reurink"
611,+/+,4,60,c.11569_11575del,r.(?),p.(Arg3857Leufs*25),Fibronectin type-III 23 (3768-3862),-,pathogenic,g.215914855_215914861del,g.215741513_215741519del,-,-,USH2A_000071,Heterozygous,PubMed: Baux 2007,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
612,"-/?, -?/., ?/.",4,60,c.11597C>T,"r.(11597c>u), r.(?)",p.(Ala3866Val),Fibronectin type-III 24 (3863-3960),ACMG,"likely benign, VUS",g.215914831G>A,g.215741489G>A,USH2A(NM_206933.2):c.11597C>T (p.A3866V),-,USH2A_000561,"Heterozygous; UV1, no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"CLASSIFICATION record, Germline",-,0/878 controls,+BsmFI;-Fnu4HI;-ApeKI;-BbvI;-TseI;-CviKI_1;,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Maria Bitner-Glindzicz, Janine Reurink"
613,"+?/., ?/.",4,61,c.11780A>G,r.(?),p.(Asp3927Gly),-,ACMG,"likely pathogenic, VUS",g.215901658T>C,g.215728316T>C,"USH2A c.11780A>G, p.Asp3927Gly, USH2A c.11780A>G, p.D3927G, USH2A c.11780A > G, p.Asp392",-,USH2A_002523,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous","PubMed: He 2020, PubMed: He, C. et al., 2020; PubMed: Meng, X. et al., 2021, PubMed: Meng 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
614,"+/., +?/.",4,61,c.11865G>A,r.(?),"p.(Trp3955*), p.(Trp3955Ter)",-,ACMG,"likely pathogenic, likely pathogenic (recessive), pathogenic",g.215901573C>T,g.215728231C>T,"c.11865G>A, NM_206933.2:c.11865G>A, NP_996816.2:p.(Trp3955Ter), NC_000001.10:g.215901573C>T, 1 more item",-,USH2A_002139,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Wang 2018",-,rs1659889270,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
615,"+/+, +/.",4,61,c.12006C>A,r.(?),"p.(Tyr4002*), p.(Tyr4002Ter)",Fibronectin type-III 25 (3961-4062),ACMG,"pathogenic, pathogenic (recessive)",g.215901432G>T,g.215728090G>T,c.12006C>A,-,USH2A_000407,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; Pathogenic","PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, PubMed: Lenarduzzi 2015, PubMed: McGee 2010",-,rs2102713360,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
616,-/-,4,61i,c.12066+73A>G,r.(=),p.(=),-,-,benign,g.215901299T>C,g.215727957T>C,-,-,USH2A_000282,Heterozygous,PubMed: Baux 2014,-,rs78380529,Germline,-,-,-,-,-,Anne-Françoise Roux
617,+?/.,4,-,c.12086dupA,r.(?),p.(His4029Glnfs*70),-,-,likely pathogenic,g.215853699dup,g.215680357dup,"USH2A c.12086dupA, p.H4029fs, USH2A c.12086dupA, p.H4029Qfs*68",-,USH2A_002521,heterozygous,"PubMed: Ng 2019, PubMed: Zhu 2020",-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
618,"+/., +?/.",4,62,c.12161G>T,r.(?),p.(Ser4054Ile),-,ACMG,"likely pathogenic, pathogenic (recessive)",g.215853624C>A,g.215680282C>A,"USH2A c.12161G>T, p.(Ser4054Ile), c.(4627+1_4628-1), _(4987+1_4988-1), del, 1 more item",-,USH2A_000497,possible duplicate,"PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, PubMed: Jespersgaar 2019",-,-,Germline,?,-,-,-,-,Anne-Françoise Roux
619,"+/., +?/.",4,-,c.12333dup,r.(?),"p.(Gly4112Trpfs*41), p.(Gly4112TrpfsTer41)",-,ACMG,"likely pathogenic, pathogenic",g.215848920dup,g.215675578dup,"12333dupT, USH2A, variant 1: c.12333dup/p.G4112Wfs*41, variant 2: c.12333dup/p.G4112Wfs*41",-,USH2A_002376,"ACMG GN005 criteria: PVS1_VS PM2_P PP1_M, solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1657996197,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
620,?/.,4,-,c.12358C>T,r.(?),p.(Arg4120Cys),-,ACMG,VUS,g.215848895G>A,g.215675553G>A,"c.12358C>T, p.Arg4120Cys, USH2A c.12358C>T, p.Arg4120Cys",-,USH2A_002270,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zampaglione 2020",-,rs727503718,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
621,"+/., +?/.",4,63,c.12394del,r.(?),"p.(Leu4132Trpfs*35), p.(Leu4132TrpfsTer35)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)","g.215848859del, g.215848861del",g.215675519del,"12394delC, USH2A, variant 1: c.12394del/p.L4132Wfs*35, variant 2: c.12394del/p.L4132Wfs*35, 1 more item",-,USH2A_001328,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, solved, homozygous","PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022, PubMed: Haer-Wigman 2017, PubMed: Weisschuh 2020",-,rs1558049084,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Barbara Vona"
622,"+/., +?/.",4,63,c.12457del,"r.(?), r.12457delU","p.(Ala4153Profs*14), p.(Ala4153ProfsTer14), p.Ala4153Profs*14",-,ACMG,"likely pathogenic, pathogenic",g.215848796del,g.215675454del,"12457delG, M13: c.12457del; p.Ala4153Profs*14",-,USH2A_001085,ACMG GN005 criteria: PVS1_VS PM2_P PM3_S PP1_M,"PubMed: Gonzalez del Pozo 2018, PubMed: Perez-Carro 2018, 1 more item",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, María González-del Pozo"
623,"+/+, +/., +?/.",4,63,c.13098dup,r.(?),"p.(Val4367Argfs*22), p.(Val4367ArgfsTer22)",Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, pathogenic",g.215848156dup,g.215674814dup,"13098dupC, USH2A, variant 1: c.13098dup/p.V4367Rfs*22, variant 2 :Deletion exon 44",-,USH2A_000773,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_P, Heterozygous; likely pathogenic, 1 more item","PubMed: Glöckle 2014, PubMed: Glockle, N. et al., 2014; PubMed: Weisschuh, N. et al., 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,+ApaI;+BaeGI;+BanII;+Bsp1286I;-BceAI;-MwoI;,-,-,"David Baux, Anne-Françoise Roux"
624,"+/., +?/.",4,-,c.13126T>G,r.(?),p.(Trp4376Gly),-,-,"likely pathogenic, pathogenic (recessive)",g.215848127A>C,g.215674785A>C,"1:215848127A>C ENST00000307340.3:c.13126T>G (Trp4376Gly), USH2A c.13126T>G, p.Trp4376Gly",-,USH2A_001802,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
625,"+?/., +?/?, ?/.",4,63,c.13268C>A,r.(?),p.(Ala4423Asp),Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, VUS",g.215847985G>T,g.215674643G>T,-,-,USH2A_001035,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 1 more item",-,rs755480221,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet, MobiDetails"
626,"+/+, +?/., ?/.",4,63,c.13491_13499dup,r.(?),p.(Thr4498_Thr4500dup),Fibronectin type-III 30 (4444-4528),ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215847754_215847762dup,g.215674412_215674420dup,"13499_13500insTACTCTCAC, USH2A c.13491_13499dup, p.T4498_T450dup",-,USH2A_000411,"ACMG GN005 criteria: PM2_P PM3_P, ACMG PM2, PM4, PP5_STRONG, Heterozygous, 1 more item","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020, PubMed: McGee 2010, PubMed: Weisschuh 2024",-,rs1349222819,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux, Anne-Françoise Roux"
627,"+/., +?/.",4,63i,c.13811+1del,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215847442del,g.215674100del,"13811+1delG, USH2A c.13811+1delG, USH2A c.13811+1delG, -",-,USH2A_002506,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
628,"+/., ?/.",4,64,c.14023A>T,r.(?),"p.(Arg4675*), p.(Arg4675Ter)",-,ACMG,"pathogenic, VUS",g.215844424T>A,g.215671082T>A,c.14023A>T,-,USH2A_001431,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"Sharon, submitted, PubMed: Khalaileh, A. et al., 2018, PubMed: Khalaileh-2018, PubMed: Sharon 2019",-,rs1571945476,"Germline, SUMMARY record, Unknown",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Dror Sharon"
629,"+/., +?/.",4,65,c.14174G>A,r.(?),"p.(Trp4725*), p.(Trp4725Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215824103C>T,g.215650761C>T,"c.14174G>A, c.14174G>A, p.Trp4725Ter",-,USH2A_001311,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Bonnet, C. et al., 2016; PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, 2 more items",-,-,"CLASSIFICATION record, Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
630,"-/., ?/.",4,-,c.14226G>A,r.(?),p.(Thr4742=),-,-,"benign, VUS",g.215824051C>T,g.215650709C>T,"USH2A(NM_206933.2):c.14226G>A (p.T4742=), USH2A(NM_206933.4):c.14226G>A (p.T4742=)",-,USH2A_001138,VKGL data sharing initiative Nederland,PubMed: Costa 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
631,"+?/., +?/?, ?/.",4,65,c.14273C>G,r.(?),p.(Pro4758Arg),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, VUS",g.215824004G>C,g.215650662G>C,-,-,USH2A_000345,"ACMG GN005 criteria: PM2_P PM3_S, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
632,"+/., +?/., ?/.",4,65i,c.14343+5G>A,"r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive), VUS",g.215823929C>T,g.215650587C>T,"USH2A c.14343+5G>A, -, USH2A c.14343+5C>T",-,USH2A_001837,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous, 1 more item","PubMed: Meng 2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Meng, X. et al., 2021, 1 more item",-,rs1188474408,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
633,"+/+, +/.",4,66,c.14403C>G,r.(?),"p.(Tyr4801*), p.(Tyr4801Ter)",Fibronectin type-III 33 (4732-4825),ACMG,"pathogenic, pathogenic (recessive)",g.215822049G>C,g.215648707G>C,-,-,USH2A_000620,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Disease causing, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Sun 2018, PubMed: Xu 2011, 1 more item",-,-,"Germline, SUMMARY record",-,"0/200 controls, 0/878 controls",+BfaI;+SpeI;,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
634,?/.,4,-,c.14413G>A,r.(?),p.(Val4805Ile),-,ACMG,VUS,g.215822039C>T,g.215648697C>T,"USH2A(NM_206933.2):c.14413G>A (p.V4805I), USH2A(NM_206933.4):c.14413G>A (p.V4805I), 1 more item",-,USH2A_001136,"ACMG GN005 criteria: BP4_P, heterozygous, individual unsolved, causality of variants unknown, 1 more item","PubMed: Rodriguez-Munoz 2020, PubMed: Rodriguez-Munoz, A. et al., 2020",-,rs147532612,"CLASSIFICATION record, Germline, SUMMARY record",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_AMC"
635,"+/+, +/., +?/.",4,67,c.14586T>G,r.(?),"p.(Tyr4862*), p.(Tyr4862Ter)",Fibronectin type-III 34 (4826-4927),ACMG,"likely pathogenic, pathogenic",g.215821069A>C,g.215647727A>C,"USH2A c.14586T>G, p.Tyr4862*",-,USH2A_000732,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous, Homozygous","PubMed: Baux 2014, PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,+BfaI,-,-,"David Baux, Anne-Françoise Roux"
636,-?/.,4,67,c.14664G>A,"r.(14664g>a), r.(?)",p.(Thr4888=),-,ACMG,likely benign,g.215820991C>T,g.215647649C>T,"USH2A(NM_206933.2):c.14664G>A (p.T4888=), USH2A(NM_206933.4):c.14664G>A (p.T4888=)",-,USH2A_001687,VKGL data sharing initiative Nederland,"PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC, Janine Reurink"
637,"+/+, +/.",4,68,c.14885dup,r.(?),"p.(Glu4963Glyfs * 38), p.(Glu4963Glyfs*38), p.(Glu4963GlyfsTer38)",Fibronectin type-III 35 (4928-5014),ACMG,"pathogenic, pathogenic (recessive)",g.215813984dup,g.215640642dup,14885dupA,-,USH2A_001052,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Karali, M. et al., 2019, 1 more item",-,rs2102636006,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi, Crystel Bonnet"
638,"+/., +?/.",4,69i,c.15053-2A>T,"r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215808047T>A,g.215634705T>A,"c.15053-2A>T, USH2A, variant 1: c.653T>A/p.V218E, variant 2: c.15053-2A>T/p.?",-,USH2A_001298,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, solved, compound heterozygous, 1 more item","PubMed: Colombo, L. et al., 2022, PubMed: Colombo-2020, PubMed: Weisschuh 2020",-,-,"CLASSIFICATION record, Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
639,?/.,4,-,c.15095G>A,r.(?),p.(Ser5032Asn),-,ACMG,VUS,g.215808003C>T,g.215634661C>T,"USH2A c.15095G>A, p.Ser5032Asn, USH2A(NM_206933.2):c.15095G>A (p.S5032N)",-,USH2A_001129,"ACMG GN005 criteria: PM2_P BP4_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs374144657,"CLASSIFICATION record, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
640,"-/., -?/., -?/?",4,70i,c.15297+3A>G,r.spl?,p.?,-,ACMG,"benign, likely benign",g.215807798T>C,g.215634456T>C,"USH2A(NM_206933.2):c.15297+3A>G, USH2A(NM_206933.4):c.15297+3A>G",-,USH2A_000805,"Homozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,rs57754754,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
641,"+?/., ?/.",4,71,c.15355C>T,r.(?),p.(Arg5119Trp),-,ACMG,"likely pathogenic, VUS",g.215802320G>A,g.215628978G>A,"c.15355C>T:p.R5119W, USH2A c.15355C>T, p.(Arg5119Trp)",-,USH2A_001454,"ACMG GN005 criteria: PM2_P BP4_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,rs767137840,"Germline, SUMMARY record, Unknown",?,10/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
642,"-/., -/?, -?/.",4,71,c.15356G>A,r.(?),p.(Arg5119Gln),Cytoplasmic (5064-5202),ACMG,"benign, likely benign",g.215802319C>T,g.215628977C>T,USH2A(NM_206933.4):c.15356G>A (p.R5119Q),-,USH2A_000778,"Heterozygous; polymorphism, VKGL data sharing initiative Nederland","PubMed: Glöckle 2014, PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d",-,rs201630132,"CLASSIFICATION record, Germline",-,-,-BsaWI;-BsaXI;-HpaII;-MspI;,-,-,"Johan den Dunnen, VKGL-NL_Nijmegen, VKGL-NL_AMC, Anne-Françoise Roux"
643,"-/., -?/?",4,71,c.15428G>A,r.(?),"p.(Arg5143Cys), p.(Arg5143His)",Cytoplasmic (5064-5202),ACMG,"benign, likely benign",g.215802247C>T,g.215628905C>T,-,-,USH2A_000242,"ACMG GN005 criteria: BA1 BS2_S BP4_P, Heterozygous, Heterozygous; benign","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 2 more items",-,rs111033435,"Germline, SUMMARY record",-,1/332 controls,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
644,"+/., +?/.",3,-,c.55del,r.(?),"p.(Met19Cysfs*2), p.(Met19CysfsTer2)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216595626del,g.216422284del,"55delA, USH2A, variant 1: c.12295-3T>A/p.?, variant 2: c.55del/p.M19Cfs*2",-,USH2A_002410,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1, PP5; no variant 2nd chromosome, 1 more item","PubMed: Weisschuh 2020, PubMed: Weisschuh 2024, PubMed: Weisschuh, N. et al., 2020",-,rs2039692173,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"Johan den Dunnen, David Baux"
645,"+/., +?/.",3,2,c.80C>A,r.(?),"p.(Ser27*), p.(Ser27Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216595599G>T,g.216422257G>T,"NM_206933.2:c.80C>A, NP_996816.2:p.(Ser27Ter), NC_000001.10:g.216595599G>T, 1 more item",-,USH2A_002149,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Wang 2018",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
646,"+/., +?/.",3,2,c.141_142dup,r.(?),"p.(Lys48Argfs*98), p.(Lys48ArgfsTer98)",-,ACMG,"likely pathogenic, pathogenic",g.216595538_216595539dup,g.216422196_216422197dup,"141_142dupGA, USH2A c.142_143insGA, p.(Lys48Argfs*98), 1 more item",-,USH2A_000742,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020, PubMed: Sun 2018",-,-,"Germline/De novo (untested), SUMMARY record",?,204,-,-,-,David Baux
647,+/.,3,2,c.194del,r.(?),"p.(Thr65Ilefs*80), p.(Thr65IlefsTer80)",-,ACMG,pathogenic,g.216595485del,g.216422143del,"194delC, c.194del",-,USH2A_002358,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Colombo, L. et al., 2022; PubMed: Mansard, L. et al., 2021; PubMed: Colombo, L. et al., 2021, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
648,+?/.,3,-,c.251G>A,r.(?),p.(Cys84Tyr),-,ACMG,VUS,g.216595428C>T,-,-,-,USH2A_002124,-,-,-,-,Germline/De novo (untested),-,-,-,-,-,Jinu Han
649,"+/+, +/.",3,3,c.545_546del,r.(?),"p.(Lys182Argfs*33), p.(Lys182ArgfsTer33)",-,ACMG,pathogenic,g.216591962_216591963del,g.216418620_216418621del,"545_546delAA, c.545_546del, p.Lys182ArgfsTer33",-,USH2A_000208,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Conflicting in silico model predictions, heterozygous, 1 more item","PubMed: Mansard, L. et al., 2021, PubMed: Seyedahmadi 2004, PubMed: Zampaglione 2020",-,rs780779563,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
650,"+?/., ?/.",3,-,c.662C>A,r.(?),p.(Thr221Lys),-,ACMG,"likely pathogenic, VUS",g.216538417G>T,g.216365075G>T,"USH2A c.662C>A, p.(Thr221Lys)",-,USH2A_001882,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Maeda 2018",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
651,"-/., -/?",3,04i,c.785-16_785-15del,"r.(=), r.=","p.(=), p.=",-,ACMG,"benign, likely benign",g.216501011_216501012del,g.216327669_216327670del,"785-16_785-15delAT, USH2A(NM_206933.4):c.785-16_785-15delAT",-,USH2A_000539,"Heterozygous; RT-PCR on hair roots cells showed normal sequence; Presumed non-pathogenic, 2 more items","PubMed: Le Quesne Stabej 2012, PubMed: Nakanishi 2011",-,-,"CLASSIFICATION record, Germline",-,"0/878 controls, 1/270",+HpyCH4IV;+PmlI;+BsaAI;-NlaIII;-FatI;-PciI;,-,-,"VKGL-NL_AMC, Anne-Françoise Roux, Maria Bitner-Glindzicz"
652,"+?/., +?/?, ?/.",3,5,c.821G>A,r.(?),p.(Arg274Gln),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216500960C>T,g.216327618C>T,-,-,USH2A_000981,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 1 more item",-,rs727504721,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
653,"+/+, +?/.",3,5,c.828C>G,r.(?),"p.(Tyr276*), p.(Tyr276Ter)",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic",g.216500953G>C,g.216327611G>C,"USH2A, variant 1: c.828C>G/p.Y276*, variant 2 :[c.6902T>C/p.L2301S; c.14219C>A/p.A4740D]",-,USH2A_000765,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; likely pathogenic, solved, compound heterozygous","PubMed: Glöckle 2014, PubMed: Glockle, N. et al., 2014; PubMed: Weisschuh, N. et al., 2020, 1 more item",-,rs1553250952,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
654,"+?/., +?/?, ?/.",3,6,c.850G>A,r.(?),p.(Glu284Lys),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216498940C>T,g.216325598C>T,"USH2A c.850G>A, p.(Glu284Lys)",-,USH2A_000093,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, PubMed: Inaba 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
655,"+?/?, ?/.",3,6,c.854T>C,r.(?),p.(Ile285Thr),Laminin N-terminal (271-517),ACMG,VUS,g.216498936A>G,g.216325594A>G,-,-,USH2A_000900,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs397518038,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi, Crystel Bonnet"
656,+?/.,3,-,c.993_994del,r.(?),"p.(Arg331Serfs*7), p.(Arg331SerfsTer7)",-,ACMG,likely pathogenic,g.216498798_216498799del,g.216325456_216325457del,"993_994delAG, c.993_994del, p.Arg331SerfsTer7, 1 more item",-,USH2A_002349,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020, PubMed: Zampaglione 2020",-,rs1571703801,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
657,"+/+, +/., +?/.",3,6,c.990_991del,r.(?),"p.(Asn330Lysfs*8), p.(Asn330LysfsTer8)",Laminin N-terminal (271-517),ACMG,"likely pathogenic, pathogenic",g.216498800_216498801del,g.216325458_216325459del,"990_991delTA, USH2A c.990_991del, p.(Asn330Lysfs*8)",-,USH2A_000982,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Falsini 2021, 1 more item",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Crystel Bonnet"
658,"+/+, +?/., ?/.",3,6,c.1040A>G,r.(?),p.(Asp347Gly),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216498750T>C,g.216325408T>C,c.1040A>G,-,USH2A_000923,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous","PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs762384558,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
659,"+/+, +/.",3,6,c.1140T>A,r.(?),"p.(Tyr380*), p.(Tyr380Ter)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216498650A>T,g.216325308A>T,"USH2A c.1140T>A, p.Y380*",-,USH2A_000971,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
660,"+/., ?/.",3,-,c.1142A>G,r.(?),p.(Gln381Arg),-,ACMG,"pathogenic (recessive), VUS",g.216498648T>C,g.216325306T>C,-,-,USH2A_002070,"ACMG PP3, PM2","PubMed: Weisschuh 2024, PubMed: Xu 2014",-,-,Germline,-,-,-,-,-,Johan den Dunnen
661,"+/+, +/.",3,"08i, 6i",c.1144-2A>C,r.spl,"p.(?), p.?",-,ACMG,pathogenic,g.216497696T>G,g.216324354T>G,"USH2A c.1144-2A > C, USH2A c.1144-2A>C",-,USH2A_000962,Heterozygous; mutation,"PubMed: Jiang 2015, PubMed: Zhu 2021",-,-,"Germline, Unknown","?, yes",-,-,-,-,Anne-Françoise Roux
662,"-?/?, ?/.",3,8,c.1346G>A,r.(?),p.(Arg449His),Laminin N-terminal (271-517),ACMG,"likely benign, VUS",g.216497020C>T,g.216323678C>T,-,-,USH2A_000878,"Heterozygous; uncertain pathogenicity, VKGL data sharing initiative Nederland","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, 1 more item",-,rs766715882,"CLASSIFICATION record, Germline",-,"5/378 controls, 8/1203 cases with retinitis pigmentosa",-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Yoshito Koyanagi"
663,"+?/., ?/.",3,-,c.1478A>G,r.(?),p.(Tyr493Cys),-,ACMG,"likely pathogenic, VUS",g.216496888T>C,g.216323546T>C,"c.1478A>G, p.Tyr493Cys, USH2A c.1478A>G, p.Y493C",-,USH2A_002344,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous, heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020, PubMed: Zampaglione 2020",-,rs756570931,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
664,"+/., +?/., ?/?",3,"08, 8",c.1481A>G,r.(?),p.(Tyr494Cys),Laminin N-terminal (271 - 517) ,ACMG,"likely pathogenic, pathogenic, VUS",g.216496885T>C,g.216323543T>C,-,-,USH2A_001779,Classification follows clingen GN005: PM2_Sup PM3_M,"PubMed: Bernardis 2016, PubMed: Sharon 2019",-,rs898430789,"Germline, SUMMARY record",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux"
665,"+/+, +/.",3,8,c.1518T>A,r.(?),"p.(Tyr506*), p.(Tyr506Ter)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216496848A>T,g.216323506A>T,-,-,USH2A_000172,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Bernal 2005, PubMed: Garcia-Garcia, G. et al., 2011, PubMed: Jaijo 2010",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
666,"+/., +?/.",3,-,c.1521_1522delinsAT,r.(?),"p.(Tyr507*), p.(Tyr507Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216496844_216496845delinsAT,g.216323502_216323503delinsAT,"USH2A, variant 1: c.1521_1522delinsAT/p.Y507*, variant 2: c.1521_1522delinsAT/p.Y507*",-,USH2A_002407,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P PP1_P, solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1571701069,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
667,"+?/., +?/?, ?/.",3,8,c.1541T>C,r.(?),p.(Ile514Thr),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216496825A>G,g.216323483A>G,"c.1541T>C,p.I514T",-,USH2A_000887,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Wafa-2021, 1 more item",-,rs768813865,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
668,"+/., +?/.",3,9,c.1560C>A,"r.(?), r.1560C>A","p.(Cys520*), p.(Cys520Ter), p.Cys520*",-,ACMG,"likely pathogenic, pathogenic",g.216495309G>T,g.216321967G>T,M8: c.1560C > A; p.Cys520*,-,USH2A_001088,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,-,"Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, María González-del Pozo"
669,"+?/., ?/.",3,9,c.1571C>A,r.(?),p.(Ala524Asp),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216495298G>T,g.216321956G>T,"c.1571C>A, USH2A Ex.9 c.1571C>A p.(Ala524Asp), Ex.26 c.5191_5192del p.(Met1731Valfs*8)",-,USH2A_002224,"ACMG GN005 criteria: PM2_P, compound heterozygous","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs772624410,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
670,"+/+, +/.",3,9,c.1589_1590insG,r.(?),"p.(Ser531Lysfs*5), p.(Ser531LysfsTer5)",Laminin EGF-like 1 (518-574),ACMG,pathogenic,g.216495279_216495280insC,g.216321937_216321938insC,"USH2A c.1589_1590insG, p.(Ser531Lysfs*5)",-,USH2A_000955,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
671,"+/+, +/.",3,"09i, 9i",c.1644+1G>A,r.spl,"p.(?), p.?",-,ACMG,pathogenic,g.216495224C>T,g.216321882C>T,USH2A c.1644 + 1G > A,-,USH2A_000966,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,rs912980910,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
672,"+/., +?/.",3,-,c.1678C>G,r.(?),p.(Pro560Ala),-,-,"likely pathogenic, pathogenic",g.216465679G>C,g.216292337G>C,USH2A p.(Pro560Ala),-,USH2A_001546,1 more item,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Koyanagi 2020",-,rs147509797,"Germline, Unknown",?,"1/1204 cases with retinitis pigmentosa, 4/1204 cases with retinitis pigmentosa",-,-,-,Yoshito Koyanagi
673,+?/.,3,-,c.1731C>A,r.(?),"p.(Cys577*), p.(Cys577Ter)",-,ACMG,likely pathogenic,g.216465626G>T,g.216292284G>T,"USH2A c.C1731A, p.C577X",-,USH2A_002592,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Zhu 2020, PubMed: Zhu, X. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
674,"+?/., ?/.",3,-,c.1804G>A,r.(?),p.(Gly602Arg),-,ACMG,"likely pathogenic, VUS",g.216465553C>T,g.216292211C>T,"USH2A c.1804G>A, p.(Gly602Arg)",-,USH2A_002132,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs2037014520,"Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Jinu Han"
675,"+?/., ?/.",3,-,c.1807G>A,r.(?),p.(Gly603Arg),-,ACMG,"likely pathogenic, VUS",g.216465550C>T,g.216292208C>T,-,-,USH2A_001932,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Stone 2017",-,rs963320925,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
676,"+?/., ?/.",3,10,c.1823G>A,"r.(1823g>a), r.(?)",p.(Cys608Tyr),-,ACMG,"likely pathogenic, VUS",g.216465534C>T,g.216292192C>T,"USH2A c.1823G>A, p.C608Y",-,USH2A_002589,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, heterozygous","PubMed: Dad, S. et al., 2015, PubMed: de Bruijn 2023, PubMed: Reurink 2023, Journal: Reurink 2023, 1 more item",-,rs1475577009,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Janine Reurink"
677,"-/-, -/?",3,10i,c.1841-61G>A,r.(=),p.(=),-,ACMG,likely benign,g.216462813C>T,g.216289471C>T,-,-,USH2A_000677,"Heterozygous, Heterozygous; Neutral","PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010",-,-,Germline,-,-,+DraI;+MseI;,-,-,Jose Maria Millan
678,?/.,3,-,c.1961T>C,r.(?),p.(Leu654Pro),-,-,VUS,g.216462632A>G,g.216289290A>G,-,-,USH2A_001452,-,-,ClinVar-000803391,-,Germline,yes,-,-,-,-,Bailey Glen
679,"+?/?, ?/.",3,12,c.1978G>A,r.(?),p.(Gly660Arg),Laminin EGF-like 3 (641-693),ACMG,VUS,g.216424434C>T,g.216251092C>T,-,-,USH2A_000730,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 1 more item",-,rs2102552084,"Germline, SUMMARY record",-,-,+BbsI;-MnlI;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
680,"+/+, +/.",3,12,c.1993_1994insT,r.(?),"p.(Lys665Ilefs*25), p.(Lys665IlefsTer25)",Fibronectin type-III 5 (1871-1949),ACMG,pathogenic,g.216424418_216424419insA,g.216251076_216251077insA,"USH2A c.1993_1994insT, p.(Lys665Ilefs*25)",-,USH2A_000967,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
681,"+/+, +/.",3,12,c.2073C>A,r.(?),"p.(Cys691*), p.(Cys691Ter)",Laminin EGF-like 3 (641-693),ACMG,pathogenic,g.216424339G>T,g.216250997G>T,-,-,USH2A_000213,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Seyedahmadi 2004",-,rs376674482,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
682,"+?/., +?/?, ?/.",3,12,c.2081G>C,r.(?),p.(Cys694Ser),Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, VUS",g.216424331C>G,g.216250989C>G,-,-,USH2A_000901,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous","PubMed: Ellingford 2016, PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs137954284,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
683,"+?/., +?/?, ?/.",3,12,c.2086T>A,r.(?),p.(Cys696Ser),Laminin EGF-like 4 (694-746),ACMG,"likely pathogenic, VUS",g.216424326A>T,g.216250984A>T,"USH2A c.2086T>A, p.C696S",-,USH2A_000989,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Zhu 2021, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Crystel Bonnet"
684,"+?/., ?/.",3,-,c.2139C>T,"r.(?), r.spl","p.(Gly713=), p.(Gly713Gly)",-,ACMG,"likely pathogenic, VUS",g.216424273G>A,g.216250931G>A,"USH2A c.2139C>T, p.(Gly713Gly)",-,USH2A_001982,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous","PubMed: Ellingford 2016, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs765293412,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
685,"+/+, +/.",3,13,c.2242C>T,r.(?),"p.(Gln748*), p.(Gln748Ter)",Laminin EGF-like 5 (747-794),ACMG,pathogenic,g.216420494G>A,g.216247152G>A,-,-,USH2A_000158,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Pennings 2004(2), PubMed: Pennings 2004, PubMed: Pennings, R. J. et al., 2004",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
686,"+/., +?/., ?/.",3,13,c.2339G>T,r.(?),p.(Cys780Phe),-,ACMG,"likely pathogenic, pathogenic, VUS",g.216420397C>A,g.216247055C>A,"USH2A c.2339G>T, p.C780F",-,USH2A_002585,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous, 1 more item","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
687,"+/+, +/.",3,13,c.2391_2392del,r.(?),p.(Cys797*),Laminin EGF-like 6 (795-846),-,pathogenic,g.216420346_216420347del,g.216247004_216247005del,2391_2392delTG,-,USH2A_000515,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-Tsp45I;-HpyCH4III;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
688,"+/+, +/.",3,13,c.2431A>T,r.(?),"p.(Lys811*), p.(Lys811Ter)",Laminin EGF-like 6 (795-846),ACMG,pathogenic,g.216420305T>A,g.216246963T>A,-,-,USH2A_000990,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Mansard, L. et al., 2021, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
689,"+?/., ?/.",3,-,c.2617G>A,r.(?),p.(Gly873Arg),-,ACMG,"likely pathogenic, VUS",g.216420119C>T,g.216246777C>T,USH2A(NM_206933.2):c.2617G>A (p.G873R),-,USH2A_002088,"ACMG GN005 criteria: PM2_P, VKGL data sharing initiative Nederland","0, PubMed: Huang, X. F. et al., 2015",-,rs1037325220,"CLASSIFICATION record, Germline, SUMMARY record",yes,-,-,-,-,"David Baux, VKGL-NL_Rotterdam"
690,"+/+, +/.",3,14,c.2878_2879del,r.(?),p.(Asn960Serfs*4),Laminin EGF-like 9 (951-1001),-,"pathogenic, pathogenic (recessive)",g.216405409_216405410del,g.216232067_216232068del,2878_2879delAA,-,USH2A_000013,"Homozygous, possible duplicate","PubMed: Dreyer 2000, PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
691,"+?/., ?/.",3,14,c.2953T>C,r.(?),p.(Cys985Arg),-,ACMG,"likely pathogenic, VUS",g.216405335A>G,g.216231993A>G,"c.2953T>C, USH2A, variant 1: c.9270C>A/p.C3090*, variant 2: c.2953T>C/p.C985R",-,USH2A_002401,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, possibly solved, compound heterozygous","PubMed: Colombo-2020, PubMed: Weisschuh 2020, 1 more item",-,rs1171264735,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
692,"+?/., ?/.",3,14i,c.2994-10T>G,"r.(=), r.spl, r.[=,2994_3157del]","p.(=), p.?, p.[=,Arg998Serfs*26]",-,ACMG,VUS,g.216390902A>C,g.216217560A>C,USH2A(NM_206933.4):c.2994-10T>G,-,USH2A_001655,"mini-gene splicing assay; changes ACMG to VUS, VKGL data sharing initiative Nederland","PubMed: Reurink 2022, Journal: Reurink 2022",-,-,"CLASSIFICATION record, Germline/De novo (untested), In vitro (cloned)",-,-,-,-,-,"VKGL-NL_AMC, Janine Reurink"
693,"+/?, ?/.",3,14,c.2993G>A,"r.(?), r.[2993g>a, 2810_2993del]","p.(Arg998Lys), p.[Arg998Lys, Gly937Aspfs*13]",Laminin EGF-like 9 (951-1001),ACMG,"likely pathogenic, VUS",g.216405295C>T,g.216231953C>T,-,-,USH2A_000292,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; E14 skipping, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, SUMMARY record",-,0/200 controls,-HpyAV,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
694,+/.,3,-,c.3063T>A,r.(?),p.(Cys1021Ter),-,ACMG,pathogenic,g.216390823A>T,g.216217481A>T,-,-,USH2A_002332,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
695,"+?/., +?/?",3,15,c.3086G>T,"r.(=), r.(?)",p.(Gly1029Val),Laminin EGF-like 10 (1002-1052),ACMG,"likely benign, likely pathogenic",g.216390800C>A,g.216217458C>A,"c.3086G>T, USH2A c.[3086G>T; 9258+1G>A]",-,USH2A_000853,"Heterozygous; likely pathogenic, no protein annotation written; heterozygous","PubMed: Charng 2020, PubMed: Eisenberger 2013, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
696,"+/., +?/.",3,-,c.3158-6A>G,"r.(=), r.spl?","p.(=), p.(?)",-,-,"likely pathogenic, pathogenic (recessive)",g.216380779T>C,g.216207437T>C,"1:216380779T>C ENST00000307340.3:c.3158-6A>G, USH2A c.3158-6A>G, USH2A c.3158-6A>G,",-,USH2A_001826,"heterozygous, protein variant annotation not written; heterozygous","PubMed: Carss 2017, PubMed: Toms 2020, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
697,"+/., +?/., ?/.",3,-,c.3158-2A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216380775T>C,g.216207433T>C,"USH2A c.31582A>G, p.(?)",-,USH2A_001980,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Ellingford 2016, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs878853404,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
698,"+?/., ?/.",3,16,c.3314A>C,r.(?),p.(Tyr1105Ser),-,ACMG,"likely pathogenic, VUS",g.216380617T>G,g.216207275T>G,"USH2A c.3314A>C, p.Tyr1105Ser, USH2A c.3314A>C, p.Y1105S",-,USH2A_002583,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
699,"+/., +?/.",3,17,c.3332T>G,r.(?),"p.(Leu1111*), p.(Leu1111Ter)",-,ACMG,"likely pathogenic (recessive), pathogenic",g.216373448A>C,g.216200106A>C,c.3332T>G,-,USH2A_002447,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
700,"+/., +?/.",3,-,c.3381del,r.(?),"p.(Thr1128Profs*10), p.(Thr1128ProfsTer10)",-,ACMG,"likely pathogenic, pathogenic",g.216373400del,g.216200058del,"3381delC, USH2A, variant 1: c.3381del/p.T1128Pfs*10, variant 2 :Deletion exon 22-24",-,USH2A_002399,"ACMG GN005 criteria: PVS1_VS PM2_P PP1_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2034948574,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
701,?/.,3,17,c.3443C>T,"r.(3443c>u), r.(?)",p.(Pro1148Leu),-,ACMG,VUS,g.216373337G>A,g.216199995G>A,USH2A(NM_206933.2):c.3443C>T (p.P1148L),-,USH2A_001646,"no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Janine Reurink"
702,"+/+, +/.",3,17,c.3420_3423del,r.(?),"p.(Tyr1141Argfs*11), p.(Tyr1141ArgfsTer11)",Fibronectin type-III 1 (1058-1143),ACMG,pathogenic,g.216373359_216373362del,g.216200017_216200020del,"3420_3423del - p.1140_1141del, 3420_3423delTTAC, USH2A c.3420_3423del, p.(Tyr1141Argfs*11)",-,USH2A_000958,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
703,"+?/., ?/.",3,17,c.3507G>C,r.(?),p.(Trp1169Cys),-,ACMG,"likely pathogenic, VUS",g.216373273C>G,g.216199931C>G,"USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.17 c.3507G>C p.(Trp1169Cys)",-,USH2A_002155,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, compound heterozygous","PubMed: Martin Merida 2019, PubMed: Perez-Carro 2018, PubMed: Perez-Carro, R. et al., 2018",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
704,"+/., +?/.",3,17,c.3635C>T,r.(?),p.(Pro1212Leu),-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216373145G>A,g.216199803G>A,"USH2A c.3635C>T(;)4576G>A, V2: c.3635C>T, (p.Pro1212Leu), 1 more item",-,USH2A_000490,"alleles in cis or trans; heterozygous, heterozygous, possible duplicate","PubMed: Chen 2021, PubMed: Chen 2021, 1 more item",-,-,"Germline, Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,Anne-Françoise Roux
705,?/.,3,-,c.3667T>C,r.(?),p.(Cys1223Arg),-,ACMG,VUS,g.216373113A>G,g.216199771A>G,"USH2A c.3667T>C, p.Cys1223Arg",-,USH2A_002579,"ACMG GN005 criteria: PM2_P PM3_P PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
706,+/+,3,17,c.3680del,r.(?),p.(Gly1227Alafs*10),Fibronectin type-III 2 (1145-1238),-,pathogenic,g.216373104del,g.216199762del,3680delG,-,USH2A_000112,Heterozygous; Pathogenic,"PubMed: Baux 2007, PubMed: Vaché 2012",-,-,Germline,-,-,none,-,-,Anne-Françoise Roux
707,"+?/?, ?/.",3,17,c.3724C>T,r.(?),p.(Pro1242Ser),Fibronectin type-III 3 (1242-1357),ACMG,VUS,g.216373056G>A,g.216199714G>A,-,-,USH2A_000880,"ACMG GN005 criteria: PM2_P PM3_P, Homozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs755849364,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
708,"+?/., ?/.",3,-,c.3745C>T,r.(?),p.(Pro1249Ser),-,ACMG,VUS,g.216373035G>A,g.216199693G>A,"USH2A c.C3745T, p.P1249S",-,USH2A_002121,"ACMG GN005 criteria: PM2_P PM3_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,rs751571261,"Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Jinu Han"
709,"+/+, +/., +?/.",3,17,c.3722_3729delinsTCA,r.(?),"p.(Ala1241Valfs*8), p.(Ala1241ValfsTer8)",-,ACMG,"likely pathogenic, pathogenic",g.216373051_216373058delinsTGA,g.216199709_216199716delinsTGA,"USH2A, variant 1: c.10073G>A/p.C3358Y, variant 2: c.3722_3729delinsTCA/ p.A1241Vfs*8",-,USH2A_000994,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation, solved, compound heterozygous","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Weisschuh, N. et al., 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Crystel Bonnet"
710,"+?/., ?/.",3,-,c.3831_3834delinsG,r.(?),p.(Leu1278del),-,ACMG,"likely pathogenic, VUS",g.216371904_216371907delinsC,g.216198562_216198565delinsC,3831_3834delACTAinsG,-,USH2A_001925,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Stone 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
711,+?/.,3,-,c.3841A>T,r.(?),"p.(Arg1281*), p.(Arg1281Ter)",-,ACMG,likely pathogenic,g.216371897T>A,g.216198555T>A,USH2A c.3841A>T,-,USH2A_002577,"ACMG GN005 criteria: PVS1_VS PM2_P, protein variant annotation not written; heterozygous","PubMed: Le Quesne Stabej, P. et al., 2012; PubMed: Wafa, T. T. et al., 2021, PubMed: Toms 2020",-,rs2034908088,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
712,?/.,3,18,c.4021G>C,r.(?),p.(Ala1341Pro),-,ACMG,VUS,"g.216198375C>G, g.216371717C>G",g.216198375C>G,"USH2A c.4021G > C, p.Ala1341Pro, heterozygous, USH2A c.4021G>C, p.Ala1341Pro",-,USH2A_002305,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Sun, Y. et al., 2020, PubMed: Sun 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
713,"+/., +?/., +?/?",3,18,c.4027A>C,r.(?),p.(Asn1343His),Fibronectin type-III 3 (1242-1357),ACMG,"likely pathogenic, pathogenic (recessive), VUS",g.216371711T>G,g.216198369T>G,"1:216371711T>G ENST00000307340.3:c.4027A>C (Asn1343His), USH2A c.4027A>C, p.Asn1343His",-,USH2A_000782,"heterozygous, Heterozygous; likely pathogenic","PubMed: Carss 2017, PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, Germline/De novo (untested)",?,-,+HpyCH4V;+NdeI;,-,-,Anne-Françoise Roux
714,"+/+, +/., +?/.",3,18,c.4046del,r.(?),"p.(Ser1349Phefs*17), p.(Ser1349PhefsTer17)",Fibronectin type-III 3 (1242-1357),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216371692del,g.216198350del,"4046delC, c.4046del",-,USH2A_000922,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs2034899784,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
715,?/.,3,-,c.4070C>T,r.(?),p.(Thr1357Met),-,ACMG,VUS,g.216371668G>A,g.216198326G>A,"USH2A c.C4070T, p.T1357M, USH2A(NM_206933.4):c.4070C>T (p.T1357M)",-,USH2A_001250,"marked as causative, heterozygous, VKGL data sharing initiative Nederland","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Ma 2021",-,rs201190539,"CLASSIFICATION record, Germline, Unknown",?,13/1204 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_AMC, Yoshito Koyanagi"
716,"+?/., ?/.",3,19,c.4102C>T,r.(?),p.(Pro1368Ser),-,ACMG,"likely pathogenic, VUS",g.216370044G>A,g.216196702G>A,"USH2A c.4102C>T, p.P1368S",-,USH2A_002032,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Zhu 2021",-,rs755867377,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
717,"+/., +?/., ?/.",3,19,c.4124C>A,r.(?),"p.(Ser1375*), p.(Ser1375Ter)",-,ACMG,"likely pathogenic (recessive), pathogenic, VUS",g.216370022G>T,g.216196680G>T,"c.4124C>A, USH2A c.4124C>A, p.Ser1375*",-,USH2A_002446,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
718,"+/., +?/.",3,19,c.4165del,r.(?),"p.(Val1389Leufs*43), p.(Val1389LeufsTer43)",-,ACMG,"likely pathogenic, pathogenic",g.216369981del,g.216196639del,"4165delG, USH2A c.4165delG, p.(Val1389Leufs*43), 1 more item",-,USH2A_000433,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020, PubMed: Sun 2018",-,-,"Germline/De novo (untested), SUMMARY record","?, yes",175,-,-,-,David Baux
719,+/+,3,20,c.4252-?_4396+?del,r.(?),p.(?),Fibronectin type-III 4 (1367-1462),-,pathogenic,g.216363565_216363709del,-,-,-,USH2A_000904,1 more item,"PubMed: Bonnet 2016, PubMed: Jaijo 2010",-,-,Germline,-,-,-,-,-,"Jose Maria Millan, Crystel Bonnet"
720,"+/+, +/.",3,20,c.4286_4396+16del,"r.(?), r.spl?","p.(?), p.?",Fibronectin type-III 4 (1367-1462),ACMG,pathogenic,"g.216363549_216363675del, g.216363550_216363676del",g.216190208_216190334del,-,-,USH2A_000735,Homozygous,"PubMed: Baux 2014, PubMed: Mansard et al, 2021",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
721,"+/+, +/., +?/.",3,20,c.4314del,r.(?),"p.(Ile1439Tyrfs*15), p.(Ile1439TyrfsTer15)",Fibronectin type-III 4 (1367-1462),ACMG,"likely pathogenic, pathogenic",g.216363648del,g.216190306del,4314delG,-,USH2A_000394,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Sandberg 2008",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
722,"+?/., ?/.",3,-,c.4385C>T,r.(?),p.(Thr1462Ile),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216363576G>A,g.216190234G>A,-,-,USH2A_001771,ACMG GN005 criteria: PM2_P PM3_M,"PubMed: Fuster-Garcia 2018, PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs2034687815,"Germline, SUMMARY record",-,-,-,-,-,"Global Variome, with Curator vacancy, David Baux, Anne-Françoise Roux"
723,"+/., +?/.",3,-,c.4429G>T,r.(?),p.(Gly1477Ter),-,ACMG,"likely pathogenic, pathogenic",g.216348792C>A,g.216175450C>A,-,-,USH2A_002030,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Patel 2016",-,rs786205452,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
724,"+/., +?/.",3,21,c.4618G>A,"r.(4618g>a), r.(?)",p.(Asp1540Asn),-,ACMG,"likely pathogenic (recessive), pathogenic",g.216348603C>T,g.216175261C>T,"1:216348603C>T ENST00000307340.3:c.4618G>A (Asp1540Asn), c.[2276G>T(;)4618G>A]",-,USH2A_001824,-,"PubMed: Carss 2017, PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Zhao 2015",-,-,Germline,-,-,-,-,-,Janine Reurink
725,+/.,3,21i,c.4627+2T>C,"r.spl, r.spl?","p.(?), p.?",-,ACMG,pathogenic,g.216348592A>G,g.216175250A>G,"c.4627+2T>C, USH2A c.4627+2T>C",-,USH2A_002154,-,"PubMed: Fu-2013, PubMed: Zhu 2021",-,-,Germline,yes,-,-,-,-,LOVD
726,"+?/., ?/.",3,22,c.4711G>C,r.(?),p.(Ala1571Pro),-,ACMG,"likely pathogenic, VUS",g.216270472C>G,g.216097130C>G,"p.A1571P, USH2A c.4711G>C, p.A1571P",-,USH2A_002319,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Wafa, T. T. et al., 2021; PubMed: Jauregui, R. et al., 2020, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
727,"+/+, +/.",3,22,c.4714del,r.(?),"p.(Leu1572Phefs*3), p.(Leu1572PhefsTer3)",Laminin G-like 1 (1517-1709),ACMG,pathogenic,g.216270469del,g.216097127del,4714delC,-,USH2A_000337,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
728,"+/+, +/., +?/.",3,22,c.4717C>T,r.(?),"p.(Gln1573*), p.(Gln1573Ter)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216270466G>A,g.216097124G>A,-,-,USH2A_001000,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Karali 2019, Journal: Karali 2019, 1 more item",-,rs2032459214,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi, Crystel Bonnet"
729,"+?/., +?/?, ?/.",3,23,c.4823A>G,r.(?),p.(His1608Arg),-,ACMG,"likely pathogenic, VUS",g.216262417T>C,g.216089075T>C,"USH2A, variant 1: c.2299del/p.E767Sfs*21, variant 2: c.4823A>G/p.H1608R",-,USH2A_000771,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; likely pathogenic, 1 more item","PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 1 more item",-,rs2032221370,"Germline, SUMMARY record, Unknown",?,-,-CviAII;-FatI;-NlaIII;,-,-,"David Baux, Anne-Françoise Roux"
730,+/.,3,24,c.4894del,r.(?),"p.(Ala1632Profs*3), p.(Ala1632ProfsTer3)",-,ACMG,pathogenic,g.216260154del,g.216086812del,"4894delG, USH2A c.4894delG, p.A1632fs, USH2A c.4894delG, p.A1633fs",-,USH2A_002572,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
731,"+?/., ?/.",3,-,c.4943T>C,r.(?),p.(Leu1648Pro),-,ACMG,"likely pathogenic, VUS",g.216260105A>G,g.216086763A>G,"USH2A, variant 1: c.2276G>T/p.C759F, variant 2: c.4943T>C/p.L1648P, 1 more item",-,USH2A_002390,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1558251712,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
732,"+/+, +?/.",3,25,c.5001dup,r.(?),"p.(Gly1668Argfs*30), p.(Gly1668ArgfsTer30)",Laminin G-like 1 (1517-1709),ACMG,"likely pathogenic, pathogenic",g.216258210dup,g.216084868dup,"4997_4998insA, 5001dupA",-,USH2A_001004,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Stone 2017",-,rs397518018,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
733,"+/+, +/., +?/.",3,25,c.5158del,r.(?),"p.(Leu1720*), p.(Leu1720Ter)",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic",g.216258050del,g.216084708del,"5158delC, USH2A c.5158delC, p.(Leu1720*)",-,USH2A_000142,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Nakanishi 2009",-,rs1571947978,"Germline, SUMMARY record, Unknown",?,0/114 controls,-,-,-,"David Baux, Anne-Françoise Roux"
734,?/.,3,-,c.5162G>A,r.(?),p.(Gly1721Glu),-,ACMG,VUS,g.216258045C>T,g.216084703C>T,"USH2A c.5162G>A, p.Gly1721Glu",-,USH2A_002569,"ACMG GN005 criteria: PM2_P PM3_P PP1_P PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
735,"+/., +?/., +?/?",3,26,c.5168G>A,"r.(?), r.[4988_5298del,5168_5298del]","p.(Gly1723Glu), p.[Glu1663Aspfs*31,Gly1723Aspfs*31]",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic, VUS",g.216256928C>T,g.216083586C>T,"USH2A c.5168G>A, p.G1723E",-,USH2A_000718,"Heterozygous, mini-gene splicing assay; changes ACMG to pathogenic","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Ng 2019, 1 more item",-,-,"Germline, In vitro (cloned)",yes,-,-NlaIV,-,-,"Anne-Françoise Roux, Janine Reurink"
736,+/.,3,-,1 more item,"r.(?), r.spl","p.(?), p.(Met1767Valfs*6)",-,-,pathogenic,g.216247745_216252636delinsATAACAGGCTGCCTGAGAGACTTAGTGTCTTGCTATCTGCTTACTAGCCATGTGACCTTGGGAAAGTTACCT,g.216074403_216079294delinsATAACAGGCTGCCTGAGAGACTTAGTGTCTTGCTATCTGCTTACTAGCCATGTGACCTTGGGAAAGTTACCT,"USH2A exon 27 deleted c.[5299-932_5572+1023del; 5572+1100_5573-1099del], p.(Met1767Valfs*6), 2 more items",-,USH2A_002494,2 more items,"PubMed: Austin-Tse 2018, PubMed: Steele-Stallard 2013",SCV000205712,-,Germline,yes,-,-,-,-,LOVD
737,"+?/., ?/.",3,27,c.5330G>A,r.(?),p.(Arg1777Gln),-,ACMG,"likely pathogenic (recessive), VUS",g.216251673C>T,g.216078331C>T,c.5330G>A,-,USH2A_002443,ACMG GN005 criteria: BP4_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,rs541275063,"Germline, SUMMARY record",-,-,-,-,-,David Baux
738,"+?/., ?/.",3,27,c.5363A>G,r.(?),p.(Asp1788Gly),-,ACMG,"likely pathogenic, VUS",g.216251640T>C,g.216078298T>C,m33: c.5363A > G; p.Asp1788Gly,-,USH2A_001957,"ACMG GN005 criteria: PM2_P, no variant 2nd chromosome","PubMed: Bravo-Gil 2017, PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,rs768237382,"Germline, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, Nereida Bravo Gil"
739,"+/., +?/.",3,27,c.5385T>A,r.(?),"p.(Tyr1795*), p.(Tyr1795Ter)",-,-,"likely pathogenic, pathogenic",g.216251618A>T,g.216078276A>T,-,-,USH2A_001102,"-, VKGL data sharing initiative Nederland","PubMed: Neveling 2013, PubMed: Zazo Seco 2017, Journal: Zazo Seco 2017",-,-,"CLASSIFICATION record, Germline, Unknown",?,-,-,-,-,"Marcel Nelen, Mieke Wesdorp, VKGL-NL_Nijmegen"
740,"+/., +?/.",3,-,c.5396del,r.(?),"p.(Lys1799Serfs*18), p.(Lys1799SerfsTer18)",-,ACMG,"likely pathogenic, pathogenic",g.216251609del,g.216078267del,"5396delA, USH2A c.5396delA, p.(Lys1799Serfs*18)",-,USH2A_002672,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
741,"+?/., ?/.",3,-,c.5462A>G,r.(?),p.(Lys1821Arg),-,ACMG,"likely pathogenic, VUS",g.216251541T>C,g.216078199T>C,-,-,USH2A_001997,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Perez-Carro 2016, PubMed: Perez-Carro 2018, PubMed: Perez-Carro, R. et al., 2018",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
742,"+?/., -?/?",3,27,c.5506C>A,r.(?),p.(Pro1836Thr),Laminin G-like 2 (1714-1891),ACMG,"likely benign, likely pathogenic",g.216251497G>T,g.216078155G>T,"c.5506C>A, p.Pro1836Thr",-,USH2A_000413,"heterozygous, Heterozygous; benign","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, PubMed: Stone 2017, 1 more item",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
743,"+/+, +?/.",3,27,c.5514T>A,r.(?),p.(Tyr1838*),Laminin G-like 2 (1714-1891),-,"likely pathogenic, pathogenic",g.216251489A>T,g.216078147A>T,USH2A p.Y1838Ter,-,USH2A_000236,"Heterozygous, 1 more item","PubMed: Jacobson 2014, PubMed: McGee 2010, PubMed: Yan 2009",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
744,"+/., +?/?, ?/.",3,28,c.5607_5615del,"r.(=), r.(?)",p.(Arg1870_Ala1872del),Fibronectin type-III 5 (1871-1949),ACMG,"pathogenic, VUS",g.216246601_216246609del,g.216073259_216073267del,-,-,USH2A_000848,"ACMG GN005 criteria: PM2_P, Heterozygous; mutation","PubMed: Krawitz 2014, PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz"
745,"+?/., ?/.",3,28,c.5752G>A,r.(?),p.(Glu1918Lys),-,ACMG,"likely pathogenic, VUS",g.216246463C>T,g.216073121C>T,"USH2A c.5752G>A, p.E1918K",-,USH2A_002086,ACMG GN005 criteria: PM2_P,"0, PubMed: Huang, X. F. et al., 2015, PubMed: Zhu 2021",-,rs529355834,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
746,"+/., +?/.",3,28i,c.5776+1G>C,"r.spl, r.spl?",p.?,-,ACMG,"likely pathogenic (recessive), pathogenic, pathogenic (recessive)",g.216246438C>G,g.216073096C>G,c.5776+1G>C,-,USH2A_001713,ACMG GN005 criteria: PVS1_VS PS1_S PM2_P,"PubMed: Karali 2019, Journal: Karali 2019, PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi"
747,"+/+, +/.",3,28i,c.5776+2T>C,r.spl,p.?,-,ACMG,"pathogenic, pathogenic (recessive)",g.216246437A>G,g.216073095A>G,-,-,USH2A_001066,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1_STRONG, PP5_STRONG; no variant 2nd chromosome, 1 more item","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Weisschuh 2024",-,rs866978361,"Germline, SUMMARY record",-,-,-,-,-,"Johan den Dunnen, David Baux, Crystel Bonnet"
748,"+/., +?/.",3,-,c.5777-2A>C,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216246313T>G,g.216072971T>G,"USH2A, variant 1: c.10561T>C/p.W3521R, variant 2: c.5777-2A>C/p.?, 1 more item",-,USH2A_002387,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous, 1 more item","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797136,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
749,+/.,3,-,c.5788C>T,r.(?),"p.(Arg1930*), p.(Arg1930Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216246300G>A,g.216072958G>A,-,-,USH2A_002754,"ACMG PM2, PVS1, PP5, VKGL data sharing initiative Nederland",PubMed: Weisschuh 2024,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Johan den Dunnen, VKGL-NL_Nijmegen"
750,"+/+, +?/.",3,29i,c.5857+2T>C,r.spl,p.?,-,-,"likely pathogenic, pathogenic",g.216246229A>G,g.216072887A>G,IVS29+2T>C,-,USH2A_000389,Heterozygous,"PubMed: McGee 2010, PubMed: Sandberg 2008, PubMed: Stone 2017",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
751,"-/., -/?",3,29i,c.5857+17A>C,r.(=),p.(=),-,ACMG,"benign, likely benign",g.216246214T>G,g.216072872T>G,-,-,USH2A_000814,"Homozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
752,-/.,3,-,c.5993G>A,r.(?),p.(Arg1998His),-,-,benign,g.216243499C>T,g.216070157C>T,"USH2A(NM_206933.2):c.5993G>A (p.R1998H), USH2A(NM_206933.4):c.5993G>A (p.R1998H)",-,USH2A_001236,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs143624066,"CLASSIFICATION record, Germline",-,1/1204 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Yoshito Koyanagi"
753,"+/+, +?/.",3,30,c.6029del,r.(?),"p.(Val2010Alafs*10), p.(Val2010AlafsTer10)",Fibronectin type-III 6 (1954-2051),ACMG,"likely pathogenic, pathogenic",g.216243463del,g.216070121del,"6029delT, c.6029del",-,USH2A_000936,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; UV3","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs762482370,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
754,"-/., ?/.",3,-,c.6050-8058G>C,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,"benign, VUS",g.216230047C>G,g.216056705C>G,"m40: c.6050-8058G > C; r.?, USH2A(NM_206933.4):c.6050-8058G>C",-,USH2A_002168,"ACMG GN005 criteria: PP3_P, VKGL data sharing initiative Nederland","PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,rs773131595,"CLASSIFICATION record, Germline/De novo (untested), SUMMARY record",?,-,-,-,-,"David Baux, VKGL-NL_AMC"
755,-?/.,3,-,c.6134A>G,r.(?),p.(His2045Arg),-,-,likely benign,g.216221905T>C,g.216048563T>C,"USH2A(NM_206933.2):c.6134A>G (p.H2045R), USH2A(NM_206933.4):c.6134A>G (p.H2045R)",-,USH2A_001381,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
756,"-/?, -?/.",3,32,c.6186A>C,r.(?),"p.(=), p.(Pro2062=)",Fibronectin type-III 7 (2052-2138),ACMG,likely benign,g.216219912T>G,g.216046570T>G,"USH2A(NM_206933.2):c.6186A>C (p.P2062=), USH2A(NM_206933.4):c.6186A>C (p.P2062=)",-,USH2A_000453,"Heterozygous; polymorphism, VKGL data sharing initiative Nederland",PubMed: McGee 2010,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
757,"-/?, -?/?",3,33,c.6341C>T,r.(?),p.(Thr2114Ile),Fibronectin type-III 7 (2052-2138),ACMG,likely benign,g.216173889G>A,g.216000547G>A,-,-,USH2A_000111,"Heterozygous, Homozygous","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
758,"-?/?, ?/.",3,33,c.6347A>G,r.(?),p.(His2116Arg),Fibronectin type-III 7 (2052-2138),ACMG,"likely benign, VUS",g.216173883T>C,g.216000541T>C,USH2A(NM_206933.2):c.6347A>G (p.H2116R),-,USH2A_000416,"Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d",-,rs111033450,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux"
759,"+/+, +/.",3,33,c.6349dup,r.(?),"p.(Gln2117Profs*41), p.(Gln2117ProfsTer41)",Fibronectin type-III 7 (2052-2138),ACMG,pathogenic,g.216173882dup,g.216000540dup,"6347_6348insC - p.H2116fs, 6349dupC, USH2A c.6347_6348insC, p.H2116fs",-,USH2A_000977,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation, 1 more item","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
760,"+/., +?/.",3,-,c.6399G>A,r.(?),"p.(Trp2133*), p.(Trp2133Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216173831C>T,g.216000489C>T,"USH2A c.6399G>A, p.(Trp2133*)",-,USH2A_002094,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Oishi 2014, 1 more item",-,rs55958016,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
761,"+/+, +/., +?/.",3,34,c.6488G>A,r.(?),"p.(Trp2163*), p.(Trp2163Ter)",Fibronectin type-III 8 (2142-2236),ACMG,"likely pathogenic, pathogenic",g.216172398C>T,g.215999056C>T,"USH2A c.6488G>A, p.W2163*",-,USH2A_000968,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,rs763389877,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
762,"-/., -?/., ?/.",3,-,c.6524G>A,r.(?),p.(Arg2175His),-,-,"benign, likely benign, VUS",g.216172362C>T,g.215999020C>T,USH2A(NM_206933.2):c.6524G>A (p.R2175H),-,USH2A_001518,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Velde 2022, Journal: Velde 2022",-,rs140845899,"CLASSIFICATION record, Germline",-,5/1204 cases with retinitis pigmentosa,-,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam, Yoshito Koyanagi"
763,"+?/., ?/.",3,-,c.6653T>C,r.(?),p.(Leu2218Pro),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.216172233A>G,g.215998891A>G,USH2A c.6653T>C,-,USH2A_001862,"ACMG GN005 criteria: PM2_P PM3_P, protein variant annotation not written; heterozygous","PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Toms 2020",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
764,"+/., +?/., -?/.",3,-,c.6815C>T,r.(?),p.(Thr2272Met),-,-,"likely benign, likely pathogenic (recessive), pathogenic",g.216144109G>A,g.215970767G>A,USH2A(NM_206933.2):c.6815C>T (p.T2272M),-,USH2A_001514,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Xu 2014",-,rs776972526,"CLASSIFICATION record, Germline",-,"1/1204 cases with retinitis pigmentosa, 1/314 case chromosomes",-,-,-,"VKGL-NL_Rotterdam, Yoshito Koyanagi"
765,"+?/., -/?, ?/.",3,36,c.6854A>G,r.(?),p.(Asn2285Ser),Fibronectin type-III 9 (2241-2325),ACMG,"likely benign, likely pathogenic, VUS",g.216144070T>C,g.215970728T>C,USH2A c.6854A>G,-,USH2A_000617,"ACMG GN005 criteria: BP4_P, Heterozygous; UV2, protein variant annotation not written; heterozygous","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Toms 2020, 1 more item",-,rs528089082,"Germline, SUMMARY record, Unknown",?,0/96 controls,+HpyCH4III;-Tsp509I;,-,-,"David Baux, Maria Bitner-Glindzicz"
766,"+?/., ?/.",3,36,c.6908C>T,r.(?),p.(Ser2303Phe),-,ACMG,"likely pathogenic, VUS",g.216144016G>A,g.215970674G>A,"USH2A c.6908C>T, p.S2303F",-,USH2A_002085,ACMG GN005 criteria: PM2_P,"PubMed: Huang 2015, PubMed: Huang, X. F. et al., 2015, PubMed: Zhu 2021",-,rs766809837,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
767,+?/.,3,36,c.6923C>A,r.(?),p.(Ala2308Glu),-,ACMG,"likely pathogenic, likely pathogenic (recessive)","g.216144001G>T, g.216419944C>T","g.215970659G>T, g.216246602C>T","c.6923G>T, p.(Ala2308Glu), USH2A c.6923C>A, p.A2308E",-,"USH2A_001657, USH2A_002063","error in annotation: c.6923G>T instead of C>A, compound heterozygous","PubMed: Wang 2019, PubMed: Xu 2014, PubMed: Zhu 2021",-,-,"Germline, Unknown",?,1/314 case chromosomes,-,-,-,LOVD
768,"+/., +?/?, ?/.",3,36,c.6928A>C,r.(?),p.(Thr2310Pro),Fibronectin type-III 9 (2241-2325),ACMG,"pathogenic, VUS",g.216143996T>G,g.215970654T>G,-,-,USH2A_000628,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; UV2","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Neuhaus 2017, 1 more item",-,-,"Germline, SUMMARY record",yes,0/96 controls,+BssKI;+StyD4I;+MspI;+HpaII;-BceAI;-HpyCH4V;,-,-,"David Baux, Maria Bitner-Glindzicz"
769,"+/+, +/.",3,36,c.6956del,r.(?),"p.(Leu2319Argfs*7), p.(Leu2319ArgfsTer7)",Fibronectin type-III 9 (2241-2325),ACMG,pathogenic,g.216143968del,g.215970626del,6956delT,-,USH2A_000719,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs1201446573,"Germline, SUMMARY record",-,-,+BsaJI;+BtgI;+HpyCH4III;-BsrI;-TspRI;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
770,"-?/., -?/?, ?/.",3,37,c.7061G>A,r.(?),p.(Arg2354His),Fibronectin type-III 10 (2328-2432),ACMG,"likely benign, VUS",g.216138718C>T,g.215965376C>T,-,-,USH2A_000178,"ACMG GN005 criteria:, Heterozygous","PubMed: Aller 2006, USMA missense analysis, missense variant in MSV3d, PubMed: Aller, E. et al., 2006",ClinVar-000803389,rs201386640,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Jose Maria Millan, Bailey Glen"
771,"+/+, +/.",3,38,c.7124del,r.(?),"p.(Gly2375Valfs*7), p.(Gly2375ValfsTer7)",Fibronectin type-III 10 (2328-2432),ACMG,"pathogenic, pathogenic (recessive)",g.216108135del,g.215934793del,"7123delG, 7124delG, c.7123delG",-,USH2A_000747,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Disease causing","PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Xu 2011",-,-,"Germline, SUMMARY record",-,0/200 controls,none,-,-,"David Baux, Anne-Françoise Roux"
772,"-/., ?/.",3,-,c.7160T>C,r.(?),p.(Met2387Thr),-,-,"benign, VUS",g.216108098A>G,g.215934756A>G,"USH2A(NM_206933.2):c.7160T>C (p.M2387T), USH2A(NM_206933.4):c.7160T>C (p.M2387T)",-,USH2A_001438,VKGL data sharing initiative Nederland,PubMed: Wang 2014,-,rs115015305,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
773,"+/+, +/.",3,38,c.7184_7194del,r.(?),"p.(Leu2395Hisfs*19), p.(Leu2395HisfsTer19)",Fibronectin type-III 10 (2328-2432),ACMG,pathogenic,g.216108065_216108075del,g.215934723_215934733del,"7184_7194del - p.2395_2398del, USH2A c.7184_7194del, p.(Leu2395Hisfs*19)",-,USH2A_000974,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Huang, L. et al., 2018; PubMed: Jiang, L. et al., 2015, PubMed: Jiang 2015, PubMed: Zhu 2021",-,rs2102499717,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
774,+/.,3,38,c.7231C>T,r.(?),"p.(Gln2411*), p.(Gln2411Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216108027G>A,g.215934685G>A,"USH2A c.7231C>T, p.Q2411*",-,USH2A_001857,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Zhu 2021",-,rs755693369,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
775,"+?/., ?/.",3,-,c.7234G>A,r.(?),p.(Val2412Met),-,ACMG,"likely pathogenic, VUS",g.216108024C>T,g.215934682C>T,"USH2A c.7234G>A, p.(Val2412Met)",-,USH2A_001856,"ACMG GN005 criteria: PM2_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Maeda 2018",-,rs755361656,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
776,"-?/., ?/.",3,-,c.7301-6C>T,r.(=),p.(=),-,-,"likely benign, VUS",g.216074253G>A,g.215900911G>A,"USH2A(NM_206933.2):c.7301-6C>T (p.(=)), USH2A(NM_206933.4):c.7301-6C>T",-,USH2A_001211,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Leiden, VKGL-NL_Rotterdam, VKGL-NL_AMC"
777,+?/.,3,39,c.7364G>A,r.(?),p.(Trp2455*),-,-,likely pathogenic,g.216074184C>T,g.215900842C>T,c.7364G>A,-,USH2A_001125,-,"PubMed: de Castro-Miró 2014, PubMed: de Castro-Miró et al. 2014, PubMed: de Castro-Miró-2014",-,-,Germline,-,-,-,-,-,Marta de Castro-Miró
778,"-/?, ?/.",3,39,c.7379G>A,r.(?),p.(Arg2460His),Fibronectin type-III 11 (2435-2528),ACMG,"likely benign, VUS",g.216074169C>T,g.215900827C>T,USH2A(NM_206933.2):c.7379G>A (p.R2460H),-,USH2A_000702,"Heterozygous; unknown, VKGL data sharing initiative Nederland","PubMed: Neveling 2012, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, Anne-Françoise Roux"
779,"+/+, +/.",3,39i,c.7452-1G>A,r.spl,p.?,-,ACMG,pathogenic,g.216073560C>T,g.215900218C>T,-,-,USH2A_001069,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Homozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs397518031,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
780,"+?/., -?/?, ?/.",3,40,c.7492A>T,r.(?),p.(Ser2498Cys),Fibronectin type-III 11 (2435-2528),ACMG,"likely benign, likely pathogenic, VUS",g.216073519T>A,g.215900177T>A,"USH2A c.A7492T, p.S2498C",-,USH2A_000969,"ACMG GN005 criteria: PM2_P, Heterozygous; mutation","PubMed: Jiang 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Jiang, L. et al., 2015, 1 more item",-,rs754310768,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
781,"-/., -/?",3,40,c.7584C>T,r.(?),"p.(=), p.(Thr2528=)",Fibronectin type-III 11 (2435-2528),ACMG,"benign, likely benign",g.216073427G>A,g.215900085G>A,-,-,USH2A_000520,"Heterozygous, Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs78250390,"CLASSIFICATION record, Germline",-,1/872 controls,+PstI;+HpyCH4V;+SfcI;-AciI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz"
782,+/.,3,-,c.7594+1G>A,r.spl,"p.(?), p.?",-,ACMG,"pathogenic, pathogenic (recessive)",g.216073416C>T,g.215900074C>T,"USH2A c.7594+1G>A, -",-,USH2A_001854,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Sun, T. et al., 2018, PubMed: Sun 2018",-,rs1558151466,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
783,"+/., +?/.",3,-,c.7645_7661del,r.(?),"p.(Met2549Alafs*3), p.(Met2549AlafsTer3)",-,ACMG,"likely pathogenic, pathogenic",g.216062330_216062346del,g.215888988_215889004del,"c.76457661del p.(Met2549Alafs*3), c.11065C>T p.(Arg3689*), USH2A c.7645_7661del",-,USH2A_002219,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, protein variant annotation not written; heterozygous","PubMed: Hagag 2020, PubMed: Toms 2020, PubMed: Toms, M. et al., 2020",-,-,"Germline/De novo (untested), SUMMARY record, Unknown",?,-,-,-,-,David Baux
784,"-?/., -?/?",3,41,c.7718G>A,r.(?),p.(Arg2573His),Fibronectin type-III 12 (2533-2619),ACMG,likely benign,g.216062273C>T,g.215888931C>T,-,-,USH2A_000421,"Heterozygous, Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
785,?/.,3,41,c.7839G>T,r.(?),p.(Glu2613Asp),-,-,VUS,g.216062152C>A,g.215888810C>A,G7839T,-,USH2A_001508,-,"PubMed: Katagiri 2014, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs568902534,Germline,-,22/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
786,"+/+, +?/., -/-",3,41,c.7873G>T,r.(?),p.(Glu2625*),Fibronectin type-III 13 (2621-2718),-,"likely pathogenic, pathogenic",g.216062118C>A,g.215888776C>A,-,-,USH2A_000725,Heterozygous,"PubMed: Baux 2014, PubMed: Stone 2017",-,-,Germline,-,-,+HpyCH4III;-BsaWI;-HpaII;-HpyAV;-MspI;,-,-,Anne-Françoise Roux
787,?/.,3,41,c.7939C>T,"r.(7939c>u), r.(?)",p.(Pro2647Ser),-,ACMG,VUS,g.216062052G>A,g.215888710G>A,c.7939C>T,-,USH2A_002436,"ACMG GN005 criteria: PM2_P PM3_P, no variant 2nd chromome","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020, 1 more item",-,rs1414367127,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Janine Reurink"
788,"+/., +?/., ?/.",3,41,c.8002G>T,r.(?),"p.(Glu2268Ter), p.(Glu2668*)",-,ACMG,"likely pathogenic, pathogenic, VUS",g.216061989C>A,g.215888647C>A,"USH2A c.8002G>T, p.Glu2268*, USH2A c.8002G>T, p.E2668*",-,USH2A_002495,"ACMG GN005 criteria: PVS1_VS PM2_P, 1 more item","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,rs2102460193,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
789,"+/+, +/.",3,41,c.8141G>A,r.(?),"p.(Trp2714*), p.(Trp2714Ter)",Fibronectin type-III 13 (2621-2718),ACMG,"pathogenic, pathogenic (recessive)",g.216061850C>T,g.215888508C>T,-,-,USH2A_000827,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Bahena, P. et al., 2022, PubMed: Baux 2014",-,rs1238086961,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona, Anne-Françoise Roux"
790,"-?/?, ?/.",3,41,c.8212G>A,r.(?),p.(Asp2738Asn),Fibronectin type-III 14 (2724-2812),ACMG,"likely benign, VUS",g.216061779C>T,g.215888437C>T,-,-,USH2A_000789,"ACMG GN005 criteria: PM2_P PP1_P, Heterozygous; Mutation","PubMed: Huang 2013, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs750687826,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
791,+/.,3,41i,c.8223+2T>A,r.spl,p.(?),-,ACMG,pathogenic,g.216061766A>T,g.215888424A>T,USH2A c.8223+2T>A,-,USH2A_002656,-,PubMed: Zhu 2021,-,-,Germline,yes,-,-,-,-,LOVD
792,"+/+, +/.",3,42,c.8231G>A,r.(?),"p.(Trp2744*), p.(Trp2744Ter), p.(Tyr2744Ter)",Fibronectin type-III 14 (2724-2812),ACMG,pathogenic,g.216052433C>T,g.215879091C>T,-,-,USH2A_000588,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Mansard et al, 2021, 1 more item",-,rs1664846292,"Germline, SUMMARY record",-,-,+DdeI,-,-,"David Baux, Anne-Françoise Roux, Maria Bitner-Glindzicz"
793,"+/+, +/., +?/.",3,42,c.8232G>A,r.(?),"p.(Trp2744*), p.(Trp2744Ter)",Fibronectin type-III 14 (2724-2812),ACMG,"likely pathogenic, pathogenic",g.216052432C>T,g.215879090C>T,-,-,USH2A_000917,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous","PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Sodi 2014",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
794,"+/., +?/.",3,-,c.8240del,r.(?),"p.(Pro2747Hisfs*22), p.(Pro2747HisfsTer22)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.216052428del,g.215879086del,8240delC,-,USH2A_002016,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PM2, PVS1, PP5","PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017, PubMed: Weisschuh 2024",-,rs1553272201,"Germline, SUMMARY record",-,-,-,-,-,"Johan den Dunnen, David Baux"
795,"+?/., ?/.",3,-,c.8339T>A,r.(?),p.(Val2780Asp),-,ACMG,"likely pathogenic, VUS",g.216052325A>T,g.215878983A>T,"USH2A c.8339T>A, p.(Val2780Asp)",-,USH2A_001502,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs1664842413,"Germline, SUMMARY record, Unknown",?,4/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
796,"+/., +?/.",3,-,c.8396del,r.(?),"p.(Gly2799Valfs*31), p.(Gly2799ValfsTer31)",-,ACMG,"likely pathogenic, pathogenic",g.216052272del,g.215878930del,"8396delG, USH2A c.8396delG, p.(Gly2799Valfs*31)",-,USH2A_002654,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous, homozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
797,"+/+, +/., +?/.",3,42,c.8435_8438del,r.(?),"p.(Thr2812Metfs*17), p.(Thr2812MetfsTer17)",Fibronectin type-III 14 (2724-2812),ACMG,"likely pathogenic, pathogenic",g.216052232_216052235del,g.215878890_215878893del,8435_8438delCCTA,-,USH2A_000180,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous","PubMed: Aller 2006, PubMed: Perez-Carro 2018, 1 more item",-,rs1664838877,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Jose Maria Millan"
798,+/.,3,42i,c.8558+1G>T,r.spl,p.?,-,ACMG,pathogenic,g.216052105C>A,g.215878763C>A,-,-,USH2A_001437,-,"Sharon, submitted, PubMed: Sharon 2019",-,-,Germline,-,"1/2420 IRD families, 2/2420 IRD families",-,-,-,"Global Variome, with Curator vacancy, Dror Sharon"
799,"+/+, +?/.",3,42,c.8557A>T,r.(?),"p.(Arg2853*), p.(Arg2853Ter)",Fibronectin type-III 15 (2821-2920),ACMG,"likely pathogenic, pathogenic",g.216052107T>A,g.215878765T>A,-,-,USH2A_000392,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Rivolta 2000",-,rs749452910,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
800,"+?/., ?/.",3,43,c.8641_8642insTATT,r.(?),p.(Ser2881Leufs*9),-,ACMG,"likely pathogenic, VUS","g.215877802_215877805dup, g.216051144_216051147dup",g.215877802_215877805dup,"USH2A c.8641-8642insTATT, p.Ser2881Phefs*9, USH2A c.8641_8642insTATT, p.Ser2881Phefs*9, 1 more item",-,"USH2A_002150, USH2A_002272","error in annotation: c.8641_8642insTATT causes p.(Ser2881LeufsTer9), and not p.(Ser2881Tyrfs9), 1 more item","PubMed: Meng 2020, PubMed: Sun 2020",-,-,Unknown,?,-,-,-,-,LOVD
801,"+/., ?/.",3,44,c.8709C>T,"r.(8682_8720del,8709c>u), r.(?), r.[8682_8720del,8709c>u]","p.(Arg2894_Asn2906del,=), p.(Arg2894_Asn2906del,Phe2903=), p.[Arg2894_Asn2906del,=]",-,ACMG,"pathogenic, VUS",g.216040485G>A,g.215867143G>A,"USH2A c.8709C>T, p.[Arg2894_Asn2906del,=]",-,USH2A_002112,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021",-,rs397518040,"Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, Janine Reurink"
802,"+?/., ?/.",3,44,c.8710G>A,"r.(8710g>a), r.(?)",p.(Val2904Ile),-,ACMG,"likely pathogenic (recessive), VUS",g.216040484C>T,g.215867142C>T,-,-,USH2A_002058,"ACMG PM2, no variant 2nd chromome","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Weisschuh 2024, PubMed: Xu 2014",-,rs142649882,Germline,-,1/314 case chromosomes,-,-,-,"Johan den Dunnen, Janine Reurink"
803,"+?/?, ?/.",3,44,c.8755A>C,"r.(=), r.(?)",p.(Thr2919Pro),Fibronectin type-III 15 (2821-2920),ACMG,VUS,g.216040439T>G,g.215867097T>G,-,-,USH2A_000835,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
804,"-/., -?/?, ?/.",3,44,c.8790T>G,r.(?),p.(Asn2930Lys),Fibronectin type-III 16 (2925-3015),ACMG,"benign, likely benign, VUS",g.216040404A>C,g.215867062A>C,"USH2A(NM_206933.2):c.8790T>G (p.N2930K), USH2A(NM_206933.4):c.8790T>G (p.N2930K)",-,USH2A_000424,"Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
805,"+/., +?/.",3,45,c.8917_8918delCT,r.(?),"p.(Leu2973Lysfs*79), p.(Leu2973LysfsTer79)",-,ACMG,"likely pathogenic, pathogenic","g.216019303_216019304delAG, g.216019307_216019308del",g.215845965_215845966del,"c.8917-8198delCT, p.L2973Kfs*79, USH2A c.8917_8918delCT, p.(Leu2973Lysfs*79)",-,USH2A_002084,heterozygous,"PubMed: Dineiro 2020, PubMed: Mansard et al, 2021, PubMed: Wafa-2021",-,rs1553268582,Germline,?,-,-,-,-,Anne-Françoise Roux
806,"-/., -/?, -?/.",3,45,c.8937A>G,r.(?),"p.(=), p.(Val2979=)",Fibronectin type-III 16 (2925-3015),ACMG,"benign, likely benign",g.216019284T>C,g.215845942T>C,"USH2A(NM_206933.2):c.8937A>G (p.V2979=), USH2A(NM_206933.4):c.8937A>G (p.V2979=)",-,USH2A_000457,"Heterozygous; polymorphism, VKGL data sharing initiative Nederland",PubMed: McGee 2010,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
807,"+/+, +/.",3,45,c.8972_8973del,r.(?),"p.(Thr2991Argfs*61), p.(Thr2991ArgfsTer61)",Fibronectin type-III 16 (2925-3015),ACMG,pathogenic,g.216019251_216019252del,g.215845909_215845910del,"8970_8971delCA, 8972_8973delCA",-,USH2A_000545,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Homozygous; Pathogenic","PubMed: Bonnet 2011, PubMed: Mansard, L. et al., 2021",-,rs1290334951,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Anne-Françoise Roux"
808,"+?/., -?/., ?/.",3,-,c.9110G>A,r.(?),p.(Arg3037His),-,ACMG,"likely benign, likely pathogenic, VUS",g.216017784C>T,g.215844442C>T,"USH2A c.9119G>A, p.R3037H",-,USH2A_001606,"ACMG GN005 criteria: BS2_S, VKGL data sharing initiative Nederland, 1 more item","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs533700989,"CLASSIFICATION record, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
809,"+/., +?/.",3,46,c.9119G>A,r.(?),p.(Trp3040*),-,ACMG,"likely pathogenic (recessive), pathogenic",g.216017775C>T,g.215844433C>T,USH2A c.9119G>A (p.Trp3040*),-,USH2A_001123,heterozygous,"PubMed: de Castro-Miró 2016, PubMed: Dineiro 2020, PubMed: Fuster-Garcia 2018",-,-,Germline,"?, yes",-,-,-,-,"Global Variome, with Curator vacancy, Marta de Castro-Miró"
810,"-?/., ?/.",3,-,c.9203T>C,r.(?),p.(Val3068Ala),-,-,"likely benign, VUS",g.216017691A>G,g.215844349A>G,"USH2A(NM_206933.2):c.9203T>C (p.V3068A), USH2A(NM_206933.4):c.9203T>C (p.V3068A)",-,USH2A_001605,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
811,"+?/., ?/.",3,-,c.9346C>A,r.(?),p.(Pro3116Thr),-,ACMG,"likely pathogenic, VUS",g.216011358G>T,g.215838016G>T,"USH2A c.10010G>T, p.(Cys3337Phe), c.9346C>A, p.(Pro3116Thr)",-,USH2A_002013,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Jespersgaar 2019, PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,rs140260219,"Germline, SUMMARY record","?, yes",-,-,-,-,David Baux
812,"+/., +?/.",3,47,c.9370A>G,r.(?),p.(Arg3124Gly),-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216011334T>C,g.215837992T>C,"5270A>G;9370A>G, 1 more item",-,USH2A_000494,possible duplicate,"PubMed: Dad 2016, PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, PubMed: Jespersgaar 2019",-,-,Germline,?,-,-,-,-,Anne-Françoise Roux
813,"+?/?, -?/., ?/.",3,47,c.9307A>G,r.(?),p.(Ile3103Val),Fibronectin type-III 17 (3020-3105),ACMG,"likely benign, VUS",g.216011397T>C,g.215838055T>C,USH2A(NM_206933.2):c.9307A>G (p.I3103V),-,USH2A_001022,"ACMG GN005 criteria: BP4_P, Heterozygous; probably pathogenic, VKGL data sharing initiative Nederland","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs143352618,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Rotterdam, Crystel Bonnet"
814,"+/., +?/.",3,47i,c.9371+1G>T,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216011332C>A,g.215837990C>A,"USH2A c.9371+1G>T, USH2A c.9371+1G>T, p.(?)",-,USH2A_002648,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Bonnet, C. et al., 2016; PubMed: Inaba, A. et al., 2020, PubMed: Inaba 2020, PubMed: Zhu 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
815,"+?/., ?/.",3,48,c.9388T>G,"r.(9388u>g), r.(?)",p.(Trp3130Gly),-,ACMG,"likely pathogenic, VUS",g.215990521A>C,g.215817179A>C,"USH2A c.9388T>G, p.(Trp3130Gly)",-,USH2A_002111,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Janine Reurink"
816,"+?/., ?/.",3,48,c.9389G>T,r.(?),p.(Trp3130Leu),-,ACMG,"likely pathogenic, VUS",g.215990520C>A,g.215817178C>A,"USH2A Ex.48 c.9389G>T p.(Trp3130Leu), Ex.61 c.11864G>A p.(Trp3955*)",-,USH2A_002151,"ACMG GN005 criteria: PM2_P PM3_M, compound heterozygous","PubMed: Martin Merida 2019, PubMed: Perez-Carro 2018, PubMed: Perez-Carro, R. et al., 2018",-,-,"Germline, Germline/De novo (untested), SUMMARY record","?, yes",-,-,-,-,David Baux
817,"+?/., ?/.",3,-,c.9413G>A,r.(?),p.(Gly3138Asp),-,ACMG,"likely pathogenic, VUS",g.215990496C>T,g.215817154C>T,"USH2A c.9413G>A, p.(Gly3138Asp)",-,USH2A_001738,"ACMG GN005 criteria: PM2_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs756163056,"CLASSIFICATION record, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
818,"+?/., ?/.",3,48,c.9422T>C,r.(?),p.(Leu3141Pro),-,ACMG,"likely pathogenic, VUS",g.215990487A>G,g.215817145A>G,"USH2A c.9422T>C, p.L3141P, USH2A c.9422T>C, p.Leu3141Pro",-,USH2A_002539,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
819,"+/+, +/.",3,48,c.9449G>A,r.(?),"p.(Trp3150*), p.(Trp3150Ter)",Fibronectin type-III 18 (3110-3200),ACMG,pathogenic,g.215990460C>T,g.215817118C>T,-,-,USH2A_000148,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Nakanishi 2009",-,rs1662880550,"Germline, SUMMARY record",-,0/114 controls,-,-,-,"David Baux, Anne-Françoise Roux"
820,"?/., ?/?",3,48,c.9503G>T,r.(?),p.(Cys3168Phe),-,ACMG,VUS,g.215990406C>A,g.215817064C>A,"USH2A c.2276G>T, p.(Cys759Phe), c.9503G>T, p.(Cys3168Phe)",-,USH2A_001353,"PM2, VKGL data sharing initiative Nederland",PubMed: Jespersgaar 2019,-,rs746007103,"CLASSIFICATION record, Germline, SUMMARY record",?,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
821,"+/+, +/.",3,48,c.9492_9498del,r.(?),"p.(Asp3165Serfs*5), p.(Asp3165SerfsTer5)",Fibronectin type-III 18 (3110-3200),ACMG,"pathogenic, pathogenic (recessive)",g.215990414_215990420del,g.215817072_215817078del,c.9492_9498delTGATGAG,-,USH2A_000746,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Disease causing","PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Xu 2011",-,-,"Germline, SUMMARY record",-,0/200 controls,none,-,-,"David Baux, Anne-Françoise Roux"
822,"+/+, +/.",3,50,c.9753T>A,r.(?),"p.(Cys3251*), p.(Cys3251Ter)",Cystein rich (3192-3358),ACMG,pathogenic,g.215972454A>T,g.215799112A>T,-,-,USH2A_000665,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,-Hpy188III,-,-,"David Baux, Jose Maria Millan"
823,"+?/., +?/?, ?/.",3,50,c.9842G>T,r.(?),p.(Cys3281Phe),Cystein rich (3192-3358),ACMG,"likely pathogenic, VUS",g.215972365C>A,g.215799023C>A,-,-,USH2A_000638,"Heterozygous; UV2, VKGL data sharing initiative Nederland","PubMed: Ellingford 2016, 1 more item",-,-,"CLASSIFICATION record, Germline",-,0/96 controls,none,-,-,"VKGL-NL_Nijmegen, Maria Bitner-Glindzicz"
824,"-/?, ?/.",3,50,c.9871G>A,"r.(=), r.(?)",p.(Gly3291Ser),Cystein rich (3192-3358),ACMG,"likely benign, VUS",g.215972336C>T,g.215798994C>T,"USH2A(NM_206933.2):c.9871G>A (p.G3291S), USH2A(NM_206933.4):c.9871G>A (p.G3291S)",-,USH2A_000849,"Heterozygous; mutation, VKGL data sharing initiative Nederland","PubMed: Krawitz 2014, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Peter Krawitz, VKGL-NL_Rotterdam, VKGL-NL_AMC"
825,"+/+, +/.",3,50,c.9874C>T,r.(?),"p.(Gln3292*), p.(Gln3292Ter)",Cystein rich (3192-3358),ACMG,pathogenic,g.215972333G>A,g.215798991G>A,-,-,USH2A_000352,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs2102778615,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
826,"+/+, +/.",3,50,c.9912dup,r.(?),"p.(Glu3305Argfs*41), p.(Glu3305ArgfsTer41)",Cystein rich (3192-3358),ACMG,pathogenic,g.215972295dup,g.215798953dup,9912dupA,-,USH2A_000618,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Lenassi 2015, 1 more item",-,rs759255743,"Germline, SUMMARY record",-,0/878 controls,+MseI,-,-,"David Baux, Maria Bitner-Glindzicz, Eva Lenassi"
827,-/-,3,50i,c.9958+128A>G,r.(=),p.(=),-,-,benign,g.215972121T>C,g.215798779T>C,-,-,USH2A_000663,Heterozygous; Neutral,"PubMed: Garcia-Garcia 2011, PubMed: Jaijo 2010",-,-,Germline,-,-,none,-,-,Jose Maria Millan
828,"+?/., ?/.",3,51,c.9974G>A,r.(?),p.(Gly3325Glu),-,ACMG,"likely pathogenic, VUS",g.215963609C>T,g.215790267C>T,"c.9974G>A p.(Gly3325Glu), USH2A c.9974G>A, p.(Gly3325Glu)",-,USH2A_002361,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Ellingsford 2018, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs1378786390,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
829,"+/., +?/.",3,51,c.10049dup,r.(?),"p.(Asn3351Glufs*2), p.(Asn3351GlufsTer2)",-,ACMG,"likely pathogenic (recessive), pathogenic","g.215963534dup, g.215963538dup",g.215790196dup,"10049dupA, c.10049dupA, 1 more item",-,USH2A_002142,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Liu-2020, PubMed: Meng, X. et al., 2021, PubMed: Wang 2018",-,-,"Germline, SUMMARY record",?,-,-,-,-,David Baux
830,"+/+, +/.",3,52,c.10190_10191del,r.(?),"p.(Lys3397Argfs*20), p.(Lys3397ArgfsTer20)",-,ACMG,pathogenic,g.215960209_215960210del,g.215786867_215786868del,"10190_10191delAA, USH2A c.10190_10191delAA, p.Lys3397ArgfsX20",-,USH2A_000398,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Mansard, L. et al., 2021, 1 more item",-,rs397517964,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
831,"+?/., -?/?, ?/.",3,52,c.10385C>T,r.(?),p.(Thr3462Ile),Fibronectin type-III 19 (3404-3494),ACMG,"likely benign, likely pathogenic, VUS",g.215960014G>A,g.215786672G>A,-,-,USH2A_000427,Heterozygous; benign,"PubMed: Batissoco 2021, PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, 1 more item",ClinVar-SCV001792226,-,"Germline, Somatic",yes,-,-,-,-,"Anne-Françoise Roux, Karina Lezirovitz Mandelbaum"
832,-/-,3,52i,c.10387+27T>C,r.(=),p.(=),-,-,benign,g.215959985A>G,g.215786643A>G,-,-,USH2A_000124,"Heterozygous, Homozygous","PubMed: Baux 2007, PubMed: Baux 2014",-,-,Germline,-,-,+BceAI;-NcoI;-FatI;-NlaIII;-CviAII;-StyI;,-,-,Anne-Françoise Roux
833,"+/., +?/.",3,-,c.10388-1G>A,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.215956278C>T,g.215782936C>T,-,-,USH2A_002011,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,rs1553261478,"Germline, SUMMARY record",-,-,-,-,-,David Baux
834,"+?/., ?/.",3,53,c.10403C>T,r.(?),p.(Pro3468Leu),-,ACMG,"likely pathogenic, VUS",g.215956262G>A,g.215782920G>A,"USH2A c.10403C>T, p.P3468L",-,USH2A_001952,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Bravo-Gil 2017, PubMed: Bravo-Gil, N. et al., 2017, PubMed: Zhu 2021",-,rs1553261476,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Nereida Bravo Gil"
835,"+?/., -/?, ?/.",3,53,c.10465G>A,r.(?),p.(Ala3489Thr),Fibronectin type-III 20 (3499-3585),ACMG,"likely benign, likely pathogenic, VUS",g.215956200C>T,g.215782858C>T,"USH2A, variant 1: c.9424G>T/p.G3142*, variant 2: c.10465G>A/p.A3489T",-,USH2A_000776,"ACMG GN005 criteria: PM2_P PM3_P BP4_P, Heterozygous; polymorphism, 1 more item","PubMed: Glöckle 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 1 more item",-,rs1553261464,"Germline, SUMMARY record, Unknown",?,-,+HpyCH4III;-MwoI;,-,-,"David Baux, Anne-Françoise Roux"
836,"+?/., ?/.",3,53,c.10505T>A,r.(?),p.(Val3502Glu),-,ACMG,"likely pathogenic, VUS",g.215956160A>T,g.215782818A>T,"USH2A c.10505T>A, p.Val3502Glu, USH2A c.10505T>A, p.V3502E",-,USH2A_002536,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021, PubMed: Zhu 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
837,+/.,3,53,c.10510C>A,r.(?),p.(Pro3504Thr),-,-,pathogenic (recessive),g.215956155G>T,g.215782813G>T,-,-,USH2A_000495,possible duplicate,"PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
838,?/.,3,53,c.10532A>G,r.(?),p.(Asp3511Gly),-,-,VUS,g.215956133T>C,g.215782791T>C,A10532G,-,USH2A_001490,-,"PubMed: Katagiri 2014, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs201997293,Germline,-,"1/1204 cases with retinitis pigmentosa, 8/1204 cases with retinitis pigmentosa",-,-,-,Yoshito Koyanagi
839,"+/., +?/?",3,53,c.10544A>G,r.(?),p.(Asp3515Gly),Fibronectin type-III 20 (3499-3585),ACMG,"pathogenic, VUS",g.215956121T>C,g.215782779T>C,-,-,USH2A_000147,Heterozygous,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Oishi 2014, 1 more item",-,rs527236119,Germline,-,"0/260 controls, 1/1204 cases with retinitis pigmentosa",-,-,-,"Anne-Françoise Roux, Yoshito Koyanagi"
840,"+/?, -/-",3,53i,c.10585+3A>G,"r.(10504_10585del), r.10504_10585del","p.(Ser3503Leufs*21), p.Ser3503Leufs*21",Fibronectin type-III 20 (3499-3585),ACMG,likely pathogenic,g.215956077T>C,g.215782735T>C,-,-,USH2A_000295,Heterozygous; del last 82 nt E53,"PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010",-,-,Germline,-,0/200 controls,none,-,-,Anne-Françoise Roux
841,-/-,3,53i,c.10586-26T>C,r.(=),p.(=),-,-,benign,g.215955564A>G,g.215782222A>G,-,-,USH2A_000367,Heterozygous,"PubMed: Aller 2006, PubMed: Najera 2002",-,-,Germline,-,-,-,-,-,Jose Maria Millan
842,"+?/., ?/.",3,-,c.10733G>A,r.(?),p.(Ser3578Asn),-,ACMG,"likely pathogenic, VUS",g.215955391C>T,g.215782049C>T,"USH2A c.10733G>A, p.Ser3578Asn",-,USH2A_001762,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Sharon 2019",-,rs1571681377,"Germline, SUMMARY record, Unknown",?,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux"
843,"-/., -?/.",3,-,c.10769C>T,r.(?),p.(Pro3590Leu),-,-,"benign, likely benign",g.215953355G>A,g.215780013G>A,"USH2A(NM_206933.2):c.10769C>T (p.P3590L), USH2A(NM_206933.4):c.10769C>T (p.P3590L)",-,USH2A_000496,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
844,"+/., ?/.",3,-,c.10820A>C,r.(?),p.(His3607Pro),-,ACMG,"pathogenic, pathogenic (recessive), VUS",g.215953304T>G,g.215779962T>G,-,-,USH2A_001909,ACMG GN005 criteria: PM2_P PM3_M PP1_P,"Villafuerte-de la Cruz RA, et al., 2023. Submitted, PubMed: Villanueva 2018, 1 more item",ClinVar-438200,rs750321557,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Rocio Villafuerte-de la Cruz"
845,"-?/?, ?/.",3,55,c.10852G>A,r.(?),p.(Gly3618Ser),Fibronectin type-III 21 (3590-3676),ACMG,"likely benign, VUS",g.215953272C>T,g.215779930C>T,USH2A(NM_206933.2):c.10852G>A (p.G3618S),-,USH2A_000432,"Heterozygous; benign, Heterozygous; likely benign, VKGL data sharing initiative Nederland","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, Anne-Françoise Roux, Crystel Bonnet"
846,"+/., ?/.",3,55,c.10904C>A,r.(?),p.(Thr3635Asn),-,ACMG,"pathogenic, VUS",g.215953220G>T,g.215779878G>T,"USH2A c.10904C>A, p.T3635N",-,USH2A_001487,"ACMG GN005 criteria: PM2_P BP4_P, 1 more item","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Yu, X. et al., 2020, PubMed: Zhu 2021",-,rs727505166,"Germline, SUMMARY record, Unknown",?,3/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
847,"+/., +?/.",3,56,c.10974_10975dup,r.(?),"p.(Thr3659Ilefs*16), p.(Thr3659IlefsTer16)",-,ACMG,"likely pathogenic, pathogenic",g.215940095_215940096dup,g.215766753_215766754dup,"10974_10975dupTA, c.10974_10975dupTA , p.Thr3659Ilefs*16, 1 more item",-,USH2A_002163,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, solved, compound heterozygous","PubMed: Birtel 2018, PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797133,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
848,"+/., +?/.",3,-,c.11054G>A,r.(?),"p.(Trp3685*), p.(Trp3685Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215933179C>T,g.215759837C>T,-,-,USH2A_002009,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
849,"+/., +?/.",3,-,c.11241C>G,r.(?),"p.(Tyr3747*), p.(Tyr3747Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215932085G>C,g.215758743G>C,"NM_206933, c.11241C>G, p.Tyr3747Ter",-,USH2A_002140,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Ezquerra-Inchausti 2018, PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
850,"+/+, ?/.",3,58i,c.11389+3A>G,"r.spl, r.spl?, r.[11232_11389del,11347_11389del,=]","p.?, p.[Tyr3745Aspfs*16,Val3783Glyfs*20,=]",-,ACMG,"pathogenic, VUS",g.215931934T>C,g.215758592T>C,-,-,USH2A_001072,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation, 1 more item","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Reurink 2022, Journal: Reurink 2022",-,-,"Germline, In vitro (cloned), SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet, Janine Reurink"
851,"-/., -?/.",3,-,c.11404G>A,r.(?),p.(Glu3802Lys),-,-,"benign, likely benign",g.215916663C>T,g.215743321C>T,"USH2A(NM_206933.2):c.11404G>A (p.E3802K), USH2A(NM_206933.4):c.11404G>A (p.E3802K)",-,USH2A_001170,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
852,"+/+, +/.",3,59,c.11533C>T,r.(?),p.(Gln3845*),Fibronectin type-III 23 (3768-3862),ACMG,pathogenic,g.215916534G>A,g.215743192G>A,"NM_206933.2:c.11533C>T, NP_996816.2:p.(Gln3845Ter), NC_000001.10:g.215916534G>A",-,USH2A_000399,Heterozygous,"PubMed: Sandberg 2008, PubMed: Wang 2018",-,-,Germline,?,-,-,-,-,Anne-Françoise Roux
853,"+/+, +/.",3,60,c.11566del,r.(?),"p.(Ser3856Valfs*28), p.(Ser3856ValfsTer28)",Fibronectin type-III 23 (3768-3862),ACMG,pathogenic,g.215914862del,g.215741520del,11566delA,-,USH2A_000681,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous; mutation, Heterozygous; Pathogenic","PubMed: Bonnet 2016, PubMed: Garcia-Garcia 2011, 1 more item",-,-,"Germline, SUMMARY record",-,-,+BsaXI,-,-,"David Baux, Jose Maria Millan, Crystel Bonnet"
854,"+?/., +?/?, ?/.",3,60,c.11594C>A,r.(?),p.(Ala3865Glu),Fibronectin type-III 24 (3863-3960),ACMG,"likely pathogenic, VUS",g.215914834G>T,g.215741492G>T,"USH2A, variant 1: c.12892T>A/p.Y4298N, variant 2: c.11594C>A/p.A3865E",-,USH2A_001030,"ACMG GN005 criteria: PM2_P, Heterozygous; Possibly pathogenic, possibly solved, compound heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2020, 1 more item",-,rs1064797132,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Crystel Bonnet"
855,+/.,3,60,c.11683G>T,"r.(11683g>u), r.(?)","p.(Gly3895*), p.(Gly3895Ter)",-,ACMG,pathogenic,g.215914745C>A,g.215741403C>A,"USH2A c.11683G>T, p.(Gly3895*)",-,USH2A_002107,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021",-,-,"Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, Janine Reurink"
856,"+/., +?/.",3,-,c.11694del,r.(?),p.(Asn3899Thrfs*34),-,-,"likely pathogenic, pathogenic (recessive)",g.215914734del,g.215741392del,"1:215914733TG>T ENST00000307340.3:c.11694delC (Asn3899ThrfsTer34), USH2A c.11694del, 1 more item",-,USH2A_001807,"heterozygous, protein variant annotation not written; heterozygous","PubMed: Carss 2017, PubMed: Toms 2020, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
857,"+?/., ?/.",3,-,c.11699A>G,r.(?),p.(Tyr3900Cys),-,ACMG,"likely pathogenic, VUS",g.215914729T>C,g.215741387T>C,"USH2A c.11699A>G, p.(Tyr3900Cys), 1 more item",-,USH2A_002228,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, compound heterozygous, heterozygous","PubMed: Jiman 2020, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs1386612395,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
858,"+/., +?/.",3,-,c.11811_11812del,r.(?),"p.(Tyr3938Argfs*8), p.(Tyr3938ArgfsTer8)",-,ACMG,"likely pathogenic, pathogenic",g.215901628_215901629del,g.215728286_215728287del,"11811_11812delCT, USH2A c.11811_11812delCT, p.(Tyr3938Argfs*8)",-,USH2A_001478,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs1242150130,"Germline, SUMMARY record, Unknown",?,1/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
859,"+?/., -?/?, ?/.",3,61,c.11815G>A,r.(?),p.(Glu3939Lys),Fibronectin type-III 24 (3863-3960),ACMG,"likely benign, likely pathogenic, VUS",g.215901623C>T,g.215728281C>T,"RP1 c.3101A>T, p.(His1034Leu), c.5805T>G, p.(Phe1935Leu), USH2A c.11815G>A, p.(Glu3939Lys)",-,USH2A_000700,"Heterozygous; unknown, VKGL data sharing initiative Nederland","PubMed: Jespersgaar 2019, PubMed: Neveling 2012, USMA missense analysis, missense variant in MSV3d",-,rs146264950,"CLASSIFICATION record, Germline",?,-,none,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
860,+/.,3,-,c.11875C>T,r.(?),p.(Gln3959Ter),-,-,pathogenic,g.215901563G>A,g.215728221G>A,"USH2A(NM_206933.2):c.11875C>T (p.Q3959*), USH2A(NM_206933.4):c.11875C>T (p.Q3959*)",-,USH2A_001163,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen, VKGL-NL_AMC"
861,"+/+, +/., +?/.",3,61,c.11918del,r.(?),"p.(Ala3973Valfs*11), p.(Ala3973ValfsTer11)",Fibronectin type-III 25 (3961-4062),ACMG,"likely pathogenic, pathogenic",g.215901520del,g.215728178del,"11918delC, USH2A c.11918delC, p.(?)",-,USH2A_000924,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, 1 more item","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020, PubMed: Sodi 2014",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
862,"+/+, +/.",3,61,c.11994C>A,r.(?),"p.(Tyr3998*), p.(Tyr3998Ter)",Fibronectin type-III 25 (3961-4062),ACMG,pathogenic,g.215901444G>T,g.215728102G>T,"USH2A c.11994C>A, p.Tyr3998*",-,USH2A_000120,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Baux 2007, PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
863,"+/+, +/., +?/.",3,62,c.12093C>A,r.(?),"p.(Tyr4031*), p.(Tyr4031Ter)",Fibronectin type-III 25 (3961-4062),ACMG,"likely pathogenic, pathogenic",g.215853692G>T,g.215680350G>T,-,-,USH2A_000884,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous, VKGL data sharing initiative Nederland","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015",-,rs55921307,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Nijmegen, Eva Lenassi"
864,"+?/., ?/.",3,62,c.12104C>T,r.(?),p.(Pro4035Leu),-,ACMG,"likely pathogenic, likely pathogenic (recessive), VUS",g.215853681G>A,g.215680339G>A,"USH2A c.12104C>T, p.P4035L",-,USH2A_001843,ACMG GN005 criteria: PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
865,"+/., +?/.",3,-,c.12232G>T,r.(?),"p.(Glu4078*), p.(Glu4078Ter), p.(Glu54078Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215853553C>A,g.215680211C>A,-,-,USH2A_001906,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, ACMG PM2, PVS1, PP5","PubMed: Sloan-Heggen, C. M. et al., 2016, PubMed: Stone 2017, PubMed: Weisschuh 2024",-,rs988693758,"Germline, SUMMARY record",-,-,-,-,-,"Johan den Dunnen, David Baux"
866,"+/+, +?/.",3,62,c.12172_12174delinsTAAA,r.(?),p.(Leu4058*),Fibronectin type-III 25 (3961-4062),-,"likely pathogenic, pathogenic",g.215853611_215853613delinsTTTA,g.215680269_215680271delinsTTTA,"USH2A c.12172_12172delCTGinsTAAA, p.Leu4058fs",-,USH2A_000750,"Homozygous, 1 more item","PubMed: Baux 2014, PubMed: Dockery 2017",-,-,Germline,yes,-,- Hpy188I;-MlyI;-PleI;,-,-,Anne-Françoise Roux
867,"+?/?, ?/.",3,62,c.12283G>A,r.(?),p.(Gly4095Ser),Fibronectin type-III 26 (4066-4150),ACMG,VUS,g.215853502C>T,g.215680160C>T,-,-,USH2A_001033,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1315543696,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
868,"+/., +?/.",3,-,c.12294+1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215853490C>T,g.215680148C>T,"USH2A c.12294+1G>A, p.(?)",-,USH2A_001949,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous","PubMed: Bravo-Gil 2017, PubMed: Jauregui 2020, 1 more item",-,rs111033526,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Nereida Bravo Gil"
869,+/.,3,-,c.(12294+1_12295-1)_(14133+1_14134-1)del,r.(?),p.(?),-,ACMG,pathogenic,"g.(215650802_215670971)_(215675617_215680148)del, g.?",g.?,"USH2A allele 1: Exon 63-64 deletion, genomic coordinates not determined, allele 2: p.Arg334GlyMS, 1 more item",-,"NPHS2_000000, USH2A_002243",-,"PubMed: Austin-Tse 2018, PubMed: Mansard et al, 2021",SCV000204167,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
870,"+?/., ?/.",3,63,c.12332C>T,r.(?),p.(Ser4111Phe),-,-,"likely pathogenic, VUS",g.215848921G>A,g.215675579G>A,"USH2A c.12332C>T, p.Ser4111Phe, USH2A(NM_206933.2):c.12332C>T (p.S4111F), 1 more item",-,USH2A_002207,"compound heterozygous, heterozygous, VKGL data sharing initiative Nederland","PubMed: Martin Merida 2019, PubMed: Zampaglione 2020",-,-,"CLASSIFICATION record, Germline/De novo (untested), Unknown",?,-,-,-,-,VKGL-NL_Rotterdam
871,"+?/., ?/.",3,63,c.12361C>T,r.(?),p.(Arg4121Cys),-,ACMG,"likely pathogenic, VUS",g.215848892G>A,g.215675550G>A,"USH2A c.12361C>T, p.Arg4121Cys, USH2A c.12361C>T, p.R4121C",-,USH2A_002519,"ACMG GN005 criteria: PM2_P, heterozygous, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,rs772357461,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
872,"+/+, +/.",3,63,c.12381_12382del,r.(?),"p.(Tyr4128Hisfs*24), p.(Tyr4128HisfsTer24)",Fibronectin type-III 26 (4066-4150),ACMG,pathogenic,g.215848875_215848876del,g.215675533_215675534del,12381_12382delCT,-,USH2A_000546,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation, Heterozygous; Pathogenic","PubMed: Bonnet 2011, PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs2102667069,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
873,"+/+, +/.",3,63,c.12409del,r.(?),"p.(Arg4137Glufs*30), p.(Arg4137GlufsTer30)",Fibronectin type-III 26 (4066-4150),ACMG,pathogenic,g.215848844del,g.215675502del,"12409delA, USH2A c.12409delA, p.(Arg4137Glufs*30)",-,USH2A_000964,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,rs1657992342,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
874,"+?/., +?/?, ?/.",3,63,c.12419G>T,r.(?),p.(Cys4140Phe),Fibronectin type-III 26 (4066-4150),ACMG,"likely pathogenic, VUS",g.215848834C>A,g.215675492C>A,-,-,USH2A_001037,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Mansard et al, 2021, 1 more item",-,rs1064797131,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
875,"+?/., -?/?, ?/.",3,63,c.12457G>A,r.(?),p.(Ala4153Thr),-,ACMG,"likely benign, likely pathogenic, VUS",g.215848796C>T,g.215675454C>T,"USH2A c.12457G>A, p.(Ala4153Thr)",-,USH2A_000596,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, probably non-causal incidental finding, 1 more item","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, PubMed: Zhu 2022, 1 more item",-,rs145531316,"Germline, Germline/De novo (untested), SUMMARY record",?,1/862 controls,-CviKI_1,-,-,"David Baux, Maria Bitner-Glindzicz"
876,"+/., +?/.",3,-,c.12525G>A,r.(?),"p.(Trp4175*), p.(Trp4175Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215848728C>T,g.215675386C>T,"USH2A, variant 1: c.10712C>T/p.T3571M, variant 2: c.12525G>A/p.W4175*",-,USH2A_002008,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, solved, compound heterozygous","PubMed: Neuhaus 2017, PubMed: Weisschuh 2020, 1 more item",-,rs1657987278,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
877,"+?/., +?/?, ?/.",3,63,c.12525G>C,r.(?),p.(Trp4175Cys),Fibronectin type-III 27 (4154-4258),ACMG,"likely pathogenic, VUS",g.215848728C>G,g.215675386C>G,-,-,USH2A_000233,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous","PubMed: Stone 2017, PubMed: Yan 2009, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1657987278,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
878,-/.,3,-,c.12608A>G,r.(?),p.(Gln4203Arg),-,-,benign,g.215848645T>C,g.215675303T>C,USH2A(NM_206933.2):c.12608A>G (p.Q4203R),-,USH2A_001475,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs148556640,"CLASSIFICATION record, Germline",-,"113/1204 cases with retinitis pigmentosa, 5/1204 cases with retinitis pigmentosa",-,-,-,"VKGL-NL_Rotterdam, Yoshito Koyanagi"
879,"+/., +?/?, ?/.",3,63,c.12695C>T,r.(?),"p.(Pro4232Leu ), p.(Pro4232Leu)",Fibronectin type-III 27 (4154-4258),ACMG,"pathogenic (recessive), VUS",g.215848558G>A,g.215675216G>A,-,-,USH2A_001040,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Fuster-Garcia 2018, 1 more item",-,rs745371873,"Germline, SUMMARY record",-,-,-,-,-,"Global Variome, with Curator vacancy, David Baux, Crystel Bonnet"
880,"+?/., ?/.",3,-,c.12697T>C,r.(?),p.(Trp4233Arg),-,ACMG,"likely pathogenic, VUS",g.215848556A>G,g.215675214A>G,"USH2A c.12697T>C, p.Trp4233Arg",-,USH2A_001900,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Stone 2017",-,rs780692918,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
881,"+/+, +/.",3,63,c.12703C>T,"r.(=), r.(?)","p.(Gln4235*), p.(Gln4235Ter)",Fibronectin type-III 27 (4154-4258),ACMG,pathogenic,g.215848550G>A,g.215675208G>A,-,-,USH2A_000836,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, PubMed: Krawitz 2014",-,rs1657976232,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Peter Krawitz, Crystel Bonnet"
882,"+/+, +?/.",3,63,c.12708T>A,r.(?),p.(Cys4236*),Fibronectin type-III 27 (4154-4258),ACMG,pathogenic,g.215848545A>T,g.215675203A>T,-,-,USH2A_000531,Homozygous; Probable pathogenic,PubMed: Nakanishi 2011,-,-,"Germline, Germline/De novo (untested)",-,0/220 controls,none,-,-,"Anne-Françoise Roux, Jinu Han"
883,"+/+, +/.",3,63,c.12729G>A,r.(?),p.(Trp4243*),Fibronectin type-III 27 (4154-4258),-,"pathogenic, pathogenic (recessive)",g.215848524C>T,g.215675182C>T,-,-,USH2A_000710,"Heterozygous; Pathogenic, VKGL data sharing initiative Nederland","PubMed: Fuster-Garcia 2018, PubMed: Neveling 2012",-,-,"CLASSIFICATION record, Germline",-,-,-EcoRI,-,-,"Global Variome, with Curator vacancy, VKGL-NL_Nijmegen, Anne-Françoise Roux"
884,"+?/., ?/.",3,63,c.12752G>T,r.(?),p.(Ser4251Ile),-,ACMG,"likely pathogenic, VUS",g.215848501C>A,g.215675159C>A,"USH2A c.12752G>T, p.S4251I, USH2A c.12752G>T, p.Ser4251Ile",-,USH2A_002517,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
885,"+/+, +/., +?/.",3,63,c.12859_12863del,r.(?),"p.(Pro4287Argfs*4), p.(Pro4287ArgfsTer4)",Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, pathogenic","g.215848390_215848394del, g.215848391_215848395del",g.215675049_215675053del,"12859_12863delCCACC, c.12859_12863del",-,USH2A_000920,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Sodi 2014, PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs1553252469,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
886,?/.,3,63,c.12863C>A,r.(?),p.(Pro4288Gln),-,-,VUS,g.215848390G>T,g.215675048G>T,c.12863C>A:p.P4288Q,-,USH2A_001471,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Numa-2020",-,-,"Germline, Unknown",-,1/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
887,"+?/?, ?/., ?/?",3,63,c.12893A>G,r.(?),p.(Tyr4298Cys),Fibronectin type-III 28 (4265-4351),ACMG,VUS,g.215848360T>C,g.215675018T>C,-,-,USH2A_001042,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous, PM2_S, PM3_M, PP3_S (following ClinGen GN005)","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1657962849,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
888,"-/?, ?/.",3,63,c.12910G>A,r.(?),p.(Glu4304Lys),Fibronectin type-III 28 (4265-4351),ACMG,"likely benign, VUS",g.215848343C>T,g.215675001C>T,"USH2A(NM_206933.2):c.12910G>A (p.E4304K), USH2A(NM_206933.4):c.12910G>A (p.E4304K)",-,USH2A_000605,"Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,0/878 controls,none,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Maria Bitner-Glindzicz"
889,"+?/., ?/.",3,63,c.12992A>G,r.(?),p.(Tyr4331Cys),-,ACMG,"likely pathogenic, VUS",g.215848261T>C,g.215674919T>C,"USH2A c.12992A>G, p.Y4331C",-,USH2A_001320,VKGL data sharing initiative Nederland,PubMed: Zhu 2021,-,-,"CLASSIFICATION record, Unknown",?,-,-,-,-,VKGL-NL_Nijmegen
890,"+/+, +/.",3,63,c.13060_13063del,r.(?),"p.(Ala4354Leufs*18), p.(Ala4354LeufsTer18)",-,ACMG,pathogenic,g.215848191_215848194del,g.215674849_215674852del,"13060_13063delGCTG, USH2A c.13060_13063delGCTG, p.(Ala4354Leufs*18)",-,USH2A_000960,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
891,"+?/., ?/.",3,63,c.13121T>A,r.(?),p.(Val4374Glu),-,ACMG,"likely pathogenic, VUS",g.215848132A>T,g.215674790A>T,"USH2A c.13121T>A, p.Val4374Glu, USH2A c.T13121A, p.V4374E",-,USH2A_002513,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021, PubMed: Zhu 2021",-,rs1314783581,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
892,"+?/., +?/?, ?/.",3,63,c.13156A>T,r.(?),p.(Ile4386Phe),Fibronectin type-III 29 (4356-4439),ACMG,"likely pathogenic, VUS",g.215848097T>A,g.215674755T>A,"USH2A c.13156A>T, p.I4386F",-,USH2A_000952,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation","PubMed: Shu 2015, USMA missense analysis, missense variant in MSV3d, PubMed: Shu, H. R. et al., 2015, 1 more item",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, Anne-Françoise Roux"
893,"+?/., ?/.",3,63,c.13270T>C,r.(?),p.(Cys4424Arg),-,ACMG,"likely pathogenic (recessive), VUS",g.215847983A>G,g.215674641A>G,"USH2A c.13270T>C, p. Cys4424Arg",-,USH2A_001840,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Sun 2018, PubMed: Sun, T. et al., 2018; PubMed: Meng, X. et al., 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
894,"+?/., ?/.",3,-,c.13283G>A,r.(?),p.(Gly4428Asp),-,ACMG,"likely pathogenic, VUS",g.215847970C>T,g.215674628C>T,"USH2A c.13283G>A, p.(Gly4428Asp), USH2A(NM_206933.2):c.13283G>A (p.G4428D)",-,USH2A_001577,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous, VKGL data sharing initiative Nederland","PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs1234273599,"CLASSIFICATION record, SUMMARY record, Unknown",?,-,-,-,-,"David Baux, VKGL-NL_Rotterdam"
895,"+/., +?/.",3,-,c.13396C>T,r.(?),p.(Pro4466Ser),-,-,"likely pathogenic, pathogenic (recessive)",g.215847857G>A,g.215674515G>A,"1:215847857G>A ENST00000307340.3:c.13396C>T (Pro4466Ser), USH2A c.13396C>T, p.Pro4466Ser",-,USH2A_001800,"homozygous, VKGL data sharing initiative Nederland","PubMed: Carss 2017, PubMed: Turro 2020",-,-,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,-,-,-,-,VKGL-NL_Nijmegen
896,"+?/., ?/.",3,-,c.13441A>G,r.(?),p.(Arg4481Gly),-,ACMG,"likely pathogenic, VUS",g.215847812T>C,g.215674470T>C,"USH2A c.13441A>G, p.(Arg4481Gly)",-,USH2A_001969,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Ellingford 2016, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs878853406,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
897,"+?/., ?/.",3,-,c.13481A>G,r.(?),p.(Tyr4494Cys),-,ACMG,"likely pathogenic, VUS",g.215847772T>C,g.215674430T>C,-,-,USH2A_001897,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021, PubMed: Stone 2017",-,rs1322092837,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
898,"+/., +?/.",3,63,c.13510G>T,r.(?),"p.(Glu4504*), p.(Glu4504Ter)",-,ACMG,"likely pathogenic, pathogenic, pathogenic (recessive)",g.215847743C>A,g.215674401C>A,"USH2A c.13510G>T, p.Glu4504*",-,USH2A_001984,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Bahena 2021, PubMed: Gao 2021, 1 more item",-,-,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,"David Baux, Barbara Vona"
899,"+?/., ?/.",3,63,c.13531G>A,r.(?),p.(Ala4511Thr),-,ACMG,"likely pathogenic, VUS",g.215847722C>T,g.215674380C>T,"USH2A Ex.54 c.10712C>T p.(Thr3571Met), Ex.63 c.13531G>A p.(Ala4511Thr)",-,USH2A_001896,"ACMG GN005 criteria: PM2_P, compound heterozygous","PubMed: Del Pozo-Valero, M. et al., 2022, PubMed: Martin Merida 2019, PubMed: Stone 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
900,"+/., +?/.",3,-,c.13631dup,r.(?),"p.(Pro4545Serfs*17), p.(Pro4545SerfsTer17)",-,ACMG,"likely pathogenic, pathogenic",g.215847625dup,g.215674283dup,"13631dupG, c.13631dupG, USH2A c.13631dupG, p.(Pro4545Serfs*17)",-,USH2A_001839,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Maeda 2018",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
901,"+/+, +/.",3,63,c.13700del,r.(?),"p.(Leu4567Profs*16), p.(Leu4567ProfsTer16)",Fibronectin type-III 31 (4529-4627),ACMG,pathogenic,g.215847553del,g.215674211del,13700delT,-,USH2A_000246,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016, 1 more item",-,rs1212608410,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
902,"+?/., ?/.",3,-,c.13804T>C,r.(?),p.(Phe4602Leu),-,ACMG,"likely pathogenic, VUS",g.215847449A>G,g.215674107A>G,"USH2A, variant 1: c.2231G>A/p.C744Y, variant 2: c.13804T>C/p.F4602L, 1 more item",-,USH2A_002371,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs755099565,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
903,"+?/., ?/.",3,-,c.13894C>G,r.(?),p.(Pro4632Ala),-,ACMG,"likely pathogenic, VUS",g.215844553G>C,g.215671211G>C,"USH2A c.13894C>G, p.(Pro4632Ala)",-,USH2A_001465,"ACMG GN005 criteria: PM2_P PM3_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs1397044127,"Germline, SUMMARY record, Unknown",?,2/1204 cases with retinitis pigmentosa,-,-,-,"David Baux, Yoshito Koyanagi"
904,"+/., +?/.",3,-,c.13898del,r.(?),"p.(Leu4633*), p.(Leu4633Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215844551del,g.215671209del,"13898delT, USH2A, variant 1: c.10073G>A/p.C3358Y, variant 2: c.13898del/p.L4633*",-,USH2A_002007,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Neuhaus 2017, PubMed: Weisschuh 2020, 1 more item",-,rs1553252052,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
905,"+/+, +/., +?/.",3,64,c.13903C>T,r.(?),"p.(Gln4635*), p.(Gln4635Ter)",Fibronectin type-III 32 (4633-4730),ACMG,pathogenic,g.215844544G>A,g.215671202G>A,-,-,USH2A_001045,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, Germline/De novo (untested), SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet, Jinu Han"
906,"-/., -?/?",3,64,c.13984C>G,r.(?),p.(Gln4662Glu),Fibronectin type-III 32 (4633-4730),ACMG,"benign, likely benign",g.215844463G>C,g.215671121G>C,-,-,USH2A_000443,"Heterozygous; benign, Heterozygous; UV1, VKGL data sharing initiative Nederland","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs41302237,"CLASSIFICATION record, Germline",-,0/878 controls,+BpmI;-NlaIV;-BbvI;-Fnu4HI;-ApeKI;-HpyCH4V;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux, Maria Bitner-Glindzicz"
907,"+/., +?/.",3,64,c.14011G>T,"r.(?), r.14011U>T","p.(Glu4671*), p.(Glu4671Ter), p.Glu4671*",-,ACMG,"likely pathogenic, pathogenic",g.215844436C>A,g.215671094C>A,M16: c.14011G > T; p.Glu4671*,-,USH2A_001023,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M PP1_P,"PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, María González-del Pozo"
908,"+/., +?/.",3,-,c.14065del,r.(?),"p.(Ile4689Serfs*10), p.(Ile4689SerfsTer10)",-,ACMG,"likely pathogenic, pathogenic",g.215844383del,g.215671041del,"14065delA, USH2A c.14065delA, p.Ile4689Serfs10",-,USH2A_002504,"ACMG GN005 criteria: PVS1_VS PM2_P PP3_P PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Meng, X. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
909,"+/+, +?/., ?/.",3,64i,c.14134-3169A>G,"r.(14133_14134ins14134-3221_14134-3168), r.(?)","p.(Gln14711_Val4712delinsEKPTH*), p.(Val4711GlufsTer6)",Fibronectin type-III 32 (4633-4730),ACMG,"likely pathogenic, VUS",g.215827312T>C,g.215653970T>C,Val4711Glufs*6,-,USH2A_001080,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, effect on splicing predicted from minigene splicing assay","PubMed: Baux, Vaché 2017, PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs998302546,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
910,"+/+, +/., +?/.",3,65,c.14180G>A,r.(?),"p.(Trp4727*), p.(Trp4727Ter)",Fibronectin type-III 32 (4633-4730),ACMG,"likely pathogenic, pathogenic",g.215824097C>T,g.215650755C>T,-,-,USH2A_000898,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_S, Heterozygous","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015; PubMed: Perez-Carro, R. et al., 2018, 1 more item",-,rs397517989,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Eva Lenassi"
911,"+/+, +/.",3,65,c.14175G>A,r.(?),"p.(Trp4725*), p.(Trp4725Ter)",Fibronectin type-III 32 (4633-4730),ACMG,pathogenic,g.215824102C>T,g.215650760C>T,-,-,USH2A_000671,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation, Heterozygous; Pathogenic","PubMed: Bonnet 2016, PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,rs886042722,"Germline, SUMMARY record",-,-,-PflMI;-BslI;,-,-,"David Baux, Jose Maria Millan, Crystel Bonnet"
912,+?/.,3,65,c.14222C>T,r.(?),p.(Pro4741Leu),-,ACMG,likely pathogenic,g.215824055G>A,g.215650713G>A,"NM_206933.2:c.14222C>T, NP_996816.2:p.(Pro4741Leu), NC_000001.10:g.215824055G>A, 2 more items",-,USH2A_002136,compound heterozygous,"PubMed: Martin Merida 2019, PubMed: Wang 2018, PubMed: Zhu 2021",-,-,Germline,"?, yes",-,-,-,-,LOVD
913,"+/+, +/.",3,65,c.14248C>T,r.(?),"p.(Gln4750*), p.(Gln4750Ter)",Fibronectin type-III 33 (4732-4825),ACMG,pathogenic,g.215824029G>A,g.215650687G>A,"USH2A c.14248C>T, p.(Gln4750*)",-,USH2A_001048,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; mutation, homozygous","PubMed: Bonnet 2016, PubMed: Falsini 2021, 1 more item",-,rs727504867,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Crystel Bonnet"
914,"+?/., ?/.",3,65,c.14303A>C,"r.(14303a>c), r.(?)",p.(Tyr4768Ser),-,ACMG,"likely pathogenic, VUS",g.215823974T>G,g.215650632T>G,"USH2A c.14303A>C, p.(Tyr4768Ser)",-,USH2A_002105,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Janine Reurink"
915,"-/., -/?, -?/.",3,65,c.14315C>T,r.(?),p.(Ser4772Phe),Fibronectin type-III 33 (4732-4825),ACMG,"benign, likely benign",g.215823962G>A,g.215650620G>A,"USH2A(NM_206933.2):c.14315C>T (p.S4772F), USH2A(NM_206933.4):c.14315C>T (p.S4772F)",-,USH2A_000931,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Bujakowska 2014, USMA missense analysis, missense variant in MSV3d",-,rs149222801,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Anne-Françoise Roux"
916,"+?/., ?/.",3,66,c.14354G>T,r.(?),p.(Gly4785Val),-,ACMG,"likely pathogenic (recessive), VUS",g.215822098C>A,g.215648756C>A,"c.14354G>T, USH2A c.14354G>T, p.Gly4785Val",-,USH2A_002422,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,rs1326338026,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
917,"+?/., ?/.",3,66,c.14374C>T,r.(?),p.(Leu4792Phe),-,ACMG,"likely pathogenic (recessive), VUS",g.215822078G>A,g.215648736G>A,"c.14374C>T, USH2A c.14374C>T, p.Leu4792Phe",-,USH2A_002421,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Liu-2020, PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,-,"Germline, SUMMARY record, Unknown",?,-,-,-,-,David Baux
918,?/.,3,66,c.14408T>C,"r.(14408u>c), r.(?)",p.(Ile4803Thr),-,ACMG,VUS,g.215822044A>G,g.215648702A>G,USH2A(NM_206933.4):c.14408T>C (p.I4803T),-,USH2A_002703,"ACMG PM2, VKGL data sharing initiative Nederland","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Weisschuh 2024",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Johan den Dunnen, VKGL-NL_AMC, Janine Reurink"
919,"+?/., +?/?, ?/.",3,66,c.14450G>A,r.(?),p.(Gly4817Glu),Fibronectin type-III 33 (4732-4825),ACMG,"likely pathogenic, VUS",g.215822002C>T,g.215648660C>T,-,-,USH2A_001050,"ACMG GN005 criteria: PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Oishi 2014, 1 more item",-,rs527236125,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
920,"+?/., +?/?, ?/.",3,66,c.14570G>C,r.(?),p.(Gly4857Ala),Fibronectin type-III 34 (4826-4927),ACMG,"likely pathogenic, VUS",g.215821882C>G,g.215648540C>G,-,-,USH2A_001051,"ACMG GN005 criteria: PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, PubMed: Sharon 2019, 1 more item",-,rs749889050,"Germline, SUMMARY record",-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, David Baux, Crystel Bonnet"
921,+/?,3,66i,c.14582+39C>T,r.14582_14583ins14582+1_14582+37,p.Ser4861Argfs*,Fibronectin type-III 32 (4633-4730),ACMG,likely pathogenic,g.215821831G>A,g.215648489G>A,-,-,USH2A_000316,"Heterozygous; ins first 37 nt IVS66, Homozygous",PubMed: Le Guédard-Méreuze 2010,-,-,Germline,-,0/200 controls,-,-,-,Anne-Françoise Roux
922,"+/+, +/.",3,67,c.14667del,r.(?),"p.(Leu4890Trpfs*18), p.(Leu4890TrpfsTer18)",Fibronectin type-III 34 (4826-4927),ACMG,pathogenic,g.215820991del,g.215647649del,"14667delG, USH2A c.14667delG, p.(Leu4890Trpfs*18)",-,USH2A_000961,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Jiang 2015, PubMed: Jiang, L. et al., 2015, PubMed: Zhu 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Anne-Françoise Roux"
923,"+/., +?/., ?/.",3,-,c.14761G>T,r.(?),"p.(Glu4921*), p.(Glu4921Ter)",-,ACMG,"likely pathogenic, pathogenic, VUS",g.215820894C>A,g.215647552C>A,"USH2A, variant 1: c.11549-1G>A/p.?, variant 2: c.14761G>T/p.E4921*, 1 more item",-,USH2A_002367,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous, 1 more item","PubMed: Hull 2020, PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs754834155,"Germline, SUMMARY record","?, yes",-,-,-,-,David Baux
924,"+/., +?/.",3,-,c.14791+2T>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215820862A>T,g.215647520A>T,"USH2A c.14791+2T>A, p.(?), USH2A c.14791+2T>A, p.?",-,USH2A_002476,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous, 1 more item","PubMed: Dockery 2017, PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs1553250050,"Germline, SUMMARY record, Unknown","?, yes",-,-,-,-,David Baux
925,"+/+, +/., +?/.",3,67i,c.14791+2T>C,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.215820862A>G,g.215647520A>G,-,-,USH2A_001073,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016, 1 more item",-,rs1553250050,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet, Janine Reurink"
926,+/.,3,-,c.14835del,r.(?),"p.(Val4946Trpfs*4), p.(Val4946TrpfsTer4)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215814033del,g.215640691del,"14835delT, USH2A c.14835del, p.S4945fs*",-,USH2A_001795,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, ACMG PVS1, PM2, PM3_P, 1 more item","PubMed: Kim 2022, Journal: Kim 2022, PubMed: Lee 2020, PubMed: Lee, S. Y. et al., 2020",-,rs2102636076,"Germline, Germline/De novo (untested), SUMMARY record",yes,-,-,-,-,"David Baux, So Young Kim"
927,-/.,3,-,c.14960C>T,r.(?),p.(Ala4987Val),-,-,benign,g.215813908G>A,g.215640566G>A,"USH2A(NM_206933.2):c.14960C>T (p.A4987V), USH2A(NM_206933.4):c.14960C>T (p.A4987V)",-,USH2A_001130,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs111033498,"CLASSIFICATION record, Germline",-,2/1204 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC, Yoshito Koyanagi"
928,"+/., +?/.",3,69,c.15020C>T,r.(?),p.(Pro5007Leu),-,-,"likely pathogenic, pathogenic (recessive)",g.215812529G>A,g.215639187G>A,"USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.69 c.15020C>T p.(Pro5007Leu)",-,USH2A_001686,"compound heterozygous, VKGL data sharing initiative Nederland","PubMed: Martin Merida 2019, PubMed: Tiwari 2016",-,-,"CLASSIFICATION record, Germline, Germline/De novo (untested)",?,-,-,-,-,VKGL-NL_Nijmegen
929,"+?/?, ?/.",3,69,c.14996C>T,r.(?),p.(Thr4999Ile),Fibronectin type-III 35 (4928-5014),ACMG,VUS,g.215812553G>A,g.215639211G>A,-,-,USH2A_000516,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Bonnet, C. et al., 2016, 1 more item",-,rs1407860955,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
930,"+/+, +/.",3,70,c.15053-26_15298-708del,"r.?, r.spl",p.(Leu5019Valfs*77),-,-,pathogenic,g.215803086_215808072del,g.215629744_215634730del,"USH2A exon 70 deleted c.15053-26_15298-708del, p.(Leu5019Valfs*77)",-,USH2A_000800,Heterozygous; Pathogenic,"PubMed: Le Quesne Stabej 2012, PubMed: Steele-Stallard 2013",-,-,Germline,yes,-,-,-,-,Maria Bitner-Glindzicz
931,"+/+, +/.",3,69i,c.15053-1G>A,r.spl,p.?,-,ACMG,pathogenic,g.215808046C>T,g.215634704C>T,-,-,USH2A_000682,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Baux 2014, PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,+AluI;+HindIII;,-,-,"David Baux, Anne-Françoise Roux, Jose Maria Millan"
932,+/.,3,70,c.15286del,"r.(15286del), r.(?)","p.(Glu5096Lysfs*6), p.(Glu5096LysfsTer6)",-,ACMG,pathogenic,g.215807816del,g.215634474del,"15286delG, USH2A c.15286del, p.(Glu5096Lysfs*6)",-,USH2A_002104,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","Journal: Reurink 2021, PubMed: Reurink 2021, PubMed: Reurink, J. et al., 2021",-,rs1656408131,"Germline, SUMMARY record, Unknown","?, no",-,-,-,-,"David Baux, Janine Reurink"
933,?/.,3,71,c.15373C>T,r.(?),p.(Arg5125Cys),-,ACMG,VUS,g.215802302G>A,g.215628960G>A,"c.15373C>T, USH2A(NM_206933.2):c.15373C>T (p.R5125C)",-,USH2A_002417,"ACMG GN005 criteria: PM2_P, VKGL data sharing initiative Nederland","PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,rs771243585,"CLASSIFICATION record, Germline, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Rotterdam"
934,"+/+, +/.",3,71,c.15380del,r.(?),"p.(Pro5127Argfs*8), p.(Pro5127ArgfsTer8)",Cytoplasmic (5064-5202),ACMG,pathogenic,g.215802297del,g.215628955del,15380delC,-,USH2A_001055,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Homozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Mansard, L. et al., 2021",-,"rs1553248216, rs201513512","Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
935,"-/?, ?/.",3,71,c.15364T>C,r.(?),p.(Cys5122Arg),Cytoplasmic (5064-5202),ACMG,"likely benign, VUS",g.215802311A>G,g.215628969A>G,-,-,USH2A_000783,"ACMG GN005 criteria: BP4_P, Heterozygous; polymorphism, Heterozygous; Possibly pathogenic","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 2 more items",-,rs111033402,"Germline, SUMMARY record",-,-,+AflIII;+ApaLI;+BaeGI;-CviAII;-FatI;-NlaIII;,-,-,"David Baux, Anne-Françoise Roux, Crystel Bonnet"
936,-/-,3,71i,c.15520-19T>A,r.(=),p.(=),-,-,benign,g.215799231A>T,g.215625889A>T,-,-,USH2A_000370,Heterozygous,"PubMed: Aller 2004, PubMed: Aller 2006",-,-,Germline,-,-,-,-,-,Jose Maria Millan
937,"-/., -?/?",3,72,c.15522T>C,r.(?),"p.(=), p.(Tyr5174=)",-,ACMG,"benign, likely benign",g.215799210A>G,g.215625868A>G,-,-,USH2A_000243,"Heterozygous, Heterozygous; polymorphism, VKGL data sharing initiative Nederland","PubMed: Baux 2014, PubMed: McGee 2010",-,rs77792891,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
938,"+/., +?/.",3,-,c.15520-22_15524del,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215799208_215799234del,g.215625866_215625892del,"GPR98 c.15520-22_15524del, p.(?), USH2A c.15520-22_15524del, p.(?)",-,USH2A_002246,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous, 1 more item","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
939,"+/., +?/.",3,-,c.15575_15579del,r.(?),"p.(Lys5192Thrfs*48), p.(Lys5192ThrfsTer48)",-,ACMG,"likely pathogenic, pathogenic",g.215799154_215799158del,g.215625812_215625816del,"15575_15579delAGGAA, USH2A c.15575_15579delAGGAA, p.Lys5192ThrfxX?",-,USH2A_002497,"ACMG GN005 criteria: PVS1_M PM2_P PM3_M, heterozygous, homozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
940,-/-,3,72,c.*902T>C,r.(=),p.(=),3'UTR,-,benign,g.215798221A>G,g.215624879A>G,-,-,USH2A_000557,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs77919435,Germline,-,14/826 controls,-SspI,-,-,Maria Bitner-Glindzicz
941,-/-,3,72,c.*969G>A,r.(=),p.(=),3'UTR,-,benign,g.215798154C>T,g.215624812C>T,-,-,USH2A_000558,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs77634617,Germline,-,"6/840 controls, 6/842 controls",-BsmAI,-,-,Maria Bitner-Glindzicz
942,-/-,3,72,c.*1024C>T,r.(=),p.(=),3'UTR,-,benign,g.215798099G>A,g.215624757G>A,-,-,USH2A_000554,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs439940,Germline,-,-,+CviQI;-RsaI;-BsgI;-HpyCH4V;,-,-,Maria Bitner-Glindzicz
943,+?/.,2,-,c.(4627+1_4628-1)_(5857+1_5858-1),r.(?),p.(?),-,-,likely pathogenic,g.?,g.?,del Ex.22-29,-,NPHS2_000000,-,PubMed: Perez-Carro 2018,-,-,Germline,yes,-,-,-,-,LOVD
944,+?/.,2,42i,c.8559-2A >,r.(?),p.(?),-,-,likely pathogenic,g.216051224T>C,g.215877882T>C,USH2A c.8559-2A > ,-,USH2A_000003,"heterozygous, single heterozygous variant in a recessive gene",PubMed: He 2020,-,-,"Germline, Unknown",?,-,-,-,-,LOVD
945,+/.,2,22i,c.22+3A>G,r.spl?,p.(Gly9=),-,-,pathogenic,g.216595654C=,g.216422312C=,"USH2A c.22+3A>G, -",-,USH2A_002496,heterozygous,PubMed: Qu 2020,-,-,Germline,yes,-,-,-,-,LOVD
946,+/+,2,2,c.72T>G,r.(?),p.(Tyr24*),Signal peptide (1-31),-,pathogenic,g.216595607A>C,g.216422265A>C,-,-,USH2A_000734,Homozygous,PubMed: Baux 2014,-,-,Germline,-,-,+BfaI,-,-,Anne-Françoise Roux
947,"-/., -?/.",2,-,c.78T>C,r.(?),p.(Ala26=),-,-,"benign, likely benign",g.216595601A>G,g.216422259A>G,"USH2A(NM_206933.2):c.78T>C (p.A26=), USH2A(NM_206933.4):c.78T>C (p.A26=)",-,USH2A_001681,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
948,+/+,2,2,c.83del,r.(?),p.(Ile28Asnfs*3),Signal peptide (1-31),-,pathogenic,g.216595596del,g.216422254del,83delT,-,USH2A_000360,Homozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
949,+/+,2,2,c.98_99insT,r.(?),p.(Arg34Thrfs*41),-,-,pathogenic,g.216595580_216595581insA,g.216422238_216422239insA,-,-,USH2A_000004,Heterozygous,PubMed: Dai 2008,-,-,Germline,-,0/200 controls,-,-,-,Anne-Françoise Roux
950,+?/.,2,-,c.163C>T,r.(?),p.(Gln55*),-,-,likely pathogenic,g.216595516G>A,g.216422174G>A,"c.163C>T p.(Gln55*), c.2299del p.(Glu767Serfs*21), 1 more item",-,USH2A_002226,-,PubMed: Hagag 2020,-,-,Germline/De novo (untested),?,-,-,-,-,LOVD
951,"-?/., -?/?",2,2,c.188G>A,r.(?),p.(Arg63Gln),-,ACMG,likely benign,g.216595491C>T,g.216422149C>T,-,-,USH2A_000791,"ACMG GN005 criteria: BP4_P, Heterozygous; Mutation","PubMed: Yang 2013, USMA missense analysis, missense variant in MSV3d, PubMed: Yang, T. et al., 2013",-,rs369806765,"Germline, SUMMARY record",-,0/400 controls,-,-,-,"David Baux, Anne-Françoise Roux"
952,?/.,2,-,c.202C>T,r.(?),p.(His68Tyr),-,ACMG,VUS,g.216595477G>A,g.216422135G>A,"USH2A c.202C>T, p.H68Y",-,USH2A_001780,-,"PubMed: Kim 2019, PubMed: Kim 2019",-,-,Germline,?,1/86 cases,-,-,-,"Global Variome, with Curator vacancy"
953,?/.,2,2,c.236-239dup,r.(?),p.?,-,-,VUS,g.216595682dup,-,c.236-239Dup,-,USH2A_002459,-,PubMed: Khalaileh-2018,-,-,Unknown,-,-,-,-,-,LOVD
954,+/.,2,-,c.252T>A,r.(?),"p.(Cys84*), p.(Cys84Ter)",-,ACMG,pathogenic,g.216595427A>T,g.216422085A>T,"USH2A c.252T>A, p.Cys84*",-,USH2A_002601,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
955,"+?/., ?/.",2,-,c.274T>G,r.(?),p.(Ser92Ala),-,ACMG,"likely pathogenic, VUS",g.216595405A>C,g.216422063A>C,"USH2A c.274T>G, p.S92A",-,USH2A_002357,"ACMG GN005 criteria: PM2_P BP4_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs192918169,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
956,+/.,2,2,c.377del,r.(?),p.(Ser126Ilefs*19),-,ACMG,"pathogenic, pathogenic (recessive)",g.216595302del,g.216421960del,"377delG, c.377delG",-,USH2A_001450,-,"PubMed: Sharon 2015, PubMed: Beryozkin 2015, PubMed: Sharon 2019, PubMed: Sharon 2019",-,-,Germline,-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Dror Sharon"
957,"-/., -?/.",2,-,c.432G>A,r.(?),p.(Leu144=),-,-,"benign, likely benign",g.216595247C>T,g.216421905C>T,"USH2A(NM_206933.2):c.432G>A (p.L144=), USH2A(NM_206933.4):c.432G>A (p.L144=)",-,USH2A_001290,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
958,-?/.,2,-,c.441A>T,r.(?),p.(Ser147=),-,-,likely benign,g.216595238T>A,g.216421896T>A,"USH2A(NM_206933.2):c.441A>T (p.S147=), USH2A(NM_206933.4):c.441A>T (p.S147=)",-,USH2A_001289,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
959,"+?/., ?/.",2,-,c.457T>A,r.(?),p.(Trp153Arg),-,ACMG,"likely pathogenic, VUS",g.216595222A>T,g.216421880A>T,"USH2A c.457T>A, p.W153R",-,USH2A_002355,"ACMG GN005 criteria: PM2_P PP3_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022, PubMed: Jauregui 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
960,"+/., +?/.",2,2,c.475C>T,r.(?),"p.(Gln159*), p.(Gln159Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216595204G>A,g.216421862G>A,"USH2A c.475C>T, p.(Gln159*)",-,USH2A_002237,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,rs1558081965,"Germline/De novo (untested), SUMMARY record",?,-,-,-,-,David Baux
961,-?/.,2,-,c.486-15C>T,r.(=),p.(=),-,-,likely benign,g.216592036G>A,g.216418694G>A,USH2A(NM_206933.4):c.486-15C>T,-,USH2A_001287,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
962,"+/+, +?/.",2,02i,c.486-2A>C,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.216592023T>G,g.216418681T>G,-,-,USH2A_001056,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
963,"+/., ?/.",2,2i,c.486-1G>A,"r.spl, r.spl?",p.?,-,-,"pathogenic, VUS",g.216592022C>T,g.216418680C>T,c.486-1G>A,-,USH2A_001112,-,PubMed: Wang-2014,-,-,Unknown,-,-,-,-,-,Feng Wang
964,?/.,2,-,c.503C>T,r.(?),p.(Thr168Ile),-,ACMG,VUS,g.216592004G>A,g.216418662G>A,"USH2A c.503C>T, p.Thr168Ile",-,USH2A_002599,"ACMG GN005 criteria: PM2_P PM3_P BP4_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs754523763,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
965,?/.,2,3,c.510T>A,r.(?),p.(Asp170Glu),-,ACMG,VUS,g.216591997A>T,g.216418655A>T,"USH2A c.510T>A, p.Asp170Glu",-,USH2A_002598,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
966,+/+,2,3,c.532dup,r.(=),p.(Thr178Asnfs*4),Laminin EGF-like 1 (518-574),-,pathogenic,g.216591975dup,g.216418633dup,532dupA,-,USH2A_000871,Homozygous; mutation,PubMed: Reddy 2014,-,-,Germline,-,-,-,-,-,Rima Slim
967,+/.,2,3,c.545_548delAAGA,r.(?),p.(Lys182Argfs*9),-,-,pathogenic,g.216591962_216591965del,g.216418620_216418623del,c.545_548delAAGA,-,USH2A_001962,-,PubMed: Bernardis 2016,-,-,Germline,-,-,-,-,-,LOVD
968,"+?/?, ?/.",2,3,c.562T>A,r.(?),p.(Tyr188Asn),-,ACMG,VUS,g.216591945A>T,g.216418603A>T,-,-,USH2A_000980,"ACMG GN005 criteria: PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
969,"+?/., ?/.",2,-,c.563A>G,r.(?),p.(Tyr188Cys),-,ACMG,"likely pathogenic (recessive), VUS",g.216591944T>C,g.216418602T>C,-,-,USH2A_001890,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Eandi 2017, PubMed: Eandi, C. M. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
970,"+/+, +?/.",2,3,c.612dup,r.(?),p.(Arg205Glufs*11),-,-,"likely pathogenic, pathogenic",g.216591898dup,g.216418556dup,"c.612dup, p.Arg205GlufsTer11",-,USH2A_000008,Heterozygous,"PubMed: Ebermann 2009, PubMed: Zampaglione 2020",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
971,"+/+, +?/.",2,3,c.633G>A,r.(?),"p.(Trp211*), p.(Trp211Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216591874C>T,g.216418532C>T,-,-,USH2A_000885,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
972,+/.,2,-,c.(651+1_652-1)_(2809+1_28010-1)dup,r.spl,p.?,-,-,pathogenic,g.?,g.?,"USH2A exons 4–13 duplicated, p",-,NPHS2_000000,-,PubMed: Steele-Stallard 2013,-,-,Germline,yes,-,-,-,-,LOVD
973,?/.,2,4,c.656A>C,r.(?),p.(His219Pro),-,ACMG,VUS,g.216538423T>G,g.216365081T>G,"USH2A c.656A>C, p.(His219Pro)",-,USH2A_002236,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
974,"+?/., ?/.",2,-,c.668T>C,r.(?),p.(Ile223Thr),-,ACMG,"likely pathogenic, VUS",g.216538411A>G,g.216365069A>G,"USH2A, variant 1: c.668T>C/p.I223T, variant 2: c.1986T>A/p.C662*",-,USH2A_002409,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2038569132,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
975,+/+,2,1-Apr,c.672_1840+1160del,r.spl,p.?,Laminin N-terminal (271-517);Laminin EGF-like 1 (518-574);Laminin EGF-like 2 (575-640),-,pathogenic,g.216464359_216538409del,g.216291017_216365067del,hg19:chr1:g.216464357_216538407del,-,USH2A_000903,Heterozygous,"PubMed: Dad 2015, PubMed: Dad 2016",-,-,Germline,-,-,-,-,-,Shzeena Dad
976,+?/.,2,4,c.768A>G,r.(?),p.(Ile256Met),-,ACMG,likely pathogenic,g.216538311T>C,g.216364969T>C,"USH2A c.768A>G, p.I256M",-,USH2A_002696,-,PubMed: Zhu 2021,-,-,Unknown,?,-,-,-,-,LOVD
977,+/+,2,4,c.779T>G,r.(?),p.(Leu260*),-,-,pathogenic,g.216538300A>C,g.216364958A>C,-,-,USH2A_000167,"Heterozygous, Heterozygous; Pathogenic","PubMed: Malm 2010, PubMed: Weston 2000",-,rs121912598,Germline,-,-,-DraI;-MseI;,-,-,Anne-Françoise Roux
978,-/-,2,04i,c.784+18G>A,r.(=),p.(=),-,-,benign,g.216538277C>T,g.216364935C>T,-,-,USH2A_000106,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
979,"+/., +?/.",2,4i,c.784+14389G>T,"r.(784_785ins[784+14397_784+14493]), r.784_785ins[784+14397_784+14493]","p.(Gly262Aspfs*26), p.Gly262Aspfs*26",-,ACMG,pathogenic (recessive),g.216523906C>A,g.216350564C>A,-,-,USH2A_002001,-,"PubMed: Ben Yosef 2023, PubMed: Fadaie 2021",-,-,"Germline, Unknown",yes,-,-,-,-,"Zeinab Fadaie, Tamar Ben-Yosef"
980,+?/?,2,5,c.838C>T,r.(?),p.(Leu280Phe),Laminin N-terminal (271-517),ACMG,VUS,g.216500943G>A,g.216327601G>A,-,-,USH2A_000119,Heterozygous,"PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
981,+/.,2,-,c.848+1G>C,"r.(?), r.spl","p.(?), p.?",-,ACMG,pathogenic,g.216500932C>G,g.216327590C>G,-,-,USH2A_002352,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
982,"+/+, +/.",2,6,c.859G>T,r.(?),"p.(Glu287*), p.(Glu287Ter)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216498931C>A,g.216325589C>A,-,-,USH2A_000983,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
983,"+?/., -/-",2,6,c.907C>T,r.(?),p.(Arg303Cys),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216498883G>A,g.216325541G>A,-,-,USH2A_000488,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-BceAI,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
984,"+?/., ?/.",2,-,c.953A>G,r.(?),p.(Tyr318Cys),-,ACMG,"likely pathogenic (recessive), VUS",g.216498837T>C,g.216325495T>C,-,-,USH2A_001714,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Karali 2019, Journal: Karali 2019, PubMed: Karali, M. et al., 2019",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi"
985,"+/., +?/.",2,-,c.944_951dup,r.(?),"p. (Cys318Hisfs*21), p.(Tyr318HisfsTer21)",-,ACMG,"likely pathogenic, pathogenic",g.216498841_216498848dup,g.216325499_216325506dup,-,-,USH2A_002156,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Perez-Carro 2018, PubMed: Perez-Carro, R. et al., 2018",-,-,"Germline, SUMMARY record",?,-,-,-,-,David Baux
986,+/+,2,6,c.944_952dup,r.(?),p.(Tyr318Hisfs*21),Laminin N-terminal (271-517),-,pathogenic,g.216498838_216498846dup,g.216325496_216325504dup,-,-,USH2A_000198,Heterozygous,PubMed: Bernal 2005,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
987,?/.,2,-,c.1000C>G,r.(?),p.(Arg334Gly),-,-,VUS,g.216498790G>C,g.216325448G>C,"USH2A allele 1: Exon 63-64 deletion, genomic coordinates not determined, allele 2: p.Arg334GlyMS, 1 more item",-,USH2A_002596,VKGL data sharing initiative Nederland,PubMed: Austin-Tse 2018,SCV000065359,-,"CLASSIFICATION record, Germline",yes,-,-,-,-,VKGL-NL_AMC
988,"+/., +?/.",2,6,c.1004T>A,r.(?),"p.(Leu335*), p.(Leu335Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216498786A>T,g.216325444A>T,"USH2A c.1004T>A, p.L335X",-,USH2A_002595,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
989,"+?/?, ?/.",2,6,c.1018C>G,r.(?),p.(His340Asp),Laminin N-terminal (271-517),ACMG,VUS,g.216498772G>C,g.216325430G>C,-,-,USH2A_000984,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs753579610,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
990,"+?/?, ?/.",2,6,c.1019A>T,r.(?),p.(His340Leu),Laminin N-terminal (271-517),ACMG,VUS,g.216498771T>A,g.216325429T>A,-,-,USH2A_000615,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; UV3","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,0/878 controls,+HpyAV;+XmnI;-BtsCI;-BccI;-FokI;,-,-,"David Baux, Maria Bitner-Glindzicz"
991,+/.,2,-,c.1031_1032del,r.(?),"p.(Phe344Cysfs*3), p.(Phe344CysfsTer3)",-,ACMG,pathogenic,g.216498760_216498761del,g.216325418_216325419del,"USH2A c.1031_1032del, p.(Phe344Cysfs*3)",-,USH2A_002694,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
992,"+/., ?/.",2,-,c.1039G>C,r.(?),p.(Asp347His),-,ACMG,"pathogenic, VUS",g.216498751C>G,g.216325409C>G,-,-,USH2A_002036,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,rs772317024,"Germline, SUMMARY record",-,-,-,-,-,David Baux
993,"+/+, +/.",2,6,c.1111_1112del,r.(?),"p.(Ile371Phefs*3), p.(Ile371PhefsTer3)",Laminin N-terminal (271-517),ACMG,pathogenic,g.216498679_216498680del,g.216325337_216325338del,"1110_1111delTA, 1111_1112delAT",-,USH2A_000386,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Molina-Ramirez, L. P. et al., 2020, PubMed: Sandberg 2008",-,rs1366496013,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
994,?/.,2,6,c.1143G>C,r.(?),p.(Gln381His),-,ACMG,VUS,g.216498647C>G,g.216325305C>G,"USH2A c.1143G>C, p.(Gln381His)",-,USH2A_002235,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,rs760918807,"Germline/De novo (untested), SUMMARY record",?,-,-,-,-,David Baux
995,"+/., +?/.",2,-,c.1143+1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216498646C>T,g.216325304C>T,"USH2A, variant 1: c.1143+1G>A/p.?, variant 2: c.2276G>T/p.C759F",-,USH2A_002408,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs397517974,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
996,+?/.,2,-,c.1143+2T>C,r.spl,"p.(?), p.?",-,ACMG,likely pathogenic,g.216498645A>G,g.216325303A>G,"USH2A c.1143+2T>C, -",-,USH2A_002594,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs2102655666,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
997,"+?/., +?/?",2,7,c.1144G>A,r.(?),p.(Val382Met),Laminin N-terminal (271-517),ACMG,"likely pathogenic, VUS",g.216497694C>T,g.216324352C>T,"USH2A c.1144G>A, p.V382M",-,USH2A_000684,Heterozygous; UV3,"PubMed: Garcia-Garcia 2011, USMA missense analysis, missense variant in MSV3d, PubMed: Zhu 2021",-,-,"Germline, Unknown",?,0/200 controls,+Hpy188I;-BslI;,-,-,Jose Maria Millan
998,"+?/?, ?/.",2,7,c.1225T>C,r.(?),p.(Trp409Arg),Laminin N-terminal (271-517),ACMG,VUS,g.216497613A>G,g.216324271A>G,-,-,USH2A_000888,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs2037682266,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
999,"+?/., ?/.",2,-,c.1246G>A,r.(?),p.(Ala416Thr),-,ACMG,"likely pathogenic, VUS",g.216497592C>T,g.216324250C>T,"USH2A c.1246G>A, p.A416T",-,USH2A_002347,"ACMG GN005 criteria: PM2_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs187897763,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1000,"+/., +?/.",2,7,c.1267G>T,"r.(1267g>u), r.(?)","p.(Gly423*), p.(Gly423Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216497571C>A,g.216324229C>A,-,-,USH2A_001549,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Reurink 2023, Journal: Reurink 2023",-,-,Germline,-,1/1204 cases with retinitis pigmentosa,-,-,-,"Yoshito Koyanagi, Janine Reurink"
1001,"+/., +?/.",2,-,c.1271del,r.(?),"p.(Met424Argfs*34), p.(Met424ArgfsTer34)",-,ACMG,"likely pathogenic, pathogenic",g.216497567del,g.216324225del,1271delT,-,USH2A_002035,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1002,"+/+, +/.",2,07i,c.1328+1G>T,r.spl,p.?,-,ACMG,pathogenic,g.216497509C>A,g.216324167C>A,-,-,USH2A_000669,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,+Tsp509I,-,-,"David Baux, Jose Maria Millan"
1003,-/-,2,07i,c.1328+35del,r.(=),p.(=),-,-,benign,g.216497475del,g.216324133del,1328+35delT,-,USH2A_000375,Heterozygous,"PubMed: Garcia-Garcia 2011, PubMed: Vaché 2012",-,-,Germline,-,-,none,-,-,Jose Maria Millan
1004,-/-,2,07i,c.1328+52T>C,r.(=),p.(=),-,-,benign,g.216497458A>G,g.216324116A>G,-,-,USH2A_000687,Homozygous; Neutral,PubMed: Garcia-Garcia 2011,-,rs115517730,Germline,-,-,+HpyCH4IV;-BsrGI;,-,-,Jose Maria Millan
1005,"+?/., ?/.",2,-,c.1346G>T,r.(?),p.(Arg449Leu),-,ACMG,"likely pathogenic (recessive), VUS",g.216497020C>A,g.216323678C>A,-,-,USH2A_001879,ACMG GN005 criteria: PM2_P PM3_P BP4_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs766715882,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1006,"+/., +?/.",2,-,c.1416_1441del,r.(?),p.(Asn472LysfsTer17),-,ACMG,"likely pathogenic, pathogenic","g.216496925_216496950del, g.216496928_216496953del",g.216323586_216323611del,-,-,USH2A_002346,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1571701243,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1007,"+/., +?/.",2,-,c.1450C>T,r.(?),p.(Gln484Ter),-,ACMG,"likely pathogenic, pathogenic",g.216496916G>A,g.216323574G>A,-,-,USH2A_002345,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Kim, Y. N. et al., 2021; PubMed: Mansard, L. et al., 2021, PubMed: Mansard et al, 2021",-,rs766370703,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1008,-?/.,2,-,c.1530C>T,r.(?),p.(Asp510=),-,-,likely benign,g.216496836G>A,-,"USH2A(NM_206933.2):c.1530C>T (p.D510=), USH2A(NM_206933.4):c.1530C>T (p.D510=)",-,USH2A_001750,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1009,"+?/?, ?/.",2,8,c.1546G>A,r.(?),p.(Gly516Arg),Laminin N-terminal (271-517),ACMG,VUS,g.216496820C>T,g.216323478C>T,-,-,USH2A_000987,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1010,-/-,2,08i,c.1551-82T>C,r.(=),p.(=),-,-,benign,g.216495400A>G,g.216322058A>G,-,-,USH2A_000810,Homozygous,PubMed: Baux 2014,-,rs2089947,Germline,-,-,-,-,-,Anne-Françoise Roux
1011,+/.,2,9i,c.1551-27A>G,r.spl?,p.(?),-,ACMG,pathogenic,g.216495345T>C,g.216322003T>C,USH2A c.1551-27A>G,-,USH2A_002692,-,PubMed: Zhu 2021,-,-,Germline,yes,-,-,-,-,LOVD
1012,?/.,2,8i,c.1551-5T>G,"r.spl, r.spl?",p.?,-,ACMG,VUS,g.216495323A>C,g.216321981A>C,c.1551-5T>G,-,USH2A_002457,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,rs770011395,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1013,?/.,2,-,c.1556A>G,r.(?),p.(Gln519Arg),-,-,VUS,g.216495313T>C,g.216321971T>C,USH2A(NM_206933.2):c.1556A>G (p.Q519R),-,USH2A_001273,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
1014,"+/., ?/.",2,-,c.1558del,r.(?),"p.(Cys520Alafs*71), p.(Cys520AlafsTer71)",-,ACMG,"pathogenic, VUS",g.216495311del,g.216321969del,1558delT,-,USH2A_001983,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Ellingford 2016, PubMed: Molina-Ramirez, L. P. et al., 2020",-,rs878853410,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1015,?/.,2,-,c.1582G>A,r.(?),p.(Asp528Asn),-,-,VUS,g.216495287C>T,g.216321945C>T,USH2A(NM_206933.2):c.1582G>A (p.D528N),-,USH2A_001272,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
1016,"+/+, +/.",2,9,c.1603_1606dup,r.(?),"p.(Cys536*), p.(Cys536Ter)",Laminin EGF-like 1 (518-574),ACMG,pathogenic,g.216495265_216495268dup,g.216321923_216321926dup,1603_1606dupAGAT,-,USH2A_000988,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1017,+/.,2,-,c.1608C>A,r.(?),p.(Cys536Ter),-,ACMG,pathogenic,g.216495261G>T,g.216321919G>T,-,-,USH2A_002341,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1018,?/.,2,-,c.1612T>C,r.(?),p.(Cys538Arg),-,ACMG,VUS,g.216495257A>G,g.216321915A>G,-,-,USH2A_002340,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1019,"+/+, +/.",2,9,c.1629_1644del,r.(?),"p.(Thr544Valfs*42), p.(Thr544ValfsTer42)",Laminin EGF-like 1 (518-574),ACMG,pathogenic,g.216495226_216495241del,g.216321884_216321899del,1629_1645del p.(Phe543leufs*2),-,USH2A_000661,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Jose Maria Millan"
1020,+/.,2,-,c.1645-1G>C,r.spl,p.?,-,ACMG,"pathogenic, pathogenic (recessive)",g.216465713C>G,g.216292371C>G,-,-,USH2A_001878,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1021,+?/.,2,"9i_14i, _10_14_",c.(1644+1_1645-1)_(2993+1_2994-1)del,"r.(?), r.?","p.(Cys549Metfs*5), p.?",-,-,likely pathogenic,"g.(216390893_216405294)_(216465713_216495224)del, g.?",g.?,"del ex10-14, USH2A Exon 10 to 14 del, p.(Cys549Metfs5)",-,"NPHS2_000000, USH2A_002364",protein change probably extrapolated in the paper; heterozygous,"PubMed: Ellingsford 2018, PubMed: Molina-Ramirez 2020",-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
1022,?/.,2,-,c.1651C>T,r.(?),p.(Arg551Cys),-,ACMG,VUS,g.216465706G>A,g.216292364G>A,USH2A(NM_206933.2):c.1651C>T (p.R551C),-,USH2A_001670,"ACMG PM2, VKGL data sharing initiative Nederland",PubMed: Weisschuh 2024,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Johan den Dunnen, VKGL-NL_Rotterdam"
1023,"+?/?, ?/.",2,10,c.1655G>C,r.(?),p.(Cys552Ser),Laminin EGF-like 1 (518-574),ACMG,VUS,g.216465702C>G,g.216292360C>G,-,-,USH2A_000934,"Heterozygous; UV3, VKGL data sharing initiative Nederland","PubMed: Lenarduzzi 2015, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
1024,"+/., ?/.",2,-,c.1723T>A,r.(?),p.(Cys575Ser),-,ACMG,"pathogenic (recessive), VUS",g.216465634A>T,g.216292292A>T,-,-,USH2A_001877,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1025,+?/.,2,-,c.1752C>A,r.(?),"p.(Cys584*), p.(Cys584Ter)",-,ACMG,likely pathogenic,g.216465605G>T,g.216292263G>T,-,-,USH2A_002034,ACMG GN005 criteria: PVS1_VS PM2_P2,"PubMed: Neuhaus 2017, PubMed: Wheeldon, N. M. et al., 1996",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1026,?/.,2,-,c.1757A>C,r.(?),p.(Tyr586Ser),-,ACMG,VUS,g.216465600T>G,g.216292258T>G,"USH2A c.1757A>C, p.Tyr586Ser",-,USH2A_002591,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1027,?/.,2,10,c.1772A>G,r.(?),p.(Asp591Gly),-,-,VUS,g.216465585T>C,g.216292243T>C,-,-,USH2A_001117,-,"PubMed: Zazo Seco 2017, Journal: Zazo Seco 2017",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Mieke Wesdorp, MobiDetails"
1028,"+?/., ?/.",2,10,c.1837A>G,r.(?),p.(Thr613Ala),-,-,"likely pathogenic, VUS",g.216465520T>C,g.216292178T>C,"A1837G, 1 more item",-,USH2A_002098,compound heterozygous,"PubMed: Katagiri 2014, PubMed: Martin Merida 2019",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1029,+?/?,2,11,c.1859G>A,r.(?),p.(Cys620Tyr),Laminin EGF-like 2 (575-640),ACMG,VUS,g.216462734C>T,g.216289392C>T,-,-,USH2A_000517,Homozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,+CviQI;+BsrGI;+RsaI;-HpyCH4V;,-,-,Anne-Françoise Roux
1030,"+?/., ?/.",2,11,c.1891G>C,r.(?),p.(Asp631His),-,ACMG,"likely pathogenic (recessive), VUS",g.216462702C>G,g.216289360C>G,c.1891G>C,-,USH2A_002452,ACMG GN005 criteria: PM2_P,"PubMed: Colombo, L. et al., 2022, PubMed: Colombo-2020",-,rs552400144,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1031,+?/?,2,11,c.1913G>T,r.(?),p.(Cys638Phe),Laminin EGF-like 2 (575-640),ACMG,VUS,g.216462680C>A,g.216289338C>A,-,-,USH2A_000691,Homozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-HpyCH4V,-,-,Anne-Françoise Roux
1032,"+/., +?/.",2,-,c.1923T>A,r.(?),"p.(Cys641*), p.(Cys641Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216462670A>T,g.216289328A>T,"USH2A c.1923T>A, p.(Cys641*)",-,USH2A_002689,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs2036952419,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1033,"-/., -?/.",2,-,c.1935A>T,r.(?),p.(Thr645=),-,-,"benign, likely benign",g.216462658T>A,g.216289316T>A,"USH2A(NM_206933.2):c.1935A>T (p.T645=), USH2A(NM_206933.4):c.1935A>T (p.T645=)",-,USH2A_001269,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1034,"+/., ?/.",2,-,c.1965T>G,r.(?),p.(Cys655Trp),-,-,"pathogenic, VUS",g.216462628A>C,g.216289286A>C,-,-,USH2A_001411,VKGL data sharing initiative Nederland,PubMed: Haer-Wigman 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1035,-/?,2,11i,c.1971+85G>A,r.(=),p.(=),-,ACMG,likely benign,g.216462537C>T,g.216289195C>T,-,-,USH2A_000563,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs12123574,Germline,-,-,-BbsI;-MboII;,-,-,Maria Bitner-Glindzicz
1036,+?/.,2,-,c.1986T>A,r.(?),"p.(Cys662*), p.(Cys662Ter)",-,ACMG,likely pathogenic,g.216424426A>T,g.216251084A>T,"USH2A, variant 1: c.668T>C/p.I223T, variant 2: c.1986T>A/p.C662*",-,USH2A_002405,"ACMG GN005 criteria: PVS1_VS PM2_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2036152207,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1037,"+?/., ?/.",2,12,c.1991G>T,r.(?),p.(Cys664Phe),-,ACMG,"likely pathogenic (recessive), VUS",g.216424421C>A,g.216251079C>A,c.1991G>T,-,USH2A_002451,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1038,"+/+, +/.",2,12,c.1992dup,r.(?),"p.(Lys665*), p.(Lys665Ter)",Laminin EGF-like 3 (641-693),ACMG,pathogenic,g.216424420dup,g.216251078dup,"1992dupT, 1992_1993insT",-,USH2A_000795,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Mutation","PubMed: Yang 2013, PubMed: Yang, T. et al., 2013",-,rs730880349,"Germline, SUMMARY record",-,0/400 controls,-,-,-,"David Baux, Anne-Françoise Roux"
1039,-?/.,2,-,c.2001C>T,r.(?),p.(His667=),-,-,likely benign,g.216424411G>A,g.216251069G>A,"USH2A(NM_206933.2):c.2001C>T (p.H667=), USH2A(NM_206933.4):c.2001C>T (p.H667=)",-,USH2A_001268,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1040,+/.,2,12,c.2014C>T,r.(?),"p.(Gln672*), p.(Gln672Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216424398G>A,g.216251056G>A,-,-,USH2A_002068,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1041,?/.,2,12,c.2017T>A,r.(?),p.(Cys673Ser),-,ACMG,VUS,g.216424395A>T,g.216251053A>T,"USH2A c.2017T>A, p.(Cys673Ser)",-,USH2A_002234,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, homozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,-,"Germline, SUMMARY record",?,-,-,-,-,David Baux
1042,"+?/?, ?/.",2,12,c.2072G>A,r.(?),p.(Cys691Tyr),Laminin EGF-like 3 (641-693),ACMG,VUS,g.216424340C>T,g.216250998C>T,-,-,USH2A_000151,"ACMG PM2, Heterozygous","PubMed: Nakanishi 2009, USMA missense analysis, missense variant in MSV3d, PubMed: Weisschuh 2024",-,-,Germline,-,0/270 controls,-,-,-,"Johan den Dunnen, Anne-Françoise Roux"
1043,"+?/., ?/.",2,-,c.2080T>A,r.(?),p.(Cys694Ser),-,ACMG,"likely pathogenic, VUS",g.216424332A>T,g.216250990A>T,"USH2A, variant 1: c.2080T>A/p.C694S, variant 2: c.6835G>T/p.D2279Y",-,USH2A_002404,"ACMG GN005 criteria: PM2_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2036149054,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1044,?/.,2,-,c.2149T>A,r.(?),p.(Cys717Ser),-,ACMG,VUS,g.216424263A>T,g.216250921A>T,-,-,USH2A_002337,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1304016981,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1045,"+/., +?/.",2,-,c.2167+1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216424244C>T,g.216250902C>T,"USH2A c.2167+1G>A, -",-,USH2A_002587,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs2102551610,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1046,"+/., +?/.",2,12i,c.2168-2A>G,"r.spl, r.spl?",p.?,-,ACMG,"likely pathogenic, pathogenic",g.216420570T>C,g.216247228T>C,c.2168-2A>G,-,USH2A_002491,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs993185407,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1047,"+?/., ?/.",2,-,c.2231G>A,r.(?),p.(Cys744Tyr),-,ACMG,"likely pathogenic, VUS",g.216420505C>T,g.216247163C>T,"USH2A, variant 1: c.2231G>A/p.C744Y, variant 2: c.13804T>C/p.F4602L",-,USH2A_002403,"ACMG GN005 criteria: PM2_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs751035557,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1048,"+?/?, ?/.",2,13,c.2236C>G,r.(?),p.(Pro746Ala),Laminin EGF-like 4 (694-746),ACMG,VUS,g.216420500G>C,g.216247158G>C,-,-,USH2A_000590,"ACMG GN005 criteria: PM2_P, Heterozygous; UV4","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs2036068018,"Germline, SUMMARY record",-,-,+MnlI;+PhoI;+HaeIII;+StuI;-,-,-,"David Baux, Maria Bitner-Glindzicz"
1049,?/.,2,-,c.2291G>T,r.(?),p.(Gly764Val),-,-,VUS,g.216420445C>A,g.216247103C>A,USH2A(NM_206933.2):c.2291G>T (p.G764V),-,USH2A_001709,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
1050,"+/., +?/.",2,-,c.2310dup,r.(?),"p.(Glu771Argfs*8), p.(Glu771ArgfsTer8)",-,ACMG,"likely pathogenic, pathogenic",g.216420431dup,g.216247089dup,"2310dupA, USH2A c.2310_2311insA, p.Glu771Argfs8",-,USH2A_002586,"ACMG GN005 criteria: PVS1_VS PS4_P PP1_S, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs2036065933,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1051,?/.,2,13,c.2344del,r.(?),p.(Glu782Lysfs*6),-,-,VUS,g.216420392del,-,1bpdel codon 782,-,USH2A_002177,unknown variant 2nd chromosome,PubMed: Mezer-2006,-,-,Germline,-,-,-,-,-,LOVD
1052,"+/., +?/.",2,-,c.2363del,r.(?),"p.(Asp788Valfs*68), p.(Asp788ValfsTer68)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216420373del,g.216247031del,"2363delA, c.2363delA",-,USH2A_001876,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1053,"+?/., ?/.",2,13,c.2435C>T,r.(?),p.(Thr812Ile),-,ACMG,"likely pathogenic, VUS",g.216420301G>A,g.216246959G>A,c.2435C>T,-,USH2A_002449,ACMG GN005 criteria: PM2_P PM3_M,"PubMed: Colombo, L. et al., 2022, PubMed: Colombo-2020",-,rs768560709,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1054,+/+,2,13,c.2440C>T,r.(?),p.(Gln814*),Laminin EGF-like 6 (795-846),-,pathogenic,g.216420296G>A,g.216246954G>A,-,-,USH2A_000866,Heterozygous; damaging,PubMed: Vona 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1055,"+?/., ?/.",2,-,c.2444G>C,r.(?),p.(Cys815Ser),-,ACMG,"likely pathogenic, VUS",g.216420292C>G,g.216246950C>G,"USH2A, variant 1 :[c.4946G>A/p.G1649E; c.4949G>C/p.G1650A], variant 2: c.2444G>C/p.C815S",-,USH2A_002402,"ACMG GN005 criteria: PM2_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1558341842,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1056,+/.,2,-,c.2484del,r.(?),"p.(Lys828Asnfs*28), p.(Lys828AsnfsTer28)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216420254del,g.216246912del,"2484delA, c.2484delA",-,USH2A_001874,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1057,+/.,2,13,c.2512C>T,r.(?),"p.(Gln838*), p.(Gln838Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216420224G>A,g.216246882G>A,-,-,USH2A_002074,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1058,"+/+, +/.",2,13,c.2541C>A,r.(?),p.(Cys847*),Laminin EGF-like 7 (847-899),-,pathogenic,g.216420195G>T,g.216246853G>T,-,-,USH2A_000202,"3 heterozygous, no homozygous; Clinindb (India), Heterozygous","PubMed: Narang 2020, Journal: Narang 2020, PubMed: Weston 2000",-,rs727503736,Germline,-,3/2795 individuals,-,-,-,"Anne-Françoise Roux, Mohammed Faruq"
1059,"+?/., ?/.",2,-,c.2609G>T,r.(?),p.(Cys870Phe),-,ACMG,"likely pathogenic, VUS",g.216420127C>A,g.216246785C>A,"USH2A c.2609G>T, p.(Cys870Phe)",-,USH2A_002686,"ACMG GN005 criteria: PM2_P PP3_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs755752768,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1060,"+?/., ?/.",2,13,c.2750G>A,r.(?),p.(Ser917Asn),-,-,"likely pathogenic (recessive), VUS",g.216419986C>T,-,"c.2750G>A, USH2A(NM_206933.4):c.2750G>A (p.S917N)",-,USH2A_001260,VKGL data sharing initiative Nederland,PubMed: Liu-2020,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_VUmc
1061,"+/., +?/.",2,-,c.2855C>G,r.(?),"p.(Ser952*), p.(Ser952Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216405433G>C,g.216232091G>C,"USH2A c.2855C>G, p.Ser952*",-,USH2A_002584,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1062,"+/+, +/.",2,14,c.2859C>A,r.(?),"p.(Cys953*), p.(Cys953Ter)",Laminin EGF-like 9 (951-1001),ACMG,pathogenic,g.216405429G>T,g.216232087G>T,-,-,USH2A_000991,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1063,-?/.,2,14,c.2920G>A,"r.(2920g>a), r.(?)",p.(Asp974Asn),-,ACMG,likely benign,g.216405368C>T,g.216232026C>T,USH2A(NM_206933.2):c.2920G>A (p.D974N),-,USH2A_001656,"no variant 2nd chromome, VKGL data sharing initiative Nederland","PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, Janine Reurink"
1064,"+/+, +/.",2,14,c.2944dup,r.(?),"p.(Cys982Leufs*2), p.(Cys982LeufsTer2)",Laminin EGF-like 9 (951-1001),ACMG,pathogenic,g.216405345dup,g.216232003dup,2944dupT,-,USH2A_000576,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,rs2102522151,"Germline, SUMMARY record",-,0/878 controls,none,-,-,"David Baux, Maria Bitner-Glindzicz"
1065,+/.,2,-,c.2955C>A,r.(?),"p.(Cys985*), p.(Cys985Ter)",-,ACMG,pathogenic,g.216405333G>T,g.216231991G>T,"USH2A c.2802T>G(;)2955C>A, V2: c.2955C>A, (p.Cys985Ter), 1 more item",-,USH2A_002472,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,LOVD
1066,"+/., +?/.",2,-,c.2994A>T,r.(?),p.(Arg998Ser),-,-,"likely pathogenic, pathogenic (recessive)",g.216390892T>A,g.216217550T>A,"1:216390892T>A ENST00000307340.3:c.2994A>T (Arg998Ser), USH2A c.2994A>T",-,USH2A_001827,protein variant annotation not written; heterozygous,"PubMed: Carss 2017, PubMed: Toms 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1067,"+/+, +/.",2,15,c.2996_3009del,r.(?),"p.(Cys999Leufs*9), p.(Cys999LeufsTer9)",Laminin EGF-like 9 (951-1001),ACMG,pathogenic,g.216390879_216390892del,g.216217537_216217550del,-,-,USH2A_000646,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,+BsaBI;-Tsp509I;-CviKI_1;,-,-,"David Baux, Maria Bitner-Glindzicz"
1068,+?/.,2,-,c.3005G>C,r.(?),p.(Cys1002Ser),-,ACMG,likely pathogenic,g.216390881C>G,g.216217539C>G,"USH2A c.3005G>C, p.(Cys1002Ser), c.11864G>A, p.(Trp3955*), 1 more item",-,USH2A_002176,-,PubMed: Jespersgaar 2019,-,-,Germline,?,-,-,-,-,LOVD
1069,"+?/., ?/.",2,-,c.3026C>A,r.(?),p.(Ala1009Asp),-,-,"likely pathogenic, VUS",g.216390860G>T,g.216217518G>T,USH2A(NM_007123.5):c.3026C>A (p.(Ala1009Asp)),-,USH2A_001256,VKGL data sharing initiative Nederland,PubMed: Stone 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Leiden
1070,?/.,2,-,c.3026C>G,r.(?),p.(Ala1009Gly),-,-,VUS,g.216390860G>C,g.216217518G>C,-,-,USH2A_001728,"heterozygous variant only, VKGL data sharing initiative Nederland",PubMed: Arno 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Johan den Dunnen, VKGL-NL_Nijmegen"
1071,+/+,2,15,c.3129dup,r.3129dup,p.Val1044Cysfs*35,Laminin EGF-like 10 (1002-1052),-,pathogenic,g.216390757dup,g.216217415dup,3129dupT,-,USH2A_000653,Heterozygous; Pathogenic,PubMed: Vaché 2012,-,-,Germline,-,-,+CspCI;-BtsCI;-FokI;-MslI;,-,-,Anne-Françoise Roux
1072,"+/., +?/.",2,-,c.3221G>A,r.(?),"p.(Trp1074*), p.(Trp1074Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216380710C>T,g.216207368C>T,"USH2A, variant 1: c.908G>A/p.R303H, variant 2: c.3221G>A/p.W1074*",-,USH2A_002400,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797138,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1073,"+/+, +/.",2,16,c.3251G>A,r.(?),"p.(Trp1084*), p.(Trp1084Ter)",Fibronectin type-III 1 (1058-1143),ACMG,pathogenic,g.216380680C>T,g.216207338C>T,-,-,USH2A_000993,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs1363689100,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1074,?/.,2,-,c.3316+6T>C,r.(=),p.(=),-,-,VUS,g.216380609A>G,g.216207267A>G,USH2A(NM_206933.4):c.3316+6T>C,-,USH2A_001649,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1075,"+/+, +/.",2,16i,c.3317-1G>A,r.spl,p.?,-,ACMG,pathogenic,g.216373464C>T,g.216200122C>T,-,-,USH2A_001063,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,"rs1553313909, rs770768766","Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1076,+/+,2,17-19,c.3317-?_4251+?del,r.?,p.?,1 more item,-,pathogenic,g.216369895_216373463del,-,-,-,USH2A_000919,1 more item,PubMed: Sodi 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1077,"+?/., ?/.",2,-,c.3367T>C,r.(?),p.(Tyr1123His),-,-,"likely pathogenic, VUS",g.216373413A>G,g.216200071A>G,-,-,USH2A_001927,VKGL data sharing initiative Nederland,PubMed: Stone 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1078,?/.,2,-,c.3375T>G,r.(?),p.(Ile1125Met),-,-,VUS,g.216373405A>C,g.216200063A>C,-,-,USH2A_002115,-,PubMed: Wang 2014,-,rs143319658,Germline,-,-,-,-,-,LOVD
1079,"+?/., ?/.",2,-,c.3461T>C,r.(?),p.(Leu1154Ser),-,ACMG,"likely pathogenic, VUS",g.216373319A>G,g.216199977A>G,"USH2A, variant 1: c.7595-2144A>G/p.?, variant 2: c.3461T>C/p.L1154S",-,USH2A_002398,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797137,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1080,"+/., +?/.",2,-,c.3485C>A,r.(?),"p.(Ser1162*), p.(Ser1162Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216373295G>T,g.216199953G>T,"USH2A c.3485C>A, p.(Ser1162)",-,USH2A_002582,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Molina-Ramirez 2020, PubMed: Molina-Ramirez, L. P. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1081,"+/., ?/.",2,9,c.3500T>G,r.(?),p.(Leu1167Arg),-,ACMG,"pathogenic, VUS",g.216373280A>C,g.216199938A>C,"USH2A c.3500T>G, p. L1167R",-,USH2A_002581,"ACMG GN005 criteria: PM2_P PM3_M, heterozygous","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1082,?/.,2,-,c.3584G>T,r.(?),p.(Cys1195Phe),-,-,VUS,g.216373196C>A,g.216199854C>A,-,-,USH2A_001644,VKGL data sharing initiative Nederland,PubMed: Ellingford 2016,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1083,+?/.,2,17,c.3629T>C,r.(?),p.(Leu1210Pro),-,ACMG,"likely pathogenic, likely pathogenic (recessive)",g.216373151A>G,g.216199809A>G,-,-,USH2A_001560,"ACMG PM1, PM2, PM3, PP3, PP4",PubMed: Zenteno 2020,-,-,Germline,-,1/143 cases,-,-,-,"Johan den Dunnen, Juan Carlos Zenteno"
1084,"+/., +?/.",2,-,c.3648C>A,r.(?),"p.(Tyr1216*), p.(Tyr1216Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216373132G>T,g.216199790G>T,-,-,USH2A_002033,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1085,?/.,2,17,c.3664G>A,"r.(3664g>a), r.(?)",p.(Ala1222Thr),-,ACMG,VUS,g.216373116C>T,g.216199774C>T,-,-,USH2A_002790,"ACMG PM2; no variant 2nd chromosome, no variant 2nd chromome","PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Weisschuh 2024",-,-,Germline,-,-,-,-,-,"Johan den Dunnen, Janine Reurink"
1086,+?/.,2,-,c.3665C>T,r.(?),p.(Ala1222Val),-,ACMG,likely pathogenic,g.216373115G>A,g.216199773G>A,"USH2A c.3665C>T(;)4576G>A, V1: c.3665C>T, (p.Ala1222Val), 1 more item",-,USH2A_002471,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0.001318; GnomAD_exome_East: 0.000655; GnomAD_All: 0.0000597,-,-,-,LOVD
1087,"+?/., ?/.",2,-,c.3692G>A,r.(?),p.(Ser1231Asn),-,ACMG,"likely pathogenic, VUS",g.216373088C>T,g.216199746C>T,"USH2A, variant 1: c.949C>A/p.R317R, variant 2: c.3692G>A/p.S1231N",-,USH2A_002397,"ACMG GN005 criteria: PM2_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs747578300,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1088,+/.,2,-,c.3700delinsTGCCCT,r.(?),"p.(Ile1234Cysfs*5), p.(Ile1234CysfsTer5)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216373080delinsAGGGCA,g.216199738delinsAGGGCA,-,-,USH2A_001870,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1089,+/?,2,17i,c.3811+3A>T,"r.[=, 3317_3811del]","p.[=, Ser1106_Gly1271delinsArg]",1 more item,ACMG,likely pathogenic,g.216372966T>A,g.216199624T>A,-,-,USH2A_000078,"Heterozygous; E17 skipping (Le Guédard-Méreuze , 2010)",PubMed: Baux 2007,-,-,Germline,-,0/200 controls,-,-,-,Anne-Françoise Roux
1090,+?/.,2,-,c.3812-2A>G,r.spl,"p.(?), p.?",-,ACMG,likely pathogenic,g.216371928T>C,g.216198586T>C,"USH2A, variant 1: c.3812-2A>G/p.?, variant 2: c.1531G>A/p.E511K",-,USH2A_002396,"ACMG GN005 criteria: PVS1_VS PM2_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs758733024,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1091,"+/., +?/.",2,-,c.3829G>T,r.(?),"p.(Glu1277*), p.(Glu1277Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216371909C>A,g.216198567C>A,"USH2A c.3829G>T, p.Glu1277*",-,USH2A_002578,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1092,"+/., +?/.",2,18,c.3862G>T,r.(?),p.(Glu1288*),-,ACMG,"likely pathogenic (recessive), pathogenic",g.216371876C>A,g.216198534C>A,"c.3862G>T, NM_206933.2:c.3862G>T, NP_996816.2:p.(Glu1288Ter), NC_000001.10:g.216371876C>A",-,USH2A_002147,-,"PubMed: Liu-2020, PubMed: Wang 2018",-,-,Germline,?,-,-,-,-,LOVD
1093,"+/+, +/.",2,18,c.3950T>A,r.(?),"p.(Leu1317*), p.(Leu1317Ter)",Fibronectin type-III 3 (1242-1357),ACMG,pathogenic,g.216371788A>T,g.216198446A>T,-,-,USH2A_000996,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1094,"+?/., ?/.",2,-,c.3958C>T,r.(?),p.(Pro1320Ser),-,ACMG,"likely pathogenic, VUS",g.216371780G>A,g.216198438G>A,"USH2A c.3958C>T, p.(Pro1320Ser)",-,USH2A_002680,"ACMG GN005 criteria: PM2_P PM3_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs1314593217,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1095,"+?/., ?/.",2,-,c.4036G>A,r.(?),p.(Gly1346Arg),-,-,"likely pathogenic, VUS",g.216371702C>T,g.216198360C>T,USH2A(NM_206933.2):c.4036G>A,-,USH2A_001399,VKGL data sharing initiative Nederland,PubMed: Haer-Wigman 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1096,"+/+, +/.",2,18,c.4049del,r.(?),"p.(Ser1350Leufs*16), p.(Ser1350LeufsTer16)",Fibronectin type-III 3 (1242-1357),ACMG,pathogenic,g.216371689del,g.216198347del,4049delC,-,USH2A_000998,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1097,+/.,2,-,c.4073del,r.(?),"p.(Gly1358Glufs*8), p.(Gly1358GlufsTer8)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216371667del,g.216198325del,"4073delG, c.4071delG",-,USH2A_001869,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1098,+/.,2,-,c.4108G>C,r.(?),p.(Val1370Leu),-,-,"pathogenic, pathogenic (recessive)",g.216370038C>G,g.216196696C>G,-,-,USH2A_001924,-,PubMed: Wang 2017,-,-,Germline,-,-,-,-,-,LOVD
1099,?/.,2,-,c.4124C>T,r.(?),p.(Ser1375Leu),-,ACMG,VUS,g.216370022G>A,g.216196680G>A,"USH2A c.4124C>T, p.Ser1375Leu",-,USH2A_002576,"ACMG GN005 criteria: PM2_P PM3_M PP1_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs751479180,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1100,"+/., +?/.",2,-,c.4128C>G,r.(?),"p.(Tyr1376*), p.(Tyr1376Ter)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216370018G>C,g.216196676G>C,-,-,USH2A_001868,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1101,"+/., +?/.",2,19,c.4133_4134dup,r.(?),"p.(Asn1379Serfs*54), p.(Asn1379SerfsTer54)",-,ACMG,"likely pathogenic, pathogenic","g.216370012_216370013dup, g.216370017_216370018dup",g.216196675_216196676dup,"4133_4134dupTC, c.4133_4134dupTC,p.N1379SfsX54",-,USH2A_002490,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Maltese, P. E. et al., 2022; PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs397518015,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1102,+?/?,2,19,c.4144T>C,r.(?),p.(Trp1382Arg),Fibronectin type-III 4 (1367-1462),ACMG,VUS,g.216370002A>G,g.216196660A>G,-,-,USH2A_000918,Heterozygous,"PubMed: Sodi 2014, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1103,+/.,2,-,c.4183del,r.(?),"p.(Val1395Trpfs*37), p.(Val1395TrpfsTer37)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216369963del,g.216196621del,"4183delG, c.4183delG",-,USH2A_001867,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1104,"+/., +?/.",2,-,c.4184_4185del,r.(?),"p.(Val1395Glyfs*3), p.(Val1395GlyfsTer3)",-,ACMG,"likely pathogenic, pathogenic",g.216369963_216369964del,g.216196621_216196622del,"USH2A, variant 1: c.2299del/p.E767Sfs*21, variant 2: c.4184_4185del/p.V1395Gfs*3",-,USH2A_002395,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2034850724,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1105,"+/., +?/.",2,-,c.4210G>T,r.(?),"p.(Glu1404*), p.(Glu1404Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216369936C>A,g.216196594C>A,"USH2A, variant 1: c.4210G>T/p.E1404*, variant 2: c.12855G>A/p.W4285*",-,USH2A_002394,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2034849647,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1106,-?/?,2,19i,c.4252-16_4252-13del,r.(?),p.(?),-,ACMG,likely benign,g.216363743_216363746del,g.216190401_216190404del,4252-16_4252-13delCTTT,-,USH2A_000308,Heterozygous,PubMed: Baux 2014,-,-,Germline,-,-,none,-,-,Anne-Françoise Roux
1107,"+?/., ?/.",2,-,c.4307C>T,r.(?),p.(Pro1436Leu),-,ACMG,"likely pathogenic, VUS",g.216363654G>A,g.216190312G>A,-,-,USH2A_002087,ACMG GN005 criteria: PM2_P PP3_P,"0, PubMed: Huang, X. F. et al., 2015",-,rs1230923403,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1108,"+?/., ?/.",2,-,c.4310_4312dup,r.(?),p.(Tyr1437_Arg1438insAsn),-,ACMG,"likely pathogenic, VUS",g.216363649_216363651dup,g.216190307_216190309dup,"4310_4312dupATA, USH2A c.4310_4312dupATA, p.(Tyr1437_Arg1438insAsn)",-,USH2A_002677,"ACMG GN005 criteria: PM2_P PM3_p, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1109,"+?/?, ?/.",2,20,c.4327A>C,r.(?),p.(Thr1443Pro),Fibronectin type-III 4 (1367-1462),ACMG,VUS,g.216363634T>G,g.216190292T>G,-,-,USH2A_000999,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs760441540,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1110,"+/., +?/.",2,-,c.4356T>A,r.(?),p.(Cys1452Ter),-,ACMG,"likely pathogenic, pathogenic",g.216363605A>T,g.216190263A>T,-,-,USH2A_002324,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1111,"+?/., ?/.",2,-,c.4365T>G,r.(?),p.(Ser1455Arg),-,ACMG,"likely pathogenic, VUS",g.216363596A>C,g.216190254A>C,"USH2A, variant 1: c.7595-2144A>G/p.?, variant 2: c.4365T>G/p.S1455R",-,USH2A_002392,"ACMG GN005 criteria: PM2_P PM3_M, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1553312493,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1112,+/.,2,20i,c.4396+2T>G,"r.spl, r.spl?",p.?,-,ACMG,pathogenic,g.216363563A>C,g.216190221A>C,c.4396+2T>G,-,USH2A_002489,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs2034687381,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1113,+?/.,2,20i,c.4397-3890A>G,r.4396_4397ins4397-3981_4397-3895,p.Ala1465_Ala1466ins*5,-,ACMG,likely pathogenic,g.216352714T>C,g.216179372T>C,-,-,USH2A_002768,-,"PubMed: Reurink 2023, Journal: Reurink 2023",-,-,Germline,-,-,-,-,-,Janine Reurink
1114,-/.,2,-,c.4457=,r.(=),p.(Lys1486=),-,-,benign,g.216348764C>T,-,"USH2A(NM_206933.2):c.4457G>A (p.R1486K), USH2A(NM_206933.4):c.4457G>A (p.R1486K)",-,USH2A_000039,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Groningen"
1115,"+/., +?/.",2,-,c.4509_4510insA,r.(?),p.(Arg1504Lysfs*26),-,-,"likely pathogenic (recessive), pathogenic (recessive)",g.216348711_216348712insT,-,1:216348710C>CT ENST00000307340.3:c.4510dupA (Arg1504LysfsTer26),-,USH2A_001825,-,PubMed: Carss 2017,-,-,Germline,-,-,-,-,-,LOVD
1116,"-/., -?/.",2,-,c.4530A>C,r.(?),p.(Pro1510=),-,-,"benign, likely benign",g.216348691T>G,g.216175349T>G,"USH2A(NM_206933.2):c.4530A>C (p.P1510=), USH2A(NM_206933.4):c.4530A>C (p.P1510=)",-,USH2A_001639,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1117,"+?/., ?/.",2,-,c.4558A>T,r.(?),p.(Ile1520Phe),-,-,"likely pathogenic, VUS",g.216348663T>A,g.216175321T>A,"m4: c.466A > G; p.Ile156Val, USH2A(NM_206933.2):c.4558A>T (p.I1520F)",-,USH2A_001246,VKGL data sharing initiative Nederland,PubMed: Gonzalez del Pozo 2018,-,-,"CLASSIFICATION record, Germline",yes,-,-,-,-,VKGL-NL_Rotterdam
1118,-/?,2,21i,c.4627+32G>T,r.(=),p.(=),-,ACMG,likely benign,g.216348562C>A,g.216175220C>A,-,-,USH2A_000811,Homozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1119,-/?,2,21i,c.4627+1456T>A,r.(=),p.(=),-,ACMG,likely benign,g.216347138A>T,g.216173796A>T,-,-,USH2A_000812,Homozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1120,+/.,2,-,c.4627+25436_4987+659del,r.?,p.?,-,ACMG,pathogenic (recessive),g.216259404_216323160del,g.216086062_216149818del,-,-,USH2A_002878,"ACMG PM2, PVS1, PP5",PubMed: Weisschuh 2024,-,-,Germline,-,-,-,-,-,Johan den Dunnen
1121,"+/+, +/.",2,22-23,c.4628-15914_4885+472del,"r.?, r.spl",p.(Ile1544_Gly1629del),Laminin G-like 1 (1517-1709),-,pathogenic,g.216261884_216286470del,g.216088542_216113128del,"USH2A exon 22–23 deleted c.4628-15914_4885+472del, p.(Ile1544_Gly1629de",-,USH2A_000798,Heterozygous; Pathogenic,"PubMed: Le Quesne Stabej 2012, PubMed: Steele-Stallard 2013",-,-,Germline,yes,-,-,-,-,Maria Bitner-Glindzicz
1122,"+/., +?/.",2,21i_55i,c.4628-2287_10939+3867del,"r.(4628_10939del), r.(?)","p.(?), p.(Ile1544_Gly3647del)",-,-,"likely pathogenic, pathogenic (recessive)",g.215949318_216272842del,g.215775976_216099500del,M23: Deletion Ex 22-55; c.4628-2287_10939 + 3867del; p.?,-,USH2A_001086,Deletion Exons 22 - 55,PubMed: Gonzalez del Pozo 2018,-,-,Germline,yes,-,-,-,-,María González-del Pozo
1123,"+/., +?/.",2,-,c.4628-2A>G,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216270557T>C,g.216097215T>C,"USH2A, variant 1: c.4628-2A>G/p.?, variant 2: c.9258G>T/p.Q3086H",-,USH2A_002391,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2032462132,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1124,+/.,2,21i,c.4628-2A>T,"r.spl, r.spl?",p.?,-,ACMG,"pathogenic, pathogenic (recessive)",g.216270557T>A,g.216097215T>A,-,-,USH2A_001990,ACMG GN005 criteria: PVS1_VS PS1_S PM2_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1125,+/+,2,22,c.4628-?_4758+?del,r.(?),p.(Ile1544Valfs*9),Laminin G-like 1 (1517-1709),-,pathogenic,g.216270425_216270555del,-,-,-,USH2A_000698,1 more item,"PubMed: Baux 2014, PubMed: Sodi 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1126,"+/+, +/.",2,22,c.4668del,r.(?),"p.(Ile1557Leufs*18), p.(Ile1557LeufsTer18)",Laminin G-like 1 (1517-1709),ACMG,pathogenic,g.216270515del,g.216097173del,4668delG,-,USH2A_001001,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs727503729,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1127,+/+,2,22-24,c.4628-?_4987+?del,r.(?),p.(?),-,-,pathogenic,g.216260061_216270555del,-,hg19:chr1:g.(216259373_216259719-_(216318878_216326830)del),-,USH2A_000831,2 more items,"PubMed: Krawitz 2014, PubMed: Van Cauwenbergh 2016",-,-,Germline,-,-,-,-,-,"Peter Krawitz, Anne-Françoise Roux"
1128,?/.,2,-,c.4670T>C,r.(?),p.(Ile1557Thr),-,ACMG,VUS,g.216270513A>G,g.216097171A>G,-,-,USH2A_002320,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs2032460768,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1129,+?/.,2,22,c.4723A>T,r.(?),p.(Lys1575*),-,-,likely pathogenic,g.216270460T>A,-,c.4723A>T (p.Lys1575*),-,USH2A_002488,-,PubMed: SkorczykWerner-2020,-,-,Germline,-,-,-,-,-,LOVD
1130,"+/+, +/.",2,23,c.4761del,r.(?),"p.(Ser1588Hisfs*5), p.(Ser1588HisfsTer5)",Laminin G-like 1 (1517-1709),ACMG,pathogenic,g.216262482del,g.216089140del,4761delG,-,USH2A_000639,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,-BslI,-,-,"David Baux, Maria Bitner-Glindzicz"
1131,"+/., +?/.",2,-,c.4773del,r.(?),"p.(Val1592*), p.(Val1592Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216262468del,g.216089126del,4773delA,-,USH2A_002028,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1132,"+/., +?/.",2,-,c.4818dup,r.(?),"p.(Trp1607Metfs*3), p.(Trp1607MetfsTer3)",-,ACMG,"likely pathogenic, pathogenic",g.216262425dup,g.216089083dup,"USH2A c.4818_4819insA, p.Lys1606Lysfs4",-,USH2A_002574,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs1553300558,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1133,"+?/., ?/.",2,23,c.4862T>A,r.(?),p.(Ile1621Asn),-,ACMG,"likely pathogenic (recessive), VUS",g.216262378A>T,g.216089036A>T,c.4862T>A,-,USH2A_002444,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1134,"+?/., ?/.",2,-,c.4946G>A,r.(?),p.(Gly1649Glu),-,ACMG,"likely pathogenic, VUS",g.216260102C>T,g.216086760C>T,"USH2A, variant 1 :[c.4946G>A/p.G1649E; c.4949G>C/p.G1650A], variant 2: c.2444G>C/p.C815S",-,USH2A_002389,"ACMG GN005 criteria: PM2_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1558251710,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1135,"+?/?, ?/.",2,25,c.5017C>T,r.(?),p.(Leu1673Phe),Laminin G-like 1 (1517-1709),ACMG,VUS,g.216258190G>A,g.216084848G>A,-,-,USH2A_000793,"ACMG GN005 criteria: PM2_P, Heterozygous; Mutation","PubMed: Yang 2013, USMA missense analysis, missense variant in MSV3d, PubMed: Yang, T. et al., 2013",-,-,"Germline, SUMMARY record",-,0/400 controls,-,-,-,"David Baux, Anne-Françoise Roux"
1136,?/.,2,-,c.5104G>A,r.(?),p.(Val1702Met),-,ACMG,VUS,g.216258103C>T,g.216084761C>T,"USH2A c.[5104G>A];[?], V1: c.5104G>A, (p.Val1702Met), USH2A c.[5104G>A];[?]; p.(Val1702Met)",-,USH2A_002470,"heterozygous; single variant in a recessive gene, no second allele found, 1 more item","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline, Unknown","?, yes",Taiwan Biobank: 0.001978; GnomAD_exome_East: 0.00087; GnomAD_All: 0.0000918,-,-,-,LOVD
1137,"+?/., ?/.",2,-,c.5122G>A,r.(?),p.(Gly1708Arg),-,ACMG,"likely pathogenic, VUS",g.216258085C>T,g.216084743C>T,-,-,USH2A_002027,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1138,"+/+, +/.",2,25,c.5129_5130insGAGC,r.(?),"p.(Ala1711Serfs*6), p.(Ala1711SerfsTer6)",-,ACMG,pathogenic,g.216258078_216258079insCTCG,g.216084736_216084737insCTCG,-,-,USH2A_001003,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1139,"-/., -/?",2,25,c.5142T>C,r.(?),"p.(=), p.(Asn1714=)",Laminin G-like 2 (1714-1891),ACMG,"benign, likely benign",g.216258065A>G,g.216084723A>G,USH2A(NM_206933.4):c.5142T>C (p.N1714=),-,USH2A_000640,"Heterozygous; UV1, VKGL data sharing initiative Nederland",PubMed: Le Quesne Stabej 2012,-,-,"CLASSIFICATION record, Germline",-,0/878 controls,none,-,-,"VKGL-NL_AMC, Maria Bitner-Glindzicz"
1140,+/.,2,-,c.5152C>T,r.(?),"p.(Gln1718*), p.(Gln1718Ter)",-,ACMG,pathogenic,g.216258055G>A,g.216084713G>A,"USH2A c.5152C>T, p.Gln1718*",-,USH2A_002570,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1141,"+/+, +/.",2,25i,c.5168-2A>G,r.spl,p.?,-,ACMG,pathogenic,g.216256930T>C,g.216083588T>C,-,-,USH2A_000896,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1142,"+/+, +?/.",2,26,c.5191_5192del,r.(?),p.(Met1731Valfs*8),Laminin G-like 2 (1714-1891),-,"likely pathogenic, pathogenic",g.216256908_216256909del,g.216083566_216083567del,"5191_5192delAT, USH2A Ex.9 c.1571C>A p.(Ala524Asp), Ex.26 c.5191_5192del p.(Met1731Valfs*8)",-,USH2A_000395,"compound heterozygous, Heterozygous","PubMed: Martin Merida 2019, PubMed: Sandberg 2008",-,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
1143,?/.,2,-,c.5204G>A,r.(?),p.(Gly1735Glu),-,ACMG,VUS,g.216256892C>T,g.216083550C>T,"USH2A c.5204G>A, p.Gly1735Glu",-,USH2A_002568,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1144,+/.,2,26,c.5218del,r.(?),p.(Ile1740Phefs*10),-,ACMG,"pathogenic, pathogenic (recessive)",g.216256878del,g.216083536del,5218delA,-,USH2A_001559,"ACMG PVS1, PM1, PM2, PM3, PP1, PP4",PubMed: Zenteno 2020,-,-,Germline,-,1/143 cases,-,-,-,"Johan den Dunnen, Juan Carlos Zenteno"
1145,"+?/., ?/.",2,-,c.5221T>C,r.(?),p.(Ser1741Pro),-,ACMG,"likely pathogenic, VUS",g.216256875A>G,g.216083533A>G,"USH2A c.5221T>C, p.(Ser1741Pro)",-,USH2A_002602,"ACMG GN005 criteria: PM2_P PM3_P, homozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1146,+/.,2,26,c.5251_5267del,r.(?),"p.(Gly1751Leufs*2), p.(Gly1751LeufsTer2)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216256830_216256846del,g.216083488_216083504del,-,-,USH2A_002075,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1147,"-?/?, ?/.",2,26,c.5252G>T,r.(?),p.(Gly1751Val),Laminin G-like 2 (1714-1891),ACMG,"likely benign, VUS",g.216256844C>A,g.216083502C>A,-,-,USH2A_000651,"ACMG GN005 criteria: PM2_P PP3_P, Heterozygous; UV2","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs370995421,"Germline, SUMMARY record",-,0/878 controls,-BstXI,-,-,"David Baux, Maria Bitner-Glindzicz"
1148,+?/.,2,-,c.5264dup,r.(?),"p.(Val1756Argfs*3), p.(Val1756ArgfsTer3)",-,ACMG,likely pathogenic,g.216256835dup,g.216083493dup,"5264dupT, USH2A c.5264_5265insT, p.Val1756Argfs3",-,USH2A_002567,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1149,-?/.,2,-,c.5265C>T,r.(?),p.(Phe1755=),-,-,likely benign,g.216256831G>A,g.216083489G>A,USH2A(NM_206933.4):c.5265C>T (p.F1755=),-,USH2A_001707,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1150,"+/+, +?/.",2,26i,c.5298+1G>C,"r.5168_5271del, r.spl","p.?, p.Gly1723Glufs*6",Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, pathogenic",g.216256797C>G,g.216083455C>G,-,-,USH2A_000173,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; E26 skipping (Jaijo , 2010)","PubMed: Aller 2006, PubMed: Aller, E. et al., 2006",-,-,"Germline, SUMMARY record",-,0/100 controls,-,-,-,"David Baux, Jose Maria Millan"
1151,+?/.,2,-,c.5298+2T>C,r.spl,"p.(?), p.?",-,ACMG,likely pathogenic,g.216256796A>G,g.216083454A>G,"USH2A c.5298+2T>C, -",-,USH2A_002566,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs763385498,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1152,"+?/., ?/.",2,-,c.5298+5G>A,"r.(?), r.spl","p.(=), p.?",-,ACMG,"likely pathogenic, VUS",g.216256793C>T,g.216083451C>T,-,-,USH2A_002313,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1176314553,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1153,+?/.,2,-,c.5299-249_5572+251del,r.spl,p.(?),-,-,likely pathogenic,g.216251180_216251953del,g.216077838_216078611del,USH2A chr1:216251180_216251953del,-,USH2A_002310,"range 272-772 bp in various techniques, heterozygous",PubMed: Zampaglione 2020,-,-,Unknown,?,-,-,-,-,LOVD
1154,+/+,2,27,c.5356C>T,r.(?),p.(Gln1786*),Laminin G-like 2 (1714-1891),-,pathogenic,g.216251647G>A,g.216078305G>A,-,-,USH2A_000326,Heterozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1155,"+?/., ?/.",2,-,c.5386T>G,r.(?),p.(Cys1796Gly),-,ACMG,"likely pathogenic, VUS",g.216251617A>C,g.216078275A>C,"USH2A c.5386T>G, p.(Cys1796Gly)",-,USH2A_002673,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1156,"+/., ?/.",2,-,c.5398T>C,r.(?),p.(Trp1800Arg),-,ACMG,"pathogenic (recessive), VUS",g.216251605A>G,g.216078263A>G,-,-,USH2A_001866,ACMG GN005 criteria: PM2_P PM3_M PP3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1157,+/.,2,27,c.5438C>A,r.(?),"p.(Ser1813*), p.(Ser1813Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216251565G>T,g.216078223G>T,-,-,USH2A_001989,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1158,"+?/., ?/.",2,27,c.5438_5443del,r.(?),p.(Ser1813_Ser1815delinsCys),-,ACMG,"likely pathogenic, VUS",g.216251560_216251565del,g.216078218_216078223del,c.5438_5443del,-,USH2A_002442,ACMG GN005 criteria: PM2_P PM3_M PM4_M,"PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,rs752992414,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1159,"+?/?, ?/.",2,27,c.5447T>G,r.(?),p.(Val1816Gly),Laminin G-like 2 (1714-1891),ACMG,VUS,g.216251556A>C,g.216078214A>C,-,-,USH2A_001006,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs777011507,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1160,+/.,2,27,c.5473G>T,r.(?),p.(Glu1825*),-,ACMG,"pathogenic, pathogenic (recessive)",g.216251530C>A,g.216078188C>A,"USH2A c.5473G>T, p.(Glu1825*), c.2276G>T, p.(Cys759Phe)",-,USH2A_000471,possible duplicate,"PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016, PubMed: Jespersgaar 2019",-,-,Germline,?,-,-,-,-,Anne-Françoise Roux
1161,+?/?,2,27,c.5498T>A,r.(?),p.(Val1833Glu),Laminin G-like 2 (1714-1891),ACMG,VUS,g.216251505A>T,g.216078163A>T,-,-,USH2A_000107,"Heterozygous, Heterozygous; Mutation","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,-,-HphI,-,-,Anne-Françoise Roux
1162,"-/., -?/.",2,-,c.5517G>A,r.(?),p.(Val1839=),-,-,"benign, likely benign",g.216251486C>T,g.216078144C>T,"USH2A(NM_206933.2):c.5517G>A (p.V1839=), USH2A(NM_206933.4):c.5517G>A (p.V1839=)",-,USH2A_001239,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1163,"+?/., ?/.",2,27,c.5521G>A,r.(?),p.(Gly1841Arg),-,ACMG,"likely pathogenic (recessive), VUS",g.216251482C>T,g.216078140C>T,-,-,USH2A_001988,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1164,"+/+, ?/.",2,27,c.5522G>A,r.(?),p.(Gly1841Glu),Laminin G-like 2 (1714-1891),ACMG,"pathogenic, VUS",g.216251481C>T,g.216078139C>T,-,-,USH2A_001005,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs766833484,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1165,+/.,2,-,c.5573-843A>G,r.(=),p.(=),-,-,pathogenic,g.216247485T>C,g.216074143T>C,"USH2A(NM_206933.2):c.5573-843A>G, USH2A(NM_206933.4):c.5573-843A>G",-,USH2A_001632,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1166,"+/?, +?/.",2,27i,c.5573-834A>G,"r.(=), r.[=,5572_5573ins5573-969_5573-839,5572_5573ins5573-911_5573-839]","p.(=), p.?",-,ACMG,likely pathogenic,g.216247476T>C,g.216074134T>C,-,-,USH2A_000949,Heterozygous; induces inclusion 131 and 73 bp (pseudo-exons) in minigenes; induces PE insertion,"Liquori et al., accepted, PubMed: Reurink 2023, Journal: Reurink 2023",-,-,Germline,-,0/342 controls,-,-,-,"Anne-Françoise Roux, Janine Reurink"
1167,"+?/., ?/.",2,27i,c.5573-19A>G,"r.(=), r.5573_5776del","p.(=), p.Gly1858_Thr1925del",-,ACMG,"likely pathogenic, VUS",g.216246661T>C,g.216073319T>C,-,-,USH2A_001631,VKGL data sharing initiative Nederland,"PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Janine Reurink"
1168,"+?/., ?/.",2,-,c.5594A>T,r.(?),p.(Asp1865Val),-,ACMG,"likely pathogenic, VUS",g.216246621T>A,g.216073279T>A,"USH2A, variant 1: c.993_994del/p.R331Sfs*7, variant 2: c.5594A>T/p.D1865V",-,USH2A_002388,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs760543320,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1169,+/.,2,-,c.5603_5613del,r.(?),"p.(Phe1868Cysfs*4), p.(Phe1868CysfsTer4)",-,ACMG,pathogenic,g.216246603_216246613del,g.216073261_216073271del,"USH2A c.11712-2A>C(;)5603_5613del, V2: c.5603_5613del, (p.Phe1868CysfsTer4), 1 more item",-,USH2A_002469,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,LOVD
1170,+?/.,2,28,c.5612G>A,r.(?),p.(Gly1871Asp),-,-,likely pathogenic,g.216246603C>T,g.216073261C>T,"USH2A Ex.15 c.3045C>G p.(His1015Gln), Ex.28 c.5612G>A p.(Gly1871Asp)",-,USH2A_001996,"compound heterozygous, no variant 2nd chromosome","PubMed: Martin Merida 2019, PubMed: Perez-Carro 2016",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1171,+?/.,2,-,c.5614delins12,r.(?),p.(Ala1872Leufs),-,-,likely pathogenic,g.?,g.?,"c.4474G>T p.(Glu1492*), c.5614delGins12 p.(Ala1872Leufs)",-,NPHS2_000000,"error in annotation, no inserted nucleotides given",PubMed: Hagag 2020,-,-,Germline/De novo (untested),?,-,-,-,-,LOVD
1172,+?/.,2,-,c.5614delinsTTAACTTGGCAT,r.(?),"p.(Ala1872Leufs*64), p.(Ala1872LeufsTer64)",-,-,likely pathogenic,g.216246601delinsATGCCAAGTTAA,g.216073259delinsATGCCAAGTTAA,"USH2A c.5614delins12, p.(Ala1872Leufs64)",-,USH2A_002486,1 more item,"PubMed: Ellingford 2016, PubMed: Molina-Ramirez 2020",-,-,"Germline, Unknown",?,-,-,-,-,Johan den Dunnen
1173,"+?/., +?/?",2,28,c.5666A>G,r.(?),p.(Asp1889Gly),Laminin G-like 2 (1714-1891),ACMG,"likely pathogenic, VUS",g.216246549T>C,g.216073207T>C,"USH2A, c.5666A>G, p.Asp1889Gly, heterozygous",-,USH2A_000909,Heterozygous; UV3,"PubMed: Aparisi 2014, USMA missense analysis, missense variant in MSV3d, PubMed: Perea-Romero 2021",-,-,Germline,yes,-,-,-,-,Anne-Françoise Roux
1174,"+/., +?/.",2,-,c.5678C>G,r.(?),"p.(Ser1893*), p.(Ser1893Ter)",-,ACMG,pathogenic,g.216246537G>C,g.216073195G>C,-,-,USH2A_002123,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Tang, K. et al., 2021",-,rs2031620246,"Germline/De novo (untested), SUMMARY record",-,-,-,-,-,"David Baux, Jinu Han"
1175,-/?,2,28,c.5751C>T,r.(?),p.(=),Fibronectin type-III 5 (1871-1949),ACMG,likely benign,g.216246464G>A,g.216073122G>A,-,-,USH2A_000452,"Heterozygous; polymorphism, Heterozygous; UV2","PubMed: Garcia-Garcia 2011, PubMed: McGee 2010",-,rs145742052,Germline,-,-,-Hpy166II,-,-,"Anne-Françoise Roux, Jose Maria Millan"
1176,"+/+, +?/.",2,28i,c.5777-2A>G,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.216246313T>C,g.216072971T>C,-,-,USH2A_001067,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1177,?/.,2,-,c.5789G>A,r.(?),p.(Arg1930Gln),-,ACMG,VUS,g.216246299C>T,g.216072957C>T,-,-,USH2A_001387,"ACMG PM2, VKGL data sharing initiative Nederland",PubMed: Weisschuh 2024,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"Johan den Dunnen, VKGL-NL_Nijmegen"
1178,?/.,2,-,c.5837G>A,r.(?),p.(Arg1946Gln),-,ACMG,VUS,g.216246251C>T,g.216072909C>T,"USH2A:NM_206933 c.G5837A, p.R1946Q",-,USH2A_001386,"heterozygous, individual solved, variant non-causal, VKGL data sharing initiative Nederland",PubMed: Rodriguez-Munoz 2020,-,-,"CLASSIFICATION record, Germline",?,-,-,-,-,VKGL-NL_Nijmegen
1179,"+?/., ?/.",2,-,c.5848A>G,r.(?),p.(Thr1950Ala),-,ACMG,"likely pathogenic, VUS",g.216246240T>C,g.216072898T>C,"USH2A c.5848A>G, p.T1950A",-,USH2A_002308,"ACMG GN005 criteria: PM2_P PM3_M BP4_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs2102548566,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1180,+?/.,2,-,c.5884del,r.(?),p.(Arg1962Glufs*5),-,-,likely pathogenic,g.216243609del,g.216070267del,USH2A c.5884del,-,USH2A_002668,"no protein annotation written; heterozygous, 1 more item",PubMed: Charng 2020,-,-,Germline,yes,-,-,-,-,LOVD
1181,"+/+, +?/.",2,30,c.5899_5900del,r.(?),"p.(Asn1967Trpfs*5), p.(Asn1967TrpfsTer5)",Fibronectin type-III 6 (1954-2051),ACMG,"likely pathogenic, pathogenic",g.216243593_216243594del,g.216070251_216070252del,5899_5900delAA,-,USH2A_000648,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,-MseI,-,-,"David Baux, Maria Bitner-Glindzicz"
1182,"+?/., ?/.",2,-,c.5917G>A,r.(?),"p.(Val1973Leu), p.(Val1973Met)",-,ACMG,"likely pathogenic (recessive), VUS",g.216243575C>T,g.216070233C>T,-,-,USH2A_001864,ACMG GN005 criteria: PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs751696730,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1183,"+?/?, ?/.",2,30,c.5932C>T,r.(?),p.(Pro1978Ser),Fibronectin type-III 6 (1954-2051),ACMG,VUS,g.216243560G>A,g.216070218G>A,"USH2A:NM_206933 c.C5932T, p.P1978S",-,USH2A_000414,"heterozygous, individual solved, variant non-causal, Heterozygous; possibly deleterious","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, PubMed: Rodriguez-Munoz 2020",-,rs75698489,Germline,?,-,-,-,-,Anne-Françoise Roux
1184,"+/., +?/.",2,-,c.5950_5960dup,r.(?),"-, p.(Tyr1987Ter)",-,ACMG,"pathogenic, pathogenic (!)",g.216243535_216243545dup,g.216070193_216070203dup,-,-,USH2A_001883,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, variant on protein level influenced by upstream deletion","PubMed: Eandi 2017, PubMed: Eandi, C. M. et al., 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1185,-/.,2,-,c.6041A>C,r.(?),p.(Asn2014Thr),-,-,benign,g.216243451T>G,g.216070109T>G,"USH2A(NM_206933.2):c.6041A>C (p.N2014T), USH2A(NM_206933.4):c.6041A>C (p.N2014T)",-,USH2A_001234,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1186,"+?/?, ?/.",2,30,c.6049G>T,r.(?),p.(Gly2017Cys),Fibronectin type-III 6 (1954-2051),ACMG,VUS,g.216243443C>A,g.216070101C>A,-,-,USH2A_000652,"ACMG GN005 criteria: PM2_P PP3_P, Heterozygous; UV1","PubMed: Le Quesne Stabej 2012, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,+NlaIII;-FatI;-PciI;-AflIII;-CviAII;-NspI;,-,-,"David Baux, Maria Bitner-Glindzicz"
1187,"+/., +?/.",2,-,c.6049+2T>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216243441A>C,g.216070099A>C,"USH2A c.6049+2T>G, p.(?)",-,USH2A_002307,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1188,?/.,2,-,c.6071C>T,r.(?),p.(Pro2024Leu),-,ACMG,VUS,g.216221968G>A,g.216048626G>A,"USH2A c.6071C>T, p.Pro2024Leu",-,USH2A_002563,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1189,"+?/., ?/.",2,-,c.6118T>G,r.(?),p.(Cys2040Gly),-,-,"likely pathogenic (recessive), VUS",g.216221921A>C,g.216048579A>C,1:216221921A>C ENST00000307340.3:c.6118T>G (Cys2040Gly),-,USH2A_001822,-,"PubMed: Carss 2017, PubMed: Ellingford 2016",-,-,Germline,-,-,-,-,-,LOVD
1190,+?/.,2,-,c.6127_6128dup,r.(?),"p.(Ser2043Argfs*6), p.(Ser2043ArgfsTer6)",-,ACMG,likely pathogenic,g.216221914_216221915dup,g.216048572_216048573dup,"6127_6128dupAG, USH2A, variant 1: c.6127_6128dup/p.S2043Rfs*6, variant 2 :Deletion exon 10-11",-,USH2A_002386,"ACMG GN005 criteria: PVS1_VS PM2_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs2030619513,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1191,+/.,2,31,c.6159del,r.(?),p.(Glu2054Lysfs*10),-,ACMG,pathogenic,"g.216221879del, g.216221880del",-,-,-,USH2A_001441,1 more item,"Sharon, submitted, PubMed: Sharon 2019",-,-,Germline,-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Dror Sharon"
1192,?/.,2,31i,c.6164-3C>G,"r.spl, r.spl?",p.?,-,ACMG,VUS,g.216219937G>C,g.216046595G>C,c.6164-3C>G,-,USH2A_002438,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,rs755593389,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1193,+/.,2,-,c.6178dup,r.(?),"p.(Gln2060Profs*43), p.(Gln2060ProfsTer43)",-,ACMG,pathogenic,g.216219920dup,g.216046578dup,"USH2A c.6178dup, p.(Gln2060Profs*43)",-,USH2A_002667,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,rs1553294144,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1194,"+?/?, ?/.",2,32,c.6225G>T,r.(?),p.(Trp2075Cys),Fibronectin type-III 7 (2052-2138),ACMG,VUS,g.216219873C>A,g.216046531C>A,-,-,USH2A_001009,"ACMG GN005 criteria: PM2_P PM3_P PP3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1553294134,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1195,"+/., +?/.",2,-,c.6239dup,r.(?),"p.(Ala2081Glyfs*22), p.(Ala2081GlyfsTer22)",-,ACMG,"likely pathogenic, pathogenic",g.216219863dup,g.216046521dup,"6239dupA, USH2A c.6239_6240insA, p.Lys2080LysfsX23",-,USH2A_002562,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs1558229491,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1196,"+/+, +/.",2,32,c.6283del,r.(?),"p.(Arg2095Glyfs*2), p.(Arg2095GlyfsTer2)",Fibronectin type-III 7 (2052-2138),ACMG,pathogenic,g.216219815del,g.216046473del,6283delA,-,USH2A_000693,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Aller, E. et al., 2006, PubMed: Baux 2014",-,-,"Germline, SUMMARY record",-,-,-MnlI,-,-,"David Baux, Anne-Françoise Roux"
1197,"+/., +?/.",2,-,c.6310_6325del,r.(?),"p.(Asn2104Ilefs*2), p.(Asn2104IlefsTer2)",-,ACMG,"likely pathogenic, pathogenic",g.216219775_216219790del,g.216046433_216046448del,"USH2A c.6310_6325delAACTACATAGTCACAG, p.Asn2104Ilefs2",-,USH2A_002561,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1198,-/.,2,-,c.6317T>C,r.(?),p.(Ile2106Thr),-,-,benign,g.216219781A>G,-,-,-,USH2A_001228,1 more item,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs6657250,Germline,-,"259/1204 cases with retinitis pigmentosa, 577/1204 cases with retinitis pigmentosa",-,-,-,Yoshito Koyanagi
1199,"+/+, +/.",2,32,c.6319_6323delinsTAA,r.(?),"p.(Val2107*), p.(Val2107Ter)",Fibronectin type-III 7 (2052-2138),ACMG,pathogenic,g.216219775_216219779delinsTTA,g.216046433_216046437delinsTTA,-,-,USH2A_000662,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,-HpyCH4III;-Tsp45I;,-,-,"David Baux, Jose Maria Millan"
1200,"+?/., ?/.",2,-,c.6470del,r.(?),p.(Arg2157Lysfs*13),-,-,"likely pathogenic, VUS",g.216173760del,g.216000418del,"6470delG, USH2A c.6470del",-,USH2A_001975,protein variant annotation not written; heterozygous,"PubMed: Ellingford 2016, PubMed: Toms 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1201,?/.,2,-,c.6485A>T,r.(?),p.(Gln2162Leu),-,ACMG,VUS,g.216173745T>A,g.216000403T>A,"USH2A c.A6485T, p.Q2162L",-,USH2A_002416,"ACMG GN005 criteria: PM2_P PM3_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,rs760264555,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1202,+/.,2,-,c.6485+1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,pathogenic,g.216173744C>T,g.216000402C>T,-,-,USH2A_002304,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1553287070,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1203,"+/., +?/.",2,-,c.6485+1G>C,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216173744C>G,g.216000402C>G,"USH2A c.6485+1G>C, -",-,USH2A_002560,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1204,?/.,2,-,c.6492A>C,r.(?),p.(Lys2164Asn),-,ACMG,VUS,g.216172394T>G,g.215999052T>G,"USH2A c.6492A>C, p.Lys2164Asn",-,USH2A_002558,"ACMG GN005 criteria: PM2_P BP4_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs727503724,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1205,+/.,2,-,c.6621C>A,r.(?),p.(Tyr2207Ter),-,-,pathogenic,g.216172265G>T,g.215998923G>T,USH2A(NM_206933.4):c.6621C>A (p.Y2207*),-,USH2A_001223,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1206,"+/., +?/.",2,-,c.6642dup,r.(?),"p.(Leu2215Serfs*16), p.(Leu2215SerfsTer16)",-,ACMG,"likely pathogenic, pathogenic",g.216172244dup,g.215998902dup,6642dupT,-,USH2A_002024,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1207,"+/+, +/.",2,34i,c.6657+1G>C,r.spl,p.?,-,ACMG,pathogenic,g.216172228C>G,g.215998886C>G,-,-,USH2A_001068,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1208,"+?/., ?/.",2,-,c.6657+3_6657+6del,r.spl,p.?,-,ACMG,"likely pathogenic, VUS",g.216172226_216172229del,g.215998884_215998887del,-,-,USH2A_002023,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1209,-?/.,2,-,c.6711C>A,r.(?),p.(Asp2237Glu),-,-,likely benign,g.216166456G>T,g.215993114G>T,"USH2A(NM_206933.2):c.6711C>A (p.D2237E), USH2A(NM_206933.4):c.6711C>A (p.D2237E)",-,USH2A_001219,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1210,"+?/?, ?/.",2,35,c.6721C>A,r.(?),"p.(Pro2241His), p.(Pro2241Thr)",Fibronectin type-III 9 (2241-2325),ACMG,VUS,g.216166446G>T,g.215993104G>T,-,-,USH2A_001013,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs111033412,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1211,"+?/?, ?/.",2,35,c.6722C>A,r.(?),"p.(Pro2241His), p.(Pro2241Thr)",Fibronectin type-III 9 (2241-2325),ACMG,VUS,g.216166445G>T,g.215993103G>T,-,-,USH2A_001012,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1057518826,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1212,"+/+, +/.",2,35,c.6724G>T,r.(?),"p.(Glu2242*), p.(Glu2242Ter)",Fibronectin type-III 9 (2241-2325),ACMG,pathogenic,g.216166443C>A,g.215993101C>A,-,-,USH2A_001011,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs375278546,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1213,"+?/?, ?/.",2,35,c.6746C>A,r.(?),p.(Ala2249Asp),Fibronectin type-III 9 (2241-2325),ACMG,VUS,g.216166421G>T,g.215993079G>T,-,-,USH2A_000191,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous","PubMed: Aller, E. et al., 2006, PubMed: Najera 2002, USMA missense analysis, missense variant in MSV3d",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Jose Maria Millan"
1214,"+?/., ?/.",2,-,c.6766T>C,r.(?),p.(Ser2256Pro),-,ACMG,"likely pathogenic (recessive), VUS",g.216166401A>G,g.215993059A>G,-,-,USH2A_001859,ACMG GN005 criteria: PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1215,"-?/?, ?/.",2,35,c.6778T>C,r.(?),p.(Ser2260Pro),Fibronectin type-III 9 (2241-2325),ACMG,"likely benign, VUS",g.216166389A>G,g.215993047A>G,"c.6778T>C, p.Ser2260Pro",-,USH2A_000420,"heterozygous, Heterozygous; benign","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, PubMed: Zampaglione 2020",-,-,"Germline, Unknown",?,-,-,-,-,Anne-Françoise Roux
1216,+?/.,2,-,c.6805+1G>A,r.spl,p.?,-,ACMG,likely pathogenic,g.216166361C>T,g.215993019C>T,-,-,USH2A_002021,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1217,?/.,2,-,c.6806-810A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,VUS,g.216144928T>C,g.215971586T>C,m39: c.6806-810A > G; r.?,-,USH2A_002166,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Gonzalez del Pozo 2018, PubMed: Gonzalez-Del Pozo, M. et al., 2018",-,rs1667495969,"Germline/De novo (untested), SUMMARY record",?,-,-,-,-,David Baux
1218,"+?/., ?/.",2,-,c.6835G>T,r.(?),p.(Asp2279Tyr),-,ACMG,"likely pathogenic, VUS",g.216144089C>A,g.215970747C>A,"USH2A, variant 1: c.2080T>A/p.C694S, variant 2: c.6835G>T/p.D2279Y",-,USH2A_002385,"ACMG GN005 criteria: PM2_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1421761057,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1219,+/+,2,35,c.6875dup,r.(?),p.(Ala2293Cysfs*38),Fibronectin type-III 9 (2241-2325),-,pathogenic,g.216144049dup,g.215970707dup,6875_6876insG,-,USH2A_000942,Heterozygous; mutation,PubMed: Qu 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1220,+/+,2,36,c.6902T>G,r.(?),p.(Leu2301*),Fibronectin type-III 9 (2241-2325),-,pathogenic,g.216144022A>C,g.215970680A>C,-,-,USH2A_000077,Heterozygous,PubMed: Baux 2007,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1221,"+/+, +?/.",2,36,c.6904_6920dup,r.(?),"p.(Gln2307Hisfs*25), p.(Gln2307HisfsTer25)",Fibronectin type-III 9 (2241-2325),ACMG,"likely pathogenic, pathogenic",g.216144005_216144021dup,g.215970663_215970679dup,-,-,USH2A_000892,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015",-,rs1667472317,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1222,+/.,2,-,c.6919C>T,r.(?),p.(Gln2307Ter),-,ACMG,pathogenic,g.216144005G>A,g.215970663G>A,-,-,USH2A_002302,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1223,"+/., +?/?",2,36,c.6925T>C,"r.(=), r.(?)",p.(Cys2309Arg),Fibronectin type-III 9 (2241-2325),ACMG,"pathogenic, VUS",g.216143999A>G,g.215970657A>G,c.6925T>C,-,USH2A_000855,Heterozygous; causative,"PubMed: Eisenberger 2013, USMA missense analysis, missense variant in MSV3d, PubMed: Eisenberger-2013",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1224,"+?/., ?/.",2,-,c.6957+5G>A,"r.(?), r.spl","p.(=), p.?",-,ACMG,"likely pathogenic, VUS",g.216143962C>T,g.215970620C>T,-,-,USH2A_002301,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1225,"-/., -?/.",2,-,c.6958-5C>T,r.spl?,p.?,-,-,"benign, likely benign",g.216138826G>A,g.215965484G>A,USH2A(NM_206933.2):c.6958-5C>T,-,USH2A_001213,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs147914083,"CLASSIFICATION record, Germline",-,9/1167 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_Rotterdam, Yoshito Koyanagi"
1226,-/?,2,37,c.6989A>G,r.(?),p.(Glu2330Gly),Fibronectin type-III 10 (2328-2432),ACMG,likely benign,g.216138790T>C,g.215965448T>C,-,-,USH2A_000802,Homozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,rs138992047,Germline,-,-,-,-,-,Anne-Françoise Roux
1227,"+/., ?/.",2,-,c.6992G>A,r.(?),p.(Gly2331Glu),-,ACMG,"pathogenic (recessive), VUS",g.216138787C>T,g.215965445C>T,-,-,USH2A_001729,ACMG GN005 criteria: PM2_P,"PubMed: Karali 2019, Journal: Karali 2019, PubMed: Karali, M. et al., 2019",-,rs754075911,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Sandro Banfi"
1228,+/.,2,37,c.7000A>G,r.(?),p.(Asn2334Asp),-,ACMG,pathogenic,g.216138779T>C,g.215965437T>C,"USH2A c.7000A>G, p.N2334D",-,USH2A_002664,-,PubMed: Zhu 2021,-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
1229,"+/., +?/.",2,-,c.7027del,r.(?),"p.(Arg2343Glyfs*5), p.(Arg2343GlyfsTer5)",-,ACMG,"likely pathogenic, pathogenic",g.216138754del,g.215965412del,"7027delC, USH2A, variant 1: c.7027del/p.R2343Gfs*5, variant 2: c.7027del/p.R2343Gfs*5",-,USH2A_002384,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1667316878,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1230,"+/., +?/.",2,37,c.7036_7057del,r.(?),p.(His2346Phefs*7),-,ACMG,"likely pathogenic (recessive), pathogenic",g.216138722_216138743del,g.215965380_215965401del,"c.7036_7057del22bp, 1 more item",-,USH2A_002143,-,"PubMed: Liu-2020, PubMed: Wang 2018",-,-,Germline,?,-,-,-,-,LOVD
1231,"+?/., ?/.",2,-,c.7040T>A,r.(?),p.(Val2347Glu),-,ACMG,"likely pathogenic, VUS",g.216138739A>T,g.215965397A>T,"USH2A, variant 1: c.14219C>A/p.A4740D, variant 2: c.7040T>A/p.V2347E",-,USH2A_002383,"ACMG GN005 criteria: PM2_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1667316070,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1232,"-?/., ?/.",2,-,c.7060C>T,r.(?),p.(Arg2354Cys),-,ACMG,"likely benign, VUS",g.216138719G>A,g.215965377G>A,-,-,USH2A_002113,ACMG GN005 criteria: BS1_P BP4_P,"PubMed: Sloan-Heggen, C. M. et al., 2016, PubMed: Wang 2014",-,rs111033508,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1233,"+?/?, ?/.",2,37,c.7076T>C,r.(?),p.(Leu2359Ser),Fibronectin type-III 10 (2328-2432),ACMG,VUS,g.216138703A>G,g.215965361A>G,-,-,USH2A_000794,"ACMG GN005 criteria: PM2_P, Heterozygous; Mutation","PubMed: Yang 2013, USMA missense analysis, missense variant in MSV3d, PubMed: Yang, T. et al., 2013",-,rs1460472883,"Germline, SUMMARY record",-,0/400 controls,-,-,-,"David Baux, Anne-Françoise Roux"
1234,+/.,2,-,c.7076T>G,r.(?),"p.(Leu2359*), p.(Leu2359Ter)",-,ACMG,pathogenic,g.216138703A>C,g.215965361A>C,-,-,USH2A_002020,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1235,+/.,2,-,c.7188G>A,r.(?),"p.(Trp2396*), p.(Trp2396Ter)",-,ACMG,pathogenic,g.216108070C>T,g.215934728C>T,"USH2A c.7188G>A, p.Trp2396*",-,USH2A_002554,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1236,"+/+, +/.",2,38,c.7195_7207del,r.(?),p.(Ile2399Phefs*10),Fibronectin type-III 10 (2328-2432),-,"pathogenic, pathogenic (recessive)",g.216108051_216108063del,g.215934709_215934721del,-,-,USH2A_000380,Heterozygous,"Tranebjaerg 2011, PubMed: Dad 2016, PubMed: Baux 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1237,"+/., +?/.",2,-,c.7198del,r.(?),"p.(Asp2400Metfs*13), p.(Asp2400MetfsTer13)",-,ACMG,"likely pathogenic, pathogenic",g.216108060del,g.215934718del,7198delG,-,USH2A_002019,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1238,?/.,2,38,c.7232A>C,r.(?),p.(Gln2411Pro),-,ACMG,VUS,g.216108026T>G,g.215934684T>G,"USH2A c.7232A>C, p.Gln2411Pro",-,USH2A_002553,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1239,"+/., +?/.",2,-,c.7343del,r.(?),"p.(Pro2448Glnfs*26), p.(Pro2448GlnfsTer26)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216074206del,g.215900864del,"7343delC, c.7343delC",-,USH2A_001855,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1240,"+/., +?/.",2,-,c.7358T>A,r.(?),p.(Val2453Asp),-,-,"likely pathogenic, pathogenic (recessive)",g.216074190A>T,g.215900848A>T,"1:216074190A>T ENST00000307340.3:c.7358T>A (Val2453Asp), USH2A c.7358T>A, p.Val2453Asp",-,USH2A_001819,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1241,+?/.,2,-,c.7381_7399dup,r.(?),"p.(Pro2467Glnfs*2), p.(Pro2467GlnfsTer2)",-,ACMG,likely pathogenic,g.216074149_216074167dup,g.215900807_215900825dup,"USH2A c7399_7400insAATAACGCTCCTGGCTCTC, p.Pro2467GlnfsX2",-,USH2A_002551,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1242,+/.,2,-,c.7451+3G>A,"r.spl, r.spl?",p.?,-,-,"pathogenic, pathogenic (recessive)",g.216074094C>T,g.215900752C>T,-,-,USH2A_001512,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Xu 2014",-,rs397518030,Germline,-,1/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1243,"+/+, +/.",2,40,c.7452-68_7594+942del,"r.?, r.spl",p.(Leu2485Thrfs*25),Fibronectin type-III 11 (2435-2528),-,pathogenic,g.216072477_216073629del,g.215899135_215900287del,"deletion of exon 40, USH2A exon 40 deleted c.7452-68_7594+942del, p.(Leu2485Thrfs*25)",-,USH2A_000796,Heterozygous; Pathogenic,"PubMed: Le Quesne Stabej 2012, PubMed: Steele-Stallard 2013",-,-,Germline,yes,-,-,-,-,Maria Bitner-Glindzicz
1244,"+?/., ?/.",2,-,c.7452-15_7452-5del,"r.spl, r.spl?","p.(?), p.?",-,ACMG,"likely pathogenic, VUS",g.216073567_216073577del,g.215900225_215900235del,"USH2A c.7452-15_7452-5delTTATTTCCCAT, -",-,USH2A_002550,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1245,"+?/., ?/.",2,40,c.7475C>T,r.(?),p.(Ser2492Leu),-,ACMG,"likely pathogenic (recessive), VUS",g.216073536G>A,g.215900194G>A,"1:216073536G>A ENST00000307340.3:c.7475C>T (Ser2492Leu), USH2A c.7475C>T, p.S2492L",-,USH2A_001818,with two variants in EYS gene,"PubMed: Carss 2017, PubMed: Zhu 2021",-,-,Germline,yes,-,-,-,-,LOVD
1246,"+/?, ?/.",2,40,c.7488A>G,r.(?),"p.(=), p.(Glu2496=)",Fibronectin type-III 11 (2435-2528),ACMG,"likely pathogenic, VUS",g.216073523T>C,g.215900181T>C,-,-,USH2A_000675,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,0/200 controls,+MnlI;+HphI;,-,-,"David Baux, Jose Maria Millan"
1247,"+/+, +?/.",2,40,c.7493del,r.(?),p.(Ser2498Metfs*30),Fibronectin type-III 11 (2435-2528),-,"likely pathogenic, pathogenic",g.216073518del,g.215900176del,7493delG,-,USH2A_000397,Heterozygous,"PubMed: Sandberg 2008, PubMed: Stone 2017",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1248,-/?,2,40i,c.7595-110del,r.(=),p.(=),-,ACMG,likely benign,g.216062507del,g.215889165del,7595-110delC,-,USH2A_000624,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,-,Germline,-,-,none,-,-,Maria Bitner-Glindzicz
1249,+/.,2,_41_42_,c.(7594+1_7595-1)_(8558+1_8559-1)del,r.(?),p.(?),-,-,pathogenic,g.?,g.?,"USH2A EX41-42del, -",-,NPHS2_000000,heterozygous,PubMed: Qu 2020,-,-,Germline,yes,-,-,-,-,LOVD
1250,+/.,2,41,c.7660C>T,r.(?),p.(Gln2554*),-,-,"pathogenic, pathogenic (recessive)",g.216062331G>A,g.215888989G>A,c.7660C>T:p.Q2554X,-,USH2A_001510,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Numa-2020",-,-,"Germline, Unknown",-,2/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1251,"+/+, +?/.",2,41,c.7697del,r.(?),"p.(Tyr2566Leufs*11), p.(Tyr2566LeufsTer11)",Fibronectin type-III 12 (2533-2619),ACMG,"likely pathogenic, pathogenic",g.216062294del,g.215888952del,7697delA,-,USH2A_001015,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1252,+?/.,2,-,c.7789A>T,r.(?),p.(Lys2597*),-,-,likely pathogenic,g.216062202T>A,g.215888860T>A,"USH2A c.7789A>T, USH2A c.7789A>T, p.Lys2597Ter",-,USH2A_002382,"heterozygous, protein variant annotation not written; heterozygous","PubMed: Toms 2020, PubMed: Turro 2020",-,-,"Germline/De novo (untested), Unknown",?,-,-,-,-,LOVD
1253,+/.,2,-,c.7853G>A,r.(?),p.(Trp2618Ter),-,ACMG,pathogenic,g.216062138C>T,g.215888796C>T,-,-,USH2A_001363,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, VKGL data sharing initiative Nederland","PubMed: Garcia-Garcia, G. et al., 2011",-,-,"CLASSIFICATION record, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_Nijmegen"
1254,"+/+, +/.",2,41,c.7854G>A,r.(?),p.(Trp2618*),Fibronectin type-III 12 (2533-2619),-,pathogenic,g.216062137C>T,g.215888795C>T,-,-,USH2A_000670,"Heterozygous; Pathogenic, VKGL data sharing initiative Nederland",PubMed: Jaijo 2010,-,-,"CLASSIFICATION record, Germline",-,-,none,-,-,"VKGL-NL_Nijmegen, Jose Maria Millan"
1255,+?/.,2,-,c.7863del,r.(?),"p.(Ala2623Hisfs*18), p.(Ala2623HisfsTer18)",-,ACMG,likely pathogenic,g.216062128del,g.215888786del,"7863delA, USH2A c.7863delA, p.2623HfsX18",-,USH2A_002298,"ACMG GN005 criteria: PVS1_VS PM2_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs2102460377,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1256,"+/+, +/.",2,41,c.7931G>A,r.(?),"p.(Trp2644*), p.(Trp2644Ter)",Fibronectin type-III 13 (2621-2718),-,pathogenic,g.216062060C>T,g.215888718C>T,-,-,USH2A_000467,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
1257,"+/., +?/.",2,-,c.7932G>A,r.(?),p.(Trp2644*),-,ACMG,"likely pathogenic (recessive), pathogenic (recessive)",g.216062059C>T,g.215888717C>T,-,-,USH2A_001765,-,"PubMed: Batissoco 2021, PubMed: Fuster-Garcia 2018",ClinVar-SCV001792225,-,Germline,yes,-,-,-,-,"Global Variome, with Curator vacancy, Karina Lezirovitz Mandelbaum"
1258,"+/., +?/.",2,-,c.7935_7936dup,r.(?),"p.(Pro2646Hisfs*29), p.(Pro2646HisfsTer29)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216062055_216062056dup,g.215888713_215888714dup,"7935_7936dupAC, c.7936_7937insAC",-,USH2A_001853,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1259,+?/.,2,41,c.7950_7951insG,r.(?),p.(Asn2651Glufs*10),-,-,"likely pathogenic, likely pathogenic (recessive)",g.216062040_216062041insC,g.215888698_215888699insC,c.7950_7951insG,-,USH2A_001104,-,"PubMed: Neveling 2013, PubMed: Neveling-2013",-,-,"Germline, Unknown",-,-,-,-,-,Marcel Nelen
1260,"+/., +?/.",2,-,c.7967del,r.(?),"p.(Asn2656Ilefs*18), p.(Asn2656IlefsTer18)",-,ACMG,"likely pathogenic, pathogenic",g.216062025del,g.215888683del,7967delA,-,USH2A_002017,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1261,?/.,2,-,c.8095C>T,r.(?),p.(Arg2699Trp),-,ACMG,VUS,g.216061896G>A,g.215888554G>A,"USH2A c.8095C>T, p.Arg2699Trp",-,USH2A_002547,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs771526931,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1262,"+?/?, ?/.",2,41,c.8099T>A,r.(?),p.(Val2700Glu),Fibronectin type-III 13 (2621-2718),ACMG,VUS,g.216061892A>T,g.215888550A>T,-,-,USH2A_001016,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1263,?/.,2,-,c.8137G>T,r.(?),p.(Ala2713Ser),-,-,VUS,g.216061854C>A,g.215888512C>A,"USH2A(NM_206933.2):c.8137G>T (p.A2713S), USH2A(NM_206933.4):c.8137G>T (p.A2713S)",-,USH2A_001205,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1264,"+/+, +/.",2,41,c.8143del,r.(?),"p.(Val2715*), p.(Val2715Ter)",Fibronectin type-III 13 (2621-2718),ACMG,pathogenic,g.216061850del,g.215888508del,8143delG,-,USH2A_001017,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1265,"+/., +?/.",2,-,c.8188C>T,r.(?),p.(Pro2730Ser),-,-,"likely pathogenic, pathogenic (recessive)",g.216061803G>A,g.215888461G>A,-,-,USH2A_001916,-,"PubMed: Consugar 2015, PubMed: Huang 2017",-,-,Germline,yes,-,-,-,-,LOVD
1266,+/.,2,-,c.8190_8193dup,r.(?),p.(Val2732CysfsTer26),-,ACMG,pathogenic,g.216061798_216061801dup,g.215888456_215888459dup,8190_8193dupTGTG,-,USH2A_002297,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Mansard 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1267,"+/+, +/.",2,41i,c.8223+1G>A,r.spl,p.?,-,ACMG,pathogenic,g.216061767C>T,g.215888425C>T,-,-,USH2A_000875,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Chen 2014, PubMed: Chen, X. et al., 2014",-,-,"Germline, SUMMARY record",-,0/300 controls,-,-,-,"David Baux, Anne-Françoise Roux"
1268,"+/., +?/.",2,-,c.8223+1G>C,"r.spl, r.spl?","p.(?), p.?",-,-,"likely pathogenic, pathogenic (recessive)",g.216061767C>G,g.215888425C>G,"1:216061767C>G ENST00000307340.3:c.8223+1G>C, USH2A c.8223+1G>C,",-,USH2A_001817,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1269,"+/., +?/.",2,-,c.8224-1G>C,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.216052441C>G,g.215879099C>G,"USH2A c.8224-1G>C, -",-,USH2A_002546,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021; PubMed: Tang, K. et al., 2021",-,rs1664846558,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1270,"+/+, +/.",2,42,c.8261del,r.(?),"p.(Ile2754Asnfs*15), p.(Ile2754AsnfsTer15)",Fibronectin type-III 14 (2724-2812),ACMG,pathogenic,g.216052403del,g.215879061del,8261delT,-,USH2A_000619,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Maria Bitner-Glindzicz"
1271,"+?/., -?/.",2,-,c.8320G>A,r.(?),p.(Ala2774Thr),-,-,"likely benign, likely pathogenic (recessive)",g.216052344C>T,g.215879002C>T,"1:216052344C>T ENST00000307340.3:c.8320G>A (Ala2774Thr), 1 more item",-,USH2A_001615,VKGL data sharing initiative Nederland,PubMed: Carss 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Rotterdam
1272,"+?/., ?/.",2,-,c.8372T>C,r.(?),p.(Val2791Ala),-,ACMG,"likely pathogenic (recessive), VUS",g.216052292A>G,g.215878950A>G,-,-,USH2A_001852,ACMG GN005 criteria: PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs375811539,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1273,+?/?,2,42,c.8383G>T,r.(?),p.(Ala2795Ser),Fibronectin type-III 14 (2724-2812),ACMG,VUS,g.216052281C>A,g.215878939C>A,-,-,USH2A_000100,"Heterozygous, Heterozygous; Mutation","PubMed: Baux 2007, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,-,-Cac8I,-,-,Anne-Françoise Roux
1274,"+?/., ?/.",2,42,c.8395G>C,r.(?),p.(Gly2799Arg),-,ACMG,"likely pathogenic (recessive), VUS",g.216052269C>G,g.215878927C>G,c.8395G>C,-,USH2A_002435,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1275,?/.,2,-,c.8426G>A,r.(?),p.(Ser2809Asn),-,ACMG,VUS,g.216052238C>T,g.215878896C>T,-,-,USH2A_002875,ACMG PM2,PubMed: Weisschuh 2024,-,-,Germline,-,-,-,-,-,Johan den Dunnen
1276,?/.,2,-,c.8440G>A,r.(?),p.(Val2814Ile),-,ACMG,VUS,g.216052224C>T,g.215878882C>T,"USH2A c.8440G>A, p.Val2814Ile",-,USH2A_002545,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs749817310,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1277,"+/., +?/.",2,-,c.8442dup,r.(?),"p.(Thr2815Tyrfs*20), p.(Thr2815TyrfsTer20)",-,ACMG,"likely pathogenic, pathogenic",g.216052223dup,g.215878881dup,"8442dupT, USH2A c.8442_8443insT, p.(?)",-,USH2A_002296,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs2102451706,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1278,"+/., +?/.",2,-,c.8483_8486del,r.(?),"p.(Ser2828*), p.(Ser2828Ter)",-,ACMG,"likely pathogenic, pathogenic",g.216052181_216052184del,g.215878839_215878842del,"8483_8486delCTGT, USH2A c.8483_8486del (p.Ser2828*)",-,USH2A_002653,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, homozygous","PubMed: Xing 2020, PubMed: Xing, D. et al., 2020",-,rs1199684717,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1279,+/.,2,42,c.8497dup,r.(?),"p.(Ser2833Lysfs*2), p.(Ser2833LysfsTer2)",-,ACMG,"pathogenic, pathogenic (recessive)",g.216052168dup,g.215878826dup,8497dupA,-,USH2A_001987,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1280,"+?/?, ?/.",2,42,c.8546G>T,r.(?),p.(Gly2849Val),Fibronectin type-III 15 (2821-2920),ACMG,VUS,g.216052118C>A,g.215878776C>A,-,-,USH2A_000883,"ACMG GN005 criteria: PM2_P, Heterozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1064794034,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1281,-/?,2,42i,c.8558+40C>A,"r.(=), r.(?)","p.(=), p.(?)",-,ACMG,likely benign,g.216052066G>T,g.215878724G>T,-,-,USH2A_000513,"Heterozygous, Heterozygous; UV1","PubMed: Baux 2014, PubMed: Le Quesne Stabej 2012",-,rs55713064,Germline,-,-,none,-,-,"Anne-Françoise Roux, Maria Bitner-Glindzicz"
1282,"+?/., ?/.",2,43,c.8576G>A,r.(?),p.(Arg2859His),-,-,"likely pathogenic, VUS",g.216051205C>T,g.215877863C>T,USH2A:NM_206933:exon43:c.8576G>A:p.R2859H,-,USH2A_002073,compound heterozygous,"PubMed: Chen 2020, PubMed: Guo 2021, Journal: Guo 2021",-,-,Germline,?,-,-,-,-,Johan den Dunnen
1283,"+/., ?/.",2,-,c.8600C>T,r.(?),p.(Ser2867Leu),-,-,"pathogenic, VUS",g.216051181G>A,g.215877839G>A,-,-,USH2A_001716,"1 heterozygous, no homozygous; Clinindb (India)","PubMed: Narang 2020, Journal: Narang 2020, PubMed: Wang 2017",-,rs145468090,Germline,-,1/2795 individuals,-,-,-,Mohammed Faruq
1284,-/-,2,43,c.8625G>A,r.(?),p.(=),Fibronectin type-III 15 (2821-2920),-,benign,g.216051156C>T,g.215877814C>T,-,-,USH2A_000372,Heterozygous,"PubMed: Aller 2004, PubMed: Najera 2002",-,-,Germline,-,-,+TspRI,-,-,Jose Maria Millan
1285,?/.,2,-,c.8631C>G,r.(?),p.(His2877Gln),-,ACMG,VUS,g.216051150G>C,g.215877808G>C,"USH2A:NM_206933 c.C8631G, p.H2877Q",-,USH2A_002238,"ACMG GN005 criteria: PM2_P, heterozygous, individual unsolved, causality of variants unknown","PubMed: Rodriguez-Munoz 2020, PubMed: Rodriguez-Munoz, A. et al., 2020",-,rs954532372,"Germline, SUMMARY record",?,-,-,-,-,David Baux
1286,+?/.,2,-,c.8671G>A,r.(?),p.(Gly2891Ser),-,-,likely pathogenic,g.216051110C>T,g.215877768C>T,"c.8671G>A, p.Gly2891Ser",-,USH2A_000001,"heterozygous, heterozygous, homozygous",PubMed: Gao 2019,-,-,Germline,?,-,-,-,-,LOVD
1287,"+/., +?/.",2,-,c.8681+1G>T,r.spl,p.?,-,ACMG,"likely pathogenic, pathogenic",g.216051099C>A,g.215877757C>A,-,-,USH2A_002015,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,rs876657733,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1288,+/?,2,43i,c.8682-17A>G,r.8682_8720del,p.Arg2894_Asn2906del,Fibronectin type-III 15 (2821-2920),ACMG,likely pathogenic,g.216040529T>C,g.215867187T>C,-,-,USH2A_000286,Heterozygous; del first 39 nt E44,PubMed: Le Guédard-Méreuze 2010,-,-,Germline,-,0/200 controls,-MseI,-,-,Anne-Françoise Roux
1289,+/.,2,43i,c.8682-1G>A,"r.spl, r.spl?",p.?,-,ACMG,pathogenic,g.216040513C>T,g.215867171C>T,-,-,USH2A_002059,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,rs1553271001,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1290,+/.,2,43i,c.8682-1G>T,r.spl,"p.(?), p.?",-,ACMG,pathogenic,g.216040513C>A,g.215867171C>A,"USH2A c.8682-1G>T, -",-,USH2A_002544,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P, heterozygous","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1291,+/+,2,44,c.8682-?_8845+?del,r.(?),p.(Arg2894Serfs*8),Fibronectin type-III 15 (2821-2920),-,pathogenic,g.216040349_216040512del,-,E14del,-,USH2A_000774,2 more items,"PubMed: Aparisi 2014, PubMed: Glöckle 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1292,"+?/?, ?/.",2,44,c.8698T>A,r.(?),"p.(Tyr2900Asn ), p.(Tyr2900Asn)",Fibronectin type-III 15 (2821-2920),ACMG,VUS,g.216040496A>T,g.215867154A>T,-,-,USH2A_001019,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1293,"+/., +?/.",2,44,c.8721T>A,r.(?),p.(Ser2907Arg),-,ACMG,"likely pathogenic, pathogenic",g.216040473A>T,g.215867131A>T,-,-,USH2A_001436,-,"Sharon, submitted, PubMed: Sharon 2019",-,-,Germline,-,1/2420 IRD families,-,-,-,"Global Variome, with Curator vacancy, Dror Sharon"
1294,"+/., +?/.",2,-,c.8769del,r.(?),"p.(Leu2924Phefs*20), p.(Leu2924PhefsTer20)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.216040425del,g.215867083del,"8769delT, c.8769delT",-,USH2A_001851,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1295,+?/.,2,-,c.8782G>T,r.(?),"p.(Gly2928*), p.(Gly2928Ter)",-,ACMG,likely pathogenic,g.216040412C>A,g.215867070C>A,"USH2A, variant 1: c.1390C>T/p.R464C, variant 2: c.8782G>T/p.G2928*",-,USH2A_002381,"ACMG GN005 criteria: PVS1_VS PM2_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1664490756,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1296,+/+,2,44,c.8835G>A,r.(?),p.(Trp2945*),Fibronectin type-III 16 (2925-3015),-,pathogenic,g.216040359C>T,g.215867017C>T,-,-,USH2A_000323,Heterozygous,"PubMed: Baux 2014, PubMed: Seyedahmadi 2004",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1297,"-/-, -?/.",2,44i,c.8845+9G>A,r.(=),p.(=),-,-,"benign, likely benign",g.216040340C>T,g.215866998C>T,USH2A(NM_206933.2):c.8845+9G>A,-,USH2A_000090,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2007,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, Anne-Françoise Roux"
1298,"+/., +/?",2,45i,c.8845+628C>T,r.(=),p.(=),-,ACMG,"likely pathogenic, pathogenic",g.216039721G>A,g.215866379G>A,USH2A(NM_206933.4):c.8845+628C>T,-,USH2A_000948,"Heterozygous; induces inclusion 179 and 219 bp (pseudo-exons) in minigenes, 1 more item",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,0/366 controls,-,-,-,"VKGL-NL_AMC, Anne-Françoise Roux"
1299,-/-,2,44i,c.8846-52del,r.(=),p.(=),-,-,benign,g.216019436del,g.215846094del,8846-52delT,-,USH2A_000373,Heterozygous,"PubMed: Aller 2004, PubMed: Najera 2002",-,rs77889398,Germline,-,-,-,-,-,Jose Maria Millan
1300,"+/., +?/.",2,_45_49_,c.(8845+1_8846-1)_(9739+1_9740-1)del,r.(?),"p.(?), p.(Thr2949_Gly3247delinsSer)",-,ACMG,"likely pathogenic, pathogenic","g.(215799126_215813735)_(215846034_215867006)del, g.?",g.?,"USH2A Ex.13 c.2276G>T p.(Cys759Phe), Ex.45-49 c.(8845+1_8846-1)_(9739+1_9740-1)del",-,NPHS2_000000,compound heterozygous,"PubMed: Mansard et al, 2021, PubMed: Martin Merida 2019",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,Anne-Françoise Roux
1301,+?/.,2,42,c.8885T>G,r.(?),p.(Leu2962Arg),-,ACMG,"likely pathogenic (recessive), VUS",g.216019336A>C,g.215845994A>C,-,-,USH2A_002038,-,PubMed: Yoon 2015,-,-,"Germline, Germline/De novo (untested)",-,-,-,-,-,Jinu Han
1302,"+/., +?/.",2,-,c.8891G>A,r.(?),p.(Trp2964Ter),-,ACMG,"likely pathogenic, pathogenic",g.216019330C>T,g.215845988C>T,-,-,USH2A_002294,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1303,"+/., +?/.",2,-,c.8915del,r.(?),"p.(Ser2972Phefs*2), p.(Ser2972PhefsTer2)",-,ACMG,"likely pathogenic, pathogenic",g.216019306del,g.215845964del,8915delC,-,USH2A_002014,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Neuhaus 2017, PubMed: Neuhaus, C. et al., 2017",-,rs1263573781,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1304,"-?/., ?/.",2,-,c.9008T>C,r.(?),p.(Val3003Ala),-,ACMG,"likely benign, VUS",g.216019213A>G,g.215845871A>G,USH2A(NM_206933.4):c.9008T>C (p.V3003A),-,USH2A_001609,"ACMG GN005 criteria: BS2_S BP4_P, VKGL data sharing initiative Nederland","PubMed: Ganapathi, M. et al., 2022",-,rs138574386,"CLASSIFICATION record, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_VUmc"
1305,"+?/?, ?/.",2,45,c.9014G>C,r.(?),p.(Ser3005Thr),Fibronectin type-III 16 (2925-3015),ACMG,VUS,g.216019207C>G,g.215845865C>G,-,-,USH2A_001020,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1553268568,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1306,+?/.,2,-,c.9022dup,r.(?),"p.(Ser3008Lysfs*45), p.(Ser3008LysfsTer45)",-,ACMG,likely pathogenic,g.216019199dup,g.215845857dup,"9022dupA, USH2A c.9022_9023insA, p.Ser3008Lysfs45",-,USH2A_002543,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1307,?/.,2,-,c.9047G>A,r.(?),p.(Cys3016Tyr),-,ACMG,VUS,g.216019174C>T,g.215845832C>T,"USH2A c.9047G>A, p.Cys3016Tyr",-,USH2A_002542,"ACMG GN005 criteria: PM2_P BP4_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs759365458,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1308,"+/., +?/.",2,45i_47i,c.9055+100_9371+5544dup,"r.(9056_9371del), r.(?)","p.(?), p.?",-,-,"likely pathogenic, pathogenic",g.216005789_216019066dup,g.215832447_215845724dup,M21: Duplication Ex 46-47 c.9055 + 100_9371 + 5544dup; p.?,-,USH2A_001087,Tandem duplication of exons 46 and 47,PubMed: Gonzalez del Pozo 2018,-,-,Germline,yes,-,-,-,-,María González-del Pozo
1309,"+/+, +/.",2,45i,c.9056-1_9056inv,r.spl,p.?,-,ACMG,pathogenic,g.216017838_216017839inv,g.215844496_215844497inv,-,-,USH2A_001070,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1310,+/+,2,46,c.9186C>A,r.(?),p.(Tyr3062*),Fibronectin type-III 17 (3020-3105),-,pathogenic,g.216017708G>T,g.215844366G>T,-,-,USH2A_000254,Heterozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1311,"+/., +?/.",2,-,c.9237_9240del,r.(?),"p.(Phe3080Leufs*16), p.(Phe3080LeufsTer16)",-,ACMG,"likely pathogenic, pathogenic",g.216017655_216017658del,g.215844313_215844316del,"USH2A c.9237_9240del, p.Phe3080Leufs16",-,USH2A_002541,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1312,+/+,2,47,c.9259-2402_9371+1537del,r.?,p.(Val3087Ilefs*5),"Fibronectin type-III 17 (3020-3105), Fibronectin type-III 18 (3110-3200), 1 more item",-,pathogenic,g.216009801_216013852del,g.215836459_215840510del,-,-,USH2A_000729,"Heterozygous, Heterozygous; mutation","PubMed: Baux 2014, PubMed: Bonnet 2016",-,-,Germline,-,-,-,-,-,"Anne-Françoise Roux, Crystel Bonnet"
1313,"+/., +?/.",2,,c.(9258+1_9259-1)_(9371+1_9372-1)del,"r.(?), r.spl",p.(?),-,ACMG,"likely pathogenic, pathogenic",g.?,g.?,"USH2A c.?, -, USH2A EX47Del, p.Cys934Trp",-,NPHS2_000000,heterozygous,"PubMed: Gao 2021, PubMed: Meng 2020",-,-,Unknown,?,-,-,-,-,LOVD
1314,"+/+, +?/.",2,47,c.9261del,r.(?),"p.(Glu3088Lysfs*9), p.(Glu3088LysfsTer9)",Fibronectin type-III 17 (3020-3105),ACMG,"likely pathogenic, pathogenic",g.216011444del,g.215838102del,9261delT,-,USH2A_000679,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; Pathogenic","PubMed: Garcia-Garcia 2011, PubMed: Garcia-Garcia, G. et al., 2011",-,-,"Germline, SUMMARY record",-,-,+HphI,-,-,"David Baux, Jose Maria Millan"
1315,"-?/., ?/.",2,47,c.9286G>A,r.(?),p.(Val3096Met),-,-,"likely benign, VUS",g.216011418C>T,g.215838076C>T,"c.9286G>A, USH2A(NM_206933.2):c.9286G>A (p.V3096M)",-,USH2A_001191,VKGL data sharing initiative Nederland,PubMed: Men-2017,-,rs147267500,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Rotterdam
1316,"+?/., ?/.",2,-,c.9328C>G,r.(?),p.(Pro3110Ala),-,ACMG,"likely pathogenic, VUS",g.216011376G>C,g.215838034G>C,"USH2A c.C9328G, p.P3110A",-,USH2A_002540,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Zhu 2020, PubMed: Zhu, X. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1317,"+?/., ?/.",2,-,c.9371+3A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, VUS",g.216011330T>C,g.215837988T>C,"USH2A c.9371+3A>G, p.(?)",-,USH2A_002289,"ACMG GN005 criteria: PM2_P PM3_M PP3_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1318,+/.,2,48,c.9433_9437delinsAGGAGATCATATCCATTCCATAGGA,r.(?),"p.(Leu3145Argfs*22), p.(Leu3145ArgfsTer22)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215990472_215990476delinsTCCTATGGAATGGATATGATCTCCT,g.215817130_215817134delinsTCCTATGGAATGGATATGATCTCCT,c.9433_9437delinsAGGAGATCATATCCATTCCATAGGA,-,USH2A_002431,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1319,"-/., -?/.",2,-,c.9459C>T,r.(?),p.(Cys3153=),-,-,"benign, likely benign",g.215990450G>A,g.215817108G>A,"USH2A(NM_206933.2):c.9459C>T (p.C3153=), USH2A(NM_206933.4):c.9459C>T (p.C3153=)",-,USH2A_001602,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1320,?/.,2,-,c.9593A>G,r.(?),p.(Tyr3198Cys),-,ACMG,VUS,g.215987224T>C,g.215813882T>C,"USH2A c.9593A>G, p.Tyr3198Cys",-,USH2A_002538,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs772611054,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1321,"+/., +?/.",2,-,c.9682C>T,r.(?),"p.(Gln3228*), p.(Gln3228Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215987135G>A,g.215813793G>A,"USH2A, variant 1: c.9682C>T/p.Q3228*, variant 2: c.9682C>T/p.Q3228*",-,USH2A_002380,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1662772955,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1322,"+/., +?/.",2,-,c.9699del,r.(?),"p.(His3234Ilefs*67), p.(His3234IlefsTer67)",-,ACMG,"likely pathogenic, pathogenic",g.215987118del,g.215813776del,"9699delT, USH2A c.9699delT, p.His3234Ilefs*67",-,USH2A_002537,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1323,-/.,2,-,c.9723C>T,r.(?),p.(Tyr3241=),-,-,benign,g.215987094G>A,g.215813752G>A,"USH2A(NM_206933.2):c.9723C>T (p.Y3241=), USH2A(NM_206933.4):c.9723C>T (p.Y3241=)",-,USH2A_001599,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1324,+/.,2,-,c.9739+2T>C,r.spl?,p.?,-,-,pathogenic,g.215987076A>G,g.215813734A>G,USH2A(NM_206933.4):c.9739+2T>C,-,USH2A_001186,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1325,"+/., +?/.",2,-,c.9740-1G>T,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215972468C>A,g.215799126C>A,"USH2A c.9740-1G>T, p.(?)",-,USH2A_002287,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1326,+/.,2,50,c.9770dup,r.(?),p.(Asn3257Lysfs*9),-,-,pathogenic (recessive),g.215972438dup,g.215799096dup,-,-,USH2A_000486,possible duplicate,"PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1327,"+/., +?/.",2,-,c.9785G>T,r.(?),p.(Gly3262Val),-,-,"likely pathogenic, pathogenic (recessive)",g.215972422C>A,g.215799080C>A,"1:215972422C>A ENST00000307340.3:c.9785G>T (Gly3262Val), USH2A c.9785G>T, p.Gly3262Val",-,USH2A_001813,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1328,"+/+, +?/.",2,50,c.9791del,r.(?),"p.(Gly3264Valfs*37), p.(Gly3264ValfsTer37)",Cystein rich (3192-3358),ACMG,"likely pathogenic, pathogenic",g.215972417del,g.215799075del,9791delG,-,USH2A_001024,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1329,?/.,2,-,c.9813G>A,r.(?),p.(Met3271Ile),-,-,VUS,g.215972394C>T,g.215799052C>T,-,-,USH2A_001495,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Xu 2014",-,rs137876918,Germline,-,"1/314 case chromosomes, 2/1204 cases with retinitis pigmentosa",-,-,-,Yoshito Koyanagi
1330,-/?,2,50,c.9862G>C,r.(?),p.(Asp3288His),Cystein rich (3192-3358),ACMG,likely benign,g.215972345C>G,g.215799003C>G,-,-,USH2A_000720,Heterozygous,"PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,Germline,-,-,+MslI;-BccI;-BspHI;-Hpy188III;,-,-,"Anne-Françoise Roux, Crystel Bonnet"
1331,?/.,2,-,c.9922G>A,r.(?),p.(Gly3308Ser),-,ACMG,VUS,g.215972285C>T,g.215798943C>T,USH2A(NM_206933.4):c.9922G>A (p.G3308S),-,USH2A_001597,"ACMG GN005 criteria: PM2_P, VKGL data sharing initiative Nederland","PubMed: Sloan-Heggen, C. M. et al., 2016",-,rs752811693,"CLASSIFICATION record, SUMMARY record",-,-,-,-,-,"David Baux, VKGL-NL_AMC"
1332,?/.,2,50,c.9949C>T,"r.(9949c>u), r.(?)",p.(Arg3317Cys),-,ACMG,VUS,g.215972258G>A,g.215798916G>A,USH2A(NM_206933.2):c.9949C>T (p.R3317C),-,USH2A_001784,VKGL data sharing initiative Nederland,"PubMed: Reurink 2023, Journal: Reurink 2023",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, Janine Reurink"
1333,+/.,2,-,c.9959-2A>G,r.spl?,p.?,-,-,pathogenic,g.215963626T>C,g.215790284T>C,USH2A(NM_206933.4):c.9959-2A>G,-,USH2A_001183,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1334,"-?/-, ?/.",2,51,c.9959G>A,r.(?),p.(Gly3320Asp),Cystein rich (3192-3358),ACMG,"likely benign, VUS",g.215963624C>T,g.215790282C>T,-,-,USH2A_000709,"Heterozygous; unknown, VKGL data sharing initiative Nederland","PubMed: Neveling 2012, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-BspMI;-BfuAI;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
1335,+?/.,2,-,c.9976C>T,r.(?),p.(Gln3326*),-,-,"likely pathogenic, likely pathogenic (recessive)",g.215963607G>A,g.215790265G>A,"1:215963607G>A ENST00000307340.3:c.9976C>T (Gln3326Ter), USH2A c.9976C>T",-,USH2A_001810,protein variant annotation not written; heterozygous,"PubMed: Carss 2017, PubMed: Toms 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1336,+?/.,2,-,c.10008C>A,r.(?),"p.(Cys3336*), p.(Cys3336Ter)",-,-,"likely pathogenic, likely pathogenic (recessive)",g.215963575G>T,g.215790233G>T,-,-,USH2A_001763,-,"PubMed: Fuster-Garcia 2018, PubMed: Perez-Carro 2016",-,-,Germline,-,-,-,-,-,"Global Variome, with Curator vacancy"
1337,"-?/., ?/.",2,-,c.10012T>A,r.(?),p.(Ser3338Thr),-,-,"likely benign, VUS",g.215963571A>T,g.215790229A>T,"USH2A(NM_206933.2):c.10012T>A (p.S3338T), USH2A(NM_206933.4):c.10012T>A (p.S3338T)",-,USH2A_001596,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1338,"+/+, +?/.",2,51,c.10102C>T,r.(?),"p.(Gln3368*), p.(Gln3368Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215963481G>A,g.215790139G>A,-,-,USH2A_000673,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; Neutral","PubMed: Garcia-Garcia, G. et al., 2011, PubMed: Jaijo 2010",-,-,"Germline, SUMMARY record",-,-,+AluI;+BfaI;,-,-,"David Baux, Jose Maria Millan"
1339,"+?/., ?/.",2,-,c.10116T>A,r.(?),p.(Asn3372Lys),-,ACMG,"likely pathogenic, VUS",g.215963467A>T,g.215790125A>T,"USH2A c.10116T>A, p.N3372K",-,USH2A_002284,"ACMG GN005 criteria: PM2_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs202172477,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1340,"+/., +?/.",2,51i,c.10182+1G>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215963400C>T,g.215790058C>T,USH2A c.10182+1G>A,-,USH2A_001912,"single heterozygous variant in a recessive disesase, no second allele","PubMed: Soens 2017, PubMed: Zhu 2021",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1341,-/-,2,51i,c.10182+53T>A,r.(=),p.(=),-,-,benign,g.215963348A>T,g.215790006A>T,-,-,USH2A_000302,Heterozygous,"PubMed: Baux 2014, PubMed: Le Guédard-Méreuze 2010",-,-,Germline,-,-,none,-,-,Anne-Françoise Roux
1342,+/.,2,-,c.10183-2A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,pathogenic,g.215960218T>C,g.215786876T>C,-,-,USH2A_002283,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1661818720,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1343,"+/+, +/.",2,51,c.10183G>T,r.(?),"p.(Glu3395*), p.(Glu3395Ter)",-,ACMG,pathogenic,g.215960216C>A,g.215786874C>A,-,-,USH2A_001025,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs2102767109,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1344,"+?/., ?/.",2,-,c.10274G>T,r.(?),p.(Cys3425Phe),-,ACMG,"likely pathogenic (recessive), VUS",g.215960125C>A,g.215786783C>A,-,-,USH2A_001849,ACMG GN005 criteria: PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs200328442,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1345,+/.,2,-,c.10334C>A,r.(?),p.(Ser3445Ter),-,ACMG,pathogenic,g.215960065G>T,g.215786723G>T,-,-,USH2A_002281,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1346,"+/., +?/.",2,-,c.10353_10356del,r.(?),"p.(His3452Glnfs*4), p.(His3452GlnfsTer4)",-,ACMG,"likely pathogenic, pathogenic",g.215960046_215960049del,g.215786704_215786707del,"10353_10356delTCAT, USH2A c.10353_10356delTCAT, p.(His3452Glnfs*4)",-,USH2A_002647,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1347,-?/.,2,-,c.10398C>G,r.(?),p.(Leu3466=),-,-,likely benign,g.215956267G>C,-,"USH2A(NM_206933.2):c.10398C>G (p.L3466=), USH2A(NM_206933.4):c.10398C>G (p.L3466=)",-,USH2A_001848,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1348,"+/+, ?/.",2,53,c.10414_10417dup,r.(?),"p.(Thr3471_Tyr3472insTyr), p.(Tyr3472dup)",Fibronectin type-III 19 (3404-3494),ACMG,"pathogenic, VUS",g.215956248_215956251dup,g.215782906_215782909dup,-,-,USH2A_000174,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Aller 2006, PubMed: Aller, E. et al., 2006",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Jose Maria Millan"
1349,"+?/., ?/.",2,53,c.10429T>C,r.(?),p.(Ser3477Pro),-,ACMG,"likely pathogenic (recessive), VUS",g.215956236A>G,g.215782894A>G,c.10429T>C,-,USH2A_002429,ACMG GN005 criteria: PM2_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1350,?/.,2,-,c.10451G>A,r.(?),p.(Arg3484Gln),-,-,VUS,g.215956214C>T,g.215782872C>T,-,-,USH2A_001888,-,PubMed: Bryant 2018,-,rs771999994,Germline,-,-,-,-,-,LOVD
1351,"+?/?, ?/.",2,53,c.10481C>G,r.(?),p.(Thr3494Arg),Fibronectin type-III 19 (3404-3494),ACMG,VUS,g.215956184G>C,g.215782842G>C,-,-,USH2A_001026,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs1661681799,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1352,+?/.,2,-,c.10488_10490del,r.(?),p.(Glu3496del),-,-,likely pathogenic,g.215956179_215956181del,g.215782837_215782839del,"c.10488_10490del p.(Glu3496deI), c.12954C>A p.(Tyr4318*), 1 more item",-,USH2A_002208,-,PubMed: Hagag 2020,-,-,Germline/De novo (untested),?,-,-,-,-,LOVD
1353,"+?/., ?/.",2,-,c.10490A>G,r.(?),p.(Asp3497Gly),-,ACMG,"likely pathogenic, VUS",g.215956175T>C,g.215782833T>C,"USH2A c.10490A>G, p.D3497G",-,USH2A_002280,"ACMG GN005 criteria: PP3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs146569216,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1354,"+?/., ?/.",2,-,c.10495C>A,r.(?),p.(Pro3499Thr),-,ACMG,"likely pathogenic, VUS",g.215956170G>T,g.215782828G>T,"USH2A, variant 1: c.2276G>T/p.C759F, variant 2: c.10495C>A/p.P3499T",-,USH2A_002379,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1553261461,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1355,"+?/., ?/.",2,-,c.10495C>T,r.(?),p.(Pro3499Ser),-,ACMG,"likely pathogenic, VUS",g.215956170G>A,g.215782828G>A,"USH2A c.10495C>T, p.(Pro3499Ser)",-,USH2A_002646,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1356,+?/.,2,-,c.10582A>G,r.(?),p.(Asn3528Asp),-,ACMG,likely pathogenic,g.215956083T>C,g.215782741T>C,"USH2A c.[100_101insT];[10582A>G], V2: c.10582A>G, (p.Asn3528Asp), 1 more item",-,USH2A_002468,"alleles in trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline, Unknown","?, yes",Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0.00000399,-,-,-,LOVD
1357,-/-,2,53i,c.10585+38C>G,r.(=),p.(=),Fibronectin type-III 20 (3499-3585),-,benign,g.215956042G>C,g.215782700G>C,-,-,USH2A_000080,Heterozygous,PubMed: Baux 2007,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1358,?/.,2,54,c.10588C>A,r.(?),p.(Pro3530Thr),-,ACMG,VUS,g.215955536G>T,g.215782194G>T,"USH2A c.10588C>A, p.(Pro3530Thr)",-,USH2A_002232,"ACMG GN005 criteria: PM2_P BP4_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,rs1298379123,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1359,+/.,2,-,c.10636G>T,r.(?),"p.(Gly3546*), p.(Gly3546Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215955488C>A,g.215782146C>A,-,-,USH2A_001846,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs1553261372,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1360,-/-,2,54i,c.10741-97G>A,r.(=),p.(=),-,-,benign,g.215953480C>T,g.215780138C>T,-,-,USH2A_000803,Homozygous,PubMed: Baux 2014,-,rs7514451,Germline,-,-,-,-,-,Anne-Françoise Roux
1361,?/.,2,-,c.10763G>C,r.(?),p.(Gly3588Ala),-,-,VUS,g.215953361C>G,g.215780019C>G,"USH2A(NM_206933.2):c.10763G>C (p.G3588A), USH2A(NM_206933.4):c.10763G>C (p.G3588A)",-,USH2A_001594,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1362,+/.,2,55,c.10830G>A,r.(?),p.(Trp3610*),-,-,pathogenic,g.215953294C>T,g.215779952C>T,"USH2A c.10830G>A, (p.W3610X), USH2A(NM_206933.2):c.10830G>A (p.W3610*)",-,USH2A_002191,VKGL data sharing initiative Nederland,PubMed: Koparir 2015,-,-,"CLASSIFICATION record, Germline",yes,-,-,-,-,VKGL-NL_Rotterdam
1363,"+?/., ?/.",2,55,c.10830G>C,r.(?),p.(Trp3610Cys),-,ACMG,"likely pathogenic, VUS","g.215779952C>G, g.215953294C>G","g.215671166C>G, g.215779952C>G","NM_206933.2:c.10830G>C, NP_996816.2:p.(Trp3610Cys), NC_000001.10:g.215953294C>G, 1 more item",-,USH2A_002141,-,"PubMed: Sun 2020, PubMed: Wang 2018",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1364,"+/+, +/.",2,55,c.10890del,r.(?),"p.(Gly3631Valfs*43), p.(Gly3631ValfsTer43)",Fibronectin type-III 21 (3590-3676),ACMG,pathogenic,g.215953236del,g.215779894del,"10888delA, 10890delA",-,USH2A_000905,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; UV4","PubMed: Aparisi 2014, PubMed: Aparisi, M. J. et al., 2014",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1365,"+/., +?/.",2,-,c.10903A>C,r.(?),p.(Thr3635Pro),-,-,"likely pathogenic, pathogenic (recessive)",g.215953221T>G,g.215779879T>G,"c.10903A>C, p.Thr3635Pro",-,USH2A_002051,heterozygous,"PubMed: Gao 2019, PubMed: Xu 2014",-,-,Germline,?,-,-,-,-,LOVD
1366,"+/., +?/.",2,-,c.10928del,r.(?),p.(His3643LeufsTer31),-,ACMG,"likely pathogenic, pathogenic",g.215953196del,g.215779854del,"10928delA, USH2A c.10928delA, p.H3643fs",-,USH2A_002415,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1367,"+/., +?/.",2,56,c.10975dup,r.(?),"p.(Thr3659Asnfs*24), p.(Thr3659AsnfsTer24)",-,ACMG,"likely pathogenic, pathogenic",g.215940095dup,g.215766753dup,"10975dupA, c.10975dup",-,USH2A_002426,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1368,"+?/., ?/.",2,-,c.10996T>G,r.(?),p.(Cys3666Gly),-,-,"likely pathogenic, VUS",g.215940074A>C,g.215766732A>C,USH2A c.10996T>G,-,USH2A_001972,protein variant annotation not written; heterozygous,"PubMed: Ellingford 2016, PubMed: Toms 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1369,"+?/?, ?/.",2,56,c.11007C>A,r.(?),p.(Ser3669Arg),Fibronectin type-III 21 (3590-3676),ACMG,VUS,g.215940063G>T,g.215766721G>T,-,-,USH2A_000705,"Heterozygous; Predicted pathogenic, VKGL data sharing initiative Nederland","PubMed: Neveling 2012, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,+Hpy188III;-MwoI;-Cac8I;,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
1370,"+?/?, ?/.",2,56,c.11027C>T,r.(?),p.(Thr3676Ile),Fibronectin type-III 21 (3590-3676),ACMG,VUS,g.215940043G>A,g.215766701G>A,-,-,USH2A_001027,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1371,+?/.,2,56i_60i,c.(11047+1_11048-1)_(11711+1_11712-1)dup,"r.?, r.spl","p.(?), p.?",-,-,likely pathogenic,"g.(215901727_215914716)_(215933186_215940022)dup, g.?",g.?,"c.(11048+1_11049-1)_(11711+1_11712-1)dup, 1 more item",-,"NPHS2_000000, USH2A_002360",compound heterozygous,"PubMed: Ellingsford 2018, PubMed: Jiman 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1372,"+/., +?/.",2,-,c.11103T>A,r.(?),p.(Tyr3701*),-,-,"likely pathogenic, pathogenic",g.215933130A>T,g.215759788A>T,USH2A p.(Tyr3701*),-,USH2A_001484,1 more item,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Koyanagi 2020",-,-,"Germline, Unknown",?,1/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1373,"+?/., ?/.",2,-,c.11129G>A,r.(?),p.(Gly3710Asp),-,ACMG,"likely pathogenic, VUS",g.215933104C>T,g.215759762C>T,"USH2A, variant 1: c.2299del/p.E767Sfs*21, variant 2: c.11129G>A/p.G3710D",-,USH2A_002378,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs764113446,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1374,?/.,2,57,c.11134G>A,r.(?),p.(Val3712Ile),-,-,VUS,g.215933099C>T,g.215759757C>T,G11134A,-,USH2A_001483,-,"PubMed: Katagiri 2014, PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs201951918,Germline,-,1/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1375,"+/+, +/.",2,57,c.11145T>G,r.(?),"p.(Tyr3715*), p.(Tyr3715Ter)",Fibronectin type-III 22 (3677-3767),ACMG,pathogenic,g.215933088A>C,g.215759746A>C,-,-,USH2A_001028,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs727504608,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1376,+/+,2,57,c.11194C>T,r.(?),p.(Gln3732*),Fibronectin type-III 22 (3677-3767),-,pathogenic,g.215933039G>A,g.215759697G>A,-,-,USH2A_000925,Homozygous,PubMed: Sodi 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1377,+?/.,2,-,c.11198dup,r.(?),"p.(Asn3733Lysfs*4), p.(Asn3733LysfsTer4)",-,ACMG,likely pathogenic,g.215933036dup,g.215759694dup,"11198dupA, USH2A c.11198_11199insA, p.Asn3733Lysfs4",-,USH2A_002532,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1378,+?/.,2,57,c.11208dup,r.(?),"p.(Lys3737*), p.(Lys3737Ter)",-,ACMG,likely pathogenic,g.215933025dup,g.215759683dup,"11208dupT, USH2A c.11208_11209insT, p.(Lys3737*)",-,USH2A_002231,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1379,"+/., +?/.",2,-,c.11238_11241dup,r.(?),"(Lys3748LeufsTer14), p.(Lys3748Leufs*14)",-,ACMG,"likely pathogenic, pathogenic",g.215932087_215932090dup,g.215758745_215758748dup,"11241_11242insTTAC, USH2A c.11241_11242insTTAC, p.Tyr3747TyrfsX15",-,USH2A_002531,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1380,"+?/., ?/.",2,58,c.11266G>A,r.(?),p.(Gly3756Ser),-,-,"likely pathogenic, VUS",g.215932060C>T,g.215758718C>T,"c.11266G>A, USH2A(NM_206933.2):c.11266G>A (p.(Gly3756Ser))",-,USH2A_001174,VKGL data sharing initiative Nederland,PubMed: Foote-2019,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Leiden
1381,+/+,2,58,c.11284dup,r.(?),p.(Asp3762Glyfs*19),Fibronectin type-III 22 (3677-3767),-,pathogenic,g.215932042dup,g.215758700dup,11284dupG,-,USH2A_000804,Homozygous,PubMed: Baux 2014,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1382,+/.,2,58,c.11357del,r.(?),"p.(Pro3786Leufs*6), p.(Pro3786LeufsTer6)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215931970del,g.215758628del,11357delC,-,USH2A_001986,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",?,-,-,-,-,"David Baux, Barbara Vona"
1383,+?/.,2,58,c.11387C>T,r.(?),p.(Pro3796Leu),-,ACMG,"likely pathogenic, likely pathogenic (recessive)",g.215931939G>A,g.215758597G>A,-,-,USH2A_001558,"ACMG PM1, PM2, PP1, PP3, PP4",PubMed: Zenteno 2020,-,-,Germline,-,1/143 cases,-,-,-,"Johan den Dunnen, Juan Carlos Zenteno"
1384,+/.,2,58i,c.11389+1G>A,"r.spl, r.spl?",p.?,-,ACMG,"pathogenic, pathogenic (recessive)",g.215931936C>T,g.215758594C>T,-,-,USH2A_001557,"ACMG PVS1, PS*, PM2, PP4",PubMed: Zenteno 2020,-,-,Germline,-,1/143 cases,-,-,-,"Johan den Dunnen, Juan Carlos Zenteno"
1385,+/.,2,-,c.11389+2dupT,r.(?),p.(?),-,ACMG,pathogenic,g.215931935dup,-,-,-,USH2A_002275,-,"PubMed: Mansard et al, 2021",-,rs1414433033,Germline,-,-,-,-,-,Anne-Françoise Roux
1386,-/-,2,58i,c.11390-55C>T,r.(=),p.(=),-,-,benign,g.215916732G>A,g.215743390G>A,-,-,USH2A_000822,Heterozygous,PubMed: Baux 2014,-,rs4053764,Germline,-,-,-,-,-,Anne-Françoise Roux
1387,"+/+, +/.",2,58i,c.11390-1G>C,r.spl,p.?,-,ACMG,pathogenic,g.215916678C>G,g.215743336C>G,-,-,USH2A_000593,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,-,none,-,-,"David Baux, Maria Bitner-Glindzicz"
1388,+?/.,2,-,c.11404G>T,r.(?),p.(Glu3802*),-,-,likely pathogenic (recessive),g.215916663C>A,g.215743321C>A,-,-,USH2A_001761,-,PubMed: Fuster-Garcia 2018,-,-,Germline,-,-,-,-,-,"Global Variome, with Curator vacancy"
1389,"+/+, ?/.",2,59,c.11411del,r.(?),p.(Pro3804Leufs*13),Fibronectin type-III 23 (3768-3862),-,"pathogenic, VUS",g.215916657del,g.215743315del,11411delC,-,USH2A_000356,Heterozygous,"PubMed: Baux 2014, PubMed: Wang 2017",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1390,"+?/., ?/.",2,-,c.11506C>T,r.(?),p.(Pro3836Ser),-,ACMG,"likely pathogenic, VUS",g.215916561G>A,g.215743219G>A,"USH2A c.11506C>T, p.P3836S",-,USH2A_002274,"ACMG GN005 criteria:, compound heterozygous","PubMed: Ganapathi, M. et al., 2022; PubMed: Jauregui, R. et al., 2020, PubMed: Jauregui 2020",-,rs371987720,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1391,"+/., +?/.",2,-,c.11507C>T,r.(?),p.(Pro3836Leu),-,-,"likely pathogenic, pathogenic (recessive)",g.215916560G>A,g.215743218G>A,"1:215916560G>A ENST00000307340.3:c.11507C>T (Pro3836Leu), USH2A c.11507C>T, p.Pro3836Leu",-,USH2A_001808,heterozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1392,+?/.,2,-,c.11520_11523del,r.(?),"p.(Tyr3840*), p.(Tyr3840Ter)",-,ACMG,likely pathogenic,g.215916544_215916547del,g.215743202_215743205del,"USH2A c.11520_11523del, p.Tyr3840*fs1",-,USH2A_002530,"ACMG GN005 criteria: PVS1_VS PM2_P, 1 more item","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1393,"+/., ?/.",2,59,c.11524A>G,r.(?),p.(Ile3842Val),-,ACMG,"pathogenic, VUS",g.215916543T>C,g.215743201T>C,"USH2A c.11524A>G, p.I3842V",-,USH2A_002529,"ACMG GN005 criteria: PM2_P PM3_M BP4_P, heterozygous","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020",-,-,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1394,-?/?,2,59,c.11532A>G,r.(?),p.(Ile3844Met),Fibronectin type-III 23 (3768-3862),ACMG,likely benign,g.215916535T>C,g.215743193T>C,-,-,USH2A_000434,Homozygous; benign,"PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1395,+/.,2,-,c.11548+1G>A,r.spl,"p.(?), p.?",-,ACMG,pathogenic,g.215916518C>T,g.215743176C>T,"USH2A c.11548+1G>A, -",-,USH2A_002528,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1396,+/.,2,59i,c.11549-2A>G,r.spl,p.(?),-,ACMG,pathogenic,g.215914881T>C,g.215741539T>C,USH2A c.11549-2A>G,-,USH2A_002640,"single heterozygous variant in a recessive disesase, no second allele",PubMed: Zhu 2021,-,-,Unknown,?,-,-,-,-,LOVD
1397,"+/., ?/.",2,59i,c.11549-1G>T,r.spl,"p.(?), p.?",-,ACMG,"pathogenic, VUS",g.215914880C>A,g.215741538C>A,"USH2A c.11549-1G>T, -",-,USH2A_002527,"ACMG GN005 criteria: PVS1_VS PS1_S PM2_P PM3_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,rs878853407,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1398,+/+,2,60,c.11549-?_11711+?del,r.(?),p.(?),-,-,pathogenic,g.215914717_215914879del,-,-,-,USH2A_001029,1 more item,PubMed: Bonnet 2016,-,-,Germline,-,-,-,-,-,Crystel Bonnet
1399,+/.,2,-,c.11566delA,r.(?),p.(Ser3856ValfsTer28),-,ACMG,pathogenic,g.215914862del,-,-,-,USH2A_000681,-,"PubMed: Mansard et al, 2021",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1400,?/.,2,-,c.11648T>C,r.(?),p.(Ile3883Thr),-,ACMG,VUS,g.215914780A>G,g.215741438A>G,"USH2A c.11648T>C, p.Ile3883Thr",-,USH2A_002526,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs1226743721,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1401,"+?/., ?/.",2,60,c.11660G>C,r.(?),p.(Trp3887Ser),-,ACMG,"likely pathogenic (recessive), VUS",g.215914768C>G,g.215741426C>G,c.11660G>C,-,USH2A_002425,ACMG GN005 criteria: PM2_P PP3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1402,"+?/., ?/.",2,-,c.11660G>T,r.(?),p.(Trp3887Leu),-,ACMG,"likely pathogenic, VUS",g.215914768C>A,g.215741426C>A,"USH2A, variant 1: c.2276G>T/p.C759F, variant 2 :[c.11660G>T/p.W3887L; c.11699A>T/p.Y3900F]",-,USH2A_002377,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1660298900,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1403,"+?/?, ?/.",2,60,c.11680A>G,r.(?),p.(Asn3894Asp),Fibronectin type-III 24 (3863-3960),ACMG,VUS,g.215914748T>C,g.215741406T>C,-,-,USH2A_000668,"ACMG GN005 criteria: PM2_P PM3_M, Heterozygous; UV3","PubMed: Garcia-Garcia, G. et al., 2011, 1 more item",-,-,"Germline, SUMMARY record",-,0/200 controls,+BccI,-,-,"David Baux, Jose Maria Millan"
1404,"+?/., ?/.",2,-,c.11683G>A,r.(?),p.(Gly3895Arg),-,ACMG,"likely pathogenic, VUS",g.215914745C>T,g.215741403C>T,"USH2A c.11683G>A, p.Gly3895Arg",-,USH2A_002525,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1405,+?/.,2,-,c.11700C>A,r.(?),p.(Tyr3900*),-,-,"likely pathogenic, likely pathogenic (recessive)",g.215914728G>T,g.215741386G>T,"1:215914728G>T ENST00000307340.3:c.11700C>A (Tyr3900Ter), USH2A c.11700C>A",-,USH2A_001806,protein variant annotation not written; heterozygous,"PubMed: Carss 2017, PubMed: Toms 2020",-,-,"Germline, Unknown",?,-,-,-,-,LOVD
1406,+/.,2,-,c.11712-2A>C,r.spl,"p.(?), p.?",-,ACMG,pathogenic,g.215901728T>G,g.215728386T>G,"USH2A c.11712-2A>C(;)5603_5613del, V1: c.11712-2A>C,, USH2A c.11712-2A>C(;)5603_5613del; p.?",-,USH2A_002466,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0.0000546; GnomAD_All: 0.00000404,-,-,-,LOVD
1407,"+/., +?/.",2,-,c.11712-1G>A,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215901727C>T,g.215728385C>T,-,-,USH2A_002273,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1408,?/.,2,61,c.11714G>C,r.(?),p.(Arg3905Pro),-,ACMG,VUS,g.215901724C>G,g.215728382C>G,"USH2A c.11714G>C, p.(Arg3905Pro)",-,USH2A_002230,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Dan 2020, PubMed: Dan, H. et al., 2020",-,-,"Germline, SUMMARY record",?,-,-,-,-,David Baux
1409,"-/., -?/.",2,-,c.11794C>T,r.(?),p.(Leu3932=),-,-,"benign, likely benign",g.215901644G>A,g.215728302G>A,"USH2A(NM_206933.2):c.11794C>T (p.L3932=), USH2A(NM_206933.4):c.11794C>T (p.L3932=)",-,USH2A_001589,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1410,"+?/?, ?/.",2,61,c.11819A>G,r.(?),p.(Tyr3940Cys),Fibronectin type-III 24 (3863-3960),ACMG,VUS,g.215901619T>C,g.215728277T>C,-,-,USH2A_001031,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1411,"+/., +?/.",2,61,c.11875_11876delCA,r.(?),"p.(Gln3959Asnfs*53), p.(Gln3959AsnfsTer53)",-,ACMG,"likely pathogenic, pathogenic","g.215901562_215901563del, g.215901562_215901563delTG",-,"c.11875_1876delCA, p.Q3959Nfs*53",-,USH2A_000276,-,"PubMed: Mansard et al, 2021, PubMed: Wafa-2021",-,rs779791079,Germline,-,-,-,-,-,Anne-Françoise Roux
1412,"+?/., ?/.",2,61,c.11955G>C,r.(?),p.(Trp3985Cys),-,ACMG,"likely pathogenic (recessive), VUS",g.215901483C>G,g.215728141C>G,-,-,USH2A_001985,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,-,"Germline, SUMMARY record",?,-,-,-,-,"David Baux, Barbara Vona"
1413,"-/?, -?/.",2,61,c.11976T>C,r.(?),"p.(=), p.(Asn3992=)",Fibronectin type-III 25 (3961-4062),ACMG,likely benign,g.215901462A>G,g.215728120A>G,USH2A(NM_206933.2):c.11976T>C (p.N3992=),-,USH2A_000333,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Rotterdam, Anne-Françoise Roux"
1414,-/-,2,61i,c.12067-8262A>G,r.(=),p.(=),-,-,benign,g.215861980T>C,g.215688638T>C,-,-,USH2A_000946,Heterozygous; no splice defects in minigene,"Liquori et al., accepted",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1415,+/.,2,61i,c.12067-1G>C,"r.spl, r.spl?",p.?,-,ACMG,"pathogenic, pathogenic (recessive)",g.215853719C>G,g.215680377C>G,-,-,USH2A_001993,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Bahena 2021, PubMed: Bahena, P. et al., 2022",-,rs397517977,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Barbara Vona"
1416,+?/.,2,62,c.12153_12175del,r.(?),"p.(Glu4051Aspfs*40), p.(Glu4051AspfsTer40)",-,-,likely pathogenic,g.215853612_215853634del,g.215680270_215680292del,"12153_12175delAATTTTAAGCCCTTGGACTCTGA, 1 more item",-,USH2A_001992,compound heterozygous,"PubMed: Martin Merida 2019, PubMed: Perez-Carro 2016",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1417,"+/+, +/.",2,62,c.12175dup,r.(?),"p.(Ile4059Asnfs*40), p.(Ile4059AsnfsTer40)",Fibronectin type-III 25 (3961-4062),ACMG,pathogenic,g.215853610dup,g.215680268dup,12175dupA,-,USH2A_001034,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1418,"+/., ?/.",2,62,c.12241C>T,r.(?),p.(Arg4081Trp),-,ACMG,"pathogenic, VUS",g.215853544G>A,g.215680202G>A,"USH2A c.12241C>T, p.R4081W",-,USH2A_002520,"ACMG GN005 criteria:, heterozygous","PubMed: Qu 2020, PubMed: Qu, L. H. et al., 2020",-,rs144783615,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1419,?/.,2,62,c.12254T>A,r.(?),p.(Leu4085Gln),-,ACMG,VUS,g.215853531A>T,g.215680189A>T,"USH2A c.12254T>A, p.L4085Q, USH2A c.12254T>A, p.L4086Q",-,USH2A_002635,1 more item,PubMed: Zhu 2021,-,-,Germline,yes,-,-,-,-,LOVD
1420,+/.,2,-,c.12275_12279delinsTGTGATGTGATTAAGGT,r.(?),"p.(Arg4092delinsMet*), p.(Arg4092delinsMetTer)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215853506_215853510delinsACCTTAATCACATCACA,g.215680164_215680168delinsACCTTAATCACATCACA,c.12275_12279delGAACCinsTGTGATGTGATTAAGGT,-,USH2A_001842,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1421,?/.,2,-,c.12294+3A>G,r.spl?,p.?,-,-,VUS,g.215853488T>C,g.215680146T>C,USH2A(NM_206933.4):c.12294+3A>G,-,USH2A_001156,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1422,-/-,2,62i,c.12294+75G>A,r.(=),p.(=),-,-,benign,g.215853416C>T,g.215680074C>T,-,-,USH2A_000108,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014",-,rs55895740,Germline,-,-,-,-,-,Anne-Françoise Roux
1423,"+?/?, ?/.",2,63,c.12302_12304del,r.(?),p.(Asn4101del),Fibronectin type-III 26 (4066-4150),ACMG,VUS,g.215848952_215848954del,g.215675610_215675612del,12302_12304delACA,-,USH2A_001036,"ACMG GN005 criteria: PM2_P PM3_M PM4_M, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016; PubMed: Mansard, L. et al., 2021",-,rs1657997491,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1424,?/.,2,-,c.12302_12304delACA,r.(?),p.(Asn4101del),-,ACMG,VUS,g.215848949_215848951del,-,-,-,USH2A_002271,-,"PubMed: Mansard et al, 2021",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1425,"+?/., ?/.",2,-,c.12305T>A,r.(?),p.(Ile4102Asn),-,ACMG,"likely pathogenic, VUS",g.215848948A>T,g.215675606A>T,"USH2A c.12305T>A, p.(Ile4102Asn)",-,USH2A_002633,"ACMG GN005 criteria: PM2_P, 1 more item","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1426,"+/., +?/.",2,-,c.12309del,r.(?),p.(Phe4103Leufs*11),-,-,"likely pathogenic, pathogenic (recessive)",g.215848944del,g.215675602del,"1:215848943TG>T ENST00000307340.3:c.12309delC (Phe4103LeufsTer11), 1 more item",-,USH2A_001805,homozygous,"PubMed: Carss 2017, PubMed: Turro 2020",-,-,"Germline, Germline/De novo (untested)",?,-,-,-,-,LOVD
1427,"+?/., ?/.",2,-,c.12371C>G,r.(?),p.(Pro4124Arg),-,ACMG,"likely pathogenic, VUS",g.215848882G>C,g.215675540G>C,-,-,USH2A_001948,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Bravo-Gil 2017, PubMed: Bravo-Gil, N. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Nereida Bravo Gil"
1428,"+?/., ?/.",2,-,c.12383A>G,r.(?),p.(Tyr4128Cys),-,ACMG,"likely pathogenic, VUS",g.215848870T>C,g.215675528T>C,"USH2A c.12383A>G, p.(Tyr4128Cys)",-,USH2A_002632,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs2102667066,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1429,?/.,2,-,c.12404G>T,r.(?),p.(Cys4135Phe),-,ACMG,VUS,g.215848849C>A,g.215675507C>A,"USH2A c.G12404T, p.C4135F",-,USH2A_002414,"ACMG GN005 criteria: PM2_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1430,"+?/., ?/.",2,-,c.12407C>T,r.(?),p.(Thr4136Ile),-,ACMG,"likely pathogenic, VUS",g.215848846G>A,g.215675504G>A,"USH2A c.12407C>T, p.(Thr4136Ile)",-,USH2A_002631,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs1657992486,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1431,"+?/., ?/.",2,-,c.12418T>G,r.(?),p.(Cys4140Gly),-,ACMG,"likely pathogenic, VUS",g.215848835A>C,g.215675493A>C,"USH2A, variant 1: c.12418T>G/p.C4140G, variant 2: c.12418T>G/p.C4140G",-,USH2A_002375,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1657992030,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1432,?/.,2,-,c.12463C>T,r.(?),p.(Pro4155Ser),-,ACMG,VUS,g.215848790G>A,g.215675448G>A,-,-,USH2A_001476,"ACMG PP3, PM2","PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Weisschuh 2024",-,-,Germline,-,1/1204 cases with retinitis pigmentosa,-,-,-,"Johan den Dunnen, Yoshito Koyanagi"
1433,+?/.,2,-,c.12503C>A,r.(?),p.(Ser4168Tyr),-,ACMG,likely pathogenic,g.215848750G>T,g.215675408G>T,"USH2A c.12503C>A(;)13731_13743del, V1: c.12503C>A, (p.Ser4168Tyr), 1 more item",-,USH2A_002464,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,LOVD
1434,+?/.,2,-,c.12512T>G,r.(?),p.(Val4171Gly),-,-,likely pathogenic,g.215848741A>C,g.215675399A>C,-,-,USH2A_001901,-,"PubMed: Huang 2017, PubMed: Stone 2017",-,-,Germline,-,-,-,-,-,LOVD
1435,+?/.,2,-,c.12525G>T,r.(?),p.(Trp4175Cys),-,-,likely pathogenic,g.215848728C>A,g.215675386C>A,"c.12525G>T, p.Trp4175Cys",-,USH2A_001326,"heterozygous, VKGL data sharing initiative Nederland",PubMed: Zampaglione 2020,-,-,"CLASSIFICATION record, Unknown",?,-,-,-,-,VKGL-NL_Nijmegen
1436,"+?/., ?/.",2,-,c.12569T>A,r.(?),p.(Val4190Glu),-,ACMG,"likely pathogenic, VUS",g.215848684A>T,g.215675342A>T,-,-,USH2A_001946,ACMG GN005 criteria: PM2_P PM3_P PP3_P,"PubMed: Bravo-Gil 2017, PubMed: Bravo-Gil, N. et al., 2017",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Nereida Bravo Gil"
1437,"+/., ?/.",2,-,c.12569T>C,r.(?),p.(Val4190Ala),-,ACMG,"pathogenic, VUS",g.215848684A>G,g.215675342A>G,-,-,USH2A_001970,ACMG GN005 criteria: PM2_P PM3_M PP1_P,"PubMed: Bravo-Gil 2016, PubMed: Bravo-Gil, N. et al., 2016",-,rs979037444,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1438,+?/?,2,63,c.12700A>C,r.(?),p.(Thr4234Pro),Fibronectin type-III 27 (4154-4258),ACMG,VUS,g.215848553T>G,g.215675211T>G,-,-,USH2A_000935,Homozygous; UV3,"PubMed: Lenarduzzi 2015, USMA missense analysis, missense variant in MSV3d",-,rs577938494,Germline,-,-,-,-,-,Anne-Françoise Roux
1439,"-?/., ?/.",2,-,c.12701C>T,r.(?),p.(Thr4234Met),-,-,"likely benign, VUS",g.215848552G>A,g.215675210G>A,USH2A(NM_206933.2):c.12701C>T (p.T4234M),-,USH2A_001474,VKGL data sharing initiative Nederland,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,rs564240175,"CLASSIFICATION record, Germline",-,1/1204 cases with retinitis pigmentosa,-,-,-,"VKGL-NL_Rotterdam, Yoshito Koyanagi"
1440,+?/.,2,63,c.12719T>G,r.(?),p.(Ile4240Ser),-,ACMG,likely pathogenic,g.215848534A>C,g.215675192A>C,"USH2A c.12719T>G, p.I4240S, USH2A c.T12719G, p.I4240S",-,USH2A_002629,-,PubMed: Zhu 2021,-,-,Unknown,?,-,-,-,-,LOVD
1441,"+?/., ?/.",2,-,c.12730A>C,r.(?),p.(Asn4244His),-,ACMG,VUS,g.215848523T>G,g.215675181T>G,-,-,USH2A_001473,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019",-,-,"Germline, Germline/De novo (untested)",-,1/1204 cases with retinitis pigmentosa,-,-,-,"Yoshito Koyanagi, Jinu Han"
1442,-/.,2,-,c.12743A>G,r.(?),p.(His4248Arg),-,-,benign,g.215848510T>C,g.215675168T>C,"USH2A(NM_206933.2):c.12743A>G (p.H4248R), USH2A(NM_206933.4):c.12743A>G (p.H4248R)",-,USH2A_001152,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1443,"+/+, +/.",2,-,c.12759G>A,r.(?),p.(Trp4253Ter),-,ACMG,"pathogenic, pathogenic (recessive)",g.215848494C>T,g.215675152C>T,-,-,USH2A_001727,"ACMG PM2, PVS1, PP5",PubMed: Weisschuh 2024,-,-,"Germline, Unknown",-,-,-,-,-,"Johan den Dunnen, IMGAG"
1444,"+?/., +?/?",2,63,c.12806C>A,r.(?),p.(Pro4269His),Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, VUS",g.215848447G>T,g.215675105G>T,-,-,USH2A_000825,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Baux 2014, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_Nijmegen, Anne-Françoise Roux"
1445,+?/?,2,63,c.12806C>G,r.(?),p.(Pro4269Arg),Fibronectin type-III 28 (4265-4351),ACMG,VUS,g.215848447G>C,g.215675105G>C,-,-,USH2A_000440,Homozygous; possibly deleterious,"PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1446,-/.,2,-,c.12817T>C,r.(?),p.(Tyr4273His),-,-,benign,g.215848436A>G,g.215675094A>G,USH2A(NM_206933.4):c.12817T>C (p.Y4273H),-,USH2A_001582,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1447,+/.,2,-,c.12819T>A,r.(?),p.(Tyr4273*),-,-,"pathogenic, pathogenic (recessive)",g.215848434A>T,g.215675092A>T,1:215848434A>T ENST00000307340.3:c.12819T>A (Tyr4273Ter),-,USH2A_001803,-,"PubMed: Carrigan 2016, PubMed: Carss 2017",-,-,Germline,-,-,-,-,-,LOVD
1448,"+/., +?/.",2,-,c.12855G>A,r.(?),"p.(Trp4285*), p.(Trp4285Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215848398C>T,g.215675056C>T,"USH2A, variant 1: c.4210G>T/p.E1404*, variant 2: c.12855G>A/p.W4285*",-,USH2A_002374,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1657965422,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1449,?/.,2,-,c.12863C>T,r.(?),p.(Pro4288Leu),-,ACMG,VUS,g.215848390G>A,g.215675048G>A,-,-,USH2A_002268,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,rs1352720909,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1450,"+?/?, ?/.",2,63,c.12877G>A,r.(?),p.(Gly4293Ser),Fibronectin type-III 28 (4265-4351),ACMG,VUS,g.215848376C>T,g.215675034C>T,-,-,USH2A_000893,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs727505117,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1451,"+?/., ?/.",2,-,c.12892T>A,r.(?),p.(Tyr4298Asn),-,ACMG,"likely pathogenic, VUS",g.215848361A>T,g.215675019A>T,"USH2A, variant 1: c.12892T>A/p.Y4298N, variant 2: c.11594C>A/p.A3865E",-,USH2A_002373,"ACMG GN005 criteria: PM2_P PP3_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797130,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1452,"+?/?, ?/.",2,63,c.12943A>C,r.(?),p.(Thr4315Pro),Fibronectin type-III 28 (4265-4351),ACMG,VUS,g.215848310T>G,g.215674968T>G,-,-,USH2A_001041,"ACMG GN005 criteria: PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1453,"+/+, +?/.",2,63,c.12987T>G,r.(?),"p.(Tyr4329*), p.(Tyr4329Ter)",Fibronectin type-III 28 (4265-4351),ACMG,"likely pathogenic, pathogenic",g.215848266A>C,g.215674924A>C,-,-,USH2A_001043,"ACMG GN005 criteria: PVS1_VS PM2_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,rs1203365063,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1454,?/.,2,-,c.13004C>A,r.(?),p.(Ala4335Asp),-,ACMG,VUS,g.215848249G>T,g.215674907G>T,"USH2A c.13004C>A, p.Ala4335Asp",-,USH2A_002515,"ACMG GN005 criteria: PM2_P PP3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs771748964,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1455,+?/.,2,-,c.13007G>A,r.(?),p.(Cys4336Tyr),-,ACMG,likely pathogenic,g.215848246C>T,g.215674904C>T,"USH2A c.2802T>G(;)13007G>A, V2: c.13007G>A, (p.Cys4336Tyr), 1 more item",-,USH2A_002463,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0.0000545; GnomAD_All: 0.00000399,-,-,-,LOVD
1456,"+?/., ?/.",2,63,c.13022G>T,r.(?),p.(Cys4341Phe),-,ACMG,"likely pathogenic, VUS",g.215848231C>A,g.215674889C>A,p.C4341F,-,USH2A_002480,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs397517985,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1457,+?/.,2,-,c.13045_13046insG,r.(?),"p.(Ile4349Serfs*40), p.(Ile4349SerfsTer40)",-,ACMG,likely pathogenic,g.215848207_215848208insC,g.215674865_215674866insC,"USH2A c.13045_13046insG(;)14287G>A, V1: c.13045_13046insG, (p.Ile4349SerfsTer40), 1 more item",-,USH2A_002462,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0.000109; GnomAD_All: 0.00000797,-,-,-,LOVD
1458,+/.,2,-,c.13128G>A,r.(?),"p.(Trp4376*), p.(Trp4376Ter)",-,ACMG,"pathogenic, pathogenic (recessive)",g.215848125C>T,g.215674783C>T,-,-,USH2A_001684,"ACMG PM2, PVS1, PP5",PubMed: Weisschuh 2024,-,-,"Germline, Unknown",-,-,-,-,-,"Johan den Dunnen, IMGAG"
1459,-?/.,2,-,c.13134G>T,r.(?),p.(Pro4378=),-,-,likely benign,g.215848119C>A,-,"USH2A(NM_206933.2):c.13134G>T (p.P4378=), USH2A(NM_206933.4):c.13134G>T (p.P4378=)",-,USH2A_000262,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1460,"+?/., ?/.",2,-,c.13151G>T,r.(?),p.(Gly4384Val),-,-,"likely pathogenic, VUS",g.215848102C>A,g.215674760C>A,USH2A(NM_206933.2):c.13151G>T (p.G4384V),-,USH2A_001578,VKGL data sharing initiative Nederland,PubMed: Huang 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Rotterdam
1461,+?/.,2,63,c.13165T>C,r.(?),p.(Tyr4389His),-,ACMG,likely pathogenic,g.215848088A>G,g.215674746A>G,"USH2A c.13165T>C, p.Y4389H",-,USH2A_002628,-,PubMed: Zhu 2021,-,-,Unknown,?,-,-,-,-,LOVD
1462,"+/., +?/.",2,-,c.13195del,r.(?),p.(Ala4400LeufsTer23),-,ACMG,"likely pathogenic, pathogenic",g.215848060del,g.215674718del,"13195delC, USH2A c.13195delC, p.L4399fs",-,USH2A_002413,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, 1 more item","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1463,+/.,2,-,c.13207_13208delGG,r.(?),p.(Gly4403ProfsTer15),-,ACMG,pathogenic,g.215848045_215848046del,-,-,-,USH2A_002267,-,"PubMed: Mansard et al, 2021",-,rs746447649,Germline,-,-,-,-,-,Anne-Françoise Roux
1464,"+?/., ?/.",2,-,c.13223T>C,r.(?),p.(Val4408Ala),-,ACMG,"likely pathogenic, VUS",g.215848030A>G,g.215674688A>G,"USH2A c.13223T>C, p.V4408A",-,USH2A_002266,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1465,"+?/., ?/.",2,-,c.13231C>G,r.(?),p.(Leu4411Val),-,ACMG,"likely pathogenic, VUS",g.215848022G>C,g.215674680G>C,"USH2A c.13231C>G, p.L4411V",-,USH2A_002265,"ACMG GN005 criteria: PM2_P PM3_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1466,"+/+, +/.",2,63,c.13231_13238dup,r.(?),"p.(Tyr4414Cysfs*12), p.(Tyr4414CysfsTer12)",Fibronectin type-III 29 (4356-4439),ACMG,pathogenic,g.215848016_215848023dup,g.215674674_215674681dup,-,-,USH2A_001044,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1467,?/.,2,-,c.13238C>A,r.(?),p.(Pro4413His),-,ACMG,VUS,g.215848015G>T,g.215674673G>T,-,-,USH2A_002867,"ACMG PM2, PM1_SUPPORTING",PubMed: Weisschuh 2024,-,-,Germline,-,-,-,-,-,Johan den Dunnen
1468,?/.,2,-,c.13259C>T,r.(?),p.(Ser4420Phe),-,ACMG,VUS,g.215847994G>A,g.215674652G>A,"USH2A c.C13259T, p.S4420F",-,USH2A_002412,"ACMG GN005 criteria: PM2_P PM3_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,rs146240320,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1469,+?/.,2,63,c.13262T>G,r.(?),p.(Leu4421Arg),-,ACMG,likely pathogenic,g.215847991A>C,g.215674649A>C,"USH2A c.13262T>G, p.L4421R",-,USH2A_002626,-,PubMed: Zhu 2021,-,-,"Germline, Unknown","?, yes",-,-,-,-,LOVD
1470,"+?/., ?/.",2,-,c.13283G>T,r.(?),p.(Gly4428Val),-,ACMG,"likely pathogenic, VUS",g.215847970C>A,g.215674628C>A,"USH2A, variant 1: c.4943T>C/p.L1648P, variant 2: c.13283G>T/p.G4428V",-,USH2A_002372,"ACMG GN005 criteria: PM2_P, possibly solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1234273599,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1471,+?/.,2,63,c.13348C>T,r.(?),p.(Pro4450Ser),-,ACMG,"likely pathogenic, likely pathogenic (recessive)",g.215847905G>A,g.215674563G>A,-,-,USH2A_001556,"ACMG PM1, PM2, PM3, PP3, PP4",PubMed: Zenteno 2020,-,-,Germline,-,1/143 cases,-,-,-,"Johan den Dunnen, Juan Carlos Zenteno"
1472,?/.,2,-,c.13361T>A,r.(?),p.(Val4454Asp),-,-,VUS,g.215847892A>T,-,USH2A(NM_206933.4):c.13361T>A (p.V4454D),-,USH2A_001733,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1473,"+?/., ?/.",2,-,c.13378A>T,r.(?),p.(Ile4460Leu),-,ACMG,"likely pathogenic, VUS",g.215847875T>A,g.215674533T>A,"USH2A c.13378A>T, p.I4460L",-,USH2A_002263,"ACMG GN005 criteria: PM2_P PM3_P BP4_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1474,"-/., -?/.",2,-,c.13404A>G,r.(?),p.(Arg4468=),-,-,"benign, likely benign",g.215847849T>C,g.215674507T>C,USH2A(NM_206933.4):c.13404A>G (p.R4468=),-,USH2A_001575,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1475,?/.,2,-,c.13422C>G,r.(?),p.(Ile4474Met),-,-,VUS,g.215847831G>C,g.215674489G>C,"c.13422C>G, p.Ile4474Met, USH2A c.13422C>G, p.Ile4474Met",-,USH2A_002262,"heterozygous, homozygous",PubMed: Zampaglione 2020,-,-,Unknown,?,-,-,-,-,LOVD
1476,+?/.,2,-,c.13436T>G,r.(?),p.(Leu4479Arg),-,-,likely pathogenic,g.215847817A>C,g.215674475A>C,USH2A c.2299delG; c.13436T>G,-,USH2A_002261,"no protein change given, compound heterozygous",PubMed: Zanolli 2020,-,-,Unknown,?,-,-,-,-,LOVD
1477,"+/., +?/.",2,63,c.13466dup,r.(?),"p.(Glu4491Glyfs*6), p.(Glu4491GlyfsTer6)",-,ACMG,"likely pathogenic, pathogenic","g.215847787dup, g.215847788dup",g.215674446dup,"13466dupG, c.13466dup",-,USH2A_002479,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1478,?/.,2,-,c.13480T>C,r.(?),p.(Tyr4494His),-,ACMG,VUS,g.215847773A>G,g.215674431A>G,"USH2A c.13480T>C, p.Tyr4494His",-,USH2A_002510,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs1657929188,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1479,?/.,2,-,c.13502C>A,r.(?),p.(Pro4501Gln),-,ACMG,VUS,g.215847751G>T,g.215674409G>T,"USH2A c.13502C>A, p.Pro4501Gln",-,USH2A_002509,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1480,"+?/., ?/.",2,-,c.13507G>A,r.(?),p.(Val4503Met),-,ACMG,"likely pathogenic, VUS",g.215847746C>T,g.215674404C>T,"USH2A c.13507G>A, p.V4503M",-,USH2A_002260,"ACMG GN005 criteria:, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs375419632,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1481,"+/+, +/.",2,63,c.13550del,r.(?),p.(Gly4517Valfs*3),Fibronectin type-III 30 (4444-4528),-,pathogenic,g.215847707del,g.215674365del,13550delG,-,USH2A_000777,Heterozygous; likely pathogenic,PubMed: Glöckle 2014,-,-,Germline,-,-,-,-,-,"Johan den Dunnen, Anne-Françoise Roux"
1482,?/.,2,63,c.13570A>G,r.(?),p.(Lys4524Glu),-,ACMG,VUS,g.215847683T>C,g.215674341T>C,"c.13570A>G, p.Lys4524Glu",-,USH2A_002158,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Birtel 2018,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1483,"+?/., ?/.",2,-,c.13577G>A,r.(?),p.(Arg4526Gln),-,ACMG,"likely pathogenic, VUS",g.215847676C>T,g.215674334C>T,"USH2A c.13577G>A, p.R4526Q",-,USH2A_002258,"ACMG GN005 criteria: PM2_P BP4_P, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs527644737,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1484,?/.,2,-,c.13609C>T,r.(?),p.(Pro4537Ser),-,-,VUS,g.215847644G>A,g.215674302G>A,USH2A(NM_206933.4):c.13609C>T (p.P4537S),-,USH2A_001141,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1485,?/.,2,63,c.13643T>A,r.(?),p.(Ile4548Asn),-,ACMG,VUS,g.215847610A>T,g.215674268A>T,"USH2A c.13643T>A, P.Ile4548Asn",-,USH2A_002508,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Meng 2020, PubMed: Meng, X. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1486,"+?/., ?/.",2,-,c.13708C>T,r.(?),p.(Arg4570Cys),-,ACMG,"likely pathogenic, VUS",g.215847545G>A,g.215674203G>A,"USH2A c.13708C>T, p.(Arg4570Cys)",-,USH2A_002624,"ACMG GN005 criteria: PM2_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs141340831,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1487,+/.,2,-,c.13731_13743del,r.(?),"p.(Lys4578*), p.(Lys4578Ter)",-,ACMG,pathogenic,g.215847512_215847524del,g.215674170_215674182del,"USH2A c.12503C>A(;)13731_13743del, V2: c.13731_13743del, (p.Lys4578Ter), 1 more item",-,USH2A_002461,"alleles in cis or trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline/De novo (untested), Unknown",?,Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,LOVD
1488,"-?/?, ?/.",2,63,c.13768G>A,r.(?),p.(Gly4590Ser),Fibronectin type-III 31 (4529-4627),ACMG,"likely benign, VUS",g.215847485C>T,g.215674143C>T,-,-,USH2A_000895,"ACMG GN005 criteria: PM2_P, Heterozygous","PubMed: Lenassi 2015, USMA missense analysis, missense variant in MSV3d, 1 more item",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1489,+/.,2,63,c.13776G>C,r.(?),p.(Gln4592His),-,-,pathogenic (recessive),g.215847477C>G,g.215674135C>G,-,-,USH2A_000500,possible duplicate,"PubMed: Dreyer 2000, PubMed: Dreyer 2008, PubMed: Dad 2016",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1490,"-?/., ?/.",2,-,c.13778C>T,r.(?),p.(Ser4593Leu),-,-,"likely benign, VUS",g.215847475G>A,g.215674133G>A,-,-,USH2A_001574,VKGL data sharing initiative Nederland,PubMed: Ellingford 2016,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Nijmegen
1491,"+?/., ?/.",2,-,c.13808A>C,r.(?),p.(His4603Pro),-,ACMG,"likely pathogenic, VUS",g.215847445T>G,g.215674103T>G,-,-,USH2A_001943,ACMG GN005 criteria: PM2_P PM3_P,"PubMed: Bravo-Gil 2017, PubMed: Bravo-Gil, N. et al., 2017",-,rs727504551,"Germline, SUMMARY record",yes,-,-,-,-,"David Baux, Nereida Bravo Gil"
1492,-/-,2,63i,c.13811+72G>A,r.(=),p.(=),-,-,benign,g.215847370C>T,g.215674028C>T,-,-,USH2A_000263,Heterozygous,PubMed: Le Guédard-Méreuze 2010,-,rs74527030,Germline,-,-,-,-,-,Anne-Françoise Roux
1493,"+/., +?/.",2,64,c.13836C>A,r.(?),p.(Cys4612*),-,ACMG,"likely pathogenic (recessive), pathogenic",g.215844611G>T,g.215671269G>T,"c.13836C>A, NM_206933.2:c.13836C>A, NP_996816.2:p.(Cys4612Ter), NC_000001.10:g.215844611G>T",-,USH2A_002137,-,"PubMed: Liu-2020, PubMed: Wang 2018",-,-,Germline,?,-,-,-,-,LOVD
1494,"-/., -/?",2,64,c.13857A>G,r.(?),"p.(=), p.(Ser4619=)",Fibronectin type-III 31 (4529-4627),ACMG,"benign, likely benign",g.215844590T>C,g.215671248T>C,USH2A(NM_206933.4):c.13857A>G (p.S4619=),-,USH2A_000247,"Heterozygous, VKGL data sharing initiative Nederland",PubMed: Baux 2014,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_AMC, Anne-Françoise Roux"
1495,"+/., +?/.",2,-,c.13877_13880del,r.(?),"p.(Gln4626Profs*7), p.(Gln4626ProfsTer7)",-,ACMG,"likely pathogenic, pathogenic",g.215844569_215844572del,g.215671227_215671230del,"USH2A c.13877_13880del, p.Gln4626Profs7",-,USH2A_002505,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1496,"+?/., ?/.",2,-,c.13887G>T,r.(?),p.(Glu4629Asp),-,ACMG,"likely pathogenic, VUS",g.215844560C>A,g.215671218C>A,"USH2A c.13887G>T, p.(Glu4629Asp)",-,USH2A_002623,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs1657804225,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1497,"+/., +?/.",2,-,c.13927C>T,r.(?),p.(Gln4643Ter),-,ACMG,"likely pathogenic, pathogenic",g.215844520G>A,g.215671178G>A,-,-,USH2A_002257,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1498,?/.,2,64,c.13939G>C,r.(?),p.(Gly4647Arg),-,ACMG,VUS,"g.215671166C>G, g.215844508C>G","g.215671166C>G, g.215779952C>G","USH2A c.13939G > C, p.Gly4647Arg, heterozygous",-,USH2A_001463,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Sun 2020",-,rs144524302,"Germline, Unknown",?,4/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1499,"+/., +?/.",2,-,c.13943del,r.(?),"p.(Gly4648Aspfs*30), p.(Gly4648AspfsTer30)",-,ACMG,"likely pathogenic, pathogenic",g.215844505del,g.215671163del,"13943delG, USH2A c.13943delG, p.(?)",-,USH2A_002256,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, no protein change annotation, compound heterozygous","PubMed: Jauregui 2020, PubMed: Jauregui, R. et al., 2020",-,rs1419913594,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1500,+/.,2,-,c.13971G>A,r.(?),p.(Trp4657Ter),-,ACMG,pathogenic,g.215844476C>T,g.215671134C>T,-,-,USH2A_002254,ACMG GN005 criteria: PVS1_VS PM2_P PM3_M,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1501,"+/., +?/.",2,-,c.14004del,r.(?),"p.(Leu4668Phefs*10), p.(Leu4668PhefsTer10)",-,ACMG,"likely pathogenic, pathogenic",g.215844443del,g.215671101del,"14004delG, USH2A c.14004delG, p.(Leu4668Phefs*10)",-,USH2A_002621,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1502,"+?/., ?/.",2,-,c.14011_14025del,r.(?),p.(Glu4671_Arg4675del),-,ACMG,"likely pathogenic, VUS",g.215844422_215844436del,g.215671080_215671094del,"USH2A, variant 1: c.11864G>A/p.W3955*, variant 2: c.14011_14025del/ p.E4671_R4675del",-,USH2A_002370,"ACMG GN005 criteria: PM2_P PM3_M PM4_M, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1657799383,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1503,"+/+, +/.",2,64,c.14026dup,r.(?),"p.(Gln4676Profs*7), p.(Gln4676ProfsTer7)",Fibronectin type-III 32 (4633-4730),ACMG,pathogenic,g.215844421dup,g.215671079dup,14026dupC,-,USH2A_001046,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; mutation","PubMed: Bonnet 2016, PubMed: Bonnet, C. et al., 2016",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Crystel Bonnet"
1504,"+/+, +/.",2,64,c.14109_14110insA,r.(?),"p.(Pro4704Thrfs*6), p.(Pro4704ThrfsTer6)",Fibronectin type-III 32 (4633-4730),ACMG,pathogenic,g.215844337_215844338insT,g.215670995_215670996insT,-,-,USH2A_000190,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Aller, E. et al., 2006, PubMed: Najera 2002",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Jose Maria Millan"
1505,"+?/., ?/.",2,-,c.14129A>C,r.(?),p.(Tyr4710Ser),-,ACMG,"likely pathogenic, VUS",g.215844318T>G,g.215670976T>G,"USH2A, variant 1: c.14129A>C/p.Y4710S, variant 2: c.14129A>C/p.Y4710S",-,USH2A_002369,"ACMG GN005 criteria: PM2_P PM3_P, possibly solved, homozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1064797129,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1506,+/+,2,64i,c.14133+1G>A,r.spl,p.?,-,-,pathogenic,g.215844313C>T,g.215670971C>T,-,-,USH2A_000097,Heterozygous,"PubMed: Baux 2007, PubMed: Baux 2014",-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1507,"+/., +?/.",2,-,c.14133+2T>A,r.spl,"p.(?), p.?",-,ACMG,"likely pathogenic, pathogenic",g.215844312A>T,g.215670970A>T,"USH2A c.14133+2T>A, p.(?)",-,USH2A_002618,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1508,"+/+, +/.",2,65,c.14139G>A,r.(?),"p.(Trp4713*), p.(Trp4713Ter)",Fibronectin type-III 32 (4633-4730),ACMG,pathogenic,g.215824138C>T,g.215650796C>T,-,-,USH2A_000634,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,0/878 controls,+Hpy188I;+DdeI;+BspCNI;,-,-,"David Baux, Maria Bitner-Glindzicz"
1509,?/.,2,-,c.14191G>A,r.(?),p.(Gly4731Arg),-,-,VUS,g.215824086C>T,-,"USH2A(NM_206933.2):c.14191G>A (p.G4731R), USH2A(NM_206933.4):c.14191G>A (p.G4731R)",-,USH2A_001732,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1510,"+/., +?/.",2,-,c.14223dup,r.(?),"p.(Thr4742Hisfs*38), p.(Thr4742HisfsTer38)",-,ACMG,"likely pathogenic, pathogenic",g.215824058dup,g.215650716dup,"14223dupC, USH2A c.14223_14224insC, -",-,USH2A_002503,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, prtotein change not written; heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1511,"+?/., -?/.",2,-,c.14276G>A,r.(?),p.(Gly4759Glu),-,-,"likely benign, likely pathogenic (recessive)",g.215824001C>T,g.215650659C>T,"1:215824001C>T ENST00000307340.3:c.14276G>A (Gly4759Glu), 1 more item",-,USH2A_001569,VKGL data sharing initiative Nederland,PubMed: Carss 2017,-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,VKGL-NL_Rotterdam
1512,?/.,2,-,c.14285A>T,r.(?),p.(Asn4762Ile),-,ACMG,VUS,g.215823992T>A,g.215650650T>A,"USH2A c.14285A>T, p.Asn4762Ile",-,USH2A_002502,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1513,?/.,2,-,c.14286C>A,r.(?),p.(Asn4762Lys),-,ACMG,VUS,g.215823991G>T,g.215650649G>T,"USH2A c.14286C>A, p.(Asn4762Lys)",-,USH2A_002617,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,rs750368946,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1514,+/.,2,-,c.14289del,r.(?),p.(Ile4764SerfsTer42),-,-,pathogenic,g.215823990del,g.215650648del,USH2A(NM_206933.4):c.14289delG (p.I4764Sfs*42),-,USH2A_001309,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1515,"-/., -/?",2,65,c.14333C>A,"r.(14333c>a), r.(?)",p.(Ala4778Asp),Fibronectin type-III 33 (4732-4825),ACMG,"benign, likely benign",g.215823944G>T,g.215650602G>T,-,-,USH2A_000445,"Heterozygous; benign, no variant 2nd chromome","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d, 1 more item",-,rs113447586,Germline,-,-,-,-,-,"Anne-Françoise Roux, Janine Reurink"
1516,+?/.,2,66,c.14411G>A,r.(?),p.(Gly4804Glu),-,ACMG,"likely pathogenic, likely pathogenic (recessive)",g.215822041C>T,g.215648699C>T,"c.14411G>A, NM_206933.2:c.14411G>A, NP_996816.2:p.(Gly4804Glu), NC_000001.10:g.215822041C>T",-,USH2A_002135,-,"PubMed: Liu-2020, PubMed: Wang 2018",-,-,Germline,?,-,-,-,-,LOVD
1517,"+/+, +/.",2,66,c.14446A>T,r.(?),"p.(Lys4816*), p.(Lys4816Ter)",Fibronectin type-III 33 (4732-4825),ACMG,pathogenic,g.215822006T>A,g.215648664T>A,-,-,USH2A_000585,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous; Pathogenic","PubMed: Le Quesne Stabej 2012, PubMed: Le Quesne Stabej, P. et al., 2012",-,-,"Germline, SUMMARY record",-,0/878 controls,+DdeI;+Bpu10I;+AluI;+CviKI_1;,-,-,"David Baux, Maria Bitner-Glindzicz"
1518,"-/., -?/.",2,-,c.14454G>A,r.(?),p.(Pro4818=),-,-,"benign, likely benign",g.215821998C>T,g.215648656C>T,"USH2A(NM_206933.2):c.14454G>A (p.P4818=), USH2A(NM_206933.4):c.14454G>A (p.P4818=)",-,USH2A_001568,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1519,"+/+, +?/.",2,66,c.14525C>A,"r.(14525c>a), r.(?)","p.(Ser4842*), p.(Ser4842Ter)",Fibronectin type-III 34 (4826-4927),ACMG,"likely pathogenic, pathogenic",g.215821927G>T,g.215648585G>T,-,-,USH2A_000161,Heterozygous,"PubMed: Reurink 2023, Journal: Reurink 2023, PubMed: Van Wijk 2004",-,-,Germline,-,0/188 controls,-,-,-,"Anne-Françoise Roux, Janine Reurink"
1520,"-?/., -?/?",2,66,c.14531C>T,r.(?),p.(Thr4844Met),Fibronectin type-III 34 (4826-4927),ACMG,likely benign,g.215821921G>A,g.215648579G>A,USH2A(NM_206933.4):c.14531C>T (p.T4844M),-,USH2A_000449,"Heterozygous; benign, VKGL data sharing initiative Nederland","PubMed: McGee 2010, USMA missense analysis, missense variant in MSV3d",-,-,"CLASSIFICATION record, Germline",-,-,-,-,-,"VKGL-NL_AMC, Anne-Françoise Roux"
1521,"+/., +?/.",2,-,c.14556del,r.(?),"p.(Met4853Cysfs*31), p.(Met4853CysfsTer31)",-,ACMG,"likely pathogenic, pathogenic (recessive)",g.215821901del,g.215648559del,"14556delC, c.14556delC",-,USH2A_001836,ACMG GN005 criteria: PVS1_VS PM2_P,"PubMed: Sun 2018, PubMed: Sun, T. et al., 2018",-,rs1656935851,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1522,"-?/., ?/.",2,66,c.14557A>G,r.(?),p.(Met4853Val),-,ACMG,"likely benign, VUS",g.215821895T>C,g.215648553T>C,"M5: USH2A c.14557A>G, M4853V",-,USH2A_002613,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Chen 2020, PubMed: Kim, Y. N. et al., 2021",-,rs753594462,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1523,?/.,2,-,c.14583-40_14583-10del,"r.spl, r.spl?","p.(?), p.?",-,ACMG,VUS,g.215821086_215821116del,g.215647744_215647774del,"USH2A c.[2187C>A];[14583-40_14583-10del], V2: c.14583-40_14583-10del,, 1 more item",-,USH2A_002460,"alleles in trans; heterozygous, heterozygous","PubMed: Chen 2021, PubMed: Chen 2021",-,-,"Germline, Unknown","?, yes",Taiwan Biobank: 0; GnomAD_exome_East: 0; GnomAD_All: 0,-,-,-,LOVD
1524,"+?/., ?/.",2,66i,c.14583-20C>G,"r.(=), r.(?)",p.(=),-,ACMG,"likely pathogenic, VUS",g.215821092G>C,g.215647750G>C,-,-,USH2A_001566,VKGL data sharing initiative Nederland,Journal: Reurink 2021,-,-,"CLASSIFICATION record, Germline",no,-,-,-,-,"VKGL-NL_Nijmegen, Janine Reurink"
1525,"-/., -?/.",2,-,c.14583-19G>A,r.(=),p.(=),-,-,"benign, likely benign",g.215821091C>T,g.215647749C>T,USH2A(NM_206933.4):c.14583-19G>A,-,USH2A_001134,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Nijmegen, VKGL-NL_AMC"
1526,"-/., -?/.",2,-,c.14625C>T,r.(?),p.(Ala4875=),-,-,"benign, likely benign",g.215821030G>A,g.215647688G>A,"USH2A(NM_206933.2):c.14625C>T (p.A4875=), USH2A(NM_206933.4):c.14625C>T (p.A4875=)",-,USH2A_001133,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1527,"+/., +?/.",2,67,c.14649del,r.(?),"p.(Ile4883Metfs*25), p.(Ile4883MetfsTer25)",-,ACMG,"likely pathogenic, pathogenic",g.215821006del,g.215647664del,"14649delA, c.14649delA",-,USH2A_002477,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Wafa, T. T. et al., 2021, PubMed: Wafa-2021",-,rs1656901821,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1528,+?/.,2,-,c.14650G>T,r.(?),"p.(Glu4884*), p.(Glu4884Ter)",-,ACMG,likely pathogenic,g.215821005C>A,g.215647663C>A,"USH2A, variant 1: c.14650G>T/p.E4884*, variant 2: c.2546G>A/p.C849Y",-,USH2A_002368,"ACMG GN005 criteria: PVS1_VS PM2_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs948087886,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1529,"+/+, +/.",2,67,c.14766del,r.(?),"p.(Trp4922*), p.(Trp4922Ter)",Fibronectin type-III 34 (4826-4927),ACMG,pathogenic,g.215820890del,g.215647548del,14766delG,-,USH2A_000724,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Besnard, Garcia-Garcia 2014, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,+BclI;-AlwI;,-,-,"David Baux, Anne-Françoise Roux"
1530,"+/., +?/.",2,-,c.14766G>A,r.(?),"p.(Trp4922*), p.(Trp4922Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215820889C>T,g.215647547C>T,"USH2A c.14766G>A, p.(Trp4922*)",-,USH2A_002611,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Inaba 2020, PubMed: Inaba, A. et al., 2020",-,rs1656893075,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1531,"+/+, +/.",2,67,c.14787del,r.(?),"p.(Glu4930Asnfs*20), p.(Glu4930AsnfsTer20)",Fibronectin type-III 35 (4928-5014),ACMG,pathogenic,g.215820872del,g.215647530del,14787delA,-,USH2A_000412,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_M, Heterozygous","PubMed: Mansard, L. et al., 2021, PubMed: McGee 2010",-,rs34713174,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1532,"+/., +?/.",2,-,c.14792dup,r.(?),"p.(Leu4931Phefs*23), p.(Leu4931PhefsTer23)",-,ACMG,"likely pathogenic, pathogenic",g.215814076dup,g.215640734dup,"14792dupT, USH2A c.14792_14793insT, p.Leu4931Phefs23",-,USH2A_002500,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1533,+/.,2,68,c.14815del,r.(?),"p.(Ser4939Argfs*11), p.(Ser4939ArgfsTer11)",-,ACMG,pathogenic,"g.215814053del, g.215814056del",g.215640714del,"14815delT, c.14815del",-,USH2A_002419,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Colombo, L. et al., 2021, PubMed: Colombo-2020",-,-,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1534,+?/.,2,68,c.14876G>A,r.(?),p.(Gly4959Asp),-,-,likely pathogenic (recessive),g.215813992C>T,-,c.14876G>A,-,USH2A_002418,-,PubMed: Liu-2020,-,-,Germline,-,-,-,-,-,LOVD
1535,?/.,2,-,c.14876G>T,r.(?),p.(Gly4959Val),-,ACMG,VUS,g.215813992C>A,g.215640650C>A,"USH2A c.14876G>T, p.Gly4959Val",-,USH2A_002499,"ACMG GN005 criteria: PM2_P PM3_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1536,"-?/., ?/.",2,-,c.14880A>G,r.(?),p.(Gln4960=),-,-,"likely benign, VUS",g.215813988T>C,g.215640646T>C,USH2A(NM_206933.2):c.14880A>G (p.Q4960=),-,USH2A_001299,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_Nijmegen"
1537,"+/., +?/.",2,-,c.14895del,r.(?),"p.(Leu4966*), p.(Leu4966Ter)",-,ACMG,"likely pathogenic, pathogenic",g.215813973del,g.215640631del,"14895delG, USH2A, variant 1: c.2276G>T/p.C759F, variant 2: c.14895delG/p.L4966*",-,USH2A_002366,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, solved, compound heterozygous","PubMed: Weisschuh 2020, PubMed: Weisschuh, N. et al., 2020",-,rs1656646424,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1538,"-?/., -?/?",2,68,c.14904C>T,r.(?),"p.(=), p.(Asp4968=)",Fibronectin type-III 35 (4928-5014),ACMG,likely benign,g.215813964G>A,g.215640622G>A,USH2A(NM_206933.2):c.14904C>T (p.D4968=),-,USH2A_000756,"Heterozygous, VKGL data sharing initiative Nederland","PubMed: Besnard, Garcia-Garcia 2014",-,rs151165599,"CLASSIFICATION record, Germline",-,-,+BccI,-,-,"VKGL-NL_Rotterdam, Anne-Françoise Roux"
1539,"+/., ?/.",2,68,c.14926G>A,r.(?),p.(Gly4976Ser),-,-,"pathogenic, VUS",g.215813942C>T,g.215640600C>T,"c.14926G>A, USH2A c.14926G>A, p.Gly4976Ser",-,USH2A_002251,heterozygous,"PubMed: Salmaninejad-202, PubMed: Zampaglione 2020",-,-,Unknown,?,-,-,-,-,LOVD
1540,"+?/., ?/.",2,-,c.15017C>G,r.(?),p.(Thr5006Arg),-,ACMG,VUS,g.215812532G>C,-,-,-,USH2A_002702,-,-,-,-,CLASSIFICATION record,-,-,-,-,-,MobiDetails
1541,"+/+, +/.",2,69,c.15031del,r.(?),"p.(Tyr5011Metfs*11), p.(Tyr5011MetfsTer11)",Fibronectin type-III 35 (4928-5014),ACMG,pathogenic,g.215812518del,g.215639176del,15031delT,-,USH2A_000881,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, Heterozygous","PubMed: Lenassi 2015, PubMed: Lenassi, E. et al., 2015",-,rs2102634627,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Eva Lenassi"
1542,-?/.,2,-,c.15053-6T>C,r.(=),p.(=),-,-,likely benign,g.215808051A>G,g.215634709A>G,"USH2A(NM_206933.2):c.15053-6T>C, USH2A(NM_206933.4):c.15053-6T>C",-,USH2A_001563,VKGL data sharing initiative Nederland,-,-,-,CLASSIFICATION record,-,-,-,-,-,"VKGL-NL_Rotterdam, VKGL-NL_AMC"
1543,+/.,2,-,c.15053-2A>G,"r.(?), r.spl","p.(?), p.?",-,ACMG,pathogenic,g.215808047T>C,g.215634705T>C,-,-,USH2A_002250,ACMG GN005 criteria: PVS1_VS PS1_S PM2_P,"PubMed: Mansard et al, 2021, PubMed: Mansard, L. et al., 2021",-,-,"Germline, SUMMARY record",-,-,-,-,-,"David Baux, Anne-Françoise Roux"
1544,"+?/., ?/.",2,70,c.15169A>T,r.(?),p.(Ile5057Phe),-,ACMG,"likely pathogenic, VUS",g.215807929T>A,g.215634587T>A,"USH2A c.15169A>T, p.I5057F",-,USH2A_001456,-,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Zhu 2021",-,rs542341955,Germline,yes,1/1204 cases with retinitis pigmentosa,-,-,-,Yoshito Koyanagi
1545,+/.,2,-,c.15199del,r.(?),"p.(Ile5067Serfs*23), p.(Ile5067SerfsTer23)",-,ACMG,pathogenic,g.215807903del,g.215634561del,"15199delA, USH2A c.15199del, p.(Ile5067Serfs*23)",-,USH2A_002605,"ACMG GN005 criteria: PVS1_VS PM2_P PM3_P, heterozygous","PubMed: Falsini 2021, PubMed: Falsini, B. et al., 2021",-,rs2102630527,"Germline, SUMMARY record",yes,-,-,-,-,David Baux
1546,"+/., +?/.",2,-,c.15208G>T,r.(?),"p.(Glu5070*), p.(Glu5070Ter)",-,ACMG,"likely pathogenic (recessive), pathogenic",g.215807890C>A,g.215634548C>A,-,-,USH2A_001884,ACMG GN005 criteria: PVS1_VS PM2_P PM3_P,"PubMed: Colombo, L. et al., 2022; PubMed: Eandi, C. M. et al., 2017, PubMed: Eandi 2017",-,rs1426135314,"Germline, SUMMARY record",-,-,-,-,-,David Baux
1547,?/.,2,-,c.15299G>C,r.(?),p.(Gly5100Ala),-,ACMG,VUS,g.215802376C>G,g.215629034C>G,"USH2A c.G15299C, p.G5100A",-,USH2A_002411,"ACMG GN005 criteria: PM2_P PM3_P, marked as causative, heterozygous","PubMed: Ma 2021, PubMed: Ma, D. J. et al., 2021",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1548,"+/., ?/.",2,71i,c.15519+2dup,"r.15298_15519del, r.spl?","p.?, p.Gly5100_Leu5173del",-,ACMG,"pathogenic, VUS",g.215802154dup,g.215628812dup,-,-,USH2A_001453,mini-gene splicing assay; changes ACMG to VUS,"PubMed: Koyanagi 2019, Journal: Koyanagi 2019, PubMed: Reurink 2022, Journal: Reurink 2022",-,-,"Germline, In vitro (cloned)",-,1/1204 cases with retinitis pigmentosa,-,-,-,"Yoshito Koyanagi, Janine Reurink"
1549,"+?/., ?/.",2,-,c.15519+5G>C,"r.(?), r.spl","p.(?), p.?",-,ACMG,"likely pathogenic, VUS",g.215802151C>G,g.215628809C>G,"USH2A c.15519+5G>C, p.(?)",-,USH2A_002247,"ACMG GN005 criteria: PM2_P PP3_P, compound heterozygous","PubMed: Ganapathi, M. et al., 2022, PubMed: Jauregui 2020",-,-,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1550,-/-,2,71i,c.15519+43G>C,r.(=),p.(=),-,-,benign,g.215802113C>G,g.215628771C>G,-,-,USH2A_000079,Heterozygous,PubMed: Baux 2007,-,-,Germline,-,-,-,-,-,Anne-Françoise Roux
1551,+?/.,2,-,c.15520-1G>A,r.spl,"p.(?), p.?",-,ACMG,likely pathogenic,g.215799213C>T,g.215625871C>T,"USH2A c.15520-1G>A, -",-,USH2A_002498,"ACMG GN005 criteria: PVS1_VS PM2_P, heterozygous","PubMed: Gao 2021, PubMed: Gao, F. J. et al., 2021",-,rs767265734,"SUMMARY record, Unknown",?,-,-,-,-,David Baux
1552,-/-,2,72,c.*1188T>G,r.(=),p.(=),3'UTR,-,benign,g.215797935A>C,g.215624593A>C,-,-,USH2A_000555,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs75496213,Germline,-,12/866 controls,-HpyCH4V,-,-,Maria Bitner-Glindzicz
1553,-/-,2,72,c.*1670G>C,r.(=),p.(=),3'UTR,-,benign,g.215797453C>G,g.215624111C>G,-,-,USH2A_000601,Heterozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs41304079,Germline,-,-,none,-,-,Maria Bitner-Glindzicz
1554,-/-,2,72,c.*2548T>C,r.(=),p.(=),3'UTR,-,benign,g.215796575A>G,g.215623233A>G,-,-,USH2A_000567,Homozygous; Not Assessed,PubMed: Le Quesne Stabej 2012,-,rs60590154,Germline,-,-,+Hpy166II;-NspI;-FatI;-NlaIII;-CviAII;,-,-,Maria Bitner-Glindzicz
1555,-/-,2,72,c.*2792_*2793del,r.(=),p.(=),3'UTR,,,,,,,,,,,,,,,,,,
,,15982,,,,,,,,,,,,,,,,,,,,,,,